Trait_category,Trait,Protein,Protein_definition,sample_size,Estimated_effect,se,lowerCI,upperCI,Pvalue
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY1,Aminoacylase-1,29478,0.164599815295992,0.00415454916447831,0.156456898933615,0.17274273165837,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH4,All-trans-retinol dehydrogenase [NAD(+)] ADH4,28916,0.256768045195537,0.00559159384848664,0.245808521252503,0.26772756913857,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADIPOQ,Adiponectin,24966,-0.212093521974534,0.00448624568320672,-0.220886563513619,-0.203300480435449,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFM,Afamin,24966,0.0568008622717641,0.00130225432507343,0.0542484437946202,0.059353280748908,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRP,Agouti-related protein,29786,0.272437149489107,0.00329969203546299,0.265969753099599,0.278904545878614,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APCS,Serum amyloid P-component,24726,0.115414032238119,0.00229218513220551,0.110921349378996,0.119906715097242,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR1,Asialoglycoprotein receptor 1,29218,0.0789859846010943,0.00200984530796273,0.0750466877974874,0.0829252814047013,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRN,"Attractin, Isoform 2",24966,0.0437655815129082,0.00111896596139137,0.0415724082285812,0.0459587547972353,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCHE,Cholinesterase,24528,0.0912627394067632,0.00185706553283426,0.0876228909624081,0.0949025878511184,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9,Complement component C9,24951,-0.151131976694837,0.00356041446915649,-0.158110389054383,-0.14415356433529,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL23,C-C motif chemokine 23,29581,0.135293205970673,0.00276670870965268,0.129870456899754,0.140715955041593,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL27,C-C motif chemokine 27,29478,0.230964614394599,0.00401954148988384,0.223086313074427,0.238842915714772,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN1,CCN family member 1,29301,0.364513559989148,0.00476749594255607,0.355169267941738,0.373857852036558,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD4,T-cell surface glycoprotein CD4,29383,0.0913909802138769,0.00199938421867549,0.0874721871452729,0.0953097732824808,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN1A,Cyclin-dependent kinase inhibitor 1,29349,0.324845650657787,0.00706489567355177,0.310998455137625,0.338692846177948,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES1,Liver carboxylesterase 1,29489,0.292058347951978,0.00532657241080287,0.281618266026805,0.302498429877152,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFH,Complement factor H,23693,0.0664015642265135,0.00156263835977399,0.0633387930413565,0.0694643354116705,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFI,Complement factor I,24966,0.0562735223299723,0.00133485026371364,0.0536572158130936,0.0588898288468511,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFP,Properdin,24966,0.066076731681951,0.00154233669162573,0.0630537517663646,0.0690997115975375,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP6,Charged multivesicular body protein 6,24922,0.16130784648712,0.00378373782511376,0.153891720349897,0.168723972624343,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN3,Contactin-3,29443,0.100846666615812,0.00215474744767218,0.0966233616183742,0.105069971613249,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPM,Carboxypeptidase M,29584,0.102389802323117,0.00229560002778678,0.0978904262686551,0.106889178377579,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIP2,Cysteine-rich protein 2,29218,0.0956940529906824,0.00245071901327488,0.0908906437246636,0.100497462256701,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL6,C-X-C motif chemokine 6,29786,0.226442361531769,0.00515185997292611,0.216344715984834,0.236540007078705,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB4A_DEFB4B,Beta-defensin 4A,29036,0.45413874138915,0.00983939585804793,0.434853525507376,0.473423957270924,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB1,DnaJ homolog subfamily B member 1,29349,0.275206872918751,0.0057903631738018,0.263857761098099,0.286555984739402,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG2,Desmoglein-2,29443,-0.0815228016550316,0.0018079361428186,-0.0850663564949561,-0.0779792468151072,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB3,Receptor tyrosine-protein kinase erbB-3,29369,0.063235888624256,0.00129800743326464,0.0606917940550573,0.0657799831934547,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F10,Coagulation factor X,24951,0.0757654525056631,0.00184774716262531,0.0721438680669175,0.0793870369444087,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F7,Coagulation factor VII,29544,0.122803919003275,0.00199504993632585,0.118893621128076,0.126714216878473,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F9,Coagulation factor IX,29545,0.0504351725144099,0.00122275370181983,0.0480385752588431,0.0528317697699768,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLI1,Friend leukemia integration 1 transcription factor,28797,0.293789776512064,0.00742933991630688,0.279228270276102,0.308351282748025,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FURIN,Furin,29566,0.121455842028759,0.0022086764979393,0.117126836092798,0.125784847964721,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCG,Pro-glucagon,28797,0.450109334948249,0.0082020616816333,0.434033294052248,0.466185375844251,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHR,Growth hormone receptor,24381,0.107545901786265,0.00186953814112599,0.103881607029658,0.111210196542872,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR37,Prosaposin receptor GPR37,28916,0.196836540472403,0.00443628867839192,0.188141414662755,0.205531666282051,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA1,Glutathione S-transferase A1,29426,0.226435492891499,0.00566980110365851,0.215322682728328,0.237548303054669,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTA3,Glutathione S-transferase A3,28797,0.209313496562505,0.00515856921356773,0.199202700903912,0.219424292221097,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUSB,Beta-glucuronidase,29604,0.162077913855458,0.00402517359231251,0.154188573614526,0.169967254096391,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HHEX,Hematopoietically-expressed homeobox protein HHEX,24845,0.282067114846356,0.00497681937303642,0.272312548875205,0.291821680817507,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST1,Heparan-sulfate 6-O-sulfotransferase 1,29725,0.101376417206093,0.00229372647571506,0.0968807133136911,0.105872121098494,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP1,Insulin-like growth factor-binding protein 1,29761,-0.35168415870991,0.00818419597609814,-0.367725182823063,-0.335643134596758,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP2,Insulin-like growth factor-binding protein 2,29757,-0.175854880067245,0.00418461074373412,-0.184056717124964,-0.167653043009526,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP3,Insulin-like growth factor-binding protein 3,29594,0.0794387027848804,0.00200910413588081,0.075500858678554,0.0833765468912068,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF9,Protein turtle homolog A,24922,0.287693766177129,0.00545249284399263,0.277006880202903,0.298380652151355,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBC,Inhibin beta C chain,29443,0.139199549701349,0.00274138997946245,0.133826425341602,0.144572674061095,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDR,Vascular endothelial growth factor receptor 2,29566,0.0667620734678546,0.00171349227940754,0.0634036286002159,0.0701205183354934,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLKB1,Plasma kallikrein,24454,0.0684979408548936,0.00168853097774784,0.0651884201385078,0.0718074615712794,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP2,Lysosome-associated membrane glycoprotein 2,28595,0.0567671249722816,0.0013157495275164,0.0541882558983495,0.0593459940462138,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCAT,Phosphatidylcholine-sterol acyltransferase,24951,0.0946626598754623,0.00141924166010138,0.0918809462216636,0.097444373529261,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLR,Low-density lipoprotein receptor,29500,0.412363633404051,0.00274706189400203,0.406979392091807,0.417747874716295,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPL,Lipoprotein lipase,29478,-0.166977362052199,0.00310239270215459,-0.173058051748422,-0.160896672355976,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF9,Multiple epidermal growth factor-like domains protein 9,29736,0.0541956917111857,0.00138368203688182,0.0514836749188974,0.0569077085034741,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFGE8,Lactadherin,29443,0.225697302741894,0.00273564898304585,0.220335430735124,0.231059174748664,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCS1,Neuronal calcium sensor 1,29725,0.0759842443060453,0.00193014250624308,0.0722011649938088,0.0797673236182817,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH3,Neurogenic locus notch homolog protein 3,29820,-0.090513038055754,0.00230175235216757,-0.0950244726660025,-0.0860016034455056,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPY,Pro-neuropeptide Y,29725,0.362226700510441,0.00404152529750725,0.354305310927326,0.370148090093555,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP1,Neuropilin-1,29628,-0.0890590389409504,0.00185242511550198,-0.0926897921673343,-0.0854282857145666,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,P4HB,Protein disulfide-isomerase,29313,0.103936686511483,0.00261184000490865,0.0988174801018625,0.109055892921104,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAMR1,Inactive serine protease PAMR1,29443,0.0815025206337725,0.00184962656417851,0.0778772525679826,0.0851277886995624,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G10,Group 10 secretory phospholipase A2,29218,-0.167056020307571,0.0039709071135206,-0.174838998250072,-0.159273042365071,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G7,Platelet-activating factor acetylhydrolase,29443,0.132498929418069,0.00206451778943832,0.12845247455077,0.136545384285369,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAT,Tissue-type plasminogen activator,29736,0.140876334510633,0.00338039360916309,0.134250763036673,0.147501905984593,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAP1,Proline-rich acidic protein 1,24938,0.135480763920508,0.00270097315470225,0.130186856537292,0.140774671303725,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROC,Vitamin K-dependent protein C,29545,0.100409982158758,0.00169113720008318,0.0970953532465953,0.103724611070921,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROS1,Vitamin K-dependent protein S,24966,0.0704819579662455,0.00171254807016762,0.0671253637487169,0.073838552183774,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSRC1,Proline/serine-rich coiled-coil protein 1,28797,0.161061016467969,0.003988157910496,0.153244226963397,0.168877805972541,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH,Parathyroid hormone,24195,0.278635790263352,0.00532448727639993,0.268199795201608,0.289071785325096,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES2,Retinoic acid receptor responder protein 2,29628,0.173494380897452,0.00310575137279708,0.16740710820677,0.179581653588134,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA4,Kallistatin,24557,0.0738201381746035,0.00158806554402548,0.0707075297083135,0.0769327466408934,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA5,Plasma serine protease inhibitor,24644,0.100169931856874,0.00211524621988899,0.0960240492658916,0.104315814447856,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPIND1,Heparin cofactor 2,24914,0.0788509576902711,0.00189076475848171,0.0751450587636469,0.0825568566168952,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF1,Pigment epithelium-derived factor,24579,0.0708465360075787,0.00175681968570501,0.0674031694235969,0.0742899025915605,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A5,Zinc transporter ZIP5,29434,0.179292419865707,0.00354100010799217,0.172352059654042,0.186232780077371,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD1,Mothers against decapentaplegic homolog 1,28797,0.267923764516792,0.00546713648829935,0.257208176999725,0.278639352033858,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC1,SPARC-related modular calcium-binding protein 1,29725,0.122759327659892,0.00215751066553781,0.118530606755438,0.126988048564346,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCA,Alpha-synuclein,24381,0.308345906695118,0.00778646796886085,0.29308442947615,0.323607383914085,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC4D,Scavenger receptor cysteine-rich domain-containing group B protein,29433,0.334774499481794,0.00765496508475175,0.31977076791568,0.349778231047907,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSC5D,Soluble scavenger receptor cysteine-rich domain-containing protein SSC5D,29594,0.149910993459373,0.00280903662191795,0.144405281680413,0.155416705238332,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF2,Inactive C-alpha-formylglycine-generating enzyme 2,29694,0.137335460870675,0.00352430109257883,0.130427830729221,0.14424309101213,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI,Tissue factor pathway inhibitor,29435,0.103760904587841,0.00210594128312027,0.0996332596729258,0.107888549502757,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS15,Enteropeptidase,29349,0.272491020460076,0.00604442221709639,0.260643952914567,0.284338088005585,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTR,Transthyretin,24707,0.0872212423314448,0.00166962527807457,0.0839487767864187,0.090493707876471,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VMO1,Vitelline membrane outer layer protein 1 homolog,29349,0.199183801428195,0.00456105221103508,0.190244139094566,0.208123463761824,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS37A,Vacuolar protein sorting-associated protein 37A,29349,0.249160851123842,0.00530565695148167,0.238761763498938,0.259559938748747,0
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR3,Anterior gradient protein 3,28764,0.156539617875377,0.00401698247705494,0.14866633222035,0.164412903530405,1.1125369292536e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLTP,Phospholipid transfer protein,29702,-0.0942788293625742,0.00242445464690062,-0.0990307604704994,-0.089526898254649,1.11253692925361e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO3,Beta-enolase,24240,0.157989364171827,0.00405246138119953,0.150046539864676,0.165932188478978,1.11253692925361e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRP,Gastrin-releasing peptide,24240,0.141336160452084,0.00363410920549708,0.13421330640931,0.148459014494858,1.11253692925387e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHBG,Sex hormone-binding globulin,24951,-0.134767477366609,0.00347454634173378,-0.141577588196408,-0.127957366536811,1.11253692926014e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYNU,Kynureninase,29786,0.117629562243861,0.00306422708726094,0.111623677152829,0.123635447334892,1.11253742791751e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CC2D1A,Coiled-coil and C2 domain-containing protein 1A,29218,0.190740260597998,0.00497739712792308,0.180984562227269,0.200495958968727,1.11254489223131e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINF2,Alpha-2-antiplasmin,24515,0.0352706798099527,0.000918485431388477,0.0334704483644313,0.0370709112554741,1.11254904398813e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPB1,Beta-ureidopropionase,24922,0.23653038401427,0.00616633160329123,0.22444437407182,0.248616393956721,1.11257743282136e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL16,C-C motif chemokine 16,29820,0.134588103254427,0.00353304450257186,0.127663336029386,0.141512870479468,1.13469611738174e-308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAPIN,SNARE-associated protein Snapin,24867,0.148326636341724,0.00390276237538029,0.140677222085978,0.155976050597469,2.87008618701704e-307
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD2,Mothers against decapentaplegic homolog 2,24793,0.177452171838741,0.00467448323355054,0.168290184700982,0.1866141589765,1.46019171873143e-306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB2,Receptor tyrosine-protein kinase erbB-2,29566,0.0633914677556716,0.00167681479142166,0.0601049107644852,0.0666780247468581,1.8180621442667e-305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUMB,Protein numb homolog,24229,0.212952935351869,0.00563652206907898,0.201905352096474,0.224000518607264,1.48946517410427e-303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRCP,Lysosomal Pro-X carboxypeptidase,29655,0.0794868930352241,0.00212439927908512,0.0753230704482173,0.083650715622231,1.99387999814974e-299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT2,Linker for activation of T-cells family member 2,29349,0.312520234354651,0.00838909238148124,0.296077613286948,0.328962855422354,7.85573036527338e-297
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP44,Endoplasmic reticulum resident protein 44,29301,0.0650175645745044,0.00174706227798876,0.0615933225096464,0.0684418066393624,3.09154575578519e-296
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LATS1,Serine/threonine-protein kinase LATS1,24229,0.213859184821548,0.00576049734107487,0.202568610033041,0.225149759610055,1.83173783544402e-293
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYAP1,Synapse-associated protein 1,24381,0.143494588487997,0.00388117407027874,0.135887487310251,0.151101689665744,3.53372635145344e-291
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF8,Immunoglobulin superfamily member 8,29478,0.0758339297337921,0.00206024676871818,0.0717958460671045,0.0798720134004797,5.11540387675095e-290
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UFD1,Ubiquitin recognition factor in ER-associated degradation protein 1,24805,0.347408848674896,0.00944552623856069,0.328895617247317,0.365922080102475,2.12896908909015e-288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKRA,Interferon-inducible double-stranded RNA-dependent protein kinase activator A,28797,0.16832545082205,0.00459074641051956,0.159327587857431,0.177323313786668,1.05762349589174e-287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS1,Protein MTSS 1,24805,0.27337553108867,0.00749957334541118,0.258676367331664,0.288074694845676,1.913399964569e-283
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORT1,Sortilin,29433,0.0916186582561831,0.00251922335038886,0.086680980489421,0.0965563360229453,2.60834745045018e-283
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGPA,N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase,24381,0.0533883735588277,0.00147726560025898,0.0504929329823201,0.0562838141353353,1.19952014423619e-278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP5,Retinol-binding protein 5,29349,0.136902619046516,0.00379956540602705,0.129455470850703,0.144349767242329,3.19571492912828e-278
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR5,Cadherin-related family member 5,29478,0.0945765636948466,0.00263409248097091,0.0894137424321436,0.0997393849575496,2.34694902575528e-276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLA,Alpha-galactosidase A,24329,0.0912590465558727,0.00254107248860473,0.0862785444782074,0.096239548633538,2.88143853361459e-275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA80,N-alpha-acetyltransferase 80,24195,0.292485700664027,0.00817171278555964,0.27646914360433,0.308502257723723,1.95175209373746e-273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MXRA8,Matrix remodeling-associated protein 8,24381,-0.0740443478120913,0.0020697511683788,-0.0781010601021137,-0.0699876355220689,3.18387371066221e-273
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKB,Creatine kinase B-type,24938,-0.143123298925207,0.00400654206725153,-0.15097612137702,-0.135270476473394,1.31992296701734e-272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A1,Collagen alpha-1(IV) chain,29478,-0.0956787229072786,0.00268593790986728,-0.100943161210619,-0.0904142846039388,3.82043008921075e-272
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RET,Proto-oncogene tyrosine-protein kinase receptor Ret,29349,0.0952659762326724,0.00268316674141288,0.0900069694195032,0.100524983045842,2.19341376038583e-270
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR2,Fibroblast growth factor receptor 2,29566,0.0531164630772546,0.00149634278065324,0.0501836312271742,0.0560492949273349,2.58012527840614e-270
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP29,Synaptosomal-associated protein 29,29566,0.219534641525757,0.00619089143559348,0.207400494311994,0.231668788739521,8.97809749389301e-270
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN2,Ficolin-2,29381,0.0980668745583567,0.00278051705008453,0.0926170611401911,0.103516687976522,6.49946142457176e-267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTYMK,Thymidylate kinase,24922,0.163460966521497,0.00463399805447805,0.15437833033472,0.172543602708274,5.07941613211584e-266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LG,CMRF35-like molecule 9,29443,-0.0895598227196396,0.00254639877494665,-0.0945507643185351,-0.0845688811207442,1.74913724607656e-265
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YES1,Tyrosine-protein kinase Yes,29349,0.270362026809929,0.00770816669630353,0.255254020085174,0.285470033534684,4.7043694155997e-264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR2,Cadherin-related family member 2,29349,0.171911873909803,0.00491577148664984,0.162276961795969,0.181546786023637,1.51796863098464e-262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH1,Somatotropin,29433,-0.420580428206921,0.0120287704404426,-0.444156818270189,-0.397004038143654,1.85243505678828e-262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH3,Inter-alpha-trypsin inhibitor heavy chain H3,29594,-0.0903368233162741,0.00258514460104379,-0.0954037067343199,-0.0852699398982283,3.39086405187409e-262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FTCD,Formimidoyltransferase-cyclodeaminase,24804,0.201641906532705,0.00576976061161249,0.190333175733945,0.212950637331466,3.01079105439747e-261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTD,Biotinidase,24966,0.0489553580916482,0.00140176215173674,0.0462079042742442,0.0517028119090522,6.09282335152683e-261
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF21,Fibroblast growth factor 21,29674,0.279839129911134,0.00803785588194605,0.26408493238252,0.295593327439748,2.52023621842252e-260
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAB2,Stabilin-2,24938,0.066568180700915,0.00190883963241934,0.0628268550213731,0.0703095063804569,3.32844950142448e-260
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOMO1,Nodal modulator 1,29443,0.0555078356909877,0.00159581474634426,0.052380038788153,0.0586356325938225,7.99773035428661e-260
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EEF1D,Elongation factor 1-delta,24922,0.215320926233751,0.00618461627000719,0.203199078344537,0.227442774122965,2.31596274771803e-259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEG1,Protein HEG homolog 1,24381,0.0641916749551538,0.0018450594522837,0.0605753584286778,0.0678079914816299,7.09089452545353e-259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH9,Myosin-9,24938,0.265147820225839,0.00764804249333583,0.250157656938901,0.280137983512777,2.99225376435288e-257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBP,Protein AMBP,29683,0.0470744281443425,0.00136499558522058,0.0443990367973102,0.0497498194913749,1.41841785609265e-255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FYB1,FYN-binding protein 1,29400,0.214203246958789,0.00623802250270533,0.201976722853486,0.226429771064091,2.1628826454816e-253
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FN1,Fibronectin,24966,0.0622906736031814,0.00181387143637247,0.0587354855878914,0.0658458616184715,1.43387362081047e-252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLN,Promotilin,29434,0.207032981347994,0.00604120001055255,0.195192229327311,0.218873733368677,2.0252779834251e-252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL2,Angiopoietin-related protein 2,29491,0.0925161407584915,0.00270282564278046,0.0872186024986418,0.0978136790183412,7.59803972640221e-252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP4,Metalloproteinase inhibitor 4,29443,-0.0935164843330564,0.00273447243173518,-0.0988760502992574,-0.0881569183668555,2.09988562536028e-251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SARG,Specifically androgen-regulated gene protein,24820,0.253018902747195,0.00740272007278915,0.238509571404528,0.267528234089861,3.12594368133104e-250
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP1G2,AP-1 complex subunit gamma-like 2,24793,0.183380826619561,0.00539181742312391,0.172812864470238,0.193948788768884,7.63093722864192e-248
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELPLG,P-selectin glycoprotein ligand 1,29434,0.0637432833440386,0.00188592621414479,0.0600468679643148,0.0674396987237624,1.01485337548194e-245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA1,Ephrin type-A receptor 1,29536,0.0761795971134832,0.00226007068704922,0.0717498585668667,0.0806093356600996,1.99730875592587e-244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11R,Junctional adhesion molecule A,29443,0.12846253522725,0.00381458664024509,0.12098594541237,0.135939125042131,5.48012269213129e-244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABL1,Tyrosine-protein kinase ABL1,29349,0.154512329832519,0.00459561270908656,0.145504928922709,0.163519730742329,3.36673289774556e-243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJAP1,Tight junction-associated protein 1,29566,0.189064654565431,0.00562413804958652,0.178041343988241,0.20008796514262,3.67556587513434e-243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB2,Carboxypeptidase B2,24914,0.0515792465406691,0.00153293229190039,0.0485746992485443,0.0545837938327939,9.24944306910431e-243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRB,Receptor-type tyrosine-protein phosphatase beta,24922,0.0674053977737334,0.00200399269801079,0.0634775720856322,0.0713332234618345,1.35119715518767e-242
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YTHDF3,YTH domain-containing family protein 3,28931,0.193416305393217,0.00578731978302729,0.182073158618483,0.20475945216795,2.5793556187907e-240
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOST,Sclerostin,29433,0.0877852837734143,0.00262779714230803,0.0826348013744905,0.092935766172338,3.43008551776593e-240
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCLY,Selenocysteine lyase,29632,0.109585004126044,0.00329137917358911,0.103133900945809,0.116036107306279,1.17167921371537e-238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADH1B,All-trans-retinol dehydrogenase,24381,0.170988672598728,0.00512697784041449,0.160939796031515,0.18103754916594,1.62610700637322e-238
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IPCEF1,Interactor protein for cytohesin exchange factors 1,29169,0.201806897372564,0.00607657462017057,0.189896811117029,0.213716983628098,2.02170977608257e-237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC4,Apical endosomal glycoprotein,24793,0.125173506106422,0.00376819290344061,0.117787848015678,0.132559164197165,9.06222490817957e-237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM20A,Pseudokinase FAM20A,24922,0.0638631705975036,0.00192516794001935,0.0600898414350656,0.0676364997599415,3.64867161882362e-236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP1,Src kinase-associated phosphoprotein 1,29163,0.163837424844382,0.00495013622707901,0.154135157839307,0.173539691849457,7.53356587369919e-236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD38,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1,29349,0.0714340627373405,0.00215944072309887,0.0672015589200667,0.0756665665546142,1.2443814824844e-235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS3,"Nitric oxide synthase, endothelial",28774,0.118823041305641,0.00359278815585744,0.11178117652016,0.125864906091121,1.90403432834325e-235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LECT2,Leukocyte cell-derived chemotaxin-2,24922,0.148166129371321,0.00447601378957252,0.139393142343759,0.156939116398883,3.42900229128085e-235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC1,"Nuclear factor of activated T-cells, cytoplasmic 1",29434,0.218790884081902,0.00662321285157988,0.205809386892806,0.231772381270999,5.23884482715416e-235
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORD,Sorbitol dehydrogenase,29595,0.152389976109759,0.00462629616431685,0.143322435627698,0.16145751659182,9.91829388348002e-234
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELN,Elastin,24922,0.0784838283720529,0.0023858254044213,0.0738076105793871,0.0831600461647186,2.35194231442922e-232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S3,Biogenesis of lysosome-related organelles complex 1 subunit 3,24845,0.0907316147770743,0.00276272576213633,0.0853166722832871,0.0961465572708615,1.35892541576377e-231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS15,A disintegrin and metalloproteinase with thrombospondin motifs 15,29349,0.096601242430817,0.00296809239919511,0.0907837813283946,0.102418703533239,2.70847049508672e-228
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHK,Ketohexokinase,24240,0.141501871109487,0.00435356001974204,0.132968893470793,0.150034848748182,7.27321642880594e-227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL16,Pro-interleukin-16,29786,0.0909676709991098,0.0028106932659654,0.0854587121978176,0.096476629800402,7.09120631736679e-226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXLNA,Alpha-taxilin,29218,0.194125880972363,0.00603037672202235,0.182306342597199,0.205945419347526,1.8879437165206e-223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRCH4,Leucine-rich repeat and calponin homology domain-containing protein 4,24111,0.148806690339308,0.00463026136818322,0.139731378057669,0.157882002620947,6.28410331860829e-222
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5D,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 1",24240,0.125026787146989,0.00389488983978971,0.117392803061001,0.132660771232976,1.89754577827669e-221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BANK1,B-cell scaffold protein with ankyrin repeats,29434,0.230942331817396,0.00721903946004195,0.216793014475713,0.245091649159078,8.95081321226574e-221
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPPL1,"Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2",29349,0.211719288021319,0.00662035994649698,0.198743382526185,0.224695193516453,1.27753596212684e-220
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAD1L1,Mitotic spindle assembly checkpoint protein MAD1,29100,0.102925467246325,0.00322922280705633,0.0965961905444951,0.109254743948156,3.72706820044025e-219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF10,Tumor necrosis factor ligand superfamily member 10,29786,0.056306424373332,0.00177084465838434,0.0528355688428987,0.0597772799037653,3.26492154631233e-218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHBP1,EH domain-binding protein 1,24922,0.16159250102876,0.00507990656742747,0.151635884156603,0.171549117900918,1.0606079271979e-217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL22,C-C motif chemokine 22,29169,0.111680511525924,0.00351630115739044,0.104788561257438,0.118572461794409,1.15990213718346e-217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPY30,Protein dpy-30 homolog,29604,0.12902323048006,0.00406821257382601,0.121049533835361,0.136996927124759,4.19279460603038e-217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFSD,Methenyltetrahydrofolate synthase domain-containing protein,24445,0.243105516111907,0.0076560005284694,0.228099755076107,0.258111277147707,7.21895945066453e-217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LDLRAP1,Low density lipoprotein receptor adapter protein 1,24867,0.21054719150448,0.00663311854144202,0.197546279163253,0.223548103845706,8.74735975516601e-217
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBXIP1,Pre-B-cell leukemia transcription factor-interacting protein 1,24805,0.064663121769218,0.00203783161031822,0.0606689718129943,0.0686572717254417,1.23387538375053e-216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT1,Glutathione hydrolase 1 proenzyme,29390,0.108381216298658,0.00342347750301659,0.101671200392746,0.115091232204571,2.53647668423939e-216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MME,Neprilysin,29349,0.172750720354649,0.0054605165553492,0.162048107906164,0.183453332803133,5.01681613300898e-216
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAG1,Phosphoprotein associated with glycosphingolipid-enriched microdomains 1,28916,0.11801417917284,0.00374358918331021,0.110676744373552,0.125351613972128,1.73732124707208e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL17,C-X-C motif chemokine 17,29786,0.0900781866464734,0.00285821179921692,0.0844760915200082,0.0956802817729385,1.78734319979143e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES3,Carboxylesterase 3,29349,0.149486575413841,0.00474742301333504,0.140181626307704,0.158791524519978,4.67351646413703e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR2A,cAMP-dependent protein kinase type II-alpha regulatory subunit,24805,0.174450514440465,0.00553266655547426,0.163606487991735,0.185294540889195,5.48547120946071e-214
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXIN1,Axin-1,29434,0.203530510759713,0.0064741481415989,0.190841180402179,0.216219841117247,2.12861649810173e-213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBEGF,Proheparin-binding EGF-like growth factor,29632,0.155153687520056,0.00494425461470234,0.14546294847524,0.164844426564873,1.13708967580562e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK9,Mitogen-activated protein kinase 9,29434,0.0916118181103898,0.00292277166081821,0.0858831856551861,0.0973404505655934,3.62703543264874e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC6,Putative tyrosine-protein phosphatase auxilin,24240,0.180509982082802,0.00574990706791844,0.169240164229682,0.191779799935922,4.37907383626039e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARF6,ADP-ribosylation factor 6,24805,0.228024917715103,0.00726822841722453,0.213779190017343,0.242270645412863,6.58998823626498e-212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTSS2,Protein MTSS 2,24793,0.21105298916254,0.00674874413571233,0.197825450656544,0.224280527668537,1.34726526627484e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CANT1,Soluble calcium-activated nucleotidase 1,29370,0.0429676533820091,0.00137689201391539,0.040268945034735,0.0456663617292833,2.40684403463382e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA2,DnaJ homolog subfamily A member 2,29704,0.173858235506436,0.00557216148017882,0.162936799005286,0.184779672007587,2.56931019833904e-210
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK1,Dickkopf-related protein 1,29694,0.125476119437359,0.00404067179219667,0.117556402724654,0.133395836150065,2.23663640026658e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAIAP2,Brain-specific angiogenesis inhibitor 1-associated protein 2,28797,0.134061872366382,0.00431790004740545,0.125598788273467,0.142524956459297,3.3203263178492e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18R1,Interleukin-18 receptor 1,29786,0.0693121272517625,0.00223420257972219,0.064933090195507,0.073691164308018,5.40270386299331e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAAM1,Disheveled-associated activator of morphogenesis 1,24381,0.17535239349268,0.00564492254943547,0.164288345295786,0.186416441689573,8.37018307458614e-208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPD1,Glycerol-3-phosphate dehydrogenase,24793,0.110705616800127,0.00356636020727446,0.103715550793869,0.117695682806385,1.39446920348444e-207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARBP2,RISC-loading complex subunit TARBP2,28774,0.166226034370802,0.00538233156098243,0.155676664511276,0.176775404230327,4.61486135514634e-206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZN,Kazrin,24805,0.219097230588079,0.00709029853893862,0.20520024545176,0.232994215724399,9.23898550823641e-206
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WWP2,NEDD4-like E3 ubiquitin-protein ligase WWP2,29218,0.112135934293767,0.00364611023407852,0.104989558234973,0.119282310352561,1.92368126767185e-204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP20,Centrosomal protein 20,28797,0.155371947215629,0.00506607648888095,0.145442437297422,0.165301457133835,2.75989033667128e-203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HJV,Hemojuvelin,24867,0.0925033856453528,0.00301306361046639,0.0865977809688387,0.0984089903218669,3.45590743669036e-203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPC,C-type natriuretic peptide,29434,0.0999106100698388,0.00326050362319496,0.0935200229683767,0.106301197171301,5.15700567457143e-203
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3S2,AP-3 complex subunit sigma-2,24845,0.0986145268710294,0.00322046301379984,0.0923024193639818,0.104926634378077,3.66046151802799e-202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB1,BPI fold-containing family B member 1,29333,-0.13124449778132,0.00429387913677646,-0.139660500889402,-0.122828494673238,5.23169399977319e-202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F13B,Coagulation factor XIII B chain,24833,0.0538274888107094,0.00175984127131056,0.0503781999189407,0.0572767777024781,1.02280665721635e-201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNA4,Plexin-A4,29434,0.169691473233854,0.00555963069742792,0.158794597066895,0.180588349400813,1.84794284509748e-201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP1,Fibroblast growth factor-binding protein 1,29566,0.0679306613038564,0.00223649909031943,0.0635471230868303,0.0723141995208825,1.43832990632144e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1B,C-type lectin domain family 1 member B,29694,0.198541584694744,0.0065375330090249,0.185728019997055,0.211355149392433,1.57833103792462e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCC1,GRIP and coiled-coil domain-containing protein 1,24845,0.22360907318875,0.00735399425537268,0.209195244448219,0.23802290192928,2.03914910423309e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD63,CD63 antigen,29169,0.106256059950745,0.00349995907255054,0.0993961401685459,0.113115979732944,2.41808663897412e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB16,Zinc finger and BTB domain-containing protein 16,28797,0.147738715632189,0.00487183551471767,0.138189918023343,0.157287513241036,7.23636649217985e-199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BECN1,Beclin-1,24240,0.12462816750602,0.00410518543972613,0.116582004044157,0.132674330967883,1.01441249243943e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON3,Serum paraoxonase/lactonase 3,29581,-0.0584896811612205,0.00193237459165564,-0.0622771353608656,-0.0547022269615754,3.18737385017903e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2AP,CD2-associated protein,29478,0.130984300590119,0.00432741120564624,0.122502574627052,0.139466026553186,3.24341629485627e-198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBLD,Phenazine biosynthesis-like domain-containing protein,28774,0.106221766773865,0.00352346977676574,0.099315766011404,0.113127767536326,1.35395137673997e-196
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL13,C-X-C motif chemokine 13,29694,0.124608108103525,0.00414731137651519,0.116479377805556,0.132736838401495,2.1194263175786e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN1,Dynactin subunit 1,29725,0.132818711787847,0.00442448366743254,0.12414672379968,0.141490699776015,4.55880675475711e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF41,E3 ubiquitin-protein ligase NRDP1,28797,0.136551073085139,0.00454946602885248,0.127634119668588,0.14546802650169,6.38470285777113e-195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP85,Centrosomal protein of 85 kDa,28797,0.130288719659057,0.00436138492107778,0.121740405213745,0.13883703410437,3.90573913019977e-193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MVK,Mevalonate kinase,28931,0.162169952594411,0.00543152581163131,0.151524162003613,0.172815743185208,6.03775913209115e-193
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD5,Mothers against decapentaplegic homolog 5,29349,0.0413441687867029,0.00138609624162224,0.0386274201531233,0.0440609174202825,1.28825416342611e-192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM7,PDZ and LIM domain protein 7,29581,0.254012249796618,0.00853184717336892,0.237289829336815,0.270734670256421,6.11455600310857e-192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF12,Rho guanine nucleotide exchange factor 12,29434,0.210666715536636,0.00707624298372534,0.196797279288534,0.224536151784737,6.5480017158775e-192
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAB2,Disabled homolog 2,29725,0.223598217704322,0.00753511813997224,0.208829386149977,0.238367049258668,1.00926715936796e-190
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB14,EF-hand calcium-binding domain-containing protein 14,24805,0.0557413071350347,0.00187609554826862,0.0520641598604282,0.0594184544096412,1.20338010210832e-190
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MASP1,Mannan-binding lectin serine protease 1,29163,0.0478093732877063,0.00161248849425721,0.0446488958389622,0.0509698507364504,2.32289955999287e-190
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCXR,L-xylulose reductase,29566,0.108375050742047,0.00365883187751709,0.101203740262114,0.115546361221981,4.95437526563653e-190
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF12A,Tumor necrosis factor receptor superfamily member 12A,29566,0.0724915485155374,0.00244828930861711,0.0676929014706479,0.077290195560427,6.81263788498153e-190
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFC,Platelet-derived growth factor C,28797,0.0584114265245082,0.00197431992102168,0.0545417594793057,0.0622810935697107,1.58154524035337e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3F,Semaphorin-3F,29478,0.0530580622638395,0.00179645542838169,0.0495370096242114,0.0565791149034676,5.8610718801194e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G1,V-type proton ATPase subunit G 1,24240,0.146243760279894,0.00494432471415896,0.136552883840143,0.155934636719646,6.51059454362484e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL5,C-X-C motif chemokine 5,29384,0.228992012679798,0.00775597761441593,0.213790296555542,0.244193728804053,8.03116288605148e-189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPY,Pancreatic prohormone,29400,0.204782487903821,0.00694442345846973,0.19117141792522,0.218393557882421,2.23657362731802e-188
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA1,Interleukin-13 receptor subunit alpha-1,29019,0.0449265787880597,0.00152870668352517,0.0419303136883503,0.047922843887769,4.26223790667006e-187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG16L1,Autophagy-related protein 16-1,24805,0.171066151206694,0.00581551216111313,0.159667747370912,0.182464555042476,5.67098982380997e-187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP23,Synaptosomal-associated protein 23,29478,0.174021936911311,0.00592537237586049,0.162408207054625,0.185635666767998,6.78982329529212e-187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A4,Protein S100-A4,29566,0.113919281349753,0.00388805561858473,0.106298692337327,0.121539870362179,4.79570752469828e-186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLUL1,Clusterin-like protein 1,29435,-0.0900776329942925,0.00307522385334801,-0.0961050717468546,-0.0840501942417304,6.25829272175601e-186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB11FIP3,Rab11 family-interacting protein 3,24922,0.214579245033468,0.00731714138741111,0.200237647914142,0.228920842152794,7.06248938540445e-186
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBIN,Erbin,29349,0.204408927304102,0.00698288600953276,0.190722470725417,0.218095383882786,1.08087424228997e-185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN1,Perilipin-1,28774,0.0696332704082946,0.00238036583194341,0.0649677533776855,0.0742987874389037,2.13361144300309e-185
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCR,Breakpoint cluster region protein,29434,0.182327712212393,0.00624766316055578,0.170082292417704,0.194573132007082,1.35357417507281e-184
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKBKG,NF-kappa-B essential modulator,29434,0.182337964261315,0.0062510884041877,0.170085830989107,0.194590097533523,2.03430098639077e-184
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R9B,Neurabin-2,29786,0.186785491897077,0.00643122468322872,0.174180291517949,0.199390692276206,6.63401928306704e-183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK2,"Interferon-induced, double-stranded RNA-activated protein kinase",24740,0.215390419755607,0.00743686739238317,0.200814159666536,0.229966679844678,2.08586847147134e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTBS,Di-N-acetylchitobiase,24653,0.053822179785015,0.00185895289669868,0.0501786321074856,0.0574657274625444,2.79391536959441e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB1,Nuclear factor NF-kappa-B p105 subunit,24111,0.146755620467607,0.00507287604987087,0.13681278340986,0.156698457525354,6.28844029521163e-181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNIP1,TNFAIP3-interacting protein 1,24845,0.174346717814683,0.0060318134751898,0.162524363403311,0.186169072226055,1.02931389935304e-180
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFC,Vascular endothelial growth factor C,29566,0.109580028088486,0.00379828712608557,0.102135385321358,0.117024670855613,1.62533220743407e-180
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTproBNP,N-terminal prohormone of brain natriuretic peptide,29478,-0.205665318540989,0.0071291458453324,-0.219638444397841,-0.191692192684138,1.71606925095264e-180
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBD1,Pterin-4-alpha-carbinolamine dehydratase,24365,0.092865090155148,0.00322233604334897,0.086549311510184,0.099180868800112,1.27596416842415e-179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL18A1,Collagen alpha-1(XVIII) chain,29559,0.0458886243690864,0.00159875408025574,0.0427550663717851,0.0490221823663876,1.00479740381111e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELP,P-selectin,29594,0.111240384970733,0.00387583119448829,0.103643755829536,0.11883701411193,1.04685006870773e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFX1,Transcriptional repressor NF-X1,24111,0.132619275867628,0.00461692963865448,0.123570093775865,0.141668457959391,1.91142100559407e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YOD1,Ubiquitin thioesterase OTU1,24111,0.122229438123371,0.00425680527838005,0.113886099777746,0.130572776468996,2.57158181723294e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMIP,C-Maf-inducing protein,24793,0.162257194921318,0.0056551771338762,0.151173047738921,0.173341342103716,3.94652209335906e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL17,C-C motif chemokine 17,29414,0.177816306690558,0.00620895456562396,0.165646755741935,0.189985857639181,6.17708161814914e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIDA,2-iminobutanoate/2-iminopropanoate deaminase,24381,0.0967626279340598,0.00337400619934162,0.0901495757833502,0.103375680084769,6.31765286881139e-178
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFE2,Transcription factor NF-E2 45 kDa subunit,24240,0.145490689955955,0.00508249873451466,0.135528992436307,0.155452387475604,2.86056405314842e-177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTS,6-pyruvoyl tetrahydrobiopterin synthase,28643,0.107396946262715,0.00375855539974489,0.100030177679215,0.114763714846215,4.34224361626597e-177
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOC1,Apolipoprotein C-I,24914,0.0728166238516834,0.0025563126786556,0.0678062510015184,0.0778269967018484,1.17782731306839e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THOP1,Thimet oligopeptidase,29343,0.0599062304216805,0.00210586371460864,0.0557787375410476,0.0640337233023135,1.28000119861632e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLA2,Src-like-adapter 2,24867,0.203111397990436,0.00714455515960473,0.18910806987761,0.217114726103261,5.6180250624858e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK9,Proprotein convertase subtilisin/kexin type 9,29820,0.0765649086624374,0.00269696651112542,0.0712788543006316,0.0818509630242432,5.86683899748799e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4R,Reticulon-4 receptor,29725,0.065525552301566,0.00230952280868345,0.0609988875965465,0.0700522170065856,9.64729604009669e-175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FETUB,Fetuin-B,29545,0.0637831489229297,0.00225419414652404,0.0593649283957426,0.0682013694501168,8.25814365938215e-174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINC1,Antithrombin-III,24914,0.0285551152428033,0.00100938395450343,0.0265767226919766,0.03053350779363,2.55354998948894e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHBP,Corticotropin-releasing factor-binding protein,29454,0.053650018622988,0.00190015804809967,0.0499257088487126,0.0573743283972633,4.48413255241059e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPD52L2,Tumor protein D54,24381,0.208851467847558,0.00739186284832108,0.194363416664849,0.223339519030267,7.71395755772117e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAK4,Serine/threonine-protein kinase PAK 4,28774,0.118028661215679,0.00418326164149961,0.10982946839834,0.126227854033018,8.79178118055008e-173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD7B,OTU domain-containing protein 7B,24867,0.121673220225557,0.00431334608416332,0.113219061900597,0.130127378550517,2.38478664136273e-172
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKBIE,NF-kappa-B inhibitor epsilon,28797,0.0950453944168138,0.00338040964783087,0.0884197915070653,0.101670997326562,1.2882161234896e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUCB2,Nucleobindin-2,29652,0.0715185163358812,0.00254583122770039,0.0665286871295885,0.076508345542174,2.14496123943079e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12A,Protein phosphatase 1 regulatory subunit 12A,29566,0.182527509071057,0.00649742578948043,0.169792554523675,0.195262463618438,2.18423413386699e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT5B,Signal transducer and activator of transcription 5B,29349,0.263082813089653,0.00937855873348714,0.244700837972018,0.281464788207288,6.9221986956563e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB3,Voltage-dependent L-type calcium channel subunit beta-3,24867,0.161343345183491,0.00574514915839566,0.150082852833035,0.172603837533946,7.2736038964324e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCK2,Cytoplasmic protein NCK2,29581,0.20212854292786,0.00720845946996388,0.187999962366731,0.216257123488989,8.99850626120274e-171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AAMDC,Mth938 domain-containing protein,24240,0.102213634714612,0.00364645591353408,0.095066581124085,0.109360688305139,3.5410408815518e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN1A2,"Mannosyl-oligosaccharide 1,2-alpha-mannosidase IB",24240,0.0499541353834134,0.00178274729852789,0.0464599506782987,0.053448320088528,4.65715449951428e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK2,Docking protein 2,29478,0.232381296384769,0.00830623205344717,0.216101081560012,0.248661511209525,5.2219850603619e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS2,RNA-binding protein with multiple splicing 2,24240,0.196466802241838,0.00701473522463468,0.182717921201554,0.210215683282122,6.65603107022798e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK1,Interleukin-1 receptor-associated kinase 1,28931,0.132701678708521,0.00474480412646498,0.12340186262065,0.142001494796393,7.33126113963787e-170
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4B,Eukaryotic translation initiation factor 4B,29218,0.110509009917685,0.00395465165680508,0.102757892670347,0.118260127165023,1.33141483701201e-169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAXX,Protein PAXX,24381,0.0873363047846161,0.00312605520855557,0.0812092365758472,0.0934633729933851,4.24137529832685e-169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOM,Apolipoprotein M,29545,0.0528535017275015,0.00189510131438435,0.0491391031513082,0.0565679003036949,5.55675867485225e-169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEP,Leptin,29478,0.127943484713775,0.00458777405768559,0.118951447560711,0.136935521866838,5.87252055375531e-169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINK1,Misshapen-like kinase 1,24845,0.176546953919037,0.0063388424464057,0.164122822724081,0.188971085113992,3.95360657409989e-168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDCCAG8,Serologically defined colon cancer antigen 8,24793,0.216656876651873,0.00778621090829839,0.201395903271608,0.231917850032138,8.05870762291841e-168
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BACH1,Transcription regulator protein BACH1,29434,0.13936164068676,0.00503211660038866,0.129498692149998,0.149224589223521,1.12335779106693e-166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPL,N-acetylneuraminate lyase,24922,0.0848663310600543,0.00306564536934398,0.0788576661361401,0.0908749959839685,3.66161414777028e-166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL10,C-X-C motif chemokine 10,29581,0.12614035956871,0.00456537258771484,0.117192229296789,0.135088489840631,6.27933450344398e-166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBI,Transforming growth factor-beta-induced protein ig-h3,29361,0.0508446500603588,0.00184533560392376,0.0472277922766683,0.0544615078440494,5.14005096430435e-165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO1,Forkhead box protein O1,29434,0.16058320114414,0.00584090102946521,0.149135035126388,0.172031367161892,2.55899690886556e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD6,T-cell differentiation antigen CD6,29760,0.0988999205680469,0.00359786351412244,0.091848108080367,0.105951733055727,2.73270514359421e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCTN3,Tectonic-3,24922,0.0560341463955551,0.00203632170716704,0.0520429558495077,0.0600253369416025,3.11382980211953e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NHLRC3,NHL repeat-containing protein 3,23825,0.0602805905882401,0.00219155854363316,0.0559851358427191,0.0645760453337611,5.46722750692331e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TANK,TRAF family member-associated NF-kappa-B activator,28931,0.131848469619368,0.00480150359454746,0.122437522574055,0.141259416664681,6.73734704389104e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL5,C-C motif chemokine 5,29594,0.188281101816484,0.00685811524896714,0.174839195928509,0.20172300770446,7.12352349347984e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIP2,CAP-Gly domain-containing linker protein 2,29434,0.21055296718967,0.00767234963420486,0.195515161906629,0.225590772472712,9.72702908158385e-164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM25,E3 ubiquitin/ISG15 ligase TRIM25,24805,0.203507006264598,0.00741247722260327,0.188978550908295,0.2180354616209,1.70489456082936e-163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGP1,SURP and G-patch domain-containing protein 1,24805,0.0749801545930944,0.00273756732926675,0.0696145226277316,0.0803457865584572,9.72042444778959e-163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUOM,Fucose mutarotase,24381,0.119141602194469,0.00435136732159045,0.110612922244152,0.127670282144786,1.3607471432933e-162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN2,CCN family member 2,29478,0.106363069453761,0.0039006448833673,0.0987178054823607,0.11400833342516,1.03608821582753e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EZR,Ezrin,29694,0.0447908692537536,0.00164291235022605,0.0415707610473105,0.0480109774601966,1.14456725351902e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLEKHO1,Pleckstrin homology domain-containing family O member 1,24845,0.128961204836566,0.00473524363099716,0.119680127319812,0.138242282353321,5.90446814647287e-161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RN,Interleukin-1 receptor antagonist protein,29379,0.10021312001054,0.00368908334778036,0.0929825166488905,0.107443723372189,1.63905523801891e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G1,Eukaryotic translation initiation factor 4 gamma 1,29786,0.183447292458969,0.00676094128720903,0.170195847536039,0.196698737381898,3.54347648830328e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPK2,SRSF protein kinase 2,29434,0.155287459923355,0.00572905246504847,0.14405851709186,0.16651640275485,7.87227490794789e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5E,5'-nucleotidase,29566,0.104059668710175,0.00383934774294837,0.0965345471339961,0.111584790286354,8.09083737208344e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP10,Stromelysin-2,29439,-0.109476139570403,0.00403914161361938,-0.117392857133097,-0.101559422007709,8.17367860301949e-160
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYY,Peptide YY,24111,0.180068347994488,0.00664248224503773,0.167049082794214,0.193087613194762,1.92045775062921e-159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINH1,Serpin H1,24445,0.237979864076597,0.00878699474847094,0.220757354369594,0.2552023737836,3.48285685963208e-159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCBP2,Poly(rC)-binding protein 2,24867,0.133744434421301,0.00494369849911612,0.124054785363033,0.143434083479568,6.9518223202236e-159
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGRN,Agrin,29581,0.0635693970300059,0.00235378572401787,0.0589559770109309,0.068182817049081,1.02632644741077e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLSCR3,Phospholipid scramblase 3,24804,0.10872206959797,0.00402229106505526,0.100838379110462,0.116605760085478,1.31153569915699e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHACTR2,Phosphatase and actin regulator 2,24867,0.210627532843657,0.00779413521900378,0.19535102781441,0.225904037872905,1.51703776644079e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R2,Interleukin-1 receptor type 2,29404,0.0367324102306111,0.00136158243637616,0.0340637086553138,0.0394011118059084,2.29807377385246e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2R,Cation-independent mannose-6-phosphate receptor,29443,0.0432706552926565,0.00160447260754538,0.0401258889818675,0.0464154216034454,2.89371142051631e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE4,Ribonuclease 4,24194,0.0507843052383107,0.00188089281201985,0.0470977553267518,0.0544708551498696,3.26788840060897e-158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM1,Isthmin-1,29434,0.0722708820495511,0.00268785292968503,0.0670026903073684,0.0775390737917337,2.43023431646254e-157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO1,Calcium-binding and coiled-coil domain-containing protein 1,29608,0.188981369572911,0.00704481259830534,0.175173536880232,0.202789202265589,1.21784477477233e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIFM1,"Apoptosis-inducing factor 1, mitochondrial",29307,0.191865112386837,0.00716267387485024,0.177826271592131,0.205903953181544,3.51656030823506e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSO,Cathepsin O,29786,0.0555355640876237,0.00207499893958578,0.0514685661660355,0.0596025620092118,5.94226006721761e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT18,"Keratin, type I cytoskeletal 18",29349,0.148609323368877,0.00555518781653287,0.137721155248473,0.159497491489282,8.81461340517832e-156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFER,FAD-linked sulfhydryl oxidase ALR,28797,0.117123779316152,0.004382108144365,0.108534847353197,0.125712711279108,1.77704457891471e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF1,Rho guanine nucleotide exchange factor 1,24845,0.165168940309625,0.00617933729826604,0.153057439205023,0.177280441414226,3.38262985986972e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP4K5,Mitogen-activated protein kinase kinase kinase kinase 5,29163,0.203883750354177,0.00764310299661205,0.188903268480817,0.218864232227536,6.57634908929408e-155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAT,Linker for activation of T-cells family member 1,29786,0.137813307267772,0.00517281405294446,0.127674591724001,0.147952022811544,1.44871536037337e-154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREG1,Protein CREG1,29079,0.0692948125033585,0.0026052681340873,0.0641884869605474,0.0744011380461696,5.01630622235763e-154
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USO1,General vesicular transport factor p115,29349,0.162940359345823,0.00614164059102953,0.150902743787405,0.174977974904241,2.78937110565749e-153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE2,Angiotensin-converting enzyme 2,28916,0.0936311774531003,0.00353696486857647,0.0866987263106904,0.10056362859551,1.34153939831304e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC42BPB,Serine/threonine-protein kinase MRCK beta,24805,0.185346399950004,0.00701228137638393,0.171602328452292,0.199090471447717,7.53516476061571e-152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BA,Platelet glycoprotein Ib alpha chain,29374,0.0591202834099609,0.00224430044602465,0.0547214545357526,0.0635191122841692,3.59321671096864e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEC31A,Protein transport protein Sec31A,24240,0.138750090690083,0.00526070867703342,0.128439101683098,0.149061079697069,3.63313249384538e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEXIM1,Protein HEXIM1,29434,0.146261536257871,0.00555474429832995,0.135374237433144,0.157148835082598,4.79202265492639e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBAG9,Receptor-binding cancer antigen expressed on SiSo cells,29218,0.170521774290452,0.00648209513028956,0.157816867835084,0.18322668074582,9.23441810108731e-151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE1,Plasminogen activator inhibitor 1,29820,0.120382086148527,0.00458410904377351,0.111397232422731,0.129366939874323,2.77103851896035e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP43,Centrosomal protein 43,28705,0.12503268008562,0.00476296123157166,0.11569727607174,0.134368084099501,4.13289100340772e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLK1,Protein delta homolog 1,29820,0.100037692545876,0.00381293605823965,0.0925643378717262,0.107511047220026,5.17936685323727e-150
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP5,Tartrate-resistant acid phosphatase type 5,29604,0.0587899800361426,0.00224429654192063,0.0543911588139782,0.063188801258307,1.52985593337808e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCAMP3,Secretory carrier-associated membrane protein 3,29349,0.151244317668017,0.00578084487427251,0.139913861714443,0.162574773621591,3.61646369169127e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH2,Neutral ceramidase,29218,0.0948070679066474,0.00362515744091151,0.0877017593224609,0.101912376490834,4.81157981868997e-149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAMR,High affinity immunoglobulin alpha and immunoglobulin mu Fc receptor,24922,0.129673962315031,0.00496284560643663,0.119946784926415,0.139401139703647,1.71471561280864e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS53,Vacuolar protein sorting-associated protein 53 homolog,29349,0.136950936049105,0.00524769168361519,0.12666546034922,0.147236411748991,1.93803501337994e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIT1,ARF GTPase-activating protein GIT1,24229,0.17399427874098,0.00665899033867592,0.160942657677175,0.187045899804785,1.93810558590737e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM5,Tripartite motif-containing protein 5,29434,0.153189539137991,0.00587437206462597,0.141675769891324,0.164703308384658,3.17483255264233e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC1,Stanniocalcin-1,29694,0.0775187372186179,0.00297477457279101,0.0716881790559475,0.0833492953812883,4.97471619210013e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS8,Prostasin,29347,0.0731664618586845,0.00280836155564808,0.0676620732096142,0.0786708505077547,6.00314764471612e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2B3,SH2B adapter protein 3,28797,0.174824891497506,0.0067104881825351,0.161672334659737,0.187977448335274,6.55591375857151e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB6,DnaJ homolog subfamily B member 6,24170,0.151246326262748,0.00580020102096412,0.139877932261658,0.162614720263838,7.5767516715871e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP8,Ubiquitin carboxyl-terminal hydrolase 8,28916,0.170889207565089,0.00656118881459133,0.15802927748849,0.183749137641688,7.71602572754411e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNST,Consortin,29478,0.192836843713907,0.00740718484498533,0.178318761417735,0.207354926010078,9.6590950367363e-148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP2B,DNA topoisomerase 2-beta,24229,0.14190739833908,0.00544693177337705,0.131231412063261,0.1525833846149,1.35461338447457e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSD,Cathepsin D,27442,0.0723427652054224,0.00278112897046777,0.0668917524233056,0.0777937779875392,2.22439279466074e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CES2,Cocaine esterase,29349,0.0970350619515713,0.00374035679420327,0.0897039626349329,0.10436616126821,9.95230508439342e-147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEP1,Rab GTPase-binding effector protein 1,24381,0.138433348169846,0.00533934896434724,0.127968224199725,0.148898472139966,3.17743363802099e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB1,Transforming growth factor beta-1 proprotein,29760,0.0678472374722343,0.00262225299324445,0.0627076216054752,0.0729868533389934,5.45372740776812e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK2A1,Casein kinase II subunit alpha,24867,-0.0796344673542686,0.00307457540277916,-0.0856606351437157,-0.0736082995648214,5.62093990874868e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS6,Growth arrest-specific protein 6,29639,-0.045108114540946,0.00174414088470801,-0.0485266306749737,-0.0416895984069183,7.31290419201002e-146
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THPO,Thrombopoietin,28916,0.06830851188715,0.00264272923579288,0.063128762584996,0.0734882611893041,1.17009908080602e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPR1,"Inositol 1,4,5-trisphosphate receptor type 1",24240,0.12280949170481,0.00474753008151487,0.11350433274504,0.132114650664579,1.44307212261766e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOMM20,Mitochondrial import receptor subunit TOM20 homolog,24922,0.136326042439251,0.00527174669105885,0.125993418924775,0.146658665953726,1.57543662087513e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD5,Programmed cell death protein 5,29694,0.102308533584114,0.00396178849799579,0.0945434281280421,0.110073639040186,1.94084080623035e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKAP2,Src kinase-associated phosphoprotein 2,29581,0.184002505608357,0.0071286131841907,0.170030423767344,0.197974587449371,2.66589143944313e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRHPR,Glyoxylate reductase/hydroxypyruvate reductase,24922,0.112628937303471,0.00436054098856073,0.104082276965892,0.12117559764105,3.40953650241234e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB3,Plexin-B3,29383,0.0834680167601167,0.00323883498949797,0.0771199001807007,0.0898161333395327,7.66213676742063e-145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP3B1,AP-3 complex subunit beta-1,24805,0.134881189860408,0.00524395388145232,0.124603040252761,0.145159339468054,5.23622225834238e-144
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CMC1,COX assembly mitochondrial protein homolog,24922,0.158964968322883,0.00620135001520207,0.146810322293087,0.171119614352679,4.57805596149489e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAB2,TGF-beta-activated kinase 1 and MAP3K7-binding protein 2,24445,0.185488593124133,0.00723896055526345,0.171300230435816,0.199676955812449,6.42473569127873e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFB,Platelet-derived growth factor subunit B,29581,0.149984554670302,0.00586145044044848,0.138496111807023,0.161472997533581,7.41038909121099e-143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZFYVE19,Abscission/NoCut checkpoint regulator,24805,0.158905972140967,0.00620672598659264,0.146740789207245,0.171071155074688,1.03154296595795e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2,Prothrombin,24966,0.0259589196092948,0.00101420201881754,0.0239710836524125,0.0279467555661772,1.19011637881402e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1S,Complement C1s subcomponent,24966,0.036646119773757,0.00143219252364447,0.0338390224274139,0.0394532171201002,1.4528610478799e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIBF1,"Progesterone-induced-blocking factor 1, Isoform 4",24867,0.13559872307116,0.00530085700785795,0.125209043335759,0.145988402806562,1.75471380348144e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP5,Fatty acid-binding protein 5,29624,0.118977338002345,0.00465770046895801,0.109848245083187,0.128106430921503,2.22423851424255e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN3A2,Butyrophilin subfamily 3 member A2,29434,0.0660717529541627,0.00259008153088591,0.0609951931536264,0.0711483127546991,5.41870052248615e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP3,Fibroblast growth factor-binding protein 3,24845,0.0644473237822348,0.0025248078323707,0.0594987004307882,0.0693959471336813,6.92292304317909e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF1,Wiskott-Aldrich syndrome protein family member 1,28916,0.163146196734998,0.0064003718702529,0.150601467869302,0.175690925600694,9.37060242809063e-142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRAP,BRCA1-associated protein,24565,0.19148740127556,0.00750608262641658,0.176775479327784,0.206199323223337,1.04577379042856e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTBDN,Retbindin,29349,0.0517089572966685,0.00202977554604081,0.0477305972264285,0.0556873173669085,1.28994266447445e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST6GAL1,"Beta-galactoside alpha-2,6-sialyltransferase 1",29820,0.0507742574808821,0.00199584259098672,0.0468624060025482,0.0546861089592161,2.93784285473538e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD1,Protein disulfide isomerase CRELD1,24381,0.0653969552486066,0.00256775135131543,0.0603641626000284,0.0704297478971848,3.09706083798281e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH2,Cadherin-2,29478,0.0616435488432343,0.0024232085112973,0.0568940601610916,0.066393037525377,3.14961373855893e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC5,Glypican-5,29218,0.0979453095732792,0.00385434730443469,0.0903907888565872,0.105499830289971,6.39117441437569e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGCC,Regulator of cell cycle RGCC,24867,0.131610584863013,0.0051760790184571,0.121465469986837,0.141755699739189,8.07534358830676e-141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BID,BH3-interacting domain death agonist,29434,0.11585234936738,0.00456313755232776,0.106908599764818,0.124796098969943,1.10165197847777e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOPC,Golgi-associated PDZ and coiled-coil motif-containing protein,29434,0.17528131662565,0.00691721941866606,0.161723566565065,0.188839066686236,3.71494049618163e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPHN1,Oligophrenin-1,24845,0.186547587582344,0.00736025393100954,0.172121489877565,0.200973685287123,6.09733709769967e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAG1,Dystroglycan,29581,0.0821773751203949,0.00324699522390703,0.0758132644815371,0.0885414857592527,7.90594485382759e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANG,Angiogenin,29435,0.0584184883033489,0.00230873068523137,0.0538933761602955,0.0629436004464024,9.20411282655206e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL13,C-C motif chemokine 13,29732,0.119547415523718,0.00472545577042084,0.110285522213693,0.128809308833743,9.99534709020176e-140
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC27,Cell division cycle protein 27 homolog,28797,0.10539854328539,0.00416765160843901,0.0972299461328497,0.113567140437931,1.3908038222785e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL3,C-X-C motif chemokine 3,29453,0.162791262100091,0.00644419727115951,0.150160635448618,0.175421888751564,2.57605878254603e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GASK1A,Golgi-associated kinase 1A,24111,0.0746029204396137,0.00295000525301639,0.0688209101437016,0.0803849307355258,2.76111071513803e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT1S1,Proline-rich AKT1 substrate 1,28774,0.116040974866737,0.00459417066272495,0.107036400367796,0.125045549365678,3.03238951702615e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNMBP,Dynamin-binding protein,29218,0.10572966014417,0.00418812093930765,0.0975209431031268,0.113938377185213,3.9871298932434e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT2,Omega-amidase NIT2,24813,0.128812756624958,0.00509919560440098,0.118818333240332,0.138807180009584,4.86784159181677e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRELD2,Protein disulfide isomerase CRELD2,29536,0.0898353465961575,0.00356112386053712,0.0828555438295047,0.0968151493628102,6.06757940887624e-139
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK11,Serine/threonine-protein kinase STK11,28916,0.125897888878973,0.00499662812379729,0.11610449775633,0.135691280001616,1.37182693482483e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP45,Rho GTPase-activating protein 45,24381,0.14262128413854,0.00565549592006461,0.131536512135214,0.153706056141867,1.51464318688416e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCLS1,Hematopoietic lineage cell-specific protein,29786,0.0958224630336358,0.00380663625619759,0.0883614559714885,0.103283470095783,2.252102007583e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAPGEF2,Rap guanine nucleotide exchange factor 2,24445,0.0918575765885898,0.00364594548297429,0.0847115234419602,0.0990036297352194,2.68722956437131e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYTL4,Synaptotagmin-like protein 4,24922,0.125803000406528,0.00499510868456864,0.116012587384773,0.135593413428282,3.12204255656986e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP25,Ubiquitin carboxyl-terminal hydrolase 25,24793,0.124434863887755,0.00494095872745629,0.114750584781941,0.13411914299357,3.25622021624498e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIRBP,Cold-inducible RNA-binding protein,24805,0.165063878744529,0.00656220294357849,0.152201960975116,0.177925796513943,6.89968351950801e-138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIRC2,Baculoviral IAP repeat-containing protein 2,28797,0.108805277280346,0.00433635242636624,0.100306026524668,0.117304528036024,1.85619798550971e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP2,Methionine aminopeptidase 2,29674,0.0987012058534579,0.00393434120472758,0.0909898970921919,0.106412514614724,1.86977729193366e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGD3,"FYVE, RhoGEF and PH domain-containing protein 3",24867,0.137572533275612,0.005479041494727,0.126833611945948,0.148311454605277,2.05511282057407e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAA1,"3-ketoacyl-CoA thiolase, peroxisomal",28797,0.141887672820152,0.00565732392613732,0.130799317924923,0.152976027715382,2.43730650431917e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA5,Integrin alpha-5,29443,0.0429940112187511,0.00171510616316697,0.0396324031389438,0.0463556192985583,3.07997275372811e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MITD1,MIT domain-containing protein 1,29218,0.165900633172455,0.00661785643042593,0.15292963456882,0.178871631776089,3.097591386677e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EREG,Proepiregulin,29163,0.137737671945552,0.00549914675209902,0.126959344311438,0.148515999579667,5.29084148858415e-137
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD1,Sushi domain-containing protein 1,28916,0.0839150624443019,0.00335508508405658,0.077339095679551,0.0904910292090528,1.30963996423429e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYN,Tyrosine-protein kinase Lyn,29349,0.144374036073056,0.00577526137152239,0.133054523784872,0.155693548361239,1.69916213739044e-136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZI2,5-azacytidine-induced protein 2,24867,0.0944223020221136,0.00378543992596724,0.0870028397672178,0.101841764277009,1.17026895928361e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACC3,Transforming acidic coiled-coil-containing protein 3,29349,0.198210457460757,0.00796445983231063,0.182600116189428,0.213820798732086,2.62071754589955e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4G3,Eukaryotic translation initiation factor 4 gamma 3,24867,0.112281704238375,0.00450823773421364,0.103445558279317,0.121117850197434,2.92781575469528e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSG,Alpha-2-HS-glycoprotein,24951,0.0458259160897644,0.00184199394895741,0.0422156079498079,0.049436224229721,5.63966901842867e-135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYOU1,Hypoxia up-regulated protein 1,29820,0.0378560180023629,0.00152641656052731,0.0348642415437294,0.0408477944609965,2.04219402499313e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMN,Protein amnionless,28931,0.0804913866672622,0.00325319963095879,0.074115115390583,0.0868676579439415,9.2732277990443e-134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRL,Appetite-regulating hormone,29478,0.13679747006714,0.00553263596527,0.12595350357521,0.147641436559069,1.31057005011515e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LZTFL1,Leucine zipper transcription factor-like protein 1,24381,0.121395945435561,0.00490927969253646,0.111773757238189,0.131018133632932,2.36446352165392e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDLIM5,PDZ and LIM domain protein 5,24867,0.200528902595169,0.00811085136549373,0.184631633918802,0.216426171271537,2.44031496762333e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSIP1,PC4 and SFRS1-interacting protein,29434,0.107943299562316,0.00437083824830016,0.0993764565956476,0.116510142528984,2.67955344608182e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCC,Tubulin-specific chaperone C,29218,0.136826478562808,0.00554105481117378,0.125966011132907,0.147686945992709,2.95008750378617e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDHD2,Phospholipase DDHD2,24867,0.112176473294959,0.00454025238757506,0.103277578615312,0.121075367974606,3.62974546805199e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL3,Angiopoietin-related protein 3,29518,0.0602192548485429,0.00244000892756198,0.0554368373505214,0.0650016723465643,3.94374725502092e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGFL2,Hepatoma-derived growth factor-related protein 2,24845,0.106742082990742,0.00432454270862668,0.0982659792818339,0.115218186699651,6.53789270504117e-133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBPL,FK506-binding protein-like,24805,0.0998843117181167,0.00405388760393084,0.0919386920144123,0.107829931421821,1.88689679770298e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR,GMP reductase 1,29786,0.0836192000507661,0.00340000451357916,0.076955191204151,0.0902832088973813,3.07639264897029e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMSAP1,Calmodulin-regulated spectrin-associated protein 1,24867,0.180515940970101,0.00733573779143879,0.166137894898881,0.194893987041321,3.98259143345324e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBR,Delta(14)-sterol reductase LBR,29694,0.112257409296156,0.00457212738133314,0.103296039628743,0.121218778963569,8.40821033438799e-132
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN1,Pantetheinase,24951,0.122262722433805,0.00498481674077775,0.112492481621881,0.13203296324573,2.73634110206572e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,A1BG,Alpha-1B-glycoprotein,24966,0.0287346038776251,0.00117158123034543,0.026438304666148,0.0310309030891021,2.77551153797079e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAMBP,STAM-binding protein,29163,0.10731267541741,0.00438298570025763,0.0987220234449047,0.115903327389915,4.63017427712717e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D23,TBC1 domain family member 23,29349,0.150544876650123,0.00614897672567007,0.13849288226781,0.162596871032437,4.65377428109628e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRKL,Crk-like protein,29491,0.177720758855043,0.00726358358852616,0.163484135021531,0.191957382688554,6.66508222003537e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGFR,Opioid growth factor receptor,29349,0.0547799187348024,0.00223907553433435,0.0503913306875071,0.0591685067820977,7.08544280682785e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDAH1,"N(G),N(G)-dimethylarginine dimethylaminohydrolase 1",29349,0.0738175126853359,0.00301849398058323,0.0679012644833927,0.079733760887279,9.08170607434156e-131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD1,COMM domain-containing protein 1,24240,0.10246111470968,0.00420095418352884,0.0942272445099637,0.110694984909397,8.04037404592901e-130
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGF,Hepatocyte growth factor,29786,0.0573694186461604,0.00235696452384102,0.052749768179432,0.0619890691128887,1.35728363392253e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM13A,Protein FAM13A,24805,0.112623982979601,0.004630007790381,0.103549167710454,0.121698798248747,3.50385916381801e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIGYF2,GRB10-interacting GYF protein 2,24867,0.126688994726483,0.00520940544947737,0.116478560045508,0.136899429407459,3.96092915941715e-129
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBNL,Drebrin-like protein,29581,0.153584867568512,0.00633576576815995,0.141166766662918,0.166002968474105,1.48487322443611e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAO1,Hydroxyacid oxidase 1,29725,0.212441108157934,0.00877434727536853,0.195243387498212,0.229638828817656,2.94230098495543e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA5A,"Carbonic anhydrase 5A, mitochondrial",28916,0.152298564229903,0.00629447971051592,0.139961383997292,0.164635744462514,4.66173847951158e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESM1,Endothelial cell-specific molecule 1,29454,-0.0568197732950824,0.00234941759342754,-0.0614246317782003,-0.0522149148119644,5.73590474318537e-128
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI5,Ecotropic viral integration site 5 protein homolog,24229,0.149475101728709,0.00618207914511844,0.137358226604277,0.161591976853141,1.21337841424317e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAPDH,Glyceraldehyde-3-phosphate dehydrogenase,23850,0.0549003821043871,0.00227229200273633,0.0504466897790239,0.0593540744297503,1.95976440805354e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXT,Oxytocin-neurophysin 1,29694,0.229918289324229,0.00953415208971583,0.211231351228386,0.248605227420072,2.90793349724078e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFB7,NADH dehydrogenase [ubiquinone] 1 beta subcomplex subunit 7,24805,0.147197839252761,0.00610037306869295,0.135241108038123,0.159154570467399,3.60679545594701e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIT1,Signaling threshold-regulating transmembrane adapter 1,28931,0.0912589754494538,0.00378570752661819,0.0838389886972822,0.0986789622016255,3.87696308171527e-127
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTPBP2,GTP-binding protein 2,24195,0.133371052559207,0.00554392015659844,0.122504969052274,0.14423713606614,2.1477730732688e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QDPR,Dihydropteridine reductase,29345,0.0709835562795516,0.00295458125415457,0.0651925770214087,0.0767745355376946,2.54351425003621e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDON,Cell adhesion molecule-related/down-regulated by oncogenes,29497,0.0440130891977741,0.00183222217839057,0.0404219337281285,0.0476042446674196,2.70495994327878e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAX1BP1,Tax1-binding protein 1,24845,0.103894784132636,0.00432882420935867,0.0954102886822926,0.112379279582979,7.42512318393243e-126
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCPEP1,Retinoid-inducible serine carboxypeptidase,24138,0.0824205657469365,0.00343801038191255,0.0756820653983879,0.0891590660954851,1.5521898491556e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT5,"Keratin, type II cytoskeletal 5",28774,0.0837112517974121,0.00349524303685811,0.0768605754451702,0.090561928149654,1.56771183330239e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB27B,Ras-related protein Rab-27B,24922,0.134931310224595,0.0056333193940378,0.123890004212281,0.14597261623691,2.28613126589238e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON2,Serum paraoxonase/arylesterase 2,28916,0.0569709344127824,0.00238052713878719,0.0523051012207595,0.0616367676048053,2.36038237843862e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM21,E3 ubiquitin-protein ligase TRIM21,29434,0.125930646315523,0.00526822626412152,0.115604922837844,0.136256369793201,4.36766679396766e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEFTY2,Left-right determination factor 2,29674,0.0850555212761076,0.0035590335383511,0.0780798155409394,0.0920312270112758,4.84104213786324e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC4,Syndecan-4,29478,0.0758807320270913,0.00317575368090583,0.0696562548125159,0.0821052092416667,5.5057336704132e-125
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS8,Galectin-8,29694,0.0992441660517267,0.00415813596402042,0.0910942195622467,0.107394112541207,1.00095176164282e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF11,Tumor necrosis factor ligand superfamily member 11,29434,0.0999138566241446,0.00418830338689966,0.0917047819858212,0.108122931262468,1.3584796276153e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F11,Coagulation factor XI,24606,0.0506964334923673,0.00212680476377094,0.0465278961553762,0.0548649708293583,3.54886666128632e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1CC,Serine/threonine-protein phosphatase PP1-gamma catalytic subunit,24793,0.13567454150212,0.0056954267887712,0.124511504996129,0.146837578008112,4.94356221501169e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLG,Plasminogen,24421,0.0361983014128196,0.00151985624566351,0.0332193831713192,0.0391772196543201,5.79389458808075e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYDGF,Myeloid-derived growth factor,24922,0.163097946284074,0.00685197490036137,0.149668075479365,0.176527817088782,7.50582466459857e-124
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGK,N-acetyl-D-glucosamine kinase,24209,0.0926154252998598,0.00390183981653095,0.0849678192594592,0.100263031340261,3.88736284987503e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIR,V-type immunoglobulin domain-containing suppressor of T-cell activation,29426,0.0995039823208391,0.00419673318444213,0.0912783852793326,0.107729579362346,4.08576413111453e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GORASP2,Golgi reassembly-stacking protein 2,24805,0.0768159797164552,0.00324071037425938,0.0704641873829068,0.0831677720500036,7.73365179477642e-123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD36,Platelet glycoprotein 4,24229,0.0735558623193696,0.00310807027868628,0.0674640445731445,0.0796476800655947,1.97959447320957e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5IF1,"ATPase inhibitor, mitochondrial",29581,0.178159846833307,0.00753944906098252,0.163382526673782,0.192937166992833,2.56382625685859e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PACS2,Phosphofurin acidic cluster sorting protein 2,24111,0.10103078279809,0.00427093834602728,0.0926597436398769,0.109401821956304,2.57472793449e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC7,Sialic acid-binding Ig-like lectin 7,29478,0.0454247191088109,0.00192492219059491,0.0416518716152449,0.0491975666023769,5.45639577241613e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS1BP3,HCLS1-binding protein 3,24240,0.146167052541133,0.00619040370889624,0.134033861271697,0.15830024381057,6.93284501812931e-122
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOK1,Docking protein 1,24845,0.221062595989214,0.00937064300923431,0.202696135691115,0.239429056287313,1.04180334770178e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHMT1,"Serine hydroxymethyltransferase, cytosolic",29536,0.139350410956601,0.00591238732563486,0.127762131798357,0.150938690114845,1.06310918259053e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGA,Protein O-GlcNAcase,24805,0.114378414527528,0.00484872056461272,0.104874922220887,0.123881906834169,1.08568424844278e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IST1,IST1 homolog,24636,0.160634881561933,0.00681474298471655,0.147277985311889,0.173991777811978,1.66974374643873e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELE,E-selectin,29820,0.0812814370136443,0.00345324967078615,0.0745130676589035,0.0880498063683852,2.15537862375555e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX15,Sorting nexin-15,24381,0.0873837012522971,0.00370882524988188,0.0801144037625286,0.0946529987420656,2.20451788806472e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSP1,Lymphocyte-specific protein 1,29434,0.064801401737113,0.00275522452253968,0.0594011616729353,0.0702016418012908,3.39454202675278e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFKFB2,"6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 2",29301,0.121867610416752,0.00518486123879145,0.111705282388721,0.132029938444783,4.85239057984448e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPHOSPH8,M-phase phosphoprotein 8,28916,0.122023787842657,0.00519320223625154,0.111845111459604,0.13220246422571,5.99433800279303e-121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99L2,CD99 antigen-like protein 2,29443,0.0389121179360523,0.00166148092157928,0.0356556153297569,0.0421686205423477,3.35744314227503e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARS1,"Methionine--tRNA ligase, cytoplasmic",24329,0.137813332484811,0.00587909196186909,0.126290312239548,0.149336352730074,3.4952125562464e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL2,Interleukin-1 receptor-like 2,28931,0.0631900484592722,0.00269960896110792,0.0578988148955007,0.0684812820230437,4.7370820251901e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC13,Mucin-13,28774,0.0826931646294646,0.00353340651108903,0.0757676878677301,0.0896186413911991,5.25062553458824e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSRA,Mitochondrial peptide methionine sulfoxide reductase,29566,0.1160851956939,0.00496313018373203,0.106357460533786,0.125812930854015,6.72516857062208e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF2,TNF receptor-associated factor 2,29434,0.112822828392893,0.00482635025506104,0.103363181892974,0.122282474892813,9.18807781181757e-120
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLGA3,Golgin subfamily A member 3,24867,0.12463314725392,0.00534903072787332,0.114149047027288,0.135117247480551,8.30176439870561e-119
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTDH,Protein LYRIC,24229,0.148444507708348,0.00638788182988153,0.135924259321781,0.160964756094916,3.65647385702528e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASHC3,WASH complex subunit 3,24845,0.120128649974239,0.00517242783244839,0.109990691422641,0.130266608525838,4.63914633139043e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP8,Vesicle-associated membrane protein 8,24229,0.140673029630412,0.00605651001922893,0.128802269992724,0.152543789268101,4.77342688344779e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBL1X,F-box-like/WD repeat-containing protein TBL1X,28797,0.135076035171781,0.00582215838605005,0.123664604735123,0.146487465608439,5.47474647928828e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILPL2,RILP-like protein 2,24922,0.155994719010829,0.006719107184678,0.14282526892886,0.169164169092798,5.54548531712928e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIA1,Nucleolysin TIA-1 isoform p40,28538,0.194110011684886,0.00836900499252736,0.177706761899533,0.21051326147024,6.48141373229219e-118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1A,Meprin A subunit alpha,24805,0.11455782902968,0.00494250123154493,0.104870526615852,0.124245131443508,1.34853677489512e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TWF2,Twinfilin-2,24938,0.13306877916328,0.00575533450832937,0.121788323526955,0.144349234799606,4.86322848870179e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAT2,Signal transducer and activator of transcription 2,24229,0.123003728773336,0.00532192182606571,0.112572761994248,0.133434695552425,6.36934835626724e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOLM2,Protein GOLM2,29694,0.0357933343802961,0.00155085544756773,0.0327536577030634,0.0388330110575289,7.92015401034704e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP4,"Fatty acid-binding protein, adipocyte",29820,0.0790795374596814,0.00342755864105273,0.0723615225232181,0.0857975523961448,9.41661563072976e-117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP3,Metalloproteinase inhibitor 3,29581,0.205535803631517,0.00891097068968148,0.188070301079741,0.223001306183293,1.1046430901961e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NIT1,Deaminated glutathione amidase,24240,0.074973829909255,0.00324819502187267,0.0686073676663845,0.0813402921521254,1.28229562288473e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT5,ADP-sugar pyrophosphatase,29443,0.0809219919895939,0.00351169942159208,0.0740390611232734,0.0878049228559144,1.83716796963861e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME1,Proteasome activator complex subunit 1,29192,0.0586458043230836,0.00254641437561198,0.0536548321468842,0.0636367764992831,2.50586975956286e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NSFL1C,NSFL1 cofactor p47,29694,0.102488473805258,0.00445971937129936,0.0937474238375117,0.111229523773005,7.43899484290277e-116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKA,Diacylglycerol kinase alpha,24229,0.0863276791228825,0.0037574207405407,0.0789631344714228,0.0936922237743423,1.41977168250818e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF12,Tumor necrosis factor ligand superfamily member 12,29786,0.0450845609947193,0.00196543902652463,0.0412323005027311,0.0489368214867076,1.91949973012624e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGLL,Monoglyceride lipase,29536,0.136418283602044,0.00595037730023956,0.124755544093575,0.148081023110514,2.60562448092717e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAVS,Mitochondrial antiviral-signaling protein,28797,0.144295797096292,0.00629716297695716,0.131953357661456,0.156638236531128,3.5879836857659e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT10,Polypeptide N-acetylgalactosaminyltransferase 10,29349,0.0438457396737492,0.00191684304977331,0.0400887272961935,0.0476027520513048,8.54764832823368e-115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GLB2,Endophilin-B2,24845,0.104263550493413,0.00456385315595835,0.0953183983077347,0.113208702679091,2.44652631849634e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPKOW,G-patch domain and KOW motifs-containing protein,28774,0.0438352198339224,0.00192014827496079,0.0400717292149993,0.0475987104528456,2.4531682162606e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY4,Protein canopy homolog 4,29349,0.117325587755528,0.00514021663031751,0.107250763160106,0.127400412350951,2.56789033768294e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAR1A,cAMP-dependent protein kinase type I-alpha regulatory subunit,29478,0.130208700475737,0.00571025171136223,0.119016607121467,0.141400793830007,4.20573070525324e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YARS1,"Tyrosine--tRNA ligase, cytoplasmic",24805,0.229460315432437,0.0100675257364546,0.209727964988986,0.249192665875888,8.12024072261576e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG4,BAG family molecular chaperone regulator 4,24229,0.0774639307357323,0.0033994021268019,0.0708011025672006,0.084126758904264,9.58883452202624e-114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPART,Spartin,24381,0.121027023876834,0.00531183815994072,0.11061582108335,0.131438226670318,1.01087150864724e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FIS1,Mitochondrial fission 1 protein,29453,0.120370129399887,0.00528985725889258,0.110002009172458,0.130738249627317,1.22898213925578e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPSCR1,Tether containing UBX domain for GLUT4,24867,0.105421843127222,0.00463485603004308,0.0963375253083372,0.114506160946106,2.28963811061941e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40,Tumor necrosis factor receptor superfamily member 5,29453,0.0776551639511701,0.00342654074729206,0.0709391440864776,0.0843711838158625,9.62566204267054e-113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFA,Vascular endothelial growth factor A,29683,0.0897415776966565,0.00396112013894685,0.0819777822243207,0.0975053731689923,1.11223699252643e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPP,Lipoma-preferred partner,24111,0.103466127898486,0.00457065017183811,0.0945076535616838,0.112424602235289,2.77472479535711e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOT,Angiomotin,24381,0.0625199099955967,0.00276676717609134,0.0570970463304577,0.0679427736607357,6.59475123892771e-112
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXN,Paxillin,28774,0.0797637329567451,0.00353644083286558,0.0728323089243286,0.0866951569891616,1.12280093461202e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDRKH,Tudor and KH domain-containing protein,28774,0.131615513147999,0.00583636470052246,0.120176238334975,0.143054787961023,1.2233980123552e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APPL2,DCC-interacting protein 13-beta,24381,0.173561239023354,0.0076958838396437,0.158477306697653,0.188645171349056,1.75820977058008e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F12,Coagulation factor XII,24966,0.0643195785824554,0.00285394985435762,0.0587258368679144,0.0699133202969963,2.32858962009036e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14A,Protein phosphatase 1 regulatory subunit 14A,24867,0.122446384861866,0.00543602325435692,0.111791779283327,0.133100990440406,3.07044250729666e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA11,Annexin A11,29373,0.103124121762478,0.00458363633114541,0.0941401945534331,0.112108048971523,3.75851932602434e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRFIP1,Leucine-rich repeat flightless-interacting protein 1,24793,0.0744018151495673,0.00330861006254015,0.0679169394269886,0.080886690872146,7.1108288686969e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAK4,Interleukin-1 receptor-associated kinase 4,29434,0.160944397926119,0.00716293768081622,0.146905040071719,0.174983755780519,7.15553340807813e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK,Neuroblast differentiation-associated protein AHNAK,24240,0.0488856752860334,0.00217409898911915,0.0446244412673598,0.0531469093047069,7.84503512877222e-111
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM40,E3 ubiquitin ligase TRIM40,24195,0.111569106301622,0.00496562937870478,0.10183647271936,0.121301739883883,1.15244853395306e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COCH,Cochlin,24922,0.0713174006203207,0.00317778043677831,0.0650889509642352,0.0775458502764061,1.88635383101282e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTI1A,Vesicle transport through interaction with t-SNAREs homolog 1A,24381,0.0894943796806248,0.00398741511680616,0.0816790460516847,0.0973097133095649,1.9206554781131e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON2,Spondin-2,29311,-0.0536069893119943,0.00239276598399432,-0.0582968106406232,-0.0489171679833654,3.05525438967406e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSB,Arylsulfatase B,29349,0.0847602243458941,0.00378379060736195,0.0773439947554647,0.0921764539363236,3.2481780875207e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R2,Protein phosphatase inhibitor 2,29478,0.122628582486761,0.00547876657191085,0.111890200005816,0.133366964967707,4.82543208333894e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGS,Hepatocyte growth factor-regulated tyrosine kinase substrate,28797,0.119578946444308,0.00534572210371127,0.109101331121034,0.130056561767582,6.81546119770507e-110
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSNA1,Sjoegren syndrome nuclear autoantigen 1,24805,0.0784862182120945,0.00351040672674572,0.0716058210276729,0.0853666153965161,1.22114678705597e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ORM1,Alpha-1-acid glycoprotein 1,24846,0.0307145669491427,0.00137422115566123,0.0280210934840467,0.0334080404142387,1.43794590072166e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASC3,Protein CASC3,24195,0.0643994339236849,0.00288221584671058,0.0587502908641321,0.0700485769832376,1.78350166995597e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNLR1,Interferon lambda receptor 1,29434,0.0567347592602061,0.00254435520096882,0.0517478230663072,0.061721695454105,3.09098613783005e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAX,Protein max,28774,0.161153788839458,0.00722689366841481,0.146989077249365,0.175318500429551,3.17787728591497e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST13,Hsc70-interacting protein,24381,0.0855115510061223,0.00383388558463258,0.0779971352602424,0.0930259667520021,4.16562259367773e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNRD1,"Thioredoxin reductase 1, cytoplasmic",29443,0.0704783342945011,0.00316264252432153,0.0642795549468309,0.0766771136421713,4.16910352277299e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIAE,Sialate O-acetylesterase,29495,0.0712921969480388,0.00319956948101395,0.0650210407652514,0.0775633531308261,4.41991343539414e-109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICA1,Islet cell autoantigen 1,28931,0.121579612140247,0.00546516356696825,0.110867891548989,0.132291332731505,1.00260497726492e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDUA,Alpha-L-iduronidase,29725,0.0703862439146509,0.00316482230841107,0.0641831921901652,0.0765892956391366,1.0841563670585e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4G,C-type lectin domain family 4 member G,29434,0.0507494820837049,0.00228339874822366,0.0462740205371865,0.0552249436302233,1.52882548948376e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPRIP,Myosin phosphatase Rho-interacting protein,24729,0.0676816116210298,0.00304400606860669,0.0617153597265607,0.073647863515499,1.85027914525766e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMKK1,Calcium/calmodulin-dependent protein kinase kinase 1,28797,0.0679554571856302,0.00306083301816285,0.061956224470031,0.0739546899012294,2.69176121326842e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHMP1A,Charged multivesicular body protein 1a,29218,0.120723052108174,0.00545007289912961,0.11004090922588,0.131405194990468,7.9457580175083e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GYS1,"Glycogen [starch] synthase, muscle",28916,0.141290748362476,0.0063808037990825,0.128784372916275,0.153797123808678,9.58513020647952e-108
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PENK,Proenkephalin-A,24381,0.04702512055878,0.00212269786858072,0.0428646327363618,0.0511856083811982,1.11757589377017e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RWDD1,RWD domain-containing protein 1,29694,0.0964025977830398,0.00435783693916373,0.0878612373822789,0.104943958183801,1.45020658046468e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED18,Mediator of RNA polymerase II transcription subunit 18,28797,0.115741146443205,0.00524203945937559,0.105466749102829,0.126015543783582,3.87096637827074e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAMD9L,Sterile alpha motif domain-containing protein 9-like,29434,0.109524421577364,0.0049683968912353,0.0997863636705428,0.119262479484185,7.96439266877448e-107
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOCS2,Molybdopterin synthase catalytic subunit,24381,0.101800503472189,0.00461900027008416,0.0927472629428237,0.110853744001554,1.32608032811007e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGF,Placenta growth factor,29786,0.0395557785005936,0.00180137932207813,0.0360250750293205,0.0430864819718667,4.9845298870097e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM17,Splicing factor 45,24867,0.115428953875,0.00525375433151286,0.105131595385235,0.125726312364765,5.60132487432935e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH2D1A,SH2 domain-containing protein 1A,29434,0.086057247227624,0.00392249942668688,0.0783691483513177,0.0937453461039302,7.73002291846762e-106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDC,Nuclear migration protein nudC,29786,0.0951596504302417,0.0043483452279744,0.0866368937834119,0.103682407077072,2.49494784204242e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD69,Early activation antigen CD69,29344,0.13157717911208,0.00602187546946123,0.119774303191936,0.143380055032224,5.3710942300444e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRAP2,GRB2-related adapter protein 2,29478,0.191589688070171,0.00877496974368804,0.174390747372542,0.2087886287678,7.54942379784859e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGLN1,Egl nine homolog 1,29434,0.0814019729943068,0.00373045163144984,0.0740902877966652,0.0887136581919485,9.95409397306839e-105
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL11,Eotaxin,29786,0.0563471434241535,0.00258614447221241,0.0512783002586172,0.0614159865896898,1.97311331410909e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD207,C-type lectin domain family 4 member K,28835,0.0578341971684483,0.00265433877050376,0.052631693178261,0.0630367011586357,2.07722257805739e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM58,E3 ubiquitin-protein ligase TRIM58,24793,0.129389124840149,0.00593525645823278,0.117756022182013,0.141022227498286,2.21791320019294e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST3,Cystatin-C,29530,0.0423041032742079,0.00194633304897,0.0384892904982267,0.0461189160501891,6.2280784026817e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLG4,Disks large homolog 4,24845,0.105962620686708,0.00487550546523223,0.096406629974853,0.115518611398563,9.14849099056978e-104
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YJU2,Splicing factor YJU2,24793,0.0484299401142056,0.00223060824713374,0.0440579479498234,0.0528019322785877,1.47451214470012e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRADD,Death domain-containing protein CRADD,29163,0.112830195793325,0.00520756612023939,0.102623366197656,0.123037025388994,2.77330879357157e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2L,Ataxin-2-like protein,24867,0.0715882519864804,0.00330763209007843,0.0651052930899267,0.0780712108830341,6.26848057398739e-103
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STIP1,Stress-induced-phosphoprotein 1,29386,0.0960164289111997,0.00444899932457602,0.0872963902350307,0.104736467587369,1.67643318339091e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH2,"Platelet-activating factor acetylhydrolase 2, cytoplasmic",24445,0.073389772837225,0.00340172339636337,0.0667223949803528,0.0800571506940972,2.82293494505933e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFEMP1,EGF-containing fibulin-like extracellular matrix protein 1,29561,-0.0463450466764969,0.00214998643099252,-0.0505590200812423,-0.0421310732717516,2.86001226790105e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK10,Kallikrein-10,29466,0.0592054501063226,0.00274806528191087,0.0538192421537772,0.0645916580588679,3.67810800328491e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA1,von Willebrand factor A domain-containing protein 1,29674,0.0623337177612038,0.00289465363504964,0.0566601966365065,0.0680072388859011,4.52336680520982e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN3,Centrin-3,24805,0.114832266058935,0.0053302985846055,0.104384880833109,0.125279651284762,5.27679903094735e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKG1,cGMP-dependent protein kinase 1,24381,0.185808251915137,0.00862913549592122,0.168895146343131,0.202721357487143,6.86104611770518e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XIAP,E3 ubiquitin-protein ligase XIAP,24229,0.0855551762642343,0.00397511681652171,0.0777639473038517,0.0933464052246168,8.59054343565384e-102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNCG,Gamma-synuclein,29218,0.0986449387027208,0.00459356241010531,0.0896415563789144,0.107648321026527,1.64273073865131e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TALDO1,Transaldolase,24888,0.0657475662698655,0.00305971950486652,0.0597505160403271,0.0717446164994039,1.68578654832717e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRP14,Signal recognition particle 14 kDa protein,29349,0.0877370118991287,0.00408607018839063,0.0797283143298831,0.0957457094683744,1.71398918499297e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMPR2,GMP reductase 2,24381,0.0991546305631681,0.00461717036597725,0.0901049766458527,0.108204284480484,2.31321462836599e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIFBP,KIF-binding protein,29349,0.121393655217585,0.00565782084006537,0.110304326371057,0.132482984064113,2.42166213586335e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX2,Heme oxygenase 2,28774,0.0688610135925674,0.00320959507517143,0.0625702072452314,0.0751518199399034,2.57197704518381e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FARSA,Phenylalanine--tRNA ligase alpha subunit,24195,0.101814180016688,0.00474253193648556,0.0925188174211768,0.1111095426122,2.71907281673078e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD226,CD226 antigen,24229,0.0621246623510688,0.0028969854845803,0.0564465708012914,0.0678027539008461,4.47264948329159e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT2,NAD-dependent protein deacetylase sirtuin-2,29349,0.129918438843496,0.0060637868719637,0.118033416574447,0.141803461112545,4.62707821343402e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMNDC1,Survival of motor neuron-related-splicing factor 30,24805,0.0877756828650173,0.00409489701791662,0.0797496847099007,0.0958016810201339,5.16803669619054e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN1,Tyrosine-protein phosphatase non-receptor type 1,29218,0.115238035941408,0.00538736060937662,0.10467880914703,0.125797262735787,9.73822514470065e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTRA2,"Serine protease HTRA2, mitochondrial",29566,0.0899164059308123,0.00420378481739332,0.0816769876887214,0.0981558241729033,9.75208372847185e-101
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGF,Pro-epidermal growth factor,29379,0.151620090671515,0.00709214735107991,0.137719481863398,0.165520699479631,1.23864253365876e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC5,Thioredoxin domain-containing protein 5,29694,0.0995594092629089,0.00465810275715968,0.0904295278588759,0.108689290666942,1.35698224116815e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APBB1IP,Amyloid beta A4 precursor protein-binding family B member 1-interacting protein,29349,0.0655397495734735,0.00307217207331454,0.059518292309777,0.07156120683717,3.21873469818043e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF3,Immunoglobulin superfamily member 3,29349,0.0525499854614679,0.00246521071187005,0.0477181724662026,0.0573817984567332,4.57702368791433e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP3K5,Mitogen-activated protein kinase kinase kinase 5,28797,0.143924549992839,0.00675310675187934,0.130688460759156,0.157160639226523,5.17758952585422e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53,Cellular tumor antigen p53,28797,0.0639137031863674,0.00300256000610859,0.0580286855743945,0.0697987207983402,8.93101522887782e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT4,Vascular endothelial growth factor receptor 3,29566,0.0491230403004999,0.00230812343363415,0.044599118370577,0.0536469622304229,9.22764302093989e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EHD3,EH domain-containing protein 3,24240,0.171995638417645,0.00807492671929857,0.15616878204782,0.18782249478747,9.34482032679019e-100
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRG2,Developmentally-regulated GTP-binding protein 2,29349,0.0823924031112518,0.0038750339998582,0.0747973364715297,0.0899874697509739,1.43129677714672e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF5,E3 ubiquitin-protein ligase RNF5,24240,0.107362429386671,0.00504924191311484,0.0974659152369657,0.117258943536376,2.02277334689305e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB2,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-2",24845,0.142566198225216,0.00671030618446209,0.12941399810367,0.155718398346762,2.75772694455343e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGBP1,Immunoglobulin-binding protein 1,24867,0.088557926982859,0.00417063720434349,0.0803834780623457,0.0967323759033722,3.55172669635769e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C19orf12,Protein C19orf12,28774,0.0940552276214732,0.00443334482453069,0.085365871765393,0.102744583477553,3.96288704094816e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLB1,Beta-galactosidase,29218,0.0609633870033624,0.00287768437224795,0.0553231256337565,0.0666036483729684,7.31223012131295e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH1A1,Retinal dehydrogenase 1,29443,0.0774376423071436,0.00365712918391597,0.0702696691066683,0.0846056155076189,8.97897764672781e-99
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRY2,Protein sprouty homolog 2,28931,0.134331674663175,0.00635139842999916,0.121882933740377,0.146780415585973,1.54298087697699e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF10,Rho guanine nucleotide exchange factor 10,24867,0.135872811575024,0.00642184578344048,0.123285993839481,0.148459629310568,1.72575648847867e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4D,Semaphorin-4D,29694,0.0434927382431548,0.00205919862274617,0.0394567089425723,0.0475287675437373,2.69045634213543e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DECR1,"2,4-dienoyl-CoA reductase, mitochondrial",29434,0.139338000340206,0.00659824362813966,0.126405442829052,0.15227055785136,2.95252118620937e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRAS,Ras-related protein R-Ras,24195,0.190007177924597,0.00899114230887632,0.172384538999199,0.207629816849994,3.07999838016339e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEXN,Nexilin,24951,0.0998741925804957,0.00473446563064175,0.0905946399444379,0.109153745216554,6.32638008678601e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED8,Protein TMED8,24805,0.149155985891681,0.00707080831919133,0.135297201586066,0.163014770197296,6.46874915615125e-98
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HARS1,"Histidine--tRNA ligase, cytoplasmic",29443,0.11138523263392,0.00530163686028522,0.100994024387761,0.121776440880079,2.77997590873807e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KYAT1,Kynurenine--oxoglutarate transaminase 1,29444,0.0818643848158007,0.0038970042668861,0.0742262564527039,0.0895025131788974,2.93319218963048e-97
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS9,Galectin-9,29453,0.0459105411816827,0.00219201970758392,0.0416141825548182,0.0502068998085472,1.07221904360494e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS1,Galectin-1,29478,0.0492687461148062,0.00235406734814738,0.0446547741124373,0.0538827181171751,1.4662191342544e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMAD3,Mothers against decapentaplegic homolog 3,24793,0.0738328791607427,0.00352757225582466,0.0669188375393263,0.080746920782159,1.94294056091206e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGL1,Fibrinogen-like protein 1,24951,-0.0917761923438167,0.00438596733259231,-0.100372688315698,-0.0831796963719357,2.13971675914825e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDNF,Cerebral dopamine neurotrophic factor,29349,0.0466912149201226,0.00223894080250716,0.0423028909472086,0.0510795388930366,6.94570818601817e-96
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R1,Na(+)/H(+) exchange regulatory cofactor NHE-RF1,24381,0.122303860085951,0.00586572068813684,0.110807047537202,0.133800672634699,1.031859049955e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATOX1,Copper transport protein ATOX1,29566,0.10222853902812,0.00490716371744267,0.0926104981419323,0.111846579914308,1.07194444211559e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN1,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 1",29132,0.0586502053611246,0.00281578645962401,0.0531312639002616,0.0641691468219877,1.17786487185853e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPK,Heterogeneous nuclear ribonucleoprotein K,28787,0.112446813484049,0.00539866509110327,0.101865429905487,0.123028197062612,1.2113300151425e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDAR,Tumor necrosis factor receptor superfamily member EDAR,29434,0.131269934886407,0.00630448536909806,0.118913143562975,0.143626726209839,1.34912020645327e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIABLO,"Diablo homolog, mitochondrial",29395,0.156634813221728,0.00752322853888192,0.141889285285519,0.171380341157936,1.39471102701953e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABGAP1L,Rab GTPase-activating protein 1-like,28931,0.0856703203113538,0.00411546028598022,0.0776040181508326,0.093736622471875,1.53568283411254e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP1BB,Platelet glycoprotein Ib beta chain,24111,0.0979783137118951,0.0047034813761343,0.0887594902146718,0.107197137209118,1.57564398700683e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADD1,Alpha-adducin,24381,0.100213026915765,0.00481324066839976,0.0907790752057017,0.109646978625829,1.92253939418188e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRACR2A,EF-hand calcium-binding domain-containing protein 4B,28797,0.121405171296043,0.00583778809799292,0.109963106623977,0.132847235968109,2.34642959710339e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA1A,Heat shock 70 kDa protein 1A,29536,0.101278409679269,0.00487044741881937,0.0917323327383832,0.110824486620155,2.34669852159891e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT3_FUT5,3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase FUT3_4-galactosyl-N-acetylglucosaminide 3-alpha-L-fucosyltransferase FUT5,29694,-0.0655048997684198,0.0031515553651349,-0.0716819482840842,-0.0593278512527554,2.83069463565674e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBXN1,UBX domain-containing protein 1,24381,0.0986373336755035,0.00474252623001194,0.0893419822646801,0.107932685086327,3.00550373761043e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTFDC1,Phosphoribosyltransferase domain-containing protein 1,28774,0.159702790019401,0.00769738587543413,0.14461591370355,0.174789666335252,6.38853724639148e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2,Ribonucleoside-diphosphate reductase subunit M2,28797,0.0727010471272391,0.00350620877823554,0.0658288779218975,0.0795732163325808,8.27960207592436e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB4,Leukocyte immunoglobulin-like receptor subfamily B member 4,28931,0.062570582924232,0.00301809139743803,0.0566551237852535,0.0684860420632105,8.75904696905797e-95
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ILKAP,Integrin-linked kinase-associated serine/threonine phosphatase 2C,28738,0.0831245241109187,0.00401095140320517,0.0752630593606365,0.0909859888612008,1.0309950241695e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS28,Vacuolar protein sorting-associated protein 28 homolog,24445,0.0948236004402392,0.00457462696171048,0.0858573315952866,0.103789869285192,1.2598311496741e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARP1,Poly [ADP-ribose] polymerase 1,29434,0.0801759490840282,0.00387369195180306,0.0725835128584942,0.0877683853095622,1.7197833074472e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMVK,Phosphomevalonate kinase,28757,0.156232557759451,0.00754824417786602,0.141437999170834,0.171027116348069,1.77177865927137e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXJ3,Forkhead box protein J3,24229,0.0631642564519698,0.00305097595268023,0.0571843435847165,0.069144169319223,2.1414758483277e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP7,Caspase-7,24845,0.119463936667811,0.00577839884065515,0.108138274940127,0.130789598395495,3.67357488813369e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BIN2,Bridging integrator 2,29443,0.127822060460294,0.00618743341582031,0.115694690965286,0.139949429955301,3.8304654076221e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPIG6B,Megakaryocyte and platelet inhibitory receptor G6b,29536,0.108361978563649,0.00524596938528538,0.0980798785684894,0.118644078558808,3.97886663615909e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE5A,"cGMP-specific 3',5'-cyclic phosphodiesterase",24381,0.147940264063341,0.00716130279452552,0.133904110586071,0.161976417540611,5.25950456350739e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AP2B1,AP-2 complex subunit beta,24195,0.0692667562759554,0.00335473170465556,0.0626914821348305,0.0758420304170803,6.64607098793878e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAC1,Zinc phosphodiesterase ELAC protein 1,24867,0.121042804373725,0.00586477394678111,0.109547847438034,0.132537761309416,7.52001669448745e-94
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARC,SPARC,29566,0.0996356260837566,0.00483460646389266,0.090159797414527,0.109111454752986,1.04408935792668e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB1,Pleckstrin homology-like domain family B member 1,24805,0.0751429696515468,0.00364396418054515,0.0680007998576783,0.0822851394454153,1.08339533076638e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAV3,Guanine nucleotide exchange factor VAV3,24101,0.140808169276023,0.00682817298024869,0.127424950234736,0.154191388317311,1.13164209845841e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP13,Dual specificity protein phosphatase 13 isoform A,24793,0.0596461691496405,0.00289290866984398,0.0539760681567463,0.0653162701425347,1.1560935900172e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RB,Interleukin-17 receptor B,29034,-0.076075036131956,0.0036921081154852,-0.083311568038307,-0.068838504225605,1.16598276983345e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C3,Complement C3,23779,0.0659918333118579,0.00320075689168531,0.0597183498041547,0.0722653168195611,1.26032950632652e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APEX1,DNA-(apurinic or apyrimidinic site) endonuclease,29604,0.0819855932172212,0.00398210019016071,0.0741806768445062,0.0897905095899362,1.5755181830943e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM172A,Cotranscriptional regulator FAM172A,24240,0.0870729365480827,0.00422857598631153,0.0787849276149122,0.0953609454812533,2.06270245314294e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUB1,NEDD8 ultimate buster 1,29434,0.118261636872429,0.00575450137034843,0.106982814186546,0.129540459558312,3.39728822282453e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8L2,Tumor necrosis factor alpha-induced protein 8-like protein 2,24381,0.0897743523977502,0.00436602977633607,0.0812169340361315,0.0983317707593689,3.71481802356644e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCAM,Cell surface glycoprotein MUC18,29594,-0.0469545118278666,0.00228606864733267,-0.0514352063766387,-0.0424738172790946,4.27688770970014e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2,Complement C2,29545,0.0329552602643681,0.00160523297748144,0.0298090036285045,0.0361015169002317,5.20138447093183e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RFC4,Replication factor C subunit 4,24793,0.030039474405732,0.00146257048654455,0.0271728362521047,0.0329061125593593,5.76640901870575e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2,Microtubule-associated protein 2,24845,0.0653102501312809,0.00318008521157276,0.0590772831165983,0.0715432171459635,5.92916519185132e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMOC2,SPARC-related modular calcium-binding protein 2,29581,0.0545800255657272,0.00266050527641226,0.0493654352239591,0.0597946159074952,7.03570175440635e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUS,RNA-binding protein FUS,28765,0.0557596930619911,0.00271907881525662,0.0504302985840882,0.0610890875398941,8.64145244998425e-93
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PF4,Platelet factor 4,24822,0.137104243384573,0.00668855852066865,0.123994668684062,0.150213818085083,1.30527091451957e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRD1,Adhesion G-protein coupled receptor D1,24381,0.0547339604943981,0.00267352351009786,0.0494938544146063,0.0599740665741899,2.26472876538541e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CETN2,Centrin-2,28774,0.0948715335087001,0.00464654296162214,0.0857643093039207,0.103978757713479,5.23973248002345e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASP,Vasodilator-stimulated phosphoprotein,24951,0.101943025783218,0.00499195957493356,0.0921587850163487,0.111727266550088,6.0984334177605e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCB,Tubulin-folding cofactor B,29218,0.141048897747702,0.00691526311647713,0.127494982039407,0.154602813455998,7.80942043285954e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK24,Serine/threonine-protein kinase 24,28774,0.0868401194652776,0.00425885990939151,0.0784927540428702,0.0951874848876849,9.06674387246565e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACYBP,Calcyclin-binding protein,24329,0.144420324435918,0.0070794250012881,0.130544651433393,0.158295997438443,9.80660110219125e-92
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS2,Trypsin-2,29594,0.0748583619808266,0.00367852993160853,0.0676484433148739,0.0820682806467794,1.96245105663294e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCOCO2,Calcium-binding and coiled-coil domain-containing protein 2,24240,0.107324525938138,0.00527010520480097,0.0969951197367284,0.117653932139548,2.00277504782123e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINE2,Glia-derived nexin,24922,0.0902204946423485,0.00443154720530902,0.0815346621199429,0.0989063271647542,2.15765537017608e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K6,Dual specificity mitogen-activated protein kinase kinase 6,29434,0.139317141731922,0.00687227585207764,0.12584748106185,0.152786802401994,9.41881157618634e-91
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPKAPK2,MAP kinase-activated protein kinase 2,24445,0.102666545228244,0.00506263544057404,0.0927437797647191,0.112589310691769,1.09448065295329e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPACT,Protein IMPACT,24845,0.0777073687740566,0.00383265698287603,0.0701953610876195,0.0852193764604936,1.15828159074821e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFA,Platelet-derived growth factor subunit A,29820,0.0999543506512917,0.00493582391119918,0.0902801357853413,0.109628565517242,1.42411508732889e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IQGAP2,Ras GTPase-activating-like protein IQGAP2,29349,0.0752933967245998,0.00371825220820618,0.0680056223965157,0.0825811710526839,1.48928771512709e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNP,"2',3'-cyclic-nucleotide 3'-phosphodiesterase",24209,0.111239413836337,0.00549160162354884,0.100475874654181,0.122002953018492,1.76148118723714e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TADA3,Transcriptional adapter 3,24793,0.0551286537113069,0.00272245279151057,0.0497926462399461,0.0604646611826676,1.93228705101794e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNDP1,Beta-Ala-His dipeptidase,29594,0.063848807316423,0.00315929376363931,0.05765659153969,0.0700410230931561,3.26564093398651e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7,Interleukin-7,29434,0.0895311459622983,0.00443027518865508,0.0808478065925343,0.0982144853320622,3.35014288091681e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSNL1,Visinin-like protein 1,24845,0.0531061609011095,0.00262777382949416,0.0479557241953009,0.058256597606918,4.2822911134023e-90
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM24,Transcription intermediary factor 1-alpha,24396,0.0900238849730122,0.00447227103162393,0.0812582337510293,0.0987895361949951,2.1762637112889e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERN1,Serine/threonine-protein kinase/endoribonuclease IRE1,24793,0.0525356021221815,0.00261093465686856,0.0474181701947191,0.0576530340496438,2.48243129278944e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTUD6B,Deubiquitinase OTUD6B,24805,0.0808156088005021,0.00401895229375459,0.072938462304743,0.0886927552962611,3.19456252418777e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERP29,Endoplasmic reticulum resident protein 29,24381,0.16431458566555,0.00818077009867458,0.148280276272147,0.180348895058952,5.19987813465545e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPBP,Platelet basic protein,24816,0.116830245584711,0.00581983674731739,0.105423365559969,0.128237125609453,6.27948307283277e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMT,Catechol O-methyltransferase,28591,0.116271558492624,0.00579541593054701,0.104912543268752,0.127630573716496,6.41485195617157e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA1,GDNF family receptor alpha-1,29674,0.0390015725030768,0.0019459109792514,0.035187586983744,0.0428155580224095,9.03484660789527e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN3,Ataxin-3,24845,0.0852190317999037,0.00424993550922847,0.0768891582018159,0.0935489053979915,9.81233640840935e-89
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC59,Leucine-rich repeat-containing protein 59,24922,0.0654552183611223,0.00327384512163915,0.0590384819227096,0.0718719547995351,3.09886343180374e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DFFA,DNA fragmentation factor subunit alpha,29786,0.0924828933142554,0.00463068773852339,0.0834067453467495,0.101559041281761,3.67105464973511e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YWHAQ,14-3-3 protein theta,24381,0.10155982048987,0.00508514164539237,0.0915929428649005,0.111526698114839,4.90285378145441e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB6,Serpin B6,29623,0.0812156763879303,0.00407107794494382,0.0732363636158405,0.0891949891600202,5.74478347961128e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB9,Serpin B9,29218,0.0455660106596771,0.00228481916942449,0.0410877650876051,0.0500442562317491,6.64988562463477e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK13,Kallikrein-13,28845,0.0604284297165576,0.00303295301751653,0.0544838418022252,0.06637301763089,9.83592581468481e-88
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF19,Fibroblast growth factor 19,29581,0.105403794916388,0.0052987459437787,0.0950182528665822,0.115789336966195,1.77718895537521e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH9,Protocadherin-9,24805,0.0463819646719592,0.00233045790185089,0.0418142671843314,0.0509496621595869,1.86693728513953e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTF1,Cardiotrophin-1,28916,0.115559993171242,0.00581151507590465,0.104169423622469,0.126950562720015,2.12493084301484e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD2,Polycystin-2,24111,0.0808563327311205,0.00406524287017612,0.0728884567055753,0.0888242087566657,2.51218392301409e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP1B,Peptidyl-prolyl cis-trans isomerase FKBP1B,29573,0.152810599822183,0.00769034499978053,0.137737523622613,0.167883676021753,2.72785243238379e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NARS1,"Asparagine--tRNA ligase, cytoplasmic",24867,0.0646825520835787,0.00325397589011469,0.0583047593389539,0.0710603448282035,3.00837957076164e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADSB,"Short/branched chain specific acyl-CoA dehydrogenase, mitochondrial",24922,0.121043435743395,0.00609341054009854,0.109100351084801,0.132986520401988,3.89622485757932e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP2,Latent-transforming growth factor beta-binding protein 2,29820,-0.0434411432496533,0.0021902415799144,-0.0477340167462855,-0.0391482697530211,5.52690023244333e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC22D1,TSC22 domain family protein 1,24867,0.0909638230616798,0.00458698885654311,0.0819733249028553,0.0999543212205043,7.5809659659233e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL4,C-C motif chemokine 4,29498,0.088936639518042,0.00448851450820156,0.0801391510819669,0.097734127954117,8.24506092247231e-87
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAB1,5'-AMP-activated protein kinase subunit beta-1,28931,0.0745004533975738,0.00376501914990836,0.0671210158637534,0.0818798909313942,1.42750912191204e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESYT2,Extended synaptotagmin-2,24845,0.112121686016577,0.00566364588108771,0.101020940089645,0.123222431943509,1.47888012798928e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT2A1,Bile salt sulfotransferase,29434,0.076185643794595,0.0038515497138443,0.0686366063554601,0.0837346812337298,1.60152490516585e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRIM1,Cysteine-rich motor neuron 1 protein,29581,-0.0278702146313668,0.00140911854602321,-0.0306320869815723,-0.0251083422811613,1.65623383866843e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPI,Mannose-6-phosphate isomerase,29349,0.116293076449046,0.00588037651426605,0.104767538481084,0.127818614417007,1.7400432631703e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELSR2,Cadherin EGF LAG seven-pass G-type receptor 2,24381,0.0392114995521693,0.00198311840450588,0.0353245874793378,0.0430984116250008,2.43626336982281e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT1,Angiopoietin-1,29322,0.114293969509228,0.00578797854284059,0.102949531565261,0.125638407453196,3.11251512113518e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A2,Secretoglobin family 3A member 2,29536,-0.111132402971657,0.00563642064880802,-0.122179787443321,-0.100085018499993,5.53351487210169e-86
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIB,Peptidyl-prolyl cis-trans isomerase B,29467,0.128488861132001,0.00652992905619131,0.115690200181866,0.141287522082136,1.20846790222378e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP2,Caspase-2,29434,0.0917245560747935,0.00466868370868399,0.0825739360057729,0.100875176143814,2.17556764833102e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THTPA,Thiamine-triphosphatase,24755,0.118956344811998,0.00606670241787724,0.107065608072958,0.130847081551037,5.83135877510398e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROD,Uroporphyrinogen decarboxylase,24381,0.0933741249985626,0.00476245553473969,0.0840397121504728,0.102708537846652,6.17288610466789e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKN2D,Cyclin-dependent kinase 4 inhibitor D,29349,0.126792609017891,0.00647403093738808,0.114103508380611,0.139481709655172,7.27066933904077e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP5,Microfibrillar-associated protein 5,29820,0.055001277864253,0.00280942532553185,0.0494948042262105,0.0605077515022954,8.22754875503355e-85
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6AP2,Renin receptor,28797,0.0546122532794435,0.00279380542560975,0.0491363946452484,0.0600881119136386,1.52925770263393e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL7,C-C motif chemokine 7,29434,0.0788804996999118,0.00403714828915409,0.0709676890531697,0.0867933103466538,1.7697895453908e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIP,Gastric inhibitory polypeptide,24240,0.0688702625572227,0.00352277536362607,0.0619656228445156,0.0757749022699298,1.84801842768369e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLOD4,Glyoxalase domain-containing protein 4,29408,0.0476184826527938,0.00243805034099874,0.0428399039844363,0.0523970613211514,2.03988594198834e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNTA,Protein farnesyltransferase/geranylgeranyltransferase type-1 subunit alpha,24793,0.0472443000068947,0.0024247176374677,0.042491853437458,0.0519967465763314,6.32304720240014e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASRGL1,Isoaspartyl peptidase/L-asparaginase,24240,0.137159621949023,0.00704005021169016,0.12336112353411,0.150958120363936,6.74933075303071e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP10,Caspase-10,28774,0.0958246704555882,0.00492280374844655,0.0861759751086329,0.105473365802543,7.47506702564559e-84
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFP,Alpha-fetoprotein,29132,0.0910647528827179,0.00468528183343055,0.081881600489194,0.100247905276242,1.2897828189283e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPRC5C,G-protein coupled receptor family C group 5 member C,24793,0.0762504400058637,0.00392277087871449,0.0685618090835833,0.0839390709281441,1.54691638179454e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2B,Low affinity immunoglobulin gamma Fc region receptor II-b,28797,0.0774158463066101,0.00398956269455574,0.0695963034252808,0.0852353891879393,2.40800634559698e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MESD,LRP chaperone MESD,29443,0.161927591585504,0.0083481226884167,0.145565271116208,0.178289912054801,2.71860850862645e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL7,Angiopoietin-related protein 7,29725,0.0492908810732574,0.00254136013429664,0.044309815210036,0.0542719469364788,2.76211441599677e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP7,Ectonucleotide pyrophosphatase/phosphodiesterase family member 7,28595,0.115291402178166,0.00594891365007304,0.103631531424023,0.126951272932309,3.87559832957818e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIT,Bis(5'-adenosyl)-triphosphatase,28774,0.0985320675516284,0.00508779993188481,0.0885599796851342,0.108504155418123,5.02140691862323e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MINDY1,Ubiquitin carboxyl-terminal hydrolase MINDY-1,24793,0.143733399919983,0.00742052397595969,0.129189172927102,0.158277626912864,5.71503532736461e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPB1,Carboxypeptidase B,29820,0.0785536167622031,0.00406152573406509,0.0705930263234355,0.0865142072009707,7.83495880740457e-83
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA1,Carboxypeptidase A1,29820,0.0808408984812621,0.0041832940845439,0.0726416420755561,0.0890401548869681,1.0686766521336e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUGT1,Protein SGT1 homolog,28797,0.107255723537404,0.00555235557653736,0.0963731066073904,0.118138340467417,1.28628066568207e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMA,Granzyme A,29786,0.0460560533226442,0.00238464220728426,0.041382154596367,0.0507299520489213,1.32293283755204e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NACC1,Nucleus accumbens-associated protein 1,24793,0.0733101423658392,0.00379477337630166,0.0658723865482879,0.0807478981833904,1.51422317484427e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG6,Large proline-rich protein BAG6,28916,0.0483404100236495,0.00250585112662066,0.043428941815473,0.053251878231826,2.10938530982149e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRPAP1,Alpha-2-macroglobulin receptor-associated protein,29694,0.0753092789073518,0.00390496961004805,0.0676555384716576,0.0829630193430459,2.27218218078082e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM3,Dynamin-3,24867,0.0728501893234563,0.00377906918509528,0.0654432137206696,0.0802571649262431,3.32211685644617e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB33A,Ras-related protein Rab-33A,24111,0.0882511603486915,0.00458030055051138,0.0792737712696892,0.0972285494276938,4.1738049780019e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L1,Bcl-2-like protein 1,24845,0.13216937582558,0.00686104195677584,0.118721733590299,0.145617018060861,4.30390783462644e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB1,Heat shock protein beta-1,29039,0.0910224410688861,0.00473036977748339,0.0817509163050186,0.100293965832754,5.33136058326356e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLPBP,Pyridoxal phosphate homeostasis protein,29478,0.0894066919959181,0.0046476311899217,0.0802973348636716,0.0985160491281647,5.77356183197029e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOA,Elongin-A,29349,0.0690863260764197,0.00359444863217776,0.0620412067573513,0.0761314453954881,7.98425252041235e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB1,Leukocyte elastase inhibitor,29354,0.117958453281441,0.00613838095301573,0.10592722661353,0.129989679949351,8.57205679491948e-82
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIAPIN1,Anamorsin,29566,0.0827666947357265,0.00431140795319855,0.0743163351474574,0.0912170543239957,1.22968099573672e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG2,Secretogranin-2,29559,0.0430792248854179,0.00224468163115804,0.0386796488883481,0.0474788008824876,1.36433753893092e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACTB2,Endoribonuclease LACTB2,29478,0.0868977889635401,0.00453613041879929,0.0780069733426935,0.0957886045843867,2.65396099621866e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC3B,Tetranectin,24381,0.0282526936360886,0.00147463938583085,0.0253624004398601,0.0311429868323171,3.22073441377139e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SETMAR,Histone-lysine N-methyltransferase SETMAR,29132,0.039599631689346,0.00207184747577778,0.0355388106368216,0.0436604527418705,6.14640737368272e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB14,DnaJ homolog subfamily B member 14,24805,0.0845589812732566,0.00442209974914523,0.075891665764932,0.0932262967815813,6.35239202853261e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPI,Glucose-6-phosphate isomerase,24951,0.0621971822992148,0.00325332447845068,0.0558206663214515,0.0685736982769782,6.78116919308324e-81
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VPS4B,Vacuolar protein sorting-associated protein 4B,24793,0.123957878837849,0.00649908080797287,0.111219680454222,0.136696077221476,1.59554501828097e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C1A,Cytosolic 5'-nucleotidase 1A,24845,0.0412635184020185,0.00216424707204457,0.0370215941408112,0.0455054426632259,1.82058918181658e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYZL1,Quinone oxidoreductase-like protein 1,24240,0.120871402622193,0.00634128537414945,0.10844248328886,0.133300321955526,2.06568389275639e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT1,Dynein light chain Tctex-type 1,24195,0.105135068490273,0.00552384683289344,0.0943083286978019,0.115961808282744,3.51262710212816e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP2,N-acetylmuramoyl-L-alanine amidase,24701,0.0397999434326663,0.00209142775740973,0.0357007450281432,0.0438991418371893,3.60983170141845e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5,T-cell surface glycoprotein CD5,29683,0.0450059234295402,0.0023664864898937,0.0403676099093485,0.0496442369497318,3.6310539248221e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS3ST3B1,Heparan sulfate glucosamine 3-O-sulfotransferase 3B1,29349,0.0498289738743242,0.00262041079300643,0.0446929687200315,0.0549649790286168,3.84096720912252e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO9B,Unconventional myosin-IXb,28931,0.0865214410120136,0.00454992767755892,0.0776035827639981,0.0954392992600291,3.88119519442706e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD22,B-cell receptor CD22,29786,0.0546851311838718,0.00287907277918291,0.0490421485366733,0.0603281138310703,5.68698847455946e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CERT,Ceramide transfer protein,28774,0.0803142999392196,0.00423014615856381,0.0720232134684345,0.0886053864100047,6.8449827144359e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP25,Rho GTPase-activating protein 25,28797,0.0783768237449898,0.00412836194627122,0.0702852343302982,0.0864684131596814,6.99586424153642e-80
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D5,TBC1 domain family member 5,29434,0.101924848586653,0.00537485303444199,0.0913901366391463,0.112459560534159,1.02657342691551e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM3,Junctional adhesion molecule C,24381,0.0660590345312864,0.0034892165312965,0.0592201701299452,0.0728978989326275,2.29483723011742e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNRNPUL1,Heterogeneous nuclear ribonucleoprotein U-like protein 1,24867,0.0626352117499771,0.00331007078457042,0.056147473012219,0.0691229504877351,2.68345476454025e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL3,C-C motif chemokine 3,29434,0.0787119550199142,0.00416355407217047,0.0705513890384601,0.0868725210013684,3.06369880157195e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPSE,Heparanase,24688,0.122338572432785,0.00647051621423249,0.10965636065289,0.135020784212681,3.62140892758749e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM106A,Transmembrane protein 106A,24793,0.0920237642308979,0.00487000485246846,0.0824785547200597,0.101568973741736,4.42781397185174e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSDL2,Hydroxysteroid dehydrogenase-like protein 2,24240,0.0624475054782506,0.00330828524249354,0.0559632664029632,0.0689317445535379,6.61251563458672e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX8,Syntaxin-8,29434,0.0627339274517836,0.00332706921814772,0.0562128717842141,0.0692549831193531,7.71624544855101e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REEP4,Receptor expression-enhancing protein 4,24867,0.0807619675805282,0.00428130298762126,0.0723706137247906,0.0891533214362659,8.03903139484962e-79
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JPT2,Jupiter microtubule associated homolog 2,24805,0.113717906988792,0.00603781743540998,0.101883784815389,0.125552029162196,1.40002672036287e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FNDC1,Fibronectin type III domain-containing protein 1,24845,0.0605377616672725,0.00321486507139692,0.0542366261273345,0.0668388972072105,1.49678856035961e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GMFG,Glia maturation factor gamma,24922,0.0930078969037693,0.00494405443728708,0.0833175502066867,0.102698243600852,2.10403184426819e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL8,C-C motif chemokine 8,29683,0.0782421304538315,0.00416309669268,0.0700824609361787,0.0864017999714843,2.40415929657466e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR1,Hepatitis A virus cellular receptor 1,29683,0.0812927597923499,0.00433277864621926,0.0728005136457602,0.0897850059389397,4.35660359741189e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRGN,Neurogranin,24951,0.117975466558505,0.00628647434956882,0.10565397683335,0.13029695628366,4.89415002711257e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF2,Growth/differentiation factor 2,29478,0.0460055873446527,0.00245344176317978,0.0411968414888203,0.0508143332004851,5.36564925877511e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP1,Syntaxin-binding protein 1,24867,0.100228225482482,0.00534222182938494,0.0897574706968876,0.110698980268077,5.39528961650789e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2L6,Ubiquitin/ISG15-conjugating enzyme E2 L6,24922,0.079631790474228,0.0042496623916176,0.0713024521866575,0.0879611287617985,8.26417851982219e-78
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSTN,Growth/differentiation factor 8,28916,0.0677922186498876,0.0036236818819684,0.0606898021612296,0.0748946351385457,1.22383599016659e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTD1,D-aminoacyl-tRNA deacylase 1,24381,0.11251464598324,0.00601129947135947,0.100732499019376,0.124296792947105,1.25702913857689e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRD54,Ankyrin repeat domain-containing protein 54,28797,0.0737002774139795,0.00394151522989035,0.0659749075633944,0.0814256472645646,1.46959612998346e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBKS,Ribokinase,28795,0.0640808035446628,0.00342717969052995,0.0573635313512241,0.0707980757381015,1.48720363494814e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA2,Glucosamine-6-phosphate isomerase 2,24381,0.0475716076295455,0.00254312620405075,0.042587080269606,0.052556134989485,1.54743407590643e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP3,Caspase-3,29820,0.112877161566884,0.00605469901507041,0.101009951497346,0.124744371636422,3.96381335905701e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICALL2,MICAL-like protein 2,24195,0.087887478545284,0.0047113170518598,0.0786532971236388,0.0971216599669292,4.03712873652487e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C,"5'(3')-deoxyribonucleotidase, cytosolic type",24922,0.0945076899549576,0.00506961534711092,0.0845712438746202,0.104444136035295,4.90936239635822e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRG1,Scrapie-responsive protein 1,24922,0.0353268772636515,0.00189558751405533,0.031611525736103,0.0390422287911999,5.44435240450318e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIF,Macrophage migration inhibitory factor,29386,0.0872185899559176,0.00468258402543084,0.0780407252660732,0.0963964546457621,5.48013959863297e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPCDC,Phosphopantothenoylcysteine decarboxylase,29694,0.0599763667757839,0.0032202153875425,0.0536647446162006,0.0662879889353672,5.54541628521996e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA4,Protein disulfide-isomerase A4,24938,0.0780201942128724,0.00418703768640469,0.0698136003475192,0.0862267880782256,5.71020528352493e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53I3,Quinone oxidoreductase PIG3,23906,0.0684801406264357,0.00367845253875915,0.0612703736504678,0.0756899076024036,8.24966106580833e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRM2B,Ribonucleoside-diphosphate reductase subunit M2 B,28797,0.0864880179285604,0.00464950854399946,0.0773749811823214,0.0956010546747993,8.81215804288954e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSTPIP2,Proline-serine-threonine phosphatase-interacting protein 2,23623,0.138478791110838,0.00743993606118431,0.123896516430917,0.153061065790759,8.95668849097109e-77
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKMY2,Ankyrin repeat and MYND domain-containing protein 2,24229,0.102651815833996,0.00551755417831925,0.0918374096444905,0.113466222023502,1.01146601459301e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTD,Deoxycytidylate deaminase,24381,0.121562055623648,0.00654093865668803,0.108741815856539,0.134382295390756,1.44420340883896e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L3HYPDH,Trans-3-hydroxy-L-proline dehydratase,24922,0.114709255657912,0.00617391535944215,0.102608381553405,0.126810129762418,1.54623044211971e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUOX,"Sulfite oxidase, mitochondrial",24867,0.0799020374296953,0.00430797805656107,0.0714584004388356,0.088345674420555,2.80046364607038e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4E,Eukaryotic translation initiation factor 4E,24229,0.115888376747114,0.00624945012373316,0.103639454504597,0.128137298989631,3.09049922605043e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABRAXAS2,BRISC complex subunit Abraxas 2,24111,0.0851267044349531,0.0045960645339511,0.0761184179484089,0.0941349909214972,4.66270288427014e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOXO3,Forkhead box protein O3,28797,0.122935099056282,0.00664240831026793,0.109915978768157,0.135954219344407,4.95678285357143e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPPED1,Serine/threonine-protein phosphatase CPPED1,29694,0.0833228932145548,0.00450365347758041,0.0744957323984972,0.0921500540306124,5.41003994792138e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT2,RAC-beta serine/threonine-protein kinase,24867,0.161160032756589,0.00871344033479195,0.144081689700396,0.178238375812781,7.2463591813531e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF14,Tumor necrosis factor ligand superfamily member 14,29218,0.0732892277424516,0.00396517824885985,0.0655174783746863,0.0810609771102169,7.6410462245698e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHM,Rab proteins geranylgeranyltransferase component A 1,24195,0.0778957465786664,0.00421275474903001,0.0696387472705676,0.0861527458867653,8.21812767085787e-76
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANF,Mesencephalic astrocyte-derived neurotrophic factor,29581,0.151721672051989,0.00821978423716769,0.13561089494714,0.167832449156837,1.19543176274147e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIAP1,TP53-regulated inhibitor of apoptosis 1,29725,0.0795425142997684,0.00431304065654264,0.0710889546129448,0.087996073986592,1.58800901680044e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARA5,Scavenger receptor class A member 5,29694,0.0382067460867179,0.00207240543260234,0.0341448314388173,0.0422686607346184,1.78651357300363e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLMAP,Sarcolemmal membrane-associated protein,24805,0.105664504049342,0.00573307039841773,0.0944276860684428,0.11690132203024,2.37663846508724e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC9,Thioredoxin domain-containing protein 9,24845,0.0675764759087652,0.00367018566590667,0.0603829120035882,0.0747700398139423,3.31887817723795e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COQ7,"5-demethoxyubiquinone hydroxylase, mitochondrial",24240,0.0576168655826194,0.00313057319070888,0.05148094212883,0.0637527890364088,3.92916663724701e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA1,Paraneoplastic antigen Ma1,24240,0.0716044065927724,0.00389376583101804,0.063972625563977,0.0792361876215677,5.16923802333863e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F2R,Proteinase-activated receptor 1,29536,0.0725098899925622,0.0039468635333635,0.0647740374671697,0.0802457425179547,5.81816714763017e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP4,Dipeptidyl peptidase 4,28990,0.0379087907814954,0.00206567145624846,0.0338600747272484,0.0419575068357423,8.48244574937501e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP11,Low-density lipoprotein receptor-related protein 11,29478,0.0455649314500536,0.00248397197810303,0.0406963463729717,0.0504335165271356,9.69452013692587e-75
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4A,C-type lectin domain family 4 member A,29434,-0.0441645015033895,0.00240820256172082,-0.0488845785243623,-0.0394444244824167,1.05133442249398e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCT5,T-complex protein 1 subunit epsilon,28797,0.0572071900770211,0.0031211222214803,0.0510897905229197,0.0633245896311225,1.2913103386937e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD244,Natural killer cell receptor 2B4,29786,0.0341184983502697,0.00186287479768783,0.0304672637468015,0.0377697329537378,1.6146771202446e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP5,Platelet glycoprotein V,24381,0.0456728843829912,0.00249287213088683,0.040786855006453,0.0505589137595294,1.76854829972888e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL16,C-X-C motif chemokine 16,29786,0.0296931104077494,0.00162234426525756,0.0265133156478446,0.0328729051676542,2.02155379803878e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB2,DnaJ homolog subfamily B member 2,24381,0.067600778131433,0.00369121959435962,0.0603659877264881,0.0748355685363778,2.02418038483718e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP5,Peptidyl-prolyl cis-trans isomerase FKBP5,29218,0.118664281483139,0.00648814188300355,0.105947523392452,0.131381039573826,2.61497408456932e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPING1,Plasma protease C1 inhibitor,24914,0.0236725553407087,0.00129492143810093,0.0211345093220309,0.0262106013593865,3.58197646376041e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEMIP2,Cell surface hyaluronidase,24229,0.0417079885773117,0.00228350019505426,0.0372323281950053,0.046183648959618,4.94799221537788e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFB,Complement factor B,24538,0.0412978559348904,0.00226344228216398,0.0368615090618489,0.0457342028079318,6.91747394545999e-74
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASH1,Tubulinyl-Tyr carboxypeptidase 1,29434,0.102518619373881,0.0056285476055509,0.0914866660670015,0.113550572680761,1.01601098411137e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APP,Amyloid-beta precursor protein,29395,0.0834687865745455,0.00458277623702744,0.0744865451499717,0.0924510279991193,1.02574185311587e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGCT,Gamma-glutamylcyclotransferase,24904,0.0602097199715651,0.003304449118998,0.0537329996983291,0.0666864402448012,1.06447338615058e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREH,Trehalase,24938,0.0940145142932247,0.00516494573806033,0.0838912206466265,0.104137807939823,1.48049306772785e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP14,Peptidyl-prolyl cis-trans isomerase FKBP14,24867,0.124641213488067,0.0068495982199338,0.111216000976996,0.138066425999137,1.64142433851771e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTX3,Pentraxin-related protein PTX3,29434,-0.0618348320858515,0.00340582459200085,-0.0685102482861732,-0.0551594158855298,2.91483632950792e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTRHD1,Putative peptidyl-tRNA hydrolase PTRHD1,24381,0.0755709645247451,0.00416052652613394,0.0674163325335226,0.0837255965159676,3.04105703219701e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAS,Tumor necrosis factor receptor superfamily member 6,29736,0.0407631121821144,0.0022472306241137,0.0363585401588515,0.0451676842053772,3.87603727759947e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF14,Tumor necrosis factor receptor superfamily member 14,29497,0.0381404797806421,0.00210322484501973,0.0340181590844035,0.0422628004768808,4.27045408473317e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1R,Complement C1r subcomponent,24966,0.0242598666812428,0.00133744258432303,0.0216384792159697,0.026881254146516,4.62733986766633e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POSTN,Periostin,24938,-0.0473711042925303,0.00261399971276286,-0.0524945437295456,-0.0422476648555151,6.27687139912968e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKT3,RAC-gamma serine/threonine-protein kinase,28662,0.0719353716093285,0.00397171332057131,0.0641508135010087,0.0797199297176482,6.55403234850809e-73
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC37,Hsp90 co-chaperone Cdc37,29566,0.104117813752082,0.00575792450491602,0.0928322817224466,0.115403345781717,1.07986504376076e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGLAP,Osteocalcin,24938,0.11047006600092,0.0061096722162576,0.0984951084570555,0.122445023544785,1.30636773942981e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECAP2,Adaptin ear-binding coat-associated protein 2,24111,0.083030077981847,0.00459337011121495,0.0740270725638657,0.0920330833998284,1.48438460353872e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOL1,Apolipoprotein L1,24951,0.0747855779462634,0.00413776722926074,0.0666755541769123,0.0828956017156144,1.48735903086713e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G4A,Cytosolic phospholipase A2,29581,0.108752352944396,0.00602580899065653,0.0969417673227092,0.120562938566083,2.01265677938345e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFB2,BPI fold-containing family B member 2,24852,0.0807446733410317,0.00447409036861933,0.0719754562185378,0.0895138904635256,2.40872676675919e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX4,Syntaxin-4,29349,0.0736611197107718,0.00408417748894428,0.065656131832441,0.0816661075891025,2.51384428952016e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNE,Bifunctional UDP-N-acetylglucosamine 2-epimerase/N-acetylmannosamine kinase,28797,0.0811847171452993,0.00450290701850322,0.072359019389033,0.0900104149015656,2.86377239753198e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LARP1,La-related protein 1,24793,0.0780388219090438,0.00432896441959118,0.069554051646645,0.0865235921714425,3.45362778580775e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL18,C-C motif chemokine 18,29166,0.0870995024435259,0.0048403850387476,0.0776123477675806,0.0965866571194712,5.29742594718853e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDAP1,28 kDa heat- and acid-stable phosphoprotein,24922,0.12151300121342,0.00675858898924247,0.108266166794505,0.134759835632335,8.09423474197106e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRB1,Chymotrypsinogen B,29443,0.0688958424267452,0.00383427884667864,0.0613806558872551,0.0764110289662353,8.34416149134423e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLMH,Bleomycin hydrolase,29820,0.039351802301913,0.00219047397455173,0.0350584733117916,0.0436451312920344,8.77159625481097e-72
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA2,Integrin alpha-2,24381,0.0424448318531421,0.00236545843657048,0.037808533317464,0.0470811303888202,1.5557791071655e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP170,Centrosomal protein of 170 kDa,24240,0.0951759052527041,0.00532005035503753,0.0847486065568306,0.105603203948578,4.04738507169605e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTNB,Dystrobrevin beta,24752,0.0535261231675251,0.0029957388770924,0.047654474968424,0.0593977713666262,5.91158788382063e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMTN,Smoothelin,24776,0.116395866633403,0.00651638872950277,0.103623744723578,0.129167988543229,6.49773745992038e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARK7,Parkinson disease protein 7,29443,0.0641743088274194,0.00359592081556596,0.0571263040289102,0.0712223136259287,7.28947721725126e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEBP1,Phosphatidylethanolamine-binding protein 1,29443,0.0704329182639813,0.00394783266394754,0.0626951662426441,0.0781706702853185,8.03671673078511e-71
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAP,Prolyl endopeptidase FAP,29820,0.0337477755377823,0.00189346865726441,0.0300365769695441,0.0374589741060206,1.08661102536246e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18,Interleukin-18,29335,0.0564297220463809,0.00316655247746425,0.050223279190551,0.0626361649022109,1.15571167565949e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA2,Apolipoprotein A-II,24951,-0.0593483184699115,0.00333264885831057,-0.0658803102322002,-0.0528163267076228,1.67085243264377e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP4,Peptidyl-prolyl cis-trans isomerase FKBP4,29218,0.0540341757850763,0.00303725881922843,0.0480811484993885,0.059987203070764,1.97430830920901e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBI,Acyl-CoA-binding protein,29329,0.0960331183185715,0.00540035118612517,0.0854484299937661,0.106617806643377,2.25397154516897e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP2,Integrin beta-1-binding protein 2,28916,0.135984825710789,0.00765151241385364,0.120987861379636,0.150981790041942,2.74434702091732e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCTD5,BTB/POZ domain-containing protein KCTD5,24429,0.0538980086284753,0.00303686822585549,0.0479457469057986,0.0598502703511521,4.931324519364e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM10,Mitochondrial import inner membrane translocase subunit Tim10,24922,0.0489681037434348,0.00276236631213144,0.0435538657716571,0.0543823417152124,6.99450275525036e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP3R1,Calcineurin subunit B type 1,29218,0.0499972367450043,0.00282197636712582,0.0444661630654377,0.0555283104245709,7.18841944465443e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSZ,Cathepsin Z,29487,0.0384896523237272,0.00217476066686938,0.0342271214166632,0.0427521832307912,9.92027779559322e-70
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTF2,Transcription termination factor 2,24195,0.0599292910261115,0.0033857583585778,0.053293204643299,0.066565377408924,1.14598079888242e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP6,Platelet glycoprotein VI,29400,0.107025653248317,0.00606050045209818,0.0951470723622047,0.11890423413443,1.96462717943302e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP2K1,Dual specificity mitogen-activated protein kinase kinase 1,24805,0.0786491977235495,0.0044558362054557,0.0699157587608564,0.0873826366862427,2.66362913004707e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL13B,ADP-ribosylation factor-like protein 13B,24111,0.0842293257926846,0.00477661013289779,0.0748671699322049,0.0935914816531643,3.69433850576539e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPP1,Dual adapter for phosphotyrosine and 3-phosphotyrosine and 3-phosphoinositide,29434,0.146015608929221,0.00828606318513924,0.129774925086348,0.162256292772094,3.79887916277142e-69
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRD2,Protein ZNRD2,24805,0.0832500267584115,0.00473818184373303,0.0739631903446948,0.0925368631721282,1.0906811603254e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL1,Growth-regulated alpha protein,29420,0.115137854750079,0.00656136879819132,0.102277571905624,0.127998137594534,1.38295143521013e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNMT,Histamine N-methyltransferase,29082,0.0569299630066324,0.00324684366354976,0.0505661494260748,0.0632937765871899,1.77815207335975e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF6B,Tumor necrosis factor receptor superfamily member 6B,29218,0.067905944456685,0.00387478840405131,0.0603113591847444,0.0755005297286256,2.06712570063557e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC3,PDZ domain-containing protein GIPC3,24805,0.118697206254036,0.00677119982805131,0.105425654591056,0.131968757917017,2.19899084515199e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMNL1,Formin-like protein 1,28774,0.0740362425047531,0.00423284884883632,0.0657398587610339,0.0823326262484723,3.7916484900182e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD4B,FERM domain-containing protein 4B,24111,0.0847970000369561,0.00484834274159972,0.0752942482634206,0.0942997518104915,4.50814082678914e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB1,Beta-crystallin B1,24922,0.07871719373958,0.00450474236436905,0.0698878987054166,0.0875464887737433,5.72518564123759e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD4L,E3 ubiquitin-protein ligase NEDD4-like,24229,0.058895846450119,0.00337157264417822,0.0522875640675297,0.0655041288327083,6.51499094574157e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RILP,Rab-interacting lysosomal protein,29632,0.0714718525623922,0.00409461949764845,0.0634463983470012,0.0794973067777832,6.8949003869099e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SESTD1,SEC14 domain and spectrin repeat-containing protein 1,28774,0.0770844534350698,0.00441930493986481,0.0684226157529348,0.0857462911172048,8.7478459704153e-68
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MGMT,Methylated-DNA--protein-cysteine methyltransferase,29434,0.145545683373646,0.00835787835217276,0.129164241803388,0.161927124943905,1.40649432373651e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBN1,Drebrin,24229,0.0616530988495129,0.00354049168787358,0.0547137351412807,0.0685924625577451,1.67517088224858e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164,Sialomucin core protein 24,29443,0.032109595504757,0.0018457869078936,0.0284918531652856,0.0357273378442285,1.92050103275264e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERMAP,Erythroid membrane-associated protein,24229,0.0536353178702535,0.00308171044326789,0.0475951654014485,0.0596754703390586,1.96707920601146e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA3,Annexin A3,29640,0.0834228358158986,0.00480126672062575,0.0740123530434721,0.0928333185883251,2.74492982972202e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDH1,"Malate dehydrogenase, cytoplasmic",24852,0.0479437025756784,0.00276117741568498,0.0425317948409358,0.0533556103104209,3.8875397058303e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRF5,Adhesion G protein-coupled receptor F5,24922,0.0341170921282616,0.00196538205962845,0.0302649432913898,0.0379692409651333,4.18893986992222e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1,Allograft inflammatory factor 1,28797,0.0627772268465921,0.00361803731264727,0.0556858737138035,0.0698685799793808,4.24479397641673e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIKFYVE,1-phosphatidylinositol 3-phosphate 5-kinase,24229,0.066985536621558,0.00386370774775373,0.0594126694359607,0.0745584038071553,6.26374028737989e-67
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL32,Interleukin-32,29434,-0.0519202495152384,0.00300165313796952,-0.0578034896656586,-0.0460370093648181,1.05622113595517e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREM2,Triggering receptor expressed on myeloid cells 2,29454,0.0617963536224304,0.00358434641284557,0.054771034653253,0.0688216725916077,2.78709819618169e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASEH2A,Ribonuclease H2 subunit A,24867,0.0579451113188353,0.00336105635439306,0.0513574408642249,0.0645327817734457,3.22339381542622e-66
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCA,Calcitonin,29163,0.0735499993042159,0.00428521689563829,0.0651509741887648,0.0819490244196669,1.04586959622721e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRC,Proto-oncogene tyrosine-protein kinase Src,29525,0.141245809782835,0.0082329141192542,0.125109298109097,0.157382321456573,1.17624914719781e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHYKPL,5-phosphohydroxy-L-lysine phospho-lyase,24381,0.0498652361439863,0.00290597534328399,0.0441695244711497,0.0555609478168229,1.29644283215257e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAEP,Glycodelin,29218,-0.155881396618497,0.00909161075135942,-0.173700953691162,-0.138061839545833,1.42002084941546e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF1,Scavenger receptor class F member 1,29820,0.0499801664586503,0.00291980518223178,0.044257348301476,0.0557029846158246,2.2531290538141e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAG3,BAG family molecular chaperone regulator 3,29169,0.0472533600065017,0.00276464733594327,0.0418346512280529,0.0526720687849505,3.53916324933343e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RP2,Protein XRP2,29349,0.0491992994328549,0.00288457329344995,0.043545535777693,0.0548530630880168,6.48870928600419e-65
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATG4A,Cysteine protease ATG4A,28797,0.0690601557326789,0.00405955766097256,0.0611034227171727,0.0770168887481851,1.39125344189545e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZT1,Mitotic-spindle organizing protein 1,28797,0.0615604553996146,0.00362618263938271,0.0544531374264245,0.0686677733728047,2.51583221345199e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP1,Inositol polyphosphate 1-phosphatase,29349,0.0626134971784561,0.00368855514422167,0.0553839290957817,0.0698430652611306,2.54924222252906e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT16,U8 snoRNA-decapping enzyme,24769,0.102446512943884,0.00603412947938911,0.0906196191642811,0.114273406723486,2.7707278045911e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNAP25,Synaptosomal-associated protein 25,24101,0.0554106722838541,0.00326663753936322,0.0490080627067022,0.061813281861006,3.66444018393177e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX5,"Peroxiredoxin-5, mitochondrial",29786,0.0792108174905219,0.00467627981025026,0.0700453090624314,0.0883763259186124,4.64547900510912e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC8,Sialic acid-binding Ig-like lectin 8,24240,0.053673602503022,0.0031692249219958,0.0474619216559102,0.0598852833501338,5.71446428826505e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GET3,ATPase GET3,24922,0.0644049051611373,0.00380329304222373,0.0569504507983787,0.0718593595238958,5.7646411320241e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C4BPB,C4b-binding protein beta chain,29566,0.0467630338910294,0.0027651131362977,0.0413434121438859,0.0521826556381729,7.36037729706032e-64
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRSK2,Serine/threonine-protein kinase BRSK2,24867,0.0446690078440563,0.00264606216825636,0.0394827259942739,0.0498552896938388,1.39713579623272e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAP3,Cytosol aminopeptidase,28931,0.0565848970123859,0.00335348001155572,0.0500120761897367,0.0631577178350351,1.42152110995863e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POMC,Pro-opiomelanocortin,24240,0.082295146726579,0.00487800280059651,0.0727342612374099,0.0918560322157482,1.70516015009879e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFT20,Intraflagellar transport protein 20 homolog,24195,0.0503379861986699,0.00298830394594273,0.0444809104646222,0.0561950619327177,2.62288886561658e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEP1B,Meprin A subunit beta,29478,0.135554874427282,0.00805236895565724,0.119772231274194,0.15133751758037,2.71158604097963e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DXO,Decapping and exoribonuclease protein,24845,0.0529293557021231,0.00314355514503533,0.0467679876178539,0.0590907237863924,2.91354745177323e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGACT,Gamma-glutamylaminecyclotransferase,24922,0.0821656012546338,0.00488999905715398,0.072581203102612,0.0917499994066556,5.18062093922001e-63
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID1,Nidogen-1,29518,0.0437932979891619,0.00261388260033914,0.0386700880924972,0.0489165078858266,1.03069914096022e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFBP2,Fibroblast growth factor-binding protein 2,24938,0.0583466931132898,0.00348421575985111,0.0515176302239816,0.065175756002598,1.33238786314502e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA13,Carbonic anhydrase 13,29114,0.120250479282041,0.0071856802599826,0.106166545972475,0.134334412591607,1.43619831319997e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDT,D-dopachrome decarboxylase,24938,0.0471155479466976,0.00281732085438332,0.0415935990721063,0.0526374968212889,1.93523821369574e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB10,Ras-related protein Rab-10,24922,0.0617357929067813,0.00369314040353604,0.0544972377158506,0.0689743480977119,2.18150192700134e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEMP1,Mast cell-expressed membrane protein 1,24229,0.104368711626109,0.00624499417090012,0.0921285230511447,0.116608900201073,2.38202909622454e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL2,C-C motif chemokine 2,29169,0.0603955576790178,0.00361947781795626,0.0533013811558236,0.0674897342022121,3.20899174515571e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG2,Bone marrow proteoglycan,24938,-0.0596980613381919,0.00357781339153778,-0.066710575585606,-0.0526855470907778,3.627643588723e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCYT2,Ethanolamine-phosphate cytidylyltransferase,24805,0.0877797984447575,0.00526838504002128,0.0774537637663158,0.0981058331231993,5.41994590654509e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GAT1,"Beta-1,4-glucuronyltransferase 1",29443,0.0279101778417227,0.00167602380153248,0.0246251711907191,0.0311951844927264,5.57025430916595e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NT5C3A,Cytosolic 5'-nucleotidase 3A,29373,0.100727277094464,0.00605098395147545,0.0888673485495722,0.112587205639356,6.180302034258e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPB,CCAAT/enhancer-binding protein beta,28916,0.0432198118639636,0.00259859400370116,0.0381265676167093,0.0483130561112179,7.92752886210202e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHDC3,"Enoyl-CoA hydratase domain-containing protein 3, mitochondrial",24922,0.0861227147648424,0.0051787408883946,0.075972382623589,0.0962730469060958,9.09724325492419e-62
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRG1,Leucine-rich alpha-2-glycoprotein,24966,-0.0298722540061382,0.00179692435627908,-0.0333942257444452,-0.0263502822678312,1.00219208062394e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTP4A3,Protein tyrosine phosphatase type IVA 3,24229,0.059981784120386,0.003617262070015,0.0528919504631566,0.0670716177776154,2.04905579636125e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BDNF,Brain-derived neurotrophic factor,24938,0.0949324740991476,0.00573661198871998,0.0836887146012564,0.106176233597039,3.48113068120427e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP7,Matrilysin,28870,0.0569160804722385,0.00344520022527107,0.0501634880307072,0.0636686729137698,4.9922359319065e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WDR46,WD repeat-containing protein 46,24793,0.0410403304152133,0.00248530859121172,0.0361691255764384,0.0459115352539883,6.24557613062575e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFR,Epidermal growth factor receptor,29820,0.0186616981207628,0.00113068115589414,0.0164455630552102,0.0208778331863153,6.31623174615983e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSNAX,Translin-associated protein X,24111,0.0448506649300928,0.00271849803726034,0.0395224087770625,0.050178921083123,8.13488167877627e-61
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFAT5,Nuclear factor of activated T-cells 5,24229,0.0982058330372092,0.00596244606002896,0.0865194387595525,0.109892227314866,1.27298716439165e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OCLN,Occludin,24867,0.0498028858053802,0.0030299704476422,0.0438641437280015,0.0557416278827589,2.17490524050065e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECHS1,"Enoyl-CoA hydratase, mitochondrial",24240,0.110124131581109,0.00670909812795074,0.0969742992503259,0.123273963911893,3.20418801649808e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM2,Paralemmin-2,24845,0.0428918078512905,0.00261365315759016,0.0377690476624138,0.0480145680401673,3.32998599397006e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMSB10,Thymosin beta-10,29443,0.0858006950219236,0.00523066687399172,0.0755485879488999,0.0960528020949474,3.34783103249288e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPA,Inosine triphosphate pyrophosphatase,24111,0.0764854266746948,0.00466073153638909,0.0673503928633721,0.0856204604860174,3.40809602488793e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FADD,FAS-associated death domain protein,29478,0.0861893227392267,0.00525708072188714,0.0758854445243279,0.0964932009541254,3.84246953169752e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP1,Inactive pancreatic lipase-related protein 1,24845,0.0900125028208038,0.00549739022494013,0.0792376179799212,0.100787387661686,6.08062861379888e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TST,Thiosulfate sulfurtransferase,28706,0.0854194244154945,0.00521974773300068,0.0751887188588132,0.0956501299721759,6.39186821725322e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPLAH,5-oxoprolinase,24240,0.0775259953664771,0.0047366540505048,0.0682421534274877,0.0868098373054665,6.87266429920911e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL24,C-C motif chemokine 24,29536,0.0933260622722785,0.00570940841878886,0.0821356217714523,0.104516502773105,8.5078872362621e-60
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBCA,Tubulin-specific chaperone A,24381,0.0964564267464524,0.00591167199139588,0.0848695496433165,0.108043303849588,1.56494922390593e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP1,Lysosome-associated membrane glycoprotein 1,24256,0.0317436593828889,0.00194624007849685,0.0279290288290351,0.0355582899367427,1.73165167527392e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC26,Anaphase-promoting complex subunit CDC26,24764,0.0789429503354491,0.00484757100402816,0.0694417111675539,0.0884441895033443,2.56507183275648e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRI1,Methylthioribose-1-phosphate isomerase,24195,0.0764619768588761,0.00470053295041374,0.0672489322760652,0.085675021441687,3.51063270660813e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPPB,Natriuretic peptides B,28916,-0.150087748726486,0.00924578970479213,-0.168209496547879,-0.131966000905094,5.37005461195694e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAC2,Glutathione-specific gamma-glutamylcyclotransferase 2,28797,0.066871010030214,0.00412311301391537,0.0587897085229399,0.0749523115374881,6.80477383292985e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD40LG,CD40 ligand,29786,0.0868443006775263,0.00535635777874184,0.0763458394311923,0.0973427619238603,7.2618279472144e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPT,Dermatopontin,29820,0.0294598243676679,0.00181709045545111,0.0258983270749837,0.033021321660352,7.3367484244013e-59
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTC,Probetacellulin,28797,0.0830087040273722,0.0051329127854585,0.0729481949678736,0.0930692130868709,1.4444210533769e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX6,Peroxiredoxin-6,29725,-0.0667188019844667,0.00412599746283267,-0.0748057570116187,-0.0586318469573146,1.45277654187039e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXYD5,FXYD domain-containing ion transport regulator 5,28931,0.0731373150797165,0.0045294214408312,0.0642596490556873,0.0820149811037456,2.14218219606664e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNLT3,Dynein light chain Tctex-type 3,24793,0.0485832852369611,0.00301007563089768,0.0426835370004017,0.0544830334735206,2.64008753553406e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFA5,NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 5,24190,0.0399365737078532,0.0024767960330536,0.0350820534830682,0.0447910939326383,3.46612083381563e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAM1,Vascular cell adhesion protein 1,29545,-0.0303468605074573,0.00188418892338342,-0.0340398707972888,-0.0266538502176258,4.09290474039529e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOD,Apolipoprotein D,23787,-0.04836906530897,0.00300535098803036,-0.0542595532455095,-0.0424785773724305,5.66479834276308e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MIA,Melanoma-derived growth regulatory protein,29566,0.040943825995874,0.00254738244237503,0.0359509564088189,0.0459366955829291,6.95709274005866e-58
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASSF2,Ras association domain-containing protein 2,28797,0.0618784714088643,0.00385528449764969,0.054322113793471,0.0694348290242578,1.01346404996521e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN4,Cerebellin-4,29725,0.0351372316494852,0.00219052421086193,0.0308438041961958,0.0394306591027746,1.16299376257518e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB2B,Ras-related protein Rab-2B,24793,0.0683063307845004,0.00426302544399495,0.0599508009142703,0.0766618606547305,1.71855322392834e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC9,DnaJ homolog subfamily C member 9,24805,0.083964252830013,0.00526649506163344,0.0736419225092115,0.0942865831508146,6.10822770904317e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3AP1,Phosphoinositide 3-kinase adapter protein 1,29434,0.0671152126076311,0.00421384041644248,0.0588560853914038,0.0753743398238584,7.08347341746345e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM1,Carcinoembryonic antigen-related cell adhesion molecule 1,29510,0.0250246090471197,0.00157284138887655,0.0219418399249216,0.0281073781693177,9.2426108515052e-57
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFL7,Epidermal growth factor-like protein 7,28797,0.0434638559358591,0.00273372219986268,0.0381057604241283,0.04882195144759,1.12015667897139e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKN3,Serine/threonine-protein kinase N3,24445,0.0826311543628395,0.00520918337768429,0.0724211549425783,0.0928411537831007,2.2006020634386e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPS8L2,Epidermal growth factor receptor kinase substrate 8-like protein 2,29655,0.0334666336582007,0.00211086976936622,0.0293293289102429,0.0376039384061585,2.23504252066876e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSS,Cathepsin S,23389,0.0267570048298588,0.0016921725908729,0.0234403465517479,0.0300736631079697,5.00407979485184e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN9,Septin-9,29349,0.0309388037812774,0.00195860999731178,0.0270999281865464,0.0347776793760085,5.61492415397838e-56
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA2_BOLA2B,BolA-like protein 2,24240,0.0594217197204185,0.00377128138901783,0.0520300081979436,0.0668134312428935,1.1738749150153e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD84,SLAM family member 5,29434,0.0338447123985351,0.00215566616056271,0.0296196067238322,0.0380698180732381,2.5239781900263e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF2,Fibroblast growth factor 2,29434,0.0730247298110378,0.00465298992015674,0.0639048695675306,0.082144590054545,2.78071075649763e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT2,Kunitz-type protease inhibitor 2,29581,0.044147515344524,0.00281350668494087,0.0386330422420399,0.0496619884470081,2.90100319250657e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PARD3,Partitioning defective 3 homolog,24445,0.0800715484985672,0.00511646818186423,0.0700432708621133,0.0900998261350211,6.16542076060349e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPDC1,Neural proliferation differentiation and control protein 1,29478,0.0345413819540266,0.00220922371867184,0.0302113034654298,0.0388714604426234,6.98242169897425e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD23B,UV excision repair protein RAD23 homolog B,28797,0.0506714149985969,0.00324085009170293,0.0443193488188592,0.0570234811783346,7.05030954565681e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PQBP1,Polyglutamine-binding protein 1,28797,0.0600611214310129,0.00384625663295457,0.052522458430422,0.0675997844316039,9.58601674257716e-55
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACYP1,Acylphosphatase-1,24297,0.0707188797771365,0.00453154250893054,0.0618370564596327,0.0796007030946404,1.22303423955702e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPGDS,Hematopoietic prostaglandin D synthase,28797,0.0406619264710172,0.00260784217583522,0.0355505558063802,0.0457732971356542,1.37675226341791e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH7,Protocadherin-7,24805,0.0374534915752988,0.00240455964565086,0.0327405546698231,0.0421664284807744,1.91982130116481e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAGR1,PAXIP1-associated glutamate-rich protein 1,24240,0.0468299530751568,0.00300953117674589,0.0409312719687348,0.0527286341815787,2.47346726414055e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS10,Regulator of G-protein signaling 10,24867,0.0640771256036054,0.0041198003664332,0.0560023168853963,0.0721519343218145,2.71874331074573e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEPR,Leptin receptor,29478,-0.0332820194043662,0.00214188044283069,-0.0374801050723144,-0.0290839337364181,3.11724660255086e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA6,Integrin alpha-6,29434,0.0557950323980558,0.00359409926718086,0.0487505978343814,0.0628394669617303,3.91153100171806e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLNK,B-cell linker protein,24229,0.0427798574383721,0.00275504984697831,0.0373799597382946,0.0481797551384496,4.10415349024356e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABHD14B,Protein ABHD14B,29121,0.0612836263990084,0.00395693516898595,0.053528033467796,0.0690392193302209,6.90027782172578e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGH,Gamma-glutamyl hydrolase,28984,0.0363965879643543,0.00235189777885168,0.031786868317805,0.0410063076109036,8.35258035630576e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARFIP1,Arfaptin-1,24867,0.0735524843939855,0.00475367783413039,0.0642352758390899,0.082869692948881,9.44222821008036e-54
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARL2BP,ADP-ribosylation factor-like protein 2-binding protein,24111,0.0432886237925406,0.00279866783415425,0.0378032348375983,0.048774012747483,1.04097268515524e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRG,Histidine-rich glycoprotein,24833,0.0334801324429786,0.00216718869891879,0.0292324425930977,0.0377278222928594,1.36899249308352e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK2,"Adenylate kinase 2, mitochondrial",24845,0.112993594041292,0.00732584735292892,0.0986349332295514,0.127352254853033,1.9992696398879e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMPER,BMP-binding endothelial regulator protein,24381,0.0242846652964757,0.00157705435310125,0.0211936387643973,0.0273756918285542,2.97427759396002e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGXT,Serine--pyruvate aminotransferase,29478,0.0818099456997498,0.00531506666472767,0.0713924150368835,0.092227476362616,2.98259762530836e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDHB,Succinate dehydrogenase,24805,0.073055864117044,0.00475005200741561,0.0637457621825094,0.0823659660515786,3.92350067772647e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B1,Aldo-keto reductase family 1 member B1,28797,0.0801529157843883,0.00521408152159019,0.0699333160020715,0.090372515566705,4.07830237926197e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCN1,Ficolin-1,24919,0.0594648314873876,0.00386749614456908,0.0518845390440322,0.067045123930743,4.19076869923886e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMM8A,Mitochondrial import inner membrane translocase subunit Tim8 A,24845,0.0917283605381144,0.00596680242106475,0.0800334277928275,0.103423293283401,4.35594600645074e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCS,Copper chaperone for superoxide dismutase,29218,0.0501587460852285,0.0032747486006997,0.0437402388278571,0.0565772533425999,9.47026951926972e-53
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOE,Apolipoprotein E,24966,0.0768449651878431,0.00501967406147381,0.0670064040273545,0.0866835263483318,1.16011364329231e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2F,"DNA-directed RNA polymerases I, II, and III subunit RPABC2",29349,0.0351076234762187,0.00229422745043947,0.0306109376733573,0.03960430927908,1.17416829412492e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD72,B-cell differentiation antigen CD72,24381,0.0452021035993437,0.00295727678967684,0.0394058410915771,0.0509983661071103,1.68620169525031e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5R2,NADH-cytochrome b5 reductase 2,24523,0.0588567455786126,0.00385499171065837,0.0513009618257221,0.066412529331503,2.1885603917237e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOX2,Ecto-NOX disulfide-thiol exchanger 2,24111,0.0295409813992803,0.0019358774315168,0.0257466616335074,0.0333353011650532,2.49210612374146e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45GIP1,Growth arrest and DNA damage-inducible proteins-interacting protein 1,24240,0.0558064131866916,0.00365756939602503,0.0486375771704825,0.0629752492029007,2.55935704218695e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGR1,Prostaglandin reductase 1,24922,0.0858130498048572,0.00563802050133612,0.0747625296222384,0.096863569987476,4.44179844815733e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XPNPEP2,Xaa-Pro aminopeptidase 2,29566,0.103136221554331,0.00679104868014106,0.0898257661412549,0.116446676967408,6.76485317402826e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3BP,Galectin-3-binding protein,24966,0.0318477165322088,0.00209653628301338,0.0277385054175025,0.035956927646915,6.96438111871199e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM1,Probable carboxypeptidase X1,29566,0.071913974419238,0.00473665950745046,0.0626301217846351,0.0811978270538409,7.25898070092075e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPPK1,Epiplakin,24240,0.0773571827898435,0.00509391924999527,0.0673731010598528,0.0873412645198342,7.56868355949084e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ING1,Inhibitor of growth protein 1,28719,0.0482134095465486,0.00317649292510818,0.0419874834133365,0.0544393356797606,7.84232445187118e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUT,"Deoxyuridine 5'-triphosphate nucleotidohydrolase, mitochondrial",24805,0.108365029342067,0.00713729325027589,0.0943759345715267,0.122354124112608,7.85127894554369e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IRAG2,"Inositol 1,4,5-triphosphate receptor associated 2",28916,0.0923369723797448,0.00608993767617133,0.080400694534449,0.104273250225041,9.95196030639965e-52
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX9,Sorting nexin-9,29478,0.0713808814756299,0.0047091354147487,0.0621509760627224,0.0806107868885373,1.05216305948093e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNAS,Neuroendocrine secretory protein 55,24867,0.0924879760292225,0.00610845379558896,0.0805154065898681,0.104460545468577,1.47654579360049e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRM,Receptor-type tyrosine-protein phosphatase mu,29398,0.0255064467290395,0.00168534317214901,0.0222031741116275,0.0288097193464516,1.50613698005204e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS3,Galectin-3,29544,0.0310854445647563,0.00205576516797074,0.0270561448355337,0.035114744293979,1.83284924059853e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASS1,Argininosuccinate synthase,24111,0.0828136182297545,0.00548173675293328,0.0720694141940052,0.0935578222655037,2.49606366531477e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO2,Gamma-enolase,29694,0.0681542318781448,0.00451896230157991,0.0592970657670482,0.0770113979892414,3.30281587682667e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRN1,Secernin-1,29434,0.0580931528801714,0.00385244234917981,0.0505423658757789,0.0656439398845638,3.43050580797655e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC79,Protein unc-79 homolog,24016,0.0583497720035305,0.00387884265801808,0.050747240393815,0.0659523036132459,6.54201815395397e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECAM1,Platelet endothelial cell adhesion molecule,29443,0.0312211469680808,0.00207653479846961,0.0271511387630804,0.0352911551730812,6.67356736650153e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJC21,DnaJ homolog subfamily C member 21,24845,0.0398710147604763,0.00265194297773141,0.0346732065241227,0.0450688229968299,7.29302034914955e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RB,Interleukin-10 receptor subunit beta,29581,0.0300826985908715,0.00200361757622884,0.0261556081414629,0.03400978904028,9.12465690688027e-51
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1F,Protein phosphatase 1F,24922,0.0545811608726015,0.00364217521858695,0.0474424974441711,0.0617198243010319,1.5090488071649e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BP1,SH3 domain-binding protein 1,24805,0.0495670431854816,0.00330953076094455,0.0430803628940303,0.056053723476933,1.72498125347854e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP2,Tumor necrosis factor alpha-induced protein 2,24805,0.0487524562331251,0.00325534303668553,0.0423719838812214,0.0551329285850287,1.74895659280175e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT8,"Alpha-(1,6)-fucosyltransferase",29218,0.0601581151916007,0.00402241229753084,0.0522741870884403,0.0680420432947612,2.19661782526241e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DARS1,"Aspartate--tRNA ligase, cytoplasmic",29163,0.0754716711589944,0.00505403195412704,0.0655657685289054,0.0853775737890834,3.0860413453434e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPOCK1,Testican-1,29218,0.0265381989373307,0.00177862081957717,0.0230521021309594,0.0300242957437019,3.70294531695906e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRK5,G protein-coupled receptor kinase 5,28916,0.0535231388125911,0.00359144354514201,0.0464839094641127,0.0605623681610694,4.83881954931277e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LONP1,"Lon protease homolog, mitochondrial",24240,0.0895668956324231,0.00601547189110667,0.077776570725854,0.101357220538992,6.42102391807224e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7,Complement component C7,24374,-0.0334260070361943,0.00224504031277183,-0.0378262860492271,-0.0290257280231615,6.46026146368341e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBN,Nibrin,28931,0.0538561783216934,0.00362333776898901,0.046754436294475,0.0609579203489119,8.66273453207468e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO1A,Coronin-1A,28847,0.0916254488269124,0.00616586229310303,0.0795403587324305,0.103710538921394,9.14490001483354e-50
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRBP,Acrosin-binding protein,24793,0.0397091926584704,0.0026774200682287,0.0344614493247422,0.0449569359921987,1.5037814685639e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZD2,PDZ domain-containing protein 2,24111,0.0616290994532825,0.00416103798109105,0.0534734650103441,0.069784733896221,2.05241728392382e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF6,SLAM family member 6,28797,0.0390221233007212,0.00264179289746518,0.0338442092216895,0.0442000373797529,3.40928339887784e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD1,Superoxide dismutase [Cu-Zn],28826,0.0491714552338064,0.00332925578506686,0.0426461138950754,0.0556967965725375,3.4876898592701e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCFD2,Multiple coagulation factor deficiency protein 2,29327,0.0448499157710142,0.00304549656994362,0.0388807424939247,0.0508190890481037,6.50533743976392e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPK1,Thiamin pyrophosphokinase 1,24922,0.0280299420887566,0.00190300262103632,0.0243000569515255,0.0317598272259878,6.71278582258617e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC27A4,Long-chain fatty acid transport protein 4,28774,0.068285289972241,0.00464317792448501,0.0591846612402504,0.0773859187042316,8.79807229602405e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLB,Beta-klotho,28774,-0.0752724752804387,0.00511862416075785,-0.0853049786355241,-0.0652399719253533,8.92512754588545e-49
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRD1,Natural killer cells antigen CD94,29786,0.0470324860751647,0.00320034380829116,0.0407598122109141,0.0533051599394154,1.0123375960624e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP1,Secreted frizzled-related protein 1,29120,0.0439230359726063,0.00299223287983548,0.0380582595281287,0.0497878124170838,1.31132173979329e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC134,Coiled-coil domain-containing protein 134,24793,0.0493637888435329,0.003364180089473,0.0427699958681658,0.0559575818189,1.52716389186196e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1RL,Complement C1r subcomponent-like protein,24925,0.0197608489642823,0.00134760466228673,0.0171195438262003,0.0224021541023643,1.75443154440659e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABCA2,ATP-binding cassette sub-family A member 2,24111,0.0369368258851265,0.00252289163003736,0.0319919582902533,0.0418816934799997,2.49313245803597e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF1,Complement C1q tumor necrosis factor-related protein 1,29594,0.0425059761456498,0.00290461976453788,0.0368129214071555,0.048199030884144,2.51897396191044e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSR,"Glutathione reductase, mitochondrial",24867,0.0228963718823735,0.00156537304039319,0.0198282407232028,0.0259645030415441,3.00867476940414e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STXBP3,Syntaxin-binding protein 3,28797,0.0441643681982483,0.0030254559267613,0.0382344745817962,0.0500942618147004,4.32366109299479e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS13,A disintegrin and metalloproteinase with thrombospondin motifs 13,29820,0.0233148043466597,0.00159827787736334,0.0201821797070276,0.0264474289862919,4.94380417232777e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF4EBP1,Eukaryotic translation initiation factor 4E-binding protein 1,29478,0.0637067346210074,0.00437153955379918,0.055138517095561,0.0722749521464538,6.12136303675365e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARAF,Serine/threonine-protein kinase A-Raf,24445,0.0681093110837281,0.00467391233571346,0.0589484429057298,0.0772701792617265,6.70403396945884e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP6,Bone morphogenetic protein 6,28884,0.0414479487749834,0.00284894065429932,0.0358640250925567,0.04703187245741,8.80850479494387e-48
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN6,Dynactin subunit 6,28774,0.071642106230087,0.00492781042081135,0.0619835978052967,0.0813006146548772,1.02316750633786e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPA1,Inositol monophosphatase 1,29218,0.0611837409930742,0.00421159016489548,0.052929024269879,0.0694384577162693,1.19050563035935e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMMT,MICOS complex subunit MIC60,24793,0.0446435855103099,0.00307287193111589,0.0386207565253228,0.0506664144952971,1.25916593501962e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3C,Protein FAM3C,29433,0.0300308188181823,0.00206999519855018,0.0259736282290239,0.0340880094073406,1.58126561465898e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNM1,Dynamin-1,24805,0.114510586522294,0.00789950404287321,0.099027558598263,0.129993614446326,2.01025285865048e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD74,HLA class II histocompatibility antigen gamma chain,29694,0.0346778121708205,0.00239371873958803,0.029986123441228,0.0393695009004131,2.12526902771117e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTN2,Dynactin subunit 2,29349,0.0942268467601833,0.00650648364559197,0.081474138814823,0.106979554705544,2.29486133117266e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSHB,Follitropin subunit beta,24240,0.0648050800275362,0.00447353616042397,0.0560369491531052,0.0735732109019671,2.33310000163265e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1D,"Methionine aminopeptidase 1D, mitochondrial",29434,0.0822603298982629,0.00569143734328167,0.0711051127054308,0.093415547091095,3.46604255127294e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAL,Integrin alpha-L,24229,0.0435433195298547,0.00301410687783863,0.037635670049291,0.0494509690104184,4.14175066108696e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12A_IL12B,Interleukin-12,29349,0.0773425018340252,0.00535693766263605,0.0668429040152586,0.0878420996527919,4.34004733147433e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB2,Calretinin,28774,0.0304499033927395,0.00211034519589611,0.0263136268087832,0.0345861799766959,4.97338830445596e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTIF3,"Translation initiation factor IF-3, mitochondrial",24805,0.0872211777961841,0.00605711668271031,0.0753492290980719,0.0990931264942963,8.0217636469711e-47
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTR1,Endosome-associated-trafficking regulator 1,24240,0.0586343261864361,0.00409814027616766,0.0506019712451475,0.0666666811277247,3.03071172998405e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSG1,Pregnancy-specific beta-1-glycoprotein 1,29218,-0.113340111936494,0.00793051904555213,-0.128883929265776,-0.097796294607212,3.53281094376767e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA2,Carboxypeptidase A2,29577,0.0643694073070529,0.0045044891940221,0.0555406084867696,0.0731982061273362,3.59775780924191e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6R,Interleukin-6 receptor subunit alpha,29361,0.0333862495951879,0.0023400323651895,0.0287997861594165,0.0379727130309594,4.97941431134413e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML2,Trem-like transcript 2 protein,29443,0.0333933240906182,0.00234238027049603,0.028802258760446,0.0379843894207904,5.84091323406305e-46
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XCL1,Lymphotactin,29725,0.0544033107249669,0.00382908306287754,0.0468983079217269,0.0619083135282069,1.15493639544708e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPXM2,Inactive carboxypeptidase-like protein X2,24922,0.0248340023257836,0.00174842245193253,0.0214070943199958,0.0282609103315713,1.31057874435935e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF23,Fibroblast growth factor 23,29693,0.0556241281975608,0.00392097554190324,0.0479390161354305,0.0633092402596912,1.56961134948215e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFASC,Neurofascin,29786,0.0277350581318493,0.00195589998084016,0.0239014941694026,0.031568622094296,1.70925568312243e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLF4,Krueppel-like factor 4,24101,0.0389778870633135,0.00274800474151424,0.0335917977699456,0.0443639763566814,1.7533753141334e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL11,C-X-C motif chemokine 11,29694,0.0770089507896632,0.00543687002662802,0.0663526855374722,0.0876652160418541,2.14555023443895e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM16,Carcinoembryonic antigen-related cell adhesion molecule 16,24805,0.0804907067011315,0.00568299495353768,0.0693520365921977,0.0916293768100654,2.3191785524917e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP3L,BCL2/adenovirus E1B 19 kDa protein-interacting protein 3-like,24229,0.0436812809267021,0.0030853907709515,0.0376339150156372,0.0497286468377671,2.54772004836102e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG3,Proteasome assembly chaperone 3,29434,0.0492141298028125,0.00347751346143364,0.0423982034184026,0.0560300561872225,2.55342959144017e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX16,Syntaxin-16,28797,0.0567309722141179,0.00401213010311326,0.0488671972120159,0.0645947472162199,3.05807603678932e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL4,Angiopoietin-related protein 4,29536,-0.0440340723014373,0.00311886671938994,-0.0501470510714416,-0.037921093531433,4.09105791704663e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX3,Probable E3 ubiquitin-protein ligase DTX3,29349,0.0235579557619686,0.00166891343917289,0.0202868854211897,0.0268290261027474,4.26896855139223e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAP18,Chromatin complexes subunit BAP18,24845,0.0645894373501903,0.00458336422059961,0.055606043477815,0.0735728312225655,6.32547772171658e-45
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR3,Toll-like receptor 3,29786,0.0592230138623519,0.00421752906235873,0.0509566569001288,0.067489370824575,1.19575257293903e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPAG1,Sperm-associated antigen 1,24867,0.0561210673829034,0.00400080648588252,0.0482794866705736,0.0639626480952331,1.56637142955085e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSL,Cathepsin L1,29478,0.0235360861122016,0.0016798100717401,0.020243658371591,0.0268285138528122,1.85084706013852e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD274,Programmed cell death 1 ligand 1,29218,0.0330966342725892,0.00236612148823727,0.0284590361556442,0.0377342323895343,2.57593757183633e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR2,Folate receptor beta,29694,-0.028293869538399,0.00202299064969982,-0.0322589312118107,-0.0243288078649874,2.61871633940269e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRPEL1,"GrpE protein homolog 1, mitochondrial",29349,0.0583533055345487,0.00417751397364581,0.0501653781462029,0.0665412329228945,3.36664218363953e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD276,CD276 antigen,29454,-0.0346884720008244,0.00248343206775047,-0.0395559988536154,-0.0298209451480335,3.3849386393168e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAM,Peptidyl-glycine alpha-amidating monooxygenase,29652,0.027143102499026,0.00194365555901451,0.0233335376033576,0.0309526673946944,3.52101167636771e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX6B1,Cytochrome c oxidase subunit 6B1,24922,0.0312030362708919,0.0022345582759197,0.0268233020500893,0.0355827704916945,3.80146395863656e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMOTL2,Angiomotin-like protein 2,24711,0.0466610798396992,0.00334292696550856,0.0401089429873024,0.053213216692096,4.12878653971997e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TF,Serotransferrin,24966,0.0208147976213253,0.00149360702743868,0.0178873278475455,0.0237422673951051,5.60239498260794e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NID2,Nidogen-2,29443,0.0703839608937344,0.00506207718683638,0.0604622896075351,0.0803056321799337,8.22456097919073e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDCP1,CUB domain-containing protein 1,29218,0.0499919378467842,0.00359615853379673,0.0429434671205426,0.0570404085730258,8.55755536452533e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP3,Stromelysin-1,29443,-0.0470799127232234,0.00338826287619265,-0.053720907960561,-0.0404389174858858,9.34035365187638e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBP3,Latent-transforming growth factor beta-binding protein 3,28797,0.0516264102061477,0.00371556864212619,0.0443438956675803,0.058908924744715,9.45694434475254e-44
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PINLYP,phospholipase A2 inhibitor and Ly6/PLAUR domain-containing protein,24381,0.0657107108647836,0.0047370272802003,0.056426137395591,0.0749952843339762,1.37701455356188e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVR,Poliovirus receptor,29694,0.0354406720826782,0.00255715516919662,0.0304286479510529,0.0404526962143036,1.52538966528004e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL26,C-C motif chemokine 26,29434,0.0851074442274904,0.00615397757962426,0.0730456481714269,0.097169240283554,2.30785455598468e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMD,Dystrophin,24240,0.0492694327592279,0.00357353831464571,0.0422652976625223,0.0562735678559335,4.42157684617671e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5RA,Interleukin-5 receptor subunit alpha,29434,-0.0534310918220917,0.00387802739307821,-0.061032025512525,-0.0458301581316584,4.71093635887871e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDZK1,Na(+)/H(+) exchange regulatory cofactor NHE-RF3,24229,0.0425417469364829,0.00308939645365766,0.0364865298873139,0.0485969639856519,5.59011489144355e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX5,"Glutaredoxin-related protein 5, mitochondrial",24381,0.0845061054559263,0.00614818377387346,0.0724556652591343,0.0965565456527183,7.89825256714852e-43
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNAR1,Interferon alpha/beta receptor 1,24805,0.0242968860280128,0.00177197919889568,0.0208238067981772,0.0277699652578483,1.23622331475017e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SWAP70,Switch-associated protein 70,24805,0.033919411111323,0.0024764285114561,0.0290656112288691,0.038773210993777,1.51380148033119e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FEN1,Flap endonuclease 1,28797,0.0595021019724323,0.00435050885689633,0.0509751046129155,0.0680290993319491,1.89055068925022e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STK4,Serine/threonine-protein kinase 4,29478,0.0815902066703597,0.00597158759144206,0.0698858949911332,0.0932945183495861,2.27206026456439e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCHFR,GTP cyclohydrolase 1 feedback regulatory protein,23721,0.0467961588250104,0.00342370231545173,0.040085702286725,0.0535066153632958,2.273654064921e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRC,Sarcoplasmic reticulum histidine-rich calcium-binding protein,24240,-0.0332507420005538,0.00243336635608037,-0.0380201400584713,-0.0284813439426362,2.37534271212936e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WAS,Wiskott-Aldrich syndrome protein,28931,0.0631806774282272,0.00462696707019567,0.0541118219706437,0.0722495328858107,2.55489450139825e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VGF,Neurosecretory protein VGF,24867,0.0286254486554831,0.00209851370090216,0.0245123618017148,0.0327385355092513,3.25010456805148e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QA,Complement C1q subcomponent subunit A,29646,-0.0213329650855915,0.00156794188432062,-0.0244061311788599,-0.0182597989923231,4.95444815045508e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMB1,Laminin subunit beta-1,24240,0.0285987203615352,0.00210386240712232,0.0244751500435755,0.032722290679495,6.24295546831032e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYCBP2,E3 ubiquitin-protein ligase MYCBP2,24867,0.0630106423359115,0.00463639795805315,0.0539233023381274,0.0720979823336957,6.44521782450987e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRB1,Killer cell lectin-like receptor subfamily B member 1,29786,0.0356170328849862,0.00262173053936186,0.0304784410278369,0.0407556247421354,6.52735287472581e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3B,Protein FAM3B,29349,0.0334075911537113,0.00246107390538722,0.0285838862991524,0.0382312960082703,7.60196649196212e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORCS2,VPS10 domain-containing receptor SorCS2,28797,0.033581528219185,0.00247396634789096,0.0287325541773187,0.0384305022610513,7.68933668609461e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERI1,3'-5' exoribonuclease 1,24445,0.0318050147358238,0.00234505240832195,0.0272087120155128,0.0364013174561349,9.45222204152846e-42
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGRN,Neugrin,24845,0.0207737454233445,0.00153259204339978,0.0177698650182809,0.0237776258284081,1.04678798788831e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELT,Tumor necrosis factor receptor superfamily member 19L,29443,0.0268451331436098,0.00198206983154227,0.022960276273787,0.0307299900134327,1.14662583175684e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF22,Kinesin-like protein KIF22,24111,0.115112641335446,0.00850346074089302,0.0984458582832954,0.131779424387596,1.33985321665823e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA4,Annexin A4,29341,0.0672710641370661,0.0049712629758171,0.0575273887044646,0.0770147395696677,1.35009984306908e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTN4IP1,"Reticulon-4-interacting protein 1, mitochondrial",24867,0.0854393651004204,0.00632649287704629,0.0730394390614097,0.0978392911394312,2.04556907250584e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSR1,Macrophage scavenger receptor types I and II,29694,0.0427933861540829,0.0031712287095194,0.0365777778834249,0.0490089944247409,2.23937380861265e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD1C,T-cell surface glycoprotein CD1c,29566,0.0226177659901448,0.00167899641574904,0.0193269330152767,0.025908598965013,3.06717824183169e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPH,Hephaestin,24922,0.024615042582155,0.00182737627405306,0.021033385085011,0.028196700079299,3.26807637636799e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSE,Cathepsin E,24381,0.0486311342868992,0.00361187170433233,0.0415518657464078,0.0557104028273905,3.56425443798409e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENR,Density-regulated protein,24229,0.0534742482181274,0.00397285295190834,0.0456874564323871,0.0612610400038678,3.7860752463939e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK7,Kallikrein-7,23801,0.0364360911914066,0.00270708641985911,0.0311302018084827,0.0417419805743304,3.82918257613901e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MENT,Protein MENT,24381,-0.0210859900628858,0.00156760062783132,-0.0241584872934352,-0.0180134928323364,4.25129404881209e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAN2B2,Epididymis-specific alpha-mannosidase,24922,0.0552716754404652,0.00411363632674351,0.0472089482400479,0.0633344026408825,5.15558237676931e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN4,CCN family member 4,29725,0.0371774231419388,0.00276826541964597,0.0317516229194327,0.0426032233644449,5.3243171460308e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFCAB2,Dynein regulatory complex protein 8,24445,0.0323981400221013,0.0024179319341343,0.027658993431198,0.0371372866130045,8.52754383806265e-41
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESAM,Endothelial cell-selective adhesion molecule,29820,0.0293893966391462,0.00219910067128299,0.0250791593234316,0.0336996339548609,1.28016710943192e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C5,Complement C5,24966,0.0139985636468022,0.00104807436418231,0.0119443378930049,0.0160527894005995,1.49700725737132e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARSA,Arylsulfatase A,29443,0.0412936057805883,0.00309307236257384,0.0352311839499436,0.0473560276112331,1.54707550101372e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLO1,Lactoylglutathione lyase,28916,0.0533831347263086,0.00400104882996882,0.0455410790195697,0.0612251904330475,1.73135161774646e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG3,Leucine-rich repeats and immunoglobulin-like domains protein 3,24178,0.0255889478536433,0.00191875799876981,0.0218281821760545,0.0293497135312321,1.98127890679847e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC1,MANSC domain-containing protein 1,29566,-0.0253263833134207,0.00190521236880609,-0.0290605995562807,-0.0215921670705608,3.3074686251119e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCRIB,Protein scribble homolog,24240,0.0831839419525411,0.0062567339391896,0.0709207434317295,0.0954471404733527,3.41849628418582e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK5RAP3,CDK5 regulatory subunit-associated protein 3,24867,0.0539388348446888,0.00406404083211889,0.0459733148137358,0.0619043548756418,4.59350526161905e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP1,Guanylate-binding protein 1,24816,0.0592736620739246,0.00446701028360936,0.0505183219180503,0.068029002229799,4.78385931351021e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LBP,Lipopolysaccharide-binding protein,29594,-0.0534405711535229,0.00403034597013433,-0.0613400492549862,-0.0455410930520596,5.16877639052313e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TACSTD2,Tumor-associated calcium signal transducer 2,25976,-0.0285545577105415,0.00215834218505751,-0.0327849083932543,-0.0243242070278288,7.94053143384745e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD46,Membrane cofactor protein,29331,0.0261687510510004,0.00197854110295072,0.022290810489217,0.0300466916127838,8.04730057666641e-40
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPMT,Thiopurine S-methyltransferase,28797,0.0664436204232348,0.00503094411335977,0.0565829699610496,0.0763042708854199,1.04347793184057e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP1,Rho GTPase-activating protein 1,28797,0.042068564321752,0.00319075643458157,0.0358146817099722,0.0483224469335319,1.40361559391496e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK2,Serine protease inhibitor Kazal-type 2,24381,0.0337772378489358,0.00256205213776267,0.028755615658921,0.0387988600389507,1.4886683557988e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIF,"Peptidyl-prolyl cis-trans isomerase F, mitochondrial",24938,0.0568440724345909,0.00431736834449615,0.0483820304793784,0.0653061143898034,1.85615948794129e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDO1,"Indoleamine 2,3-dioxygenase 1",24240,0.0582600031136461,0.00442737493415705,0.0495823482426982,0.0669376579845939,2.06177904244056e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASAH1,Acid ceramidase,24732,0.0423866547534995,0.00322173545754397,0.0360720532567133,0.0487012562502857,2.11956892233092e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COX5B,"Cytochrome c oxidase subunit 5B, mitochondrial",29349,0.0629682169797121,0.00478778347815361,0.053584161362531,0.0723522725968932,2.14701280513624e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRR,Receptor-type tyrosine-protein phosphatase R,24845,0.0333965706184334,0.0025395155246956,0.02841912019003,0.0383740210468368,2.28128696211261e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF1R,Insulin-like growth factor 1 receptor,29349,0.0197519495802242,0.0015026589776638,0.0168067379840032,0.0226971611764453,2.35972230156962e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL25,C-C motif chemokine 25,29786,0.044593002417867,0.00339430716321824,0.0379401603779593,0.0512458444577748,2.5800796315407e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB2,Lysosome membrane protein 2,28762,0.0288733870522473,0.00219911100739315,0.0245631294777568,0.0331836446267379,2.89210242992213e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAT1,Synaptic vesicle membrane protein VAT-1 homolog,29349,-0.0179137477893474,0.0013644480518596,-0.0205880659709922,-0.0152394296077025,2.90135990296288e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FST,Follistatin,29536,0.0458018243996498,0.00348884204806054,0.0389636939854511,0.0526399548138484,2.92903517721379e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPP,"ATP-dependent Clp protease proteolytic subunit, mitochondrial",29163,0.0871613526969712,0.00664093429539479,0.0741451214779974,0.100177583915945,3.06554622195555e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH4,Inter-alpha-trypsin inhibitor heavy chain H4,24966,0.0234969232308251,0.00179022584898093,0.0199880805668224,0.0270057658948277,3.18941357867515e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRDMT1,tRNA (cytosine(38)-C(5))-methyltransferase,24445,0.0789679268264219,0.00601835163725115,0.0671719576174097,0.0907638960354342,3.37932091002421e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZHX2,Zinc fingers and homeoboxes protein 2,24845,0.0288010165094227,0.00219933489993505,0.02449032010555,0.0331117129132954,4.71781091373845e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNRPB2,U2 small nuclear ribonucleoprotein B'',24845,0.0377292793810901,0.00288423879410647,0.0320761713446414,0.0433823874175388,5.67567825896787e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX3,"Thioredoxin-dependent peroxide reductase, mitochondrial",28931,0.0650631952379206,0.00497841885972838,0.055305494272853,0.0748208962029882,6.37993894484523e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPYL1,Testis-specific Y-encoded-like protein 1,24229,0.0365859203716053,0.00280228537764542,0.0310934410314203,0.0420783997117903,7.97129650977974e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HPCAL1,Hippocalcin-like protein 1,29786,0.0660678390806774,0.00506575134010969,0.0561389664540625,0.0759967117072924,9.00915536545365e-39
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UMOD,Uromodulin,29750,-0.0485868997434741,0.00372773820179208,-0.0558932666189865,-0.0412805328679616,1.00260614479582e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK6,Serine protease inhibitor Kazal-type 6,29725,0.0484438412775445,0.00371985614317012,0.0411529232369311,0.0557347593181579,1.15494959720132e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGED1,Melanoma-associated antigen D1,28797,0.0435273971624924,0.00334301176259253,0.0369750941078111,0.0500797002171738,1.20454882732124e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC80,Coiled-coil domain-containing protein 80,29478,0.0315733751273332,0.00243164445584886,0.0268073519938694,0.0363393982607969,1.91362795323503e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRN1,Leucine-rich repeat neuronal protein 1,28931,0.0354556715581509,0.00273068740110943,0.0301035242519764,0.0408078188643254,1.92779931684095e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLTA,Clathrin light chain A,28916,0.0421357802763731,0.00325233471346504,0.0357612042379816,0.0485103563147646,2.79424984753666e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAP,Prosaposin,24761,0.0254821971340715,0.00196728044542734,0.0216263274610339,0.0293380668071091,3.00872767755187e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FXN,"Frataxin, mitochondrial",29725,0.0655246063473801,0.0050636232143516,0.055599904847251,0.0754493078475092,3.38343285019701e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MOG,Myelin-oligodendrocyte glycoprotein,29725,0.0294045370972601,0.00227273298078291,0.0249499804549256,0.0338590937395946,3.48554009839121e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP1,Metalloproteinase inhibitor 1,29173,0.0253796333163111,0.00196182520788583,0.0215344559088549,0.0292248107237673,3.55683392197406e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSCAM,Down syndrome cell adhesion molecule,24867,0.0319575995478081,0.00247142829247587,0.0271136000945554,0.0368015990010608,4.0035256325017e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFRP4,Secreted frizzled-related protein 4,24381,0.0369669383583823,0.00286103869465432,0.0313593025168598,0.0425745741999047,4.58178894932189e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA2,Annexin A2,23907,0.0634310917699537,0.00491247439712934,0.0538026419515802,0.0730595415883272,5.14613816494722e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS27,Serine protease 27,29395,0.0358814148990069,0.00278100298687449,0.0304306490447329,0.0413321807532809,5.53893295865703e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLRX,Glutaredoxin-1,29291,0.0499763965710074,0.00387359317141465,0.0423841539550347,0.0575686391869801,5.5802124165213e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPH1,2'-deoxynucleoside 5'-phosphate N-hydrolase 1,29536,0.0454371543467181,0.00352439326668165,0.0385293435440221,0.0523449651494142,6.30566592841029e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRZB,Secreted frizzled-related protein 3,29123,0.0229448646214068,0.00178051735841163,0.01945505059892,0.0264346786438936,6.79724000681902e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DMP1,Dentin matrix acidic phosphoprotein 1,24240,-0.0542453019320622,0.00421040734932176,-0.0624977003367329,-0.0459929035273915,7.41206580055368e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA9,Serpin A9,29227,0.0643122913300738,0.00499647552882134,0.0545191992935839,0.0741053833665636,8.24950655955464e-38
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CARHSP1,Calcium-regulated heat-stable protein 1,28774,0.0455908963317775,0.00354728231572725,0.0386382229929521,0.0525435696706029,1.05983321708609e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIPF,Gastric triacylglycerol lipase,24240,0.0542565714906392,0.00422569789672155,0.045974203613065,0.0625389393682134,1.3038742851595e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHRS4L2,Dehydrogenase/reductase SDR family member 4-like 2,24845,0.0423983105258409,0.00330251229577692,0.0359253864261182,0.0488712346255637,1.31965802247578e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNF,Tumor necrosis factor,28868,0.0339170935228828,0.00264305775433332,0.0287367003243895,0.0390974867213761,1.36615099399663e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP1,Interstitial collagenase,28424,0.0811177399311503,0.00632435460505607,0.0687220049052404,0.0935134749570602,1.48613585729849e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR2,Interferon gamma receptor 2,29218,0.0461690943868324,0.00360117184154899,0.0391107975773964,0.0532273911962684,1.58795328293918e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA2,Pulmonary surfactant-associated protein A2,28797,0.0448849162043914,0.00350177894089986,0.0380214294802277,0.0517484029285551,1.65220589544596e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP4,Insulin-like growth factor-binding protein 4,28967,0.0387303873486771,0.0030315508402779,0.0327885477017324,0.0446722269956218,2.82394921421631e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCOF1,Treacle protein,24922,0.0275968148435953,0.00216469851886901,0.0233540057466121,0.0318396239405786,4.14768750386246e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD2,Ectonucleoside triphosphate diphosphohydrolase 2,28797,0.0385509954703142,0.00302878227748222,0.0326145822064491,0.0444874087341794,5.18685264864682e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIT2,Slit homolog 2 protein,28774,0.0458034369287035,0.00359947787607783,0.038748460291591,0.052858413565816,5.40310370277585e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN2,Matrilin-2,29497,0.0261408096530461,0.00205496700104413,0.0221130743309996,0.0301685449750926,5.67007558446408e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGDS,Prostaglandin-H2 D-isomerase,29291,0.0267604614159415,0.00210594968997215,0.0226328000235961,0.0308881228082869,6.76173098551837e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADM,Pro-adrenomedullin,29725,0.0232791006751025,0.0018355026225598,0.0196815155348853,0.0268766858153198,9.18770980698398e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13C,Tumor necrosis factor receptor superfamily member 13C,28931,0.0372544148833314,0.00293820460185485,0.0314955338636959,0.0430132959029669,9.64710097079166e-37
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOLA1,BolA-like protein 1,24101,0.0479140094334239,0.00377950737193531,0.0405061749844307,0.0553218438824171,1.03496582593892e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR3LG1,Natural cytotoxicity triggering receptor 3 ligand 1,24805,-0.0300194905252614,0.00236852213633636,-0.0346617939124806,-0.0253771871380421,1.06635735896593e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1A,T-cell leukemia/lymphoma protein 1A,29194,0.0858742503107172,0.00677971879113815,0.0725860014800864,0.0991624991413479,1.13485435742998e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM22,Disintegrin and metalloproteinase domain-containing protein 22,29218,0.0310625634943536,0.00245928174102595,0.0262423712819427,0.0358827557067644,1.78049980110839e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMM2,Phosphomannomutase 2,24111,0.052342303388523,0.00416210419547396,0.044184579165394,0.060500027611652,3.72091018049459e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP2,Retinol-binding protein 2,29349,-0.0667354767022951,0.00530850369906105,-0.0771401439524547,-0.0563308094521354,3.75834644436391e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDA,Cytidine deaminase,24890,0.0405951022518294,0.00323152596361412,0.0342613113631457,0.046928893140513,4.38495060276204e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT1,"Branched-chain-amino-acid aminotransferase, cytosolic",24922,0.0261479734452791,0.00208336856744643,0.0220645710530841,0.0302313758374741,5.05767165183521e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAA10,N-alpha-acetyltransferase 10,24111,0.0442255554903445,0.00352554484551373,0.0373154875931375,0.0511356233875514,5.53351472783901e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL19,C-C motif chemokine 19,29694,0.106446112036121,0.00849293027061714,0.0897999687057118,0.123092255366531,6.03810444268682e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEK7,Serine/threonine-protein kinase Nek7,24445,0.0648814103716112,0.00518753354000243,0.0547138446332064,0.0750489761100159,8.77960700611811e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO2,Roundabout homolog 2,29694,0.019999575775007,0.00160026396952944,0.0168630583947293,0.0231360931552847,9.45837668513426e-36
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TREML1,Trem-like transcript 1 protein,24951,0.0455255391522065,0.00364920291086565,0.0383731014469098,0.0526779768575031,1.2979661318187e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12B,Interleukin-12 subunit beta,29786,0.0468599979637947,0.00376071879950309,0.0394889891167686,0.0542310068108207,1.50610872228338e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM1,Intercellular adhesion molecule 1,29391,0.0247541955057958,0.00199147609851726,0.020850902352702,0.0286574886588896,2.20314582798176e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDNF,Glial cell line-derived neurotrophic factor,28774,0.0328288443639568,0.00264860895627524,0.0276375708096573,0.0380201179182563,3.43217085109524e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR5,Complement factor H-related protein 5,24623,0.035714767063058,0.00289117574130752,0.0300480626100953,0.0413814715160207,5.95592515912174e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMS,Spermine synthase,24101,0.0546424934486363,0.00442765257802895,0.0459642943956996,0.0633206925015731,6.92898344442563e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL2A1,Collagen alpha-1(II) chain,24240,0.068823246919845,0.00558727089106959,0.0578721959733486,0.0797742978663414,9.22534521255187e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX7,Syntaxin-7,24229,0.0423270818774053,0.00343743718341663,0.0355897049979088,0.0490644587569019,9.72905726303813e-35
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PER3,Period circadian protein homolog 3,24229,0.102248517416388,0.00830559773312338,0.0859695458594662,0.11852748897331,1.0065701043881e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD10,"Coiled-coil-helix-coiled-coil-helix domain-containing protein 10, mitochondrial",24845,0.0340505616159106,0.00276924375862819,0.0286228438489994,0.0394782793828219,1.20083488309808e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTGES2,Prostaglandin E synthase 2,24037,0.0467294748925531,0.0038105063272859,0.0392608824910727,0.0541980672940334,1.80739140119537e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100P,Protein S100-P,28916,0.0453641132518135,0.00370294397461014,0.0381063430615776,0.0526218834420493,2.02457888694592e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGMN,Legumain,29581,0.030312120099868,0.00247584703022419,0.0254594599206286,0.0351647802791074,2.21510648740504e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMCO5A,Transmembrane and coiled-coil domain-containing protein 5A,24195,0.0455813646098945,0.00372273305910716,0.0382848078140445,0.0528779214057445,2.28528592853202e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMD4,T-cell immunoglobulin and mucin domain-containing protein 4,29594,-0.0368910578630847,0.00301878330597118,-0.0428078731427882,-0.0309742425833812,2.92236878033241e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD83,CD83 antigen,29434,0.0286893795463675,0.00234959305380849,0.0240841771609028,0.0332945819318321,3.3119417504781e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSTB,Cystatin-B,29030,0.0358767859737941,0.0029397465128645,0.0301148828085797,0.0416386891390085,3.58748172211473e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SF3B4,Splicing factor 3B subunit 4,29349,0.0613550180786123,0.00503362433987398,0.0514891143724593,0.0712209217847653,4.30024882942185e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM2,Neural cell adhesion molecule 2,29443,-0.0226875865478389,0.00186348414708006,-0.0263400154761158,-0.019035157619562,5.11144577135852e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA4,Ephrin-A4,29169,0.0258870122427043,0.00212647445125797,0.0217191223182387,0.03005490216717,5.19245358698771e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC5A,C-type lectin domain family 5 member A,29395,-0.0245719000706436,0.0020195468458733,-0.0285302118885553,-0.0206135882527319,5.6220219124161e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA,Adenosine deaminase,29786,0.029189996925031,0.0024041690535344,0.0244778255801036,0.0339021682699584,7.66185817790705e-34
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCT,Secretin,24195,0.0393270413192624,0.00324763701961807,0.0329616727608109,0.0456924098777138,1.17830454369588e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRH,Corticoliberin,28751,0.0726249246267626,0.00600719498354255,0.0608508224590191,0.084399026794506,1.44525584962871e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK4,Dickkopf-related protein 4,29169,0.0383562186178391,0.00317323620693377,0.0321366756522489,0.0445757615834293,1.48107005676346e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXADR,Coxsackievirus and adenovirus receptor,29434,0.0427817054839757,0.00354362982498934,0.0358361910269965,0.0497272199409548,1.76362360951306e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XRCC4,DNA repair protein XRCC4,28774,0.0308865938268103,0.00256209236802158,0.025864892785488,0.0359082948681326,2.19140615119399e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1F,V-type proton ATPase subunit F,28719,0.055155050789233,0.00458650989159641,0.0461654914017041,0.064144610176762,3.13759400037935e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF7,SLAM family member 7,29434,-0.0486537720458387,0.00405058138238285,-0.0565929115553091,-0.0407146325363683,3.69463161221934e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MARCO,Macrophage receptor MARCO,29478,0.0218289085812156,0.00181806369549966,0.0182655037380363,0.025392313424395,3.9166968641659e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APLP1,Amyloid-like protein 1,29478,-0.042650999629401,0.0035537764925163,-0.049616401554733,-0.0356855977040691,4.16351693857077e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C7orf50,Uncharacterized protein C7orf50,24845,0.0185295517578129,0.00154373884580683,0.0155038236200315,0.0215552798955943,4.22984864162436e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK4,Kallikrein-4,29725,-0.0519955170874747,0.00435017545832774,-0.0605218609857971,-0.0434691731891523,7.49337779029102e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK2,SLIT and NTRK-like protein 2,29725,0.0323175640776856,0.00270473513322962,0.0270162832165555,0.0376188449388156,7.86076865871883e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPC2,NPC intracellular cholesterol transporter 2,24609,0.0263380471781997,0.00220658692668208,0.0220131368019028,0.0306629575544966,9.45162546352683e-33
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD11B1,Corticosteroid 11-beta-dehydrogenase isozyme 1,29434,-0.0321985634133644,0.00270444965674495,-0.0374992847405845,-0.0268978420861443,1.31238412361888e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTH1R,Parathyroid hormone/parathyroid hormone-related peptide receptor,29434,0.0309111550181722,0.00259655287470776,0.025821911383745,0.0360003986525994,1.32946191475734e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP8,Caspase-8,29632,0.0505967288012861,0.00425305170215906,0.0422607474650544,0.0589327101375179,1.46294869945029e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6A,Ras-related protein Rab-6A,29434,0.0380339183397307,0.00320055702823535,0.0317608265643894,0.044307010115072,1.71082449937011e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM,Paralemmin-1,24657,0.0245680400555774,0.00206906845016,0.0205126658932638,0.028623414217891,1.98152688152312e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2L,V-set and transmembrane domain-containing protein 2-like protein,28916,0.0469246055869707,0.00395732372134244,0.0391682510931395,0.0546809600808019,2.33443189217972e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBD,Thrombomodulin,29478,0.0233790552574715,0.00197985567464306,0.0194985381351711,0.0272595723797719,4.17019339743403e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGR,Tyrosine-protein kinase Fgr,28774,0.0462931942459316,0.00392907480545154,0.0385922076272466,0.0539941808646166,5.71089653158706e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL15A1,Collagen alpha-1(XV) chain,24938,0.0215755318969242,0.00183257877765013,0.01798367749273,0.0251673863011185,6.5095603806731e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASGR2,Asialoglycoprotein receptor 2,24951,0.0212016426745092,0.00180391665392908,0.0176659660328082,0.0247373193162102,8.25791535713582e-32
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD8A,T-cell surface glycoprotein CD8 alpha chain,29694,0.0400706596122046,0.00341702580185022,0.0333732890405782,0.0467680301838311,1.09190023812545e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA4,Laminin subunit alpha-4,29581,0.0270852421168481,0.00230980347683816,0.0225580273022453,0.0316124569314509,1.09971805288378e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR7L,Aflatoxin B1 aldehyde reductase member 4,24229,0.0565394170136216,0.00482272302251438,0.0470868798894934,0.0659919541377498,1.1757900298806e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDGF,Hepatoma-derived growth factor,29688,0.0756913753926599,0.00646169920615446,0.0630264449485971,0.0883563058367226,1.27087666239252e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP2,"Fatty acid-binding protein, intestinal",29478,-0.0634156735758865,0.00542152792360675,-0.0740418683061558,-0.0527894788456173,1.55030274253503e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIP,Pancreatic triacylglycerol lipase,24951,0.0510365441264229,0.00436829799847243,0.0424746800494169,0.0595984082034288,1.87194808763885e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NADK,NAD kinase,29478,0.0434888494580323,0.00373404283004302,0.036170125511148,0.0508075734049166,2.79697836208058e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBP1,"Fructose-1,6-bisphosphatase 1",29478,0.0588356289988838,0.00505680057645264,0.0489242998690366,0.068746958128731,3.20377953412903e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RARRES1,Retinoic acid receptor responder protein 1,28797,0.026940235732213,0.00231556690209705,0.0224017246041028,0.0314787468603232,3.23636989677342e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BGN,Biglycan,28750,-0.0963580244243513,0.00828475445376725,-0.112596143153735,-0.0801199056949675,3.37751230130561e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB103A_DEFB103B,Beta-defensin 103,24109,0.0332545020216675,0.00285933408328239,0.027650207218434,0.0388587968249009,3.50827624493336e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTN,Pleiotrophin,28916,0.0401366176341634,0.00345981744896028,0.0333553754342013,0.0469178598341256,4.78409335231665e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMARCA2,Probable global transcription activator SNF2L2,28774,0.0587576677363186,0.00506919922714517,0.0488220372511141,0.0686932982215231,5.35793391365949e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELOB,Elongin-B,24111,0.0318196239602458,0.00274566252772621,0.0264381254059025,0.0372011225145892,5.65837136841036e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOT13,Acyl-coenzyme A thioesterase 13,24805,0.0911486883975856,0.00786913221477389,0.0757251892566287,0.106572187538542,6.03346678612165e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPP1,Tripeptidyl-peptidase 1,29286,0.0367265726837812,0.00317156935530289,0.0305102967473875,0.0429428486201748,6.0840043407988e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2AK3,Eukaryotic translation initiation factor 2-alpha kinase 3,24111,0.0531062872948062,0.00458661442769088,0.0441165230165321,0.0620960515730804,6.39259872566168e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX6,Syntaxin-6,28797,0.0538344626061189,0.00465304940937499,0.0447144857637439,0.0629544394484939,6.86826013662188e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WARS,"Tryptophan--tRNA ligase, cytoplasmic",29443,0.030594368391317,0.00264529351189713,0.0254095931079987,0.0357791436746354,7.1806112969275e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMT1,Glycylpeptide N-tetradecanoyltransferase 1,24867,0.0529668659487452,0.00458241175038787,0.043985338917985,0.0619483929795054,7.99653783041267e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP6,Lysophosphatidic acid phosphatase type 6,29674,0.0533639665176883,0.00461798572719067,0.0443127144923946,0.0624152185429821,8.04482069462848e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH5,Cadherin-5,29820,-0.0242526805878895,0.0020996624336158,-0.0283680189577765,-0.0201373422180026,8.51121521659449e-31
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDF1,Endothelial differentiation-related factor 1,24867,0.0543051823493289,0.00470890131101722,0.0450757357797351,0.0635346289189226,1.08375920077288e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRDT,Bromodomain testis-specific protein,24111,0.0294197649039236,0.00255279051870525,0.0244162954872613,0.0344232343205859,1.19402238299185e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP2R5A,Serine/threonine-protein phosphatase 2A 56 kDa regulatory subunit alpha isoform,24805,0.0939737385686766,0.00815623984688044,0.0779875084687909,0.109959968668562,1.22764895546353e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC37A2,Leucine-rich repeat-containing protein 37A2,24805,0.034149073385987,0.00296438725929441,0.0283388743577699,0.039959272414204,1.25522278590829e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APRT,Adenine phosphoribosyltransferase,29192,0.0380224499884969,0.00330351041659307,0.0315475695719744,0.0444973304050193,1.37245730767521e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP1,Ran-specific GTPase-activating protein,24240,0.0417059441635992,0.00362819635832259,0.0345946793012869,0.0488172090259115,1.67814391104174e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDK,Midkine,29455,0.040367096663031,0.00351436177171192,0.0334789475904757,0.0472552457355864,1.79489831254625e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS4,A disintegrin and metalloproteinase with thrombospondin motifs 4,24229,0.0285245507312659,0.00248518087646503,0.0236535962133944,0.0333955052491373,2.04322409453542e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF2S2,Eukaryotic translation initiation factor 2 subunit 2,24240,0.0335211690813473,0.0029232051983154,0.0277916868926491,0.0392506512700455,2.30760654592343e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP9,Caspase-9,24229,0.0499494497411785,0.00436045984690721,0.0414029484412404,0.0584959510411166,2.654215463648e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPE,Ribulose-phosphate 3-epimerase,24445,0.0559376574984833,0.00488587030081263,0.0463613517088905,0.065513963288076,2.84626244044454e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL15,C-C motif chemokine 15,29820,0.0346604005525424,0.00304240040578954,0.0286972957571949,0.0406235053478899,5.2609476054047e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLIF,Cobalamin binding intrinsic factor,29433,0.0586183839624349,0.0051466948264692,0.0485308621025552,0.0687059058223145,5.45040941903687e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LACRT,Extracellular glycoprotein lacritin,24732,0.0392350841762961,0.0034460856657945,0.0324807562713389,0.0459894120812533,5.87136838167757e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAPK2,Death-associated protein kinase 2,24229,0.0422959331675236,0.00371504855509022,0.0350144379995468,0.0495774283355004,5.91774491635721e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMNAT1,Nicotinamide/nicotinic acid mononucleotide adenylyltransferase 1,29218,0.0559821030126625,0.00492132600105975,0.0463363040505854,0.0656279019747396,6.41001977511784e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPL14,60S ribosomal protein L14,24240,0.031707698297248,0.00278796720991137,0.0262432825658217,0.0371721140286743,6.78322804793439e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO2,Amphoterin-induced protein 2,29349,0.0180167637053263,0.00158641024051164,0.0149073996339235,0.0211261277767291,7.90774877953966e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP6,Gastrotropin,28872,0.0441962281885152,0.00389151679711702,0.0365688552661659,0.0518236011108646,7.91463271823295e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSNK1D,Casein kinase I isoform delta,24229,0.0502456746258756,0.00442349299768648,0.0415756283504101,0.0589157209013411,7.97757154149207e-30
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOF,Apolipoprotein F,24951,-0.0195976005949925,0.00173013480942711,-0.0229886648214696,-0.0162065363685153,1.13713049671649e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC1,WAP four-disulfide core domain protein 1,24326,0.0425693017803275,0.00375892507862368,0.0352018086262251,0.0499367949344299,1.17288203535844e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX1,Peroxiredoxin-1,28669,-0.0705250593392943,0.00624579611234291,-0.0827668197194864,-0.0582832989591022,1.66675136877209e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SGSH,N-sulphoglucosamine sulphohydrolase,24571,0.0437823959908231,0.00387993299756376,0.0361777273155981,0.051387064666048,1.85377404619726e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL1,Fc receptor-like protein 1,29478,0.0354105658177176,0.00313890440893771,0.0292583131761997,0.0415628184592356,1.86810678199179e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENAH,Protein enabled homolog,28931,0.0371688304296338,0.00329785231038697,0.0307050399012753,0.0436326209579923,2.11092725500924e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMP3,Lysosome-associated membrane glycoprotein 3,29760,0.0399813551134725,0.00354886615174812,0.0330255774560461,0.0469371327708988,2.21655134258861e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SV2A,Synaptic vesicle glycoprotein 2A,24195,0.0482487970709871,0.00428882578450382,0.0398426985333596,0.0566548956086146,2.74212869864436e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAP1L4,Nucleosome assembly protein 1-like 4,24764,0.0319243422057856,0.00283824960675268,0.0263613729765504,0.0374873114350209,2.79352665299912e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3LG,Fms-related tyrosine kinase 3 ligand,29786,0.0263156500136955,0.00234703634992927,0.0217154587678342,0.0309158412595569,4.05961805219576e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGKZ,Diacylglycerol kinase zeta,28931,0.0275040553291895,0.00245645023660165,0.0226894128654502,0.0323186977929287,4.8583540436801e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLU,Clusterin,24966,0.0245991882654803,0.00219762028770922,0.0202918525015702,0.0289065240293904,5.1418455404265e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SBSN,Suprabasin,24905,-0.0266169267845905,0.0023873972173421,-0.031296225330581,-0.0219376282386,8.48039528358783e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FKBP7,Peptidyl-prolyl cis-trans isomerase FKBP7,28719,0.0369666552686357,0.00331870273818003,0.0304619979018028,0.0434713126354685,9.29304309415579e-29
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD93,Complement component C1q receptor,28353,-0.0242311410115463,0.00217693564743859,-0.028497934880526,-0.0199643471425667,1.01842421774007e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GC,Vitamin D-binding protein,24966,0.0199020774917117,0.00179149958643407,0.0163907383023009,0.0234134166811225,1.32125209025303e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL5,Insulin-like peptide INSL5,24805,0.0750944026774511,0.00676345567079301,0.0618380295626968,0.0883507757922054,1.41727956773817e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRC,Receptor-type tyrosine-protein phosphatase C,24938,0.0174852345359638,0.00157829688130872,0.0143917726485988,0.0205786964233289,1.85809379347973e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX5,Sorting nexin-5,24240,0.0228879996754525,0.00206731576400423,0.0188360607780042,0.0269399385729008,2.02131963912278e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYM,Ketimine reductase mu-crystallin,24101,0.0582915360128172,0.0052843440204281,0.0479342217327781,0.0686488502928562,3.16499415326987e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX58,Antiviral innate immune response receptor RIG-I,28797,0.0433468155875809,0.00393657558754406,0.0356311274359946,0.0510625037391673,3.83682702292461e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EBI3_IL27,Interleukin-27,29674,-0.0235439071656141,0.00213902419799815,-0.0277363945936905,-0.0193514197375377,4.01515974156685e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXN,Thioredoxin,24647,0.0333191746131126,0.00303115823659363,0.0273781044693891,0.0392602447568361,4.83996579601595e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFATC3,"Nuclear factor of activated T-cells, cytoplasmic 3",28931,0.0453700383461809,0.00413086987683911,0.0372735333875763,0.0534665433047856,5.23120196937022e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL2,ADAMTS-like protein 2,24938,0.0249828380158251,0.00227649260849513,0.0205209125031746,0.0294447635284755,5.88879751653592e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPR,Nucleoprotein TPR,24111,0.0362184200405369,0.00330685897560178,0.0297369764483574,0.0426998636327164,7.51829102777506e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL8,Interleukin-8,29218,0.0513236979845613,0.00468816750842246,0.0421348896680533,0.0605125063010694,7.73785846128107e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPB6,Heat shock protein beta-6,29725,0.0290733572960714,0.0026571571564524,0.0238653292694247,0.0342813853227181,8.24500858248976e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNRF4,E3 ubiquitin-protein ligase ZNRF4,24793,0.0410863034982831,0.00375574105660021,0.0337250510273467,0.0484475559692195,8.6281297502734e-28
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPQ,Carboxypeptidase Q,24920,0.0278857967303235,0.00255396971766731,0.0228800160836956,0.0328915773769514,1.08533954204368e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRA,Platelet-derived growth factor receptor alpha,29478,-0.021487581208692,0.00196927507400278,-0.0253473603537374,-0.0176278020636465,1.1484551651308e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD101,Immunoglobulin superfamily member 2,24805,0.0323341187327367,0.00296550336024781,0.026521732146651,0.0381465053188224,1.28260900528517e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECI2,Enoyl-CoA delta isomerase 2,24111,0.0464300330451688,0.00427899575651336,0.0380432013624026,0.0548168647279349,2.29001054167128e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA3A,Chymotrypsin-like elastase family member 3A,29789,0.043119703824976,0.0039802777753222,0.0353183593853445,0.0509210482646075,2.69043727959524e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AK1,Adenylate kinase isoenzyme 1,29478,0.0470248714452506,0.00434470031254256,0.0385092588326672,0.0555404840578341,2.99799263729145e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNER,Delta and Notch-like epidermal growth factor-related receptor,29382,0.01908956987221,0.00176409442940563,0.015631944790575,0.022547194953845,3.07605598503643e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA4,Carbonic anhydrase 4,29820,-0.0177904264543557,0.00164425210939382,-0.0210131605887676,-0.0145676923199438,3.11795009831353e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHPS,Deoxyhypusine synthase,24793,0.0304772671124611,0.00282049328279308,0.0249491002781866,0.0360054339467355,3.72087209026745e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSB,Cathepsin B,29480,-0.0390200020638568,0.00362868872447936,-0.0461322319638363,-0.0319077721638772,6.4225456153192e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD302,CD302 antigen,29349,0.0226792183849856,0.00211011542876714,0.018543392144602,0.0268150446253692,6.80726835099864e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACOX1,Peroxisomal acyl-coenzyme A oxidase 1,29478,0.0363980652745392,0.00338687135139644,0.0297597974258022,0.0430363331232763,6.88111648020964e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL14,C-C motif chemokine 14,29435,0.0294152244134931,0.0027375368591031,0.0240496521696511,0.0347807966573352,7.00730864948095e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPL,Periplakin,24229,0.0243313724027893,0.00226539702980015,0.019891194224381,0.0287715505811976,7.55522501783783e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCL,"Hydroxymethylglutaryl-CoA lyase, mitochondrial",24240,0.0368647445708421,0.00343265203069516,0.0301367465906796,0.0435927425510046,7.63743219927027e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2,Brorin,29114,0.0296153983126398,0.00276050663329977,0.0242048053113723,0.0350259913139074,8.4185983003697e-27
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM3,Carcinoembryonic antigen-related cell adhesion molecule 3,28797,0.0351351957670353,0.00328003783660641,0.0287063216072868,0.0415640699267839,1.00597945774681e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST5,Cystatin-D,28890,0.0411886739982,0.00384721762506507,0.0336481274530724,0.0487292205433275,1.06956994000255e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2orf69,UPF0565 protein C2orf69,24195,0.0442022878890076,0.00412793200305195,0.0361115411630258,0.0522930346149895,1.07046241656789e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MECR,"Enoyl-[acyl-carrier-protein] reductase, mitochondrial",24240,0.0677984020721697,0.00633784758716955,0.0553762208013174,0.080220583343022,1.20068279874787e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF10,Multiple epidermal growth factor-like domains protein 10,29454,0.0292979508061135,0.00273950264058021,0.0239285256305763,0.0346673759816507,1.20726749024881e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECE1,Endothelin-converting enzyme 1,28774,0.0260925053920714,0.00244270959900706,0.0213047945780175,0.0308802162061252,1.38936732933003e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR2,Complement factor H-related protein 2,24789,0.0420677695494133,0.00394918848937856,0.0343273601102313,0.0498081789885952,1.9416561571527e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA12,Serpin A12,28628,0.0823088160993659,0.00773792075005725,0.0671424914292536,0.0974751407694781,2.24410079151766e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMFR,E3 ubiquitin-protein ligase AMFR,28774,0.0469804370559432,0.00441990523674523,0.0383174227919226,0.0556434513199639,2.43733859475203e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXNB2,Plexin-B2,29701,0.0175347274383227,0.00165049019732288,0.0142997666515698,0.0207696882250755,2.57118313243996e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK6,Kallikrein-6,29519,0.0225020139750142,0.00211844626902896,0.0183498592877175,0.026654168662311,2.62867945402901e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KITLG,Kit ligand,29478,-0.027363490428532,0.00257776728013087,-0.0324159142975885,-0.0223110665594755,2.82548014580421e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH5A1,"Succinate-semialdehyde dehydrogenase, mitochondrial",24867,0.0349094641448518,0.00328815595226153,0.0284646784784192,0.0413542498112844,2.83628254154937e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS1,Nephrin,24229,0.0250258425070001,0.0023609882888505,0.0203983054608531,0.0296533795531471,3.41083013486904e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST2,Bone marrow stromal antigen 2,29694,0.0384527962297585,0.00362998199445813,0.0313380315206206,0.0455675609388965,3.57223001242831e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA12,Carbonic anhydrase 12,29349,-0.0238646057344542,0.00225453882755823,-0.0282835018364684,-0.0194457096324401,3.89336275994406e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSDE1,Cold shock domain-containing protein E1,24111,0.0866014700616157,0.00820383535592517,0.0705219527640023,0.102680987359229,5.41834748921473e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY75,Lymphocyte antigen 75,29434,0.0283045922074748,0.00268709319354677,0.0230378895481232,0.0335712948668265,6.73002106491248e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BPIFA2,BPI fold-containing family A member 2,23405,-0.0807513241407396,0.00767887361705559,-0.0958019164301686,-0.0657007318513107,8.32109493831893e-26
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGREF1,Cell growth regulator with EF hand domain protein 1,29478,0.0308669978349533,0.00294354612837175,0.0250976474233446,0.0366363482465619,1.10793922415133e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFI30,Gamma-interferon-inducible lysosomal thiol reductase,24230,0.0281939889425879,0.00269640325710336,0.0229090385586653,0.0334789393265105,1.55654610734179e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHCHD6,MICOS complex subunit MIC25,24793,0.0209748505376662,0.00200794968706249,0.0170392691510237,0.0249104319243087,1.72834768859199e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17D,Interleukin-17D,28931,0.0246645879528391,0.00236419802877888,0.0200307598164325,0.0292984160892457,1.95425948179423e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COLEC12,Collectin-12,29454,0.0189212408834843,0.00182315209314009,0.0153478627809298,0.0224946189860389,3.43994938751982e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LETM1,Mitochondrial proton/calcium exchanger protein,24867,0.0376365287116445,0.00364641403628484,0.0304895572005262,0.0447835002227627,6.32512824398417e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK6,SLIT and NTRK-like protein 6,28916,-0.0244811113968354,0.00237358758355525,-0.0291333430606037,-0.0198288797330671,6.73038297394262e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN2,Nectin-2,29433,0.0212106943891893,0.00206015854154729,0.0171727836477566,0.025248605130622,8.12233544545482e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG4,Chondroitin sulfate proteoglycan 4,24938,-0.0235389527443006,0.00228833099303477,-0.0280240814906487,-0.0190538239979525,9.08530380777926e-25
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK2,BDNF/NT-3 growth factors receptor,29478,0.0182804196402913,0.00177955819349976,0.0147924855810318,0.0217683536995508,1.03247778477946e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSF,Cathepsin F,29566,0.0284804084031599,0.00277380365774235,0.0230437532339849,0.0339170635723349,1.08477667584618e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERBB4,Receptor tyrosine-protein kinase erbB-4,29566,-0.0169734361698994,0.00165649317118865,-0.0202201627854291,-0.0137267095543696,1.34757845870206e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD2,Sushi domain-containing protein 2,29443,-0.0201587497803065,0.00197661492035039,-0.0240329150241933,-0.0162845845364197,2.20801894868001e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGT,Angiotensinogen,24951,0.0162991938086303,0.00159928800039512,0.0131645893278559,0.0194337982894047,2.41465905248005e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL20,C-C motif chemokine 20,29786,0.0617842210225831,0.00606606726717923,0.0498947291789118,0.0736737128662544,2.53057549293867e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBS,Cystathionine beta-synthase,24240,0.0361509551905003,0.00354887472443896,0.0291951607306,0.0431067496504007,2.54801479026732e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HGFAC,Hepatocyte growth factor activator,24720,0.0198022862178115,0.00194457288557864,0.0159909233620774,0.0236136490735456,2.62810108863569e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRF1,Killer cell lectin-like receptor subfamily F member 1,24229,0.0307644565846789,0.00302244948387445,0.024840455596285,0.0366884575730728,2.76404925216266e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR3,Small proline-rich protein 3,24845,0.0478884423966081,0.00470551268649371,0.0386656375310804,0.0571112472621357,2.80061809268902e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMB,RGM domain family member B,29694,0.0189317004654203,0.00186311015709467,0.0152800045575147,0.0225833963733258,3.23193212706738e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRSF1,G-rich sequence factor 1,23862,0.0568731090169039,0.00559628791797394,0.045904384697675,0.0678418333361328,3.26090733204629e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11A,Tumor necrosis factor receptor superfamily member 11A,29786,0.0271726457858557,0.00268365864061276,0.0219126748502546,0.0324326167214567,4.67101473599641e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAFA5,Chemokine-like protein TAFA-5,29349,0.0253493647362151,0.0025054808889946,0.0204386221937857,0.0302601072786445,5.05666931853036e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGHMBP2,DNA-binding protein SMUBP-2,24111,0.0390398726404676,0.00386194566931361,0.0314704591286129,0.0466092861523223,5.63436466371186e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAM,Signal transducing adapter molecule 1,24793,0.0257740994113074,0.00255224820226459,0.0207716929348688,0.030776505887746,6.23538824615526e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI2,Serpin I2,24805,0.0397034500171494,0.00393178537406006,0.0319971506839917,0.0474097493503072,6.26775798605668e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPD,Pulmonary surfactant-associated protein D,29478,0.0465564711250077,0.00462348102440634,0.0374944483171713,0.0556184939328441,8.22942825079887e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AARSD1,Alanyl-tRNA editing protein Aarsd1,29349,0.0381024893501635,0.00378598790274796,0.0306819530607775,0.0455230256395495,8.70342010226424e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SRPX,Sushi repeat-containing protein SRPX,24922,-0.0247053552396152,0.00245701428226558,-0.0295211032328558,-0.0198896072463747,9.68938162512853e-24
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJB8,DnaJ homolog subfamily B member 8,28916,0.0398324264454166,0.00398144281319645,0.0320287985315516,0.0476360543592817,1.5901634798105e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGER,Advanced glycosylation end product-specific receptor,29378,0.028125113866124,0.00281749014238001,0.0226028331870592,0.0336473945451889,1.9850420728196e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL4,ADAMTS-like protein 4,24240,0.0165827038008793,0.00166444661349229,0.0133203884384344,0.0198450191633242,2.45659236652387e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RABEPK,Rab9 effector protein with kelch motifs,28797,0.0406048251331932,0.00408052624754901,0.0326069936879972,0.0486026565783893,2.72596992625179e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L11,"Bcl-2-like protein 11, Isoform BimL ",29434,0.0298246894572466,0.00299853026870906,0.0239475701305768,0.0357018087839164,2.84467022026723e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PVALB,Parvalbumin alpha,29599,0.0772263541355391,0.00776432468801688,0.062008277747026,0.0924444305240522,2.84701585633931e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2Z,Ubiquitin-conjugating enzyme E2 Z,24229,0.0409488050528407,0.00413007758756586,0.0328538529812116,0.0490437571244698,3.97414507222111e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASF3,Wiskott-Aldrich syndrome protein family member 3,28774,0.0577977445816286,0.00583170892851728,0.0463675950817347,0.0692278940815225,4.06355217140756e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT2,Bis(5'-nucleosyl)-tetraphosphatase [asymmetrical],29349,0.0389364475626439,0.00393029299426593,0.0312330732938827,0.0466398218314051,4.22991950753122e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARF2,Scavenger receptor class F member 2,29694,-0.0199794989049192,0.00201838621667859,-0.0239355358896093,-0.0160234619202292,4.57687637856009e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB8,Serpin B8,29786,0.0385161966154151,0.00389276264189188,0.0308863818373071,0.0461460113935232,4.78267099577185e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CX3CL1,Fractalkine,29218,-0.0231144862511102,0.00233909728771409,-0.0276991169350299,-0.0185298555671906,5.42558359981481e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS7_LGALS7B,Galectin-7,29320,0.0286529513126709,0.00290303462167943,0.0229630034541793,0.0343428991711626,6.09904482713992e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FES,Tyrosine-protein kinase Fes/Fps,28797,0.0324027397189677,0.00328411845281392,0.0259658675514525,0.038839611886483,6.32455399676711e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARS1,"Threonine--tRNA ligase 1, cytoplasmic",24793,0.0253252818894294,0.00256860567733355,0.0202908147618557,0.0303597490170032,6.86835071515068e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB6,Integrin beta-6,28931,0.020745107081391,0.00210491850868588,0.0166194668043667,0.0248707473584154,7.04849533560236e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAM,Basal cell adhesion molecule,29443,-0.0164059706180959,0.00166614970051053,-0.0196716240310965,-0.0131403172050952,7.688059829552e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA3,Protein disulfide-isomerase A3,24381,0.0170889805692973,0.00173667921665613,0.0136850893046513,0.0204928718339433,8.34712882253467e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT7,N-acetylgalactosaminyltransferase 7,29349,0.0142568095909023,0.00145053592808332,0.011413759171859,0.0170998600099456,9.18968043233892e-23
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRN,Progranulin,29313,0.016761021886321,0.00170717057262142,0.013414967563983,0.020107076208659,1.02102224206036e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP6,Insulin-like growth factor-binding protein 6,29394,0.0203575862107121,0.00207756693788303,0.0162855550124614,0.0244296174089628,1.23452744842038e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRL,Prolactin,29694,-0.0513720308204903,0.00524416869225896,-0.0616506014573179,-0.0410934601836628,1.26725272227462e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MILR1,Allergin-1,28931,-0.0342118900420517,0.00349411032833913,-0.0410603462855964,-0.0273634337985071,1.33048964592316e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200R1,Cell surface glycoprotein CD200 receptor 1,29341,0.0235683224836007,0.00241329906227211,0.0188382563215474,0.0282983886456541,1.70469116084547e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH1,Neurogenic locus notch homolog protein 1,29820,0.0106976479929549,0.00109657668617894,0.00854835768804422,0.0128469382978657,1.88808033914862e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEK,Angiopoietin-1 receptor,29566,0.0147319566473275,0.00151151685304431,0.0117693836153607,0.0176945296792943,2.06437187621367e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT3,Interferon-induced protein with tetratricopeptide repeats 3,24445,0.0257143619577871,0.00263814627440574,0.0205435952599518,0.0308851286556223,2.08465681336648e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN4B,Sodium channel subunit beta-4,24240,0.0288304325683854,0.00295869776949398,0.0230313849401772,0.0346294801965936,2.14513274048495e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHAD,Chondroadherin,24381,0.034980935937791,0.00359030645160575,0.0279439352926437,0.0420179365829382,2.16798392573609e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31RA,Interleukin-31 receptor subunit alpha,24134,0.0266865168345449,0.00274083928546972,0.0213144718350242,0.0320585618340655,2.31372179901147e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AFAP1,Actin filament-associated protein 1,24381,0.0565558597885158,0.00582629162504972,0.0451363282034183,0.0679753913736132,3.08842999389159e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSC2,Desmocollin-2,29135,-0.0230652415413909,0.00237876843527355,-0.027727627674527,-0.0184028554082547,3.37779426593084e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTUS1,Microtubule-associated tumor suppressor 1,24445,0.0377056003377816,0.00388929611405594,0.0300825799542319,0.0453286207213312,3.48161290529233e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GNT7,"UDP-GlcNAc:betaGal beta-1,3-N-acetylglucosaminyltransferase 7",24240,0.0249816055324438,0.00257952595373711,0.0199257346631191,0.0300374764017685,3.84645345382405e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCLM,Glutamate--cysteine ligase regulatory subunit,24111,0.0301000326916635,0.00311251069898859,0.0239995117216458,0.0362005536616811,4.40686950466504e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKK3,Dickkopf-related protein 3,29820,-0.0196707390611397,0.00203648397417902,-0.0236622476505305,-0.0156792304717488,4.84229331048084e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP8,GTPase IMAP family member 8,24016,0.0341259774499045,0.00353329823642011,0.027200712906521,0.0410512419932879,4.96730911732274e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM15,Disintegrin and metalloproteinase domain-containing protein 15,28916,-0.0205512024456917,0.00213367768663448,-0.0247332107114952,-0.0163691941798881,6.33060397753695e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT2,Polypeptide N-acetylgalactosaminyltransferase 2,29725,0.0172416407263423,0.00179129900358993,0.0137306946793061,0.0207525867733786,6.7355621623871e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_E,,29434,0.0193079490044294,0.0020068204844182,0.0153745808549697,0.023241317153889,7.01053977429171e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,XG,Glycoprotein Xg,29693,0.0214241128867873,0.00222764972943079,0.0170579194171029,0.0257903063564716,7.26898910383776e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCTS1,Malignant T-cell-amplified sequence 1,24805,0.0173498316022942,0.00180435255825162,0.013813300588121,0.0208863626164674,7.50570106267859e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDM1,Nuclear protein MDM1,24195,0.020846990872295,0.0021702151975032,0.0165933690851888,0.0251006126594013,8.2535921189466e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRP2,Neuropilin-2,29443,-0.0190457200771987,0.00198340047398084,-0.0229331850062011,-0.0151582551481963,8.39428281130175e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAG3,Lymphocyte activation gene 3 protein,29349,-0.0271322293522814,0.00282631308532224,-0.032671802999513,-0.0215926557050498,8.61777409616157e-22
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL3,Insulin-like 3,24845,0.0501200028799049,0.00523086793459476,0.0398675017280992,0.0603725040317106,1.04200579742933e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FASLG,Tumor necrosis factor ligand superfamily member 6,29786,0.0243387272344792,0.0025406842991977,0.0193589860080517,0.0293184684609067,1.0471009867241e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A13,Protein S100-A13,24229,0.0233182357258687,0.0024371008117066,0.0185415181349237,0.0280949533168136,1.19015770170668e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH3A1,"Aldehyde dehydrogenase, dimeric NADP-preferring",29378,0.0431022488832507,0.00451903945697684,0.0342449315475761,0.0519595662189253,1.56577848294808e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRZ1,Receptor-type tyrosine-protein phosphatase zeta,24922,0.0216268223157184,0.0022681136568196,0.0171813195483519,0.0260723250830848,1.62866030826404e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYGD,Gamma-crystallin D,24845,0.0638983244805084,0.00670452918122423,0.0507574472853089,0.0770392016757079,1.7016199946966e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG4,Regenerating islet-derived protein 4,29497,0.0327535987889484,0.00343855585773754,0.0260140293077828,0.0394931682701139,1.76549359208998e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIT,Vitrin,24922,0.0248502175556587,0.00260867655738954,0.0197372115031752,0.0299632236081422,1.77853494376795e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX2,Sorting nexin-2,24793,0.0535348753992376,0.00563318816855433,0.0424938265888711,0.0645759242096041,2.20764175970811e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPB2,Coatomer subunit beta',24111,0.0283471650256372,0.00298343799163139,0.0224996265620397,0.0341947034892347,2.25493727227408e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPCAM,Epithelial cell adhesion molecule,29457,-0.0636056527267675,0.00670467611350666,-0.0767468179092405,-0.0504644875442944,2.55646730774419e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1A,Protein phosphatase 1A,28797,0.0203672929477342,0.00215615099801113,0.0161412369916324,0.024593348903836,3.77273869294494e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM4,Intercellular adhesion molecule 4,29434,-0.0342574420913212,0.00364041032951591,-0.0413926463371724,-0.0271222378454701,5.29410569125368e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA,Lymphotoxin-alpha,29434,0.0260880422847918,0.00277360129321263,0.020651783750095,0.0315243008194885,5.5242545691844e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MZB1,Marginal zone B- and B1-cell-specific protein,29542,-0.0333386186898302,0.00354952009493972,-0.040295678075912,-0.0263815593037483,6.27098488038048e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAS2,Growth arrest-specific protein 2,24445,0.0343508257548761,0.0036611959149093,0.0271748817616538,0.0415267697480983,6.99175794122656e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS22,Brain-specific serine protease 4,24229,0.0226997221427593,0.00242514334679097,0.017946441183049,0.0274530031024696,8.63232399621112e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REPS1,RalBP1-associated Eps domain-containing protein 1,24229,0.0249898523298041,0.00267404123404168,0.0197487315110824,0.0302309731485258,9.92482907081861e-21
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDP1,Tyrosyl-DNA phosphodiesterase 1,24793,0.0442115887946716,0.00473610382007552,0.0349288253073235,0.0534943522820196,1.091908541657e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPME1,Protein phosphatase methylesterase 1,29349,0.0385544819069906,0.00413425029301889,0.0304513513326736,0.0466576124813076,1.17831798658349e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHCY,Adenosylhomocysteinase,29478,0.0434995173774205,0.00466967626130666,0.0343469519052595,0.0526520828495816,1.29783624169467e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB4,Ephrin type-B receptor 4,29820,-0.0160566834031479,0.00172634469623667,-0.0194403190077718,-0.012673047798524,1.48379014509492e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA9,Carbonic anhydrase 9,29725,-0.0294258221287921,0.00316480293491825,-0.0356288358812318,-0.0232228083763523,1.5283666622329e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFA,Protransforming growth factor alpha,29434,0.0299984020964003,0.00323217142239329,0.0236633461085094,0.0363334580842911,1.78739205512862e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN3,Calsyntenin-3,24845,0.0194652983172027,0.0021149876118455,0.0153199225979855,0.0236106740364199,3.72984879314811e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRED2,"Sprouty-related, EVH1 domain-containing protein 2",24229,0.0284440463586814,0.00309162091557392,0.0223844693641566,0.0345036233532063,3.8472013353071e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL5,Fc receptor-like protein 5,29443,-0.0365596129562095,0.00398143571700443,-0.0443632269615382,-0.0287559989508809,4.47922236230506e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CIT,Citron Rho-interacting kinase,24195,0.0288263420289931,0.00314134055153966,0.0226693145479754,0.0349833695100108,4.8019243840225e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHOSPHO1,Phosphoethanolamine/phosphocholine phosphatase,29218,0.0189055759194541,0.00206095167451649,0.0148661106374018,0.0229450412015064,4.88398994789906e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C2CD2L,Phospholipid transfer protein C2CD2L,28719,0.0269336473534861,0.00293644385676491,0.0211782173942269,0.0326890773127453,4.93592984192883e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENSA,Alpha-endosulfine,24793,0.0335511866199743,0.00365840139538242,0.0263807198850247,0.0407216533549238,5.0410546639714e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM3,Myomesin-3,24381,-0.0593091041323428,0.0064706143837474,-0.0719915083244877,-0.0466266999401979,5.28996145267771e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CABP2,Calcium-binding protein 2,24195,0.0414462701088696,0.00452687574447306,0.0325735936497024,0.0503189465680367,5.82193239228541e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYZL2,Lysozyme-like protein 2,24016,0.022840359030576,0.00249895274592731,0.0179424116485584,0.0277383064125935,6.72830395610311e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CWC15,Spliceosome-associated protein CWC15 homolog,24681,0.0381386238399632,0.00418953072262168,0.0299271436236247,0.0463501040563017,9.40722557750721e-20
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDP1,"[Pyruvate dehydrogenase [acetyl-transferring]]-phosphatase 1, mitochondrial",28797,0.0318041915297544,0.00350219894874376,0.0249398815902166,0.0386685014692922,1.14061372165298e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKD2,Serine/threonine-protein kinase D2,24111,0.0287583461011659,0.00317019812338865,0.0225447577793242,0.0349719344230077,1.26165986393851e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFHR4,Complement factor H-related protein 4,24892,0.045986692765139,0.00507432470160554,0.0360410163499921,0.0559323691802858,1.36485423637033e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGA,Glycoprotein hormones alpha chain,29443,0.0503005210824011,0.00555150681303451,0.0394195677288534,0.0611814744359487,1.3743315822012e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L2,Seizure 6-like protein 2,29349,-0.0150208712858902,0.00165913131100932,-0.0182727686554684,-0.0117689739163119,1.46864265520228e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A14,Protein S100-A14,24867,0.0331216440687628,0.00366467885895909,0.025938873505203,0.0403044146323226,1.7077793844951e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G15,Phospholipase A2 group XV,29566,0.0165630943463504,0.00183577733364362,0.012964970772409,0.0201612179202919,1.94891694752355e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH1,Protocadherin-1,29713,0.0132499940873645,0.0014687574711873,0.0103712294438374,0.0161287587308916,1.9690661234431e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNDA,Myeloid cell nuclear differentiation antigen,29426,0.0605782098093432,0.00673067885449339,0.0473860792545362,0.0737703403641502,2.38288937180113e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL1,Follistatin-related protein 1,24240,-0.0142397780432717,0.00158387742610284,-0.0173441777984333,-0.0111353782881101,2.63778734599411e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSHB,Thyrotropin subunit beta,29478,0.0478089109234411,0.00532052149857347,0.0373806887862371,0.0582371330606452,2.71917668364973e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1R,Huntingtin-interacting protein 1-related protein,24788,0.0268698234616166,0.00299111839406795,0.0210072314092434,0.0327324155139898,2.81274874040319e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RHOC,Rho-related GTP-binding protein RhoC,29089,0.0724630212730558,0.00807069074145301,0.0566444674198079,0.0882815751263037,2.90521125333035e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCOR1,REST corepressor 1,28916,0.027761661687874,0.00309213016630691,0.0217010865619124,0.0338222368138355,2.91604283495877e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA2,Carbonic anhydrase 2,29368,0.0426007279664791,0.00475071629784331,0.0332893240227062,0.051912131910252,3.21706948340118e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOR1AIP1,Torsin-1A-interacting protein 1,24240,0.0318331556078917,0.0035509880766621,0.024873218977634,0.0387930922381494,3.33397622363859e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB3A1,Secretoglobin family 3A member 1,24381,-0.0158590500752937,0.00176949991320919,-0.0193272699051837,-0.0123908302454037,3.39789016817894e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN2,Calsyntenin-2,29786,-0.0243886761830322,0.0027392009899148,-0.0297575101232652,-0.0190198422427992,5.70775199386994e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACAN,Aggrecan core protein,29192,0.0174041292192973,0.00195702693442904,0.0135683564278164,0.0212399020107783,6.27505638083327e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAGA,Alpha-N-acetylgalactosaminidase,24177,0.0359989444769414,0.0040539287514792,0.0280532441240421,0.0439446448298406,7.13997280911652e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAMLG,Guided entry of tail-anchored proteins factor CAMLG,24195,0.0335149288392832,0.00377642284944321,0.0261131400543745,0.0409167176241919,7.48223575988221e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLC,Galectin-10,29426,-0.0406925540961475,0.00458787626035417,-0.0496847915664416,-0.0317003166258533,7.74808430810058e-19
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICOSLG,ICOS ligand,29349,0.0116773619995072,0.00132175460249739,0.00908672297861227,0.0142680010204021,1.05805351743888e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPG,Macrophage-capping protein,29174,0.0355193152224667,0.00403493590067271,0.0276108408571482,0.0434277895877852,1.40486363161317e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF19,Tumor necrosis factor receptor superfamily member 19,29725,0.0195455657195126,0.00223025090063105,0.0151742739542757,0.0239168574847494,1.98547656769202e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOB,Apolipoprotein B-100,24951,0.0136644189762053,0.0015593465481809,0.0106080997417707,0.0167207382106399,2.02138390385557e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTRK3,NT-3 growth factor receptor,29694,-0.0131278693134585,0.00149919080140285,-0.0160662832842081,-0.010189455342709,2.11629240945736e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBTB17,Zinc finger and BTB domain-containing protein 17,28916,0.0250368210807765,0.00286034407658045,0.0194305466906789,0.0306430954708742,2.18688672401622e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAA4,Serum amyloid A-4 protein,24966,0.0198289799506735,0.00226860497986112,0.0153825141901457,0.0242754457112013,2.46173527500368e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C8B,Complement component C8 beta chain,24966,0.0183787477403457,0.00210693019079348,0.0142491645663905,0.0225083309143009,2.87513505579884e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRH,Receptor-type tyrosine-protein phosphatase H,24805,0.0295985291935263,0.00339571962409277,0.0229429187303044,0.0362541396567481,3.04765571905362e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRS,Receptor-type tyrosine-protein phosphatase S,29820,-0.0148526440398133,0.0017043194529667,-0.018193110167628,-0.0115121779119985,3.0632413184335e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA7,Thyroxine-binding globulin,24966,0.0111627467262611,0.00128324298973264,0.00864759046638511,0.0136779029861371,3.5553380375133e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNC,Tenascin,29594,-0.0286603563992745,0.00330042803319592,-0.0351291953443385,-0.0221915174542105,4.01975632304355e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFD,Vascular endothelial growth factor D,29732,-0.0214840527161215,0.00247694923892468,-0.0263388732244139,-0.0166292322078292,4.39623969544813e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCF2,Neutrophil cytosol factor 2,29395,0.049624076280969,0.00574247606815299,0.0383688231873892,0.0608793293745489,5.82028878517568e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PBK,Lymphokine-activated killer T-cell-originated protein kinase,24016,-0.0183173838646338,0.00212229096100377,-0.0224770741482012,-0.0141576935810664,6.45574317235989e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A12,Protein S100-A12,29023,0.0447169602095717,0.0051905378747374,0.0345435059750864,0.054890414444057,7.33704648835057e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH1,Neurexophilin-1,28774,0.0227889673380858,0.00264726813478468,0.0176003217939078,0.0279776128822638,7.77454495862537e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R12B,Protein phosphatase 1 regulatory subunit 12B,24445,0.04313727158169,0.00501525227107159,0.0333073771303897,0.0529671660329903,8.35349890517913e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAT,Catalase,24587,0.0318800312441668,0.00370783317516802,0.0246126782208375,0.0391473842674961,8.58572637938624e-18
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFIC,Nuclear factor 1 C-type,24867,0.0264635356705356,0.00308508682404004,0.0204167654954171,0.032510305845654,1.02176699630953e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACVRL1,Serine/threonine-protein kinase receptor R3,29169,0.014764174016138,0.00172405202373284,0.0113850320496217,0.0181433159826544,1.14646974387789e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO1,Roundabout homolog 1,29497,0.0142474960867057,0.00166728114080337,0.0109796250507311,0.0175153671226803,1.34232799106515e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPM3,Tropomyosin alpha-3 chain,24111,-0.0260500945160286,0.00306283253347524,-0.0320532462816401,-0.0200469427504171,1.91612027553919e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTLC1,Serine palmitoyltransferase 1,24845,0.0218642822226684,0.00257205075478171,0.0168230627432963,0.0269055017020406,1.98856641004395e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAX,Apoptosis regulator BAX,28722,0.0531232121084188,0.00625508729896576,0.0408632410024459,0.0653831832143917,2.11311496443599e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEPD,Xaa-Pro dipeptidase,24951,0.0154013825648607,0.00181406427075037,0.01184581659419,0.0189569485355314,2.1799976612392e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR15L,Protein GPR15L,24805,0.0359785222617338,0.00423786962102917,0.0276722978045166,0.044284746718951,2.18482234296587e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22RA1,Interleukin-22 receptor subunit alpha-1,28931,0.0253289786938141,0.00298927091482263,0.0194700077007617,0.0311879496868664,2.49704791848833e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JAM2,Junctional adhesion molecule B,29694,0.0156550744421238,0.00184896144415624,0.0120311100115776,0.01927903887267,2.63330950134578e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGD,"6-phosphogluconate dehydrogenase, decarboxylating",24922,0.0312537861173382,0.00369924730558548,0.0240032613983907,0.0385043108362858,3.10462954943299e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSR,Insulin receptor,24229,0.00993301096276905,0.001177216684868,0.00762566626042776,0.0122403556651103,3.41469026142487e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL24A1,Collagen alpha-1(XXIV) chain,24805,0.032457952129501,0.00385036932329676,0.0249112282558393,0.0400046760031626,3.64740864544713e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF149,E3 ubiquitin-protein ligase RNF149,24240,0.0179654929070062,0.00213912097699073,0.0137728157921044,0.0221581700219081,4.76520848270094e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PECR,Peroxisomal trans-2-enoyl-CoA reductase,24240,0.0163656797147736,0.00195009624787519,0.0125434910689382,0.020187868360609,5.02682758944461e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PZP,Pregnancy zone protein,24966,0.0310115153411348,0.00369667058647237,0.0237660409916489,0.0382569896906206,5.15738792782393e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SORBS1,Sorbin and SH3 domain-containing protein 1,24867,0.022880131573781,0.00272941209262555,0.017530483872235,0.0282297792753271,5.43838068137428e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAST,Gastrin,24845,0.0755531010361362,0.00902653209858513,0.0578610981229094,0.0932451039493631,6.05576948490787e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LXN,Latexin,29117,-0.0389534258060594,0.00466024988109889,-0.0480875155730132,-0.0298193360391056,6.62277871043388e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFU1,"NFU1 iron-sulfur cluster scaffold homolog, mitochondrial",24805,0.0592146082525075,0.00711776058357121,0.0452637975087079,0.073165418996307,9.30033380651893e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB1,Interleukin-12 receptor subunit beta-1,28931,0.0217807236105849,0.00261991068344325,0.0166456986710361,0.0269157485501336,9.69163321797825e-17
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNED1,"Sushi, nidogen and EGF-like domain-containing protein 1",24240,0.0189825485747807,0.00228898245890304,0.0144961429553307,0.0234689541942306,1.16096398922219e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH1,Cadherin-1,28477,0.0229709155090303,0.00277604911050176,0.0175298592524469,0.0284119717656138,1.34367982848607e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTT2B,Glutathione S-transferase theta-2B,24845,0.137244169706909,0.0165975879353773,0.10471289735357,0.169775442060249,1.41871207417161e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRK1,Protein BRICK1,28774,0.0256203480888238,0.00310071897717826,0.0195429388935544,0.0316977572840932,1.48452831554776e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MST1,Hepatocyte growth factor-like protein,24615,0.0367413169438081,0.00445063991968801,0.0280180627012196,0.0454645711863966,1.59063759948134e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR1,Complement receptor type 1,24903,0.0205218586814583,0.00249005073714504,0.0156413592366541,0.0254023581262626,1.78294503924765e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD248,Endosialin,24938,-0.0229488767399585,0.00278882024256355,-0.0284149644153831,-0.017482789064534,1.98110855645733e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10B,Tumor necrosis factor receptor superfamily member 10B,29218,0.0221449456732039,0.00269514752432568,0.0168624565255256,0.0274274348208823,2.17923009495446e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL28A1,Collagen alpha-1(XXVIII) chain,24195,0.0438326799485221,0.00533879469153369,0.033368642353116,0.0542967175439281,2.31702428346003e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BNIP2,BCL2/adenovirus E1B 19 kDa protein-interacting protein 2,24922,0.019191277192199,0.00233901951757003,0.0146067989377618,0.0237757554466363,2.41950986351664e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFC1,Cryptic protein,28797,0.0267328054673535,0.00325893461042309,0.0203452936309242,0.0331203173037827,2.4427999471182e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDUFS6,"NADH dehydrogenase [ubiquinone] iron-sulfur protein 6, mitochondrial",28797,0.0450690487022741,0.00549449274572896,0.0342998429206453,0.0558382544839028,2.44974449973786e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1G2,V-type proton ATPase subunit G 2,24111,0.0563924919823307,0.00689902765101066,0.0428703977863499,0.0699145861783116,3.1293502422485e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LUZP2,Leucine zipper protein 2,24793,0.0253198252338847,0.00310362702361442,0.0192367162676004,0.0314029342001689,3.56217277608941e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGAR,"Fructose-2,6-bisphosphatase TIGAR",28719,0.0265432432708256,0.00325416814469617,0.0201650737072211,0.0329214128344301,3.58252338790044e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER2,Low affinity immunoglobulin epsilon Fc receptor,29443,0.0286131570217857,0.00351195468183611,0.0217297258453869,0.0354965881981845,3.86554120845899e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REN,Renin,29478,-0.0425986805286393,0.00526052686808017,-0.0529093131900764,-0.0322880478672022,5.81036939024245e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBAC1,Ubiquitin-associated domain-containing protein 1,29349,0.0192195257263077,0.00237962149113276,0.0145554676036875,0.0238835838489279,6.90641697898957e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OXCT1,"Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial",24240,0.0390616853792439,0.00484048420767739,0.0295743363321962,0.0485490344262916,7.36624427627619e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSC,Dipeptidyl peptidase 1,29446,0.0241766462024751,0.00300138883137793,0.0182939240929744,0.0300593683119759,8.23552498671766e-16
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSG,Basigin,29760,0.0114077801647338,0.00142109226014251,0.0086224393348545,0.0141931209946131,1.0314009506142e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD9,26S proteasome non-ATPase regulatory subunit 9,29349,0.0300822494035723,0.00374746905665993,0.0227372100525188,0.0374272887546257,1.03294617372481e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF1C,Kinesin-like protein KIF1C,24111,0.020209678397009,0.00251957935682727,0.0152713028576275,0.0251480539363904,1.09579950248957e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMD,Osteomodulin,29581,-0.0238980878830113,0.00298537829067175,-0.0297494293327279,-0.0180467464332947,1.23768935851003e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCSK7,Proprotein convertase subtilisin/kexin type 7,24793,0.0249196377734736,0.00311865102490908,0.0188070817646518,0.0310321937822954,1.40183804098951e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGA,Chromogranin-A,24938,-0.0486124813099377,0.00608865611370144,-0.0605462472927926,-0.0366787153270829,1.47608587664633e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN6,Tyrosine-protein phosphatase non-receptor type 6,29536,0.0491705860144944,0.0061655347932034,0.0370861378198157,0.061255034209173,1.57759563715871e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD1,Leiomodin-1,24867,-0.0196193100860939,0.00246036745592804,-0.0244416302997129,-0.0147969898724749,1.60009277915111e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZBP1,Z-DNA-binding protein 1,24229,0.0224638888823302,0.00282141689579319,0.0169339117665756,0.0279938659980849,1.76785496388357e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL,Podocalyxin,29349,0.00833520635412068,0.0010489810248775,0.00627920354536077,0.0103912091628806,1.99485653959097e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HS6ST2,Heparan-sulfate 6-O-sulfotransferase 2,24229,0.0185620167049637,0.00233942487004776,0.0139767439596701,0.0231472894502573,2.20554561116845e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTB,Lymphotoxin-beta,24793,0.0191398610862488,0.00242062724275092,0.0143954316904569,0.0238842904820406,2.74631707510681e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGA,Fibrinogen alpha chain,24407,0.0169343522265179,0.0021431494656065,0.0127337792739291,0.0211349251791066,2.86867985953877e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPA2,Heat shock-related 70 kDa protein 2,24793,0.0186322606734697,0.00236078462558944,0.0140051228073144,0.023259398539625,3.08624109113947e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1R1,Interleukin-1 receptor type 1,29390,-0.0125759093838856,0.0015938496951858,-0.0156998547864498,-0.00945196398132146,3.11950792558692e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST3GAL1,"CMP-N-acetylneuraminate-beta-galactosamide-alpha-2,3-sialyltransferase 1",29349,-0.0230208622086082,0.00292209271518165,-0.0287481639303642,-0.0172935604868522,3.43530342765005e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSPN,Persephin,29434,0.0511591454240277,0.00650527040380922,0.0384088154325617,0.0639094754154938,3.83931010435769e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD34,Hematopoietic progenitor cell antigen CD34,29593,0.0131899167054966,0.00168036320883054,0.00989640481618873,0.0164834285948044,4.3193847334703e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL6A3,Collagen alpha-3(VI) chain,29820,0.0189938763379217,0.00242168405206996,0.0142473755958646,0.0237403770799788,4.53631522936766e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEPE,Matrix extracellular phosphoglycoprotein,29454,0.0136757133034007,0.00174469422648335,0.0102561126194934,0.0170953139873081,4.71436052963822e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC16A1,Monocarboxylate transporter 1,28774,0.0313440458432786,0.00400389135426047,0.0234964187889281,0.0391916728976291,5.11048895777789e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLRT2,Leucine-rich repeat transmembrane protein FLRT2,29218,-0.0154898666203958,0.00198017637865629,-0.0193710123225621,-0.0116087209182295,5.35379536505269e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD1,Sphingomyelin phosphodiesterase,29530,-0.0266773097779266,0.00341060673219286,-0.0333620989730246,-0.0199925205828286,5.37753137086492e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1BP1,Integrin beta-1-binding protein 1,28797,0.0221347792835558,0.0028298968854948,0.016588181387986,0.0276813771791256,5.38646486227953e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGR2,Anterior gradient protein 2 homolog,28553,0.0545898070885001,0.00698744038027456,0.040894423943162,0.0682851902338383,5.79549702836778e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMOX1,Heme oxygenase 1,29165,-0.0259203739179204,0.00332636331597385,-0.0324400460172291,-0.0194007018186116,6.79242792810568e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPT2,Angiopoietin-2,29725,-0.020509166268937,0.0026395841948081,-0.0256827512907609,-0.0153355812471132,8.11062560296108e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN2,Alpha-actinin-2,24111,-0.0319181753939105,0.00411216058982224,-0.0399780101499621,-0.0238583406378589,8.69800280772568e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALCAM,CD166 antigen,29820,0.0105059478060405,0.00135440013259671,0.00785132354615096,0.0131605720659301,8.97992499475324e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD14,Monocyte differentiation antigen CD14,28954,0.0222076212072199,0.00286611480929023,0.016590036181011,0.0278252062334288,9.61436430905518e-15
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIPR1,Vasoactive intestinal polypeptide receptor 1,24240,-0.013389501001849,0.00173004791868141,-0.0167803949224646,-0.00999860708123346,1.03790425904705e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECM1,Extracellular matrix protein 1,24349,0.0197103291211412,0.00254858138986991,0.0147151095969961,0.0247055486452862,1.08379320803878e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300LF,CMRF35-like molecule 1,29725,0.032230946863692,0.00417602171753812,0.0240459442973173,0.0404159494300667,1.21772860839787e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP3,Cysteine-rich secretory protein 3,24738,-0.0144455897103324,0.00187904705430754,-0.0181285219367751,-0.0107626574838896,1.55338694560026e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIGR,Polymeric immunoglobulin receptor,29115,0.0191985153866681,0.00250463483729097,0.0142894311055778,0.0241075996677584,1.84110840720869e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OBP2B,Odorant-binding protein 2b,29137,-0.033240044643048,0.00433908547670998,-0.0417446521773996,-0.0247354371086965,1.90786382872327e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEL1L,Protein sel-1 homolog 1,24240,0.01696599813215,0.00221526131839226,0.0126240859481012,0.0213079103161988,1.94851652470851e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA14,Carbonic anhydrase 14,29725,-0.0188148560624328,0.00246281168123643,-0.0236419669576562,-0.0139877451672094,2.2447169785763e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFYA,Nuclear transcription factor Y subunit alpha,24111,0.0203134188145644,0.00266534543700586,0.0150893417580329,0.0255374958710959,2.60359281981664e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAM,Integrin alpha-M,29443,-0.0166928291061828,0.00219102331766474,-0.0209872348088057,-0.0123984234035599,2.63856941762458e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1B,Interleukin-1 beta,28745,0.0296621791177478,0.00389990675354253,0.0220183618808044,0.0373059963546912,2.91637701630007e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF13B,Tumor necrosis factor receptor superfamily member 13B,29497,0.0178231011661902,0.00234518889542782,0.0132265309311517,0.0224196714012287,3.05247972475479e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL3,Fc receptor-like protein 3,28931,0.0284871568518836,0.00375144233074516,0.0211343298836231,0.0358399838201441,3.20381553281923e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHPP,Phospholysine phosphohistidine inorganic pyrophosphate phosphatase,29462,0.0305040613410933,0.00402274869147299,0.0226194739058062,0.0383886487763803,3.47884859769408e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STAU1,Double-stranded RNA-binding protein Staufen homolog 1,24016,0.0350745952098451,0.00463183988657419,0.0259961890321597,0.0441530013875305,3.79301277844677e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFAIP8,Tumor necrosis factor alpha-induced protein 8,28931,0.01910835330811,0.00252398344093677,0.0141613457638739,0.0240553608523461,3.8223647224895e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSME2,Proteasome activator complex subunit 2,29081,0.0189637212513217,0.0025084958288098,0.0140470694268545,0.0238803730757889,4.15587346309742e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL7R,Interleukin-7 receptor subunit alpha,29443,-0.0274442652383312,0.00363121171121046,-0.0345614401923037,-0.0203270902843587,4.21594273410849e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM6,Carcinoembryonic antigen-related cell adhesion molecule 6,24938,-0.0208025702779924,0.0027538167498629,-0.0262000511077237,-0.0154050894482612,4.36287295152337e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGSF21,Immunoglobulin superfamily member 21,24240,0.0207859425193083,0.00275534392317618,0.015385468429883,0.0261864166087336,4.7227466250408e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2,Granulocyte-macrophage colony-stimulating factor,24111,0.0187472470088723,0.00248724892350634,0.0138722391187999,0.0236222548989448,4.96531968036793e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD28,T-cell-specific surface glycoprotein CD28,28797,0.0190436539034276,0.00252886555562578,0.0140870774144011,0.0240002303924542,5.20220168434752e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSP,Alpha-hemoglobin-stabilizing protein,29400,0.0439749087355389,0.00584670612060502,0.032515364739153,0.0554344527319247,5.57766386513849e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPF,Centromere protein F,24445,0.0282473111436213,0.00376061616549403,0.020876503459253,0.0356181188279896,6.05236886782237e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL2,Fc receptor-like protein 2,29645,0.0256203702394113,0.00341220476165821,0.0189324489065612,0.0323082915722614,6.15133838417459e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DGCR6,Protein DGCR6,24101,0.0228064397581131,0.00303739903286195,0.0168531376537036,0.0287597418625225,6.18631402444054e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB37,Ras-related protein Rab-37,28931,0.0425785420982663,0.00569870161569458,0.031409086931505,0.0537479972650277,8.14508296399355e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA7,Carbonic anhydrase 7,24445,-0.0178174463292398,0.0023846229773694,-0.0224913073648838,-0.0131435852935957,8.17520333438071e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDA2R,Tumor necrosis factor receptor superfamily member 27,29725,-0.0198304434367715,0.00265808282618516,-0.0250402857760944,-0.0146206010974486,8.85967734976355e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPC1,Glypican-1,29725,0.0152069629131975,0.00203911960359729,0.0112102884901468,0.0192036373362482,9.05088184039948e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID4B,AT-rich interactive domain-containing protein 4B,28774,0.0212448315205305,0.00285352095619028,0.0156519304463975,0.0268377325946634,9.95629109989417e-14
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KAZALD1,Kazal-type serine protease inhibitor domain-containing protein 1,29349,0.0231068646423538,0.00310928901093531,0.0170126581809206,0.029201071103787,1.10250750373214e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD59,CD59 glycoprotein,28277,0.011859298523032,0.00159584167082753,0.00873144884821001,0.0149871481978539,1.10516134569452e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKD1,Polycystin-1,24922,0.0136668184952626,0.0018425798950208,0.0100553619010218,0.0172782750895034,1.23423808446396e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA1,Apolipoprotein A-I,24966,-0.0141206599923235,0.00190458537396018,-0.0178536473252854,-0.0103876726593615,1.26412722486129e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP12,Macrophage metalloelastase,29466,0.0272022811618053,0.00367559734034353,0.019998110374732,0.0344064519488787,1.39004106797688e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM19,Carcinoembryonic antigen-related cell adhesion molecule 19,24805,0.0203115126255928,0.00275177534925712,0.0149180329410489,0.0257049923101368,1.61756965271828e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATD3,"Glutamine amidotransferase-like class 1 domain-containing protein 3B, mitochondrial",24240,0.0394435103423319,0.00535552552575851,0.0289466803118452,0.0499403403728186,1.82785977909285e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSH,Pro-cathepsin H,28852,0.0372381471884577,0.00507829710348237,0.0272846848656323,0.0471916095112832,2.31316840375896e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MATN3,Matrilin-3,29169,-0.0162751119254828,0.00222806072156157,-0.0206421109397435,-0.0119081129112221,2.85196703899564e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300A,CMRF35-like molecule 8,24381,0.0151512274897802,0.00207883743909211,0.0110767061091597,0.0192257488704008,3.23403617948859e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCP1,Plastin-2,24938,0.0239199065046988,0.00328962924165183,0.0174722331910612,0.0303675798183364,3.66518378991856e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AREG,Amphiregulin,29349,-0.0229524956408622,0.00316159935092571,-0.0291492303686766,-0.0167557609130478,3.97369226360228e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG4,Desmoglein-4,29242,0.0248835791538061,0.00343194346799119,0.0181569699565433,0.0316101883510688,4.25285729911352e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTPN,Myotrophin,28916,0.01643805057658,0.00227149612889523,0.0119859181639454,0.0208901829892147,4.71310029935093e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10A,Tumor necrosis factor receptor superfamily member 10A,29218,0.0164482535896225,0.00227425264904598,0.0119907183974923,0.0209057887817526,4.86276065611798e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CILP,Cartilage intermediate layer protein 1,24938,0.0273086312171007,0.00377647607352978,0.0199067381129823,0.0347105243212191,4.92379186378849e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST1,Cystatin-SN,21656,0.052765223175805,0.00729626702999728,0.0384645397970103,0.0670659065545996,4.92458583301012e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALY,RNA-binding protein Raly,24793,0.0240449881659997,0.00333569016733604,0.017507035438021,0.0305829408939783,5.82348272543839e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM2,Myomesin-2,24111,-0.0254846178585,0.00354204239064536,-0.0324270209441649,-0.018542214772835,6.43376573719693e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SART1,U4/U6.U5 tri-snRNP-associated protein 1,24111,0.0181707035556294,0.00253362105610656,0.0132048062856605,0.0231366008255982,7.61376621954592e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC14A,C-type lectin domain family 14 member A,29443,-0.0157447058372186,0.00219892077619257,-0.020054590558556,-0.0114348211158812,8.24492844654598e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VAMP5,Vesicle-associated membrane protein 5,28916,0.0267682947644727,0.00374656738144195,0.0194250226968465,0.0341115668320989,9.22920639484567e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPP1R14D,Protein phosphatase 1 regulatory subunit 14D,24867,-0.0187345028701827,0.00262415320563615,-0.0238778431532295,-0.0135911625871359,9.6415991993148e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTEN,"Phosphatidylinositol 3,4,5-trisphosphate 3-phosphatase and dual-specificity protein phosphatase PTEN",28774,0.0149430869475939,0.00209395921529167,0.0108389268856222,0.0190472470095655,9.81577678188431e-13
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA6,Carbonic anhydrase 6,29372,-0.0311219230159027,0.00437603503475967,-0.0396989516840317,-0.0225448943477737,1.17074004219368e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA1,Alpha-1-antitrypsin,24548,-0.00401426605850478,0.00056454212581404,-0.0051207686251003,-0.00290776349190926,1.18655780010595e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIT,Mast/stem cell growth factor receptor Kit,29545,-0.0144100487802098,0.00203478532639283,-0.0183982280199398,-0.0104218695404799,1.45420459295911e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN2A1,Butyrophilin subfamily 2 member A1,29581,0.0129543405181601,0.00183098330665479,0.00936561323711672,0.0165430677992035,1.52692837430744e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM23,Disintegrin and metalloproteinase domain-containing protein 23,29786,0.0170978200133713,0.00242185093779804,0.0123509921752872,0.0218446478514555,1.70375771361483e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL34,Interleukin-34,28722,0.0176628415185899,0.00250517278448813,0.0127527028609931,0.0225729801761866,1.82242547917639e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNLY,Granulysin,29443,0.0254305092514699,0.00361444344209572,0.0183462001049623,0.0325148183979775,2.02449084719455e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2,Apoptosis regulator Bcl-2,24805,0.0261626687081143,0.00372181566113673,0.0188679100122863,0.0334574274039423,2.12577268619507e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP6,Glycerophosphocholine cholinephosphodiesterase ENPP6,24240,0.0179809876798941,0.00255997016263628,0.012963446161127,0.0229985291986612,2.2145462895912e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOA4,Apolipoprotein A-IV,24966,0.0173556103217635,0.00247894159027832,0.012496884804818,0.022214335838709,2.60174171919189e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM3,Intercellular adhesion molecule 3,29820,-0.0126220380124944,0.00180629031808938,-0.0161623670359496,-0.00908170898903925,2.85047677647674e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ODAM,Odontogenic ameloblast-associated protein,28722,0.0259755841759889,0.0037185111163842,0.0186873023878759,0.033263865964102,2.90069450183857e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B3,Testosterone 17-beta-dehydrogenase 3,24111,0.0234073732269151,0.00335370765662655,0.0168341062199271,0.0299806402339031,3.03800101448236e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA1,Carbonic anhydrase 1,28867,0.0288036324839974,0.00413385298318004,0.0207012806369645,0.0369059843310303,3.28973351183782e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOBR,Apolipoprotein B receptor,24240,-0.0205152685064765,0.00295468931848012,-0.0263064595706976,-0.0147240774422555,3.92741286845662e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINI1,Neuroserpin,24329,0.0147054983165873,0.00212184293033927,0.0105466861731224,0.0188643104600523,4.2973459504848e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB2,Lamin-B2,24845,0.0134204633315175,0.0019414200540336,0.00961528002561159,0.0172256466374233,4.87007209397932e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG4,V-set and immunoglobulin domain-containing protein 4,29396,-0.0196212806072819,0.0028413979341936,-0.0251904205583013,-0.0140521406562624,5.10432876921944e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP47,Ubiquitin carboxyl-terminal hydrolase 47,24111,0.0410231203017418,0.00594058673204545,0.0293795703069327,0.0526666702965508,5.12455805271702e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD1,Bromodomain-containing protein 1,24445,-0.0146920648152628,0.00212898238634232,-0.0188648702924938,-0.0105192593380319,5.29070553825111e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSH3,Protein phosphatase Slingshot homolog 3,24016,0.0140438673117702,0.00203709543837911,0.0100511602525472,0.0180365743709933,5.55639928536953e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITM2A,Integral membrane protein 2A,29434,-0.0287281539001285,0.00418053216165591,-0.0369219969369741,-0.0205343108632829,6.46192171129512e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF16,Fibroblast growth factor 16,24229,0.0227932407666016,0.00332283026612865,0.0162804934449894,0.0293059880882138,7.07229728472408e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRUNE2,Protein prune homolog 2,24445,0.0138858179419334,0.00202752111261057,0.00991187656121664,0.0178597593226501,7.63084445370097e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN3,CCN family member 3,29795,0.0160272041236634,0.00234384390216928,0.0114332700754116,0.0206211381719151,8.18560489898073e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC10A,C-type lectin domain family 10 member A,29218,-0.0171533838414767,0.0025101677414247,-0.0220733126146692,-0.0122334550682843,8.44583199722855e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP4,Guanylate-binding protein 4,28774,0.0232557754375104,0.00340441982918264,0.0165831125723125,0.0299284383027084,8.59709872033563e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH15,Cadherin-15,29639,0.0273442044087426,0.00400396139451777,0.0194964400754877,0.0351919687419974,8.69842929817923e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DSG3,Desmoglein-3,29589,0.016132329551545,0.00236810225526569,0.0114908491312243,0.0207738099718658,9.78587229116587e-12
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASET2,Ribonuclease T2,29697,0.0125024717538438,0.00183862033864132,0.00889877589010685,0.0161061676175808,1.06659290713192e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GOT1,"Aspartate aminotransferase, cytoplasmic",24938,0.0197239962875916,0.00290078876426959,0.0140384503096232,0.02540954226556,1.07332402470173e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1C4,Aldo-keto reductase family 1 member C4,28916,0.0250933612096759,0.0036950424434261,0.0178510780205607,0.032335644398791,1.13444243979917e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSD17B14,17-beta-hydroxysteroid dehydrogenase 14,24845,0.0296507096977827,0.00436587624114922,0.0210935922651302,0.0382078271304351,1.13502458397492e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MDGA1,MAM domain-containing glycosylphosphatidylinositol anchor protein 1,29218,0.0328438563572589,0.00484062189866469,0.0233562374358761,0.0423314752786417,1.18261840754468e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3R,Granulocyte colony-stimulating factor receptor,24229,0.0144964977187153,0.00213785950867036,0.0103062930817214,0.0186867023557092,1.22221382279154e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA2,Leukocyte immunoglobulin-like receptor subfamily A member 2,29443,0.0168697243031337,0.00249056543000837,0.0119882160603173,0.0217512325459501,1.28110881240764e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ULBP2,UL16-binding protein 2,29218,0.0179113726149406,0.00264604912115638,0.0127251163374741,0.0230976288924071,1.32035566922964e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA6,Corticosteroid-binding globulin,24966,0.00790446957254623,0.00116823774856104,0.00561472358536659,0.0101942155597259,1.35182058986491e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGA4,Pepsin A-4,24951,0.0333056595482089,0.00493041252256613,0.0236420510039793,0.0429692680924385,1.45829205954374e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLYR1,Putative oxidoreductase GLYR1,24793,0.0276457650023487,0.00411293769552224,0.0195844071191251,0.0357071228855723,1.83566514859095e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10,V-set and immunoglobulin domain-containing protein 10,24793,0.0163603281814753,0.00243796381872208,0.01158191909678,0.0211387372661706,1.9793412581292e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGA11,Integrin alpha-11,29434,-0.015902362119624,0.00237271295891863,-0.0205528795191045,-0.0112518447201434,2.09030421153725e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC9,Sialic acid-binding Ig-like lectin 9,29683,0.0138855831983997,0.00207466113430408,0.00981924737516374,0.0179519190216357,2.22622677474534e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE3,Eosinophil cationic protein,29343,0.0502737106533123,0.00751774464375976,0.0355389311515432,0.0650084901550814,2.31342210031212e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3A,Regenerating islet-derived protein 3-alpha,29820,-0.0286277298919384,0.00428811178989723,-0.0370324290001369,-0.0202230307837398,2.49740814461962e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIMAP7,GTPase IMAP family member 7,24381,-0.0149542117962283,0.00224141835510752,-0.019347391772239,-0.0105610318202175,2.58166086616179e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11D,Transmembrane protease serine 11D,24801,0.0177194582069356,0.00266528208110742,0.0124955053279651,0.0229434110859061,3.02762758169855e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR2,TGF-beta receptor type-2,29566,0.0150640858403575,0.00226897359502608,0.0106168975941063,0.0195112740866086,3.20928667024696e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX2,Neuronal pentraxin-2,24938,-0.0152899845791319,0.00231354684736672,-0.0198245363999706,-0.0107554327582931,3.95017437609675e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRLF1,Cytokine receptor-like factor 1,29581,0.0117889024651671,0.00178649104400994,0.00828738001890763,0.0152904249114266,4.21172146571702e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADA2,Adenosine deaminase 2,29328,-0.0194844800363567,0.00296356971260029,-0.0252930766730533,-0.0136758833996602,4.95812651851803e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN10,Ataxin-10,28774,0.0331258437574196,0.00504230852490635,0.0232429190486032,0.0430087684662361,5.1318669792415e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTG,Protogenin,29725,0.0113330950129081,0.00172591432382043,0.00795030293822008,0.0147158870875962,5.23853344953985e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAP,Cartilage-associated protein,24195,0.0221849995934325,0.00338363816790257,0.0155530687843434,0.0288169304025215,5.61764374589666e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCN5,CCN family member 5,29443,0.0176591388700576,0.00269461434381434,0.0123776947561815,0.0229405829839337,5.71342299937526e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP3,Dual specificity protein phosphatase 3,28774,0.0385973935186487,0.00590480861635284,0.0270239686305972,0.0501708184067003,6.39841874610577e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPP1,Osteopontin,29757,-0.020857823852945,0.00319299604640643,-0.0271160961039016,-0.0145995516019884,6.57821874775172e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC4,Immunoglobulin superfamily DCC subclass member 4,24938,-0.0119863081915508,0.00183567579271724,-0.0155842327452766,-0.00838838363782498,6.71950612084002e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANGPTL1,Angiopoietin-related protein 1,29030,0.013164675011078,0.0020200755552163,0.009205326922854,0.0171240230993019,7.29403550462941e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMTOR5,Ragulator complex protein LAMTOR5,24793,0.0183594261995155,0.0028321789566937,0.0128083554443959,0.0239104969546352,9.19493919685128e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB1A1,Uteroglobin,29523,0.0248027290867228,0.00382832789152305,0.0172992064193376,0.032306251754108,9.39493140075993e-11
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC38,Leucine-rich repeat-containing protein 38,24195,0.0216881213431192,0.00335346233277903,0.0151153351708723,0.0282609075153661,1.01620263915479e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWF,von Willebrand factor,29820,-0.0324112444214957,0.00502322211951059,-0.0422567597757365,-0.0225657290672549,1.11867655990296e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG2,V-set and immunoglobulin domain-containing protein 2,24793,0.0265279159577342,0.00412499149236458,0.0184429326326996,0.0346128992827688,1.29058151386456e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN2,Prefoldin subunit 2,28774,0.0247834895069287,0.0038562620909405,0.0172252158086853,0.0323417632051721,1.32342677692853e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G2A,"Phospholipase A2, membrane associated",29402,-0.0247201003271782,0.00385427593676881,-0.0322744811632451,-0.0171657194911113,1.44203666925152e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDO2,"Tryptophan 2,3-dioxygenase",24195,0.0173193874478106,0.00270508265586607,0.0120174254423131,0.022621349453308,1.55623125819759e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INPP5J,"Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A",24867,0.0186970265447546,0.00293048860055964,0.0129532688876577,0.0244407842018515,1.80002707370122e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL1,Chordin-like protein 1,29536,0.0139154509954668,0.00218154260798445,0.00963962748381731,0.0181912745071163,1.81215618660651e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRN2,Receptor-type tyrosine-protein phosphatase N2,29114,0.0146960393965079,0.00230795010947258,0.0101724571819417,0.0192196216110742,1.94906684464664e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMB,Granzyme B,29434,0.0287289226374178,0.00451607721476683,0.0198774112964748,0.0375804339783608,2.02758010517139e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGFR4,Fibroblast growth factor receptor 4,24381,0.0233017762255128,0.00367216270347674,0.0161043373266984,0.0304992151243273,2.25576015112346e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD80,T-lymphocyte activation antigen CD80,24922,0.0150336535782601,0.0023719865650134,0.0103845599108339,0.0196827472456864,2.36750257965105e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG3G,Regenerating islet-derived protein 3-gamma,24793,0.0174275011282381,0.0027723804855183,0.0119936353766222,0.0228613668798539,3.30933815717908e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A11,Protein S100-A11,29208,0.0197780231165034,0.00315035978985893,0.0136033179283799,0.0259527283046269,3.47730823939043e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRSS53,Serine protease 53,24845,0.0162685001252363,0.00259134461646645,0.0111894646769621,0.0213475355735105,3.48596166222018e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UROS,Uroporphyrinogen-III synthase,24195,0.0297063688278783,0.00473623799551185,0.0204233423566751,0.0389893952990815,3.62137524046248e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BOC,Brother of CDO,28916,-0.0101741139909283,0.00162400871751368,-0.0133571710772551,-0.0069910569046015,3.78524866320927e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL3,Myosin light chain 3,24240,-0.0317837504158975,0.0050739736116668,-0.0417287386947645,-0.0218387621370306,3.81350553883907e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYAR,Cell growth-regulating nucleolar protein,28797,0.022917265132749,0.00366259037789382,0.0157385879920771,0.0300959422734209,3.97671790433465e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPE,Carboxypeptidase E,29468,-0.0167306681352672,0.00267463651738711,-0.0219729557093459,-0.0114883805611884,4.02187733620058e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA5,Protein disulfide-isomerase A5,24016,0.0264877740042522,0.00426069174977893,0.0181368181746855,0.0348387298338189,5.15826149807736e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD27,CD27 antigen,29566,-0.0179115584951344,0.00288168898962761,-0.0235596689148045,-0.0122634480754642,5.17963358940286e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALB1,Calbindin,29349,0.0187236941033136,0.00302351729988051,0.0127976001955478,0.0246497880110794,5.99314269033186e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFPI2,Tissue factor pathway inhibitor 2,29473,0.0167329383245138,0.00270413076479842,0.0114328420255089,0.0220330346235187,6.17664602543679e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEBPA,CCAAT/enhancer-binding protein alpha,24229,0.016078435400273,0.00259888709245006,0.0109846166990709,0.0211722541014751,6.24358713909287e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CR2,Complement receptor type 2,29594,0.0199359546023761,0.00322437984711046,0.0136161701020396,0.0262557391027126,6.37647156647848e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDS,Iduronate 2-sulfatase,29786,0.00379528179150473,0.000615497570154592,0.00258890655400173,0.00500165702900773,7.08484305455449e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN8,Tetraspanin-8,24805,0.042795400388437,0.00694553570413383,0.0291821504083347,0.0564086503685393,7.31362837754615e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT3,Polypeptide N-acetylgalactosaminyltransferase 3,28931,0.018174962822919,0.00295226862476484,0.01238851631838,0.0239614093274581,7.5456891992952e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGB2A2,Mammaglobin-A,24111,-0.0134726268317612,0.00219306891081954,-0.0177710418969676,-0.00917421176655495,8.21024424034701e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLGN,Calmegin,24195,0.0191532831758227,0.00311813631539868,0.0130417359976413,0.0252648303540041,8.2477653263483e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCER2,Coiled-coil domain-containing glutamate-rich protein 2,24240,0.0267210069727882,0.00435475140057488,0.0181856942276614,0.035256319717915,8.59055864118252e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13,Tumor necrosis factor ligand superfamily member 13,29581,0.0114390077447523,0.00186489288833453,0.00778381768361666,0.015094197805888,8.68538937477561e-10
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK8,Kallikrein-8,28443,0.0151719395694835,0.00249499947416993,0.0102817406001104,0.0200621385388565,1.2100259077833e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEO1,Neogenin,24867,0.00924734952758271,0.00152114271580458,0.00626590980460574,0.0122287892505597,1.22533435837812e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLIC5,Chloride intracellular channel protein 5,24195,-0.0134462026415694,0.00221240630403401,-0.017782518997476,-0.00910988628566273,1.23790656500644e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFIKKN2,"WAP, Kazal, immunoglobulin, Kunitz and NTR domain-containing protein 2",29497,-0.0141738037485846,0.00233541290639775,-0.0187512130451242,-0.00959639445204502,1.30214074706717e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RL1,Interleukin-1 receptor-like 1,29736,-0.0195379292721646,0.00322018023146833,-0.0258494825258425,-0.0132263760184867,1.31615948740833e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATXN2,Ataxin-2,24101,0.0466607210254236,0.00769742470658369,0.0315737686005196,0.0617476734503277,1.36555172666304e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUCA1,Tissue alpha-L-fucosidase,29623,0.034450015173716,0.00569459119060302,0.0232886164401341,0.0456114139072979,1.46943097840213e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL46,"39S ribosomal protein L46, mitochondrial",28774,0.0115643576988361,0.00191633805665027,0.00780833510780155,0.0153203802898706,1.61291367712018e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRELP,Prolargin,29454,0.00971211334205281,0.00161105066640284,0.00655445403590324,0.0128697726482024,1.67523359252469e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSBP1,Heat shock factor-binding protein 1,24240,0.0399717723770958,0.00663834336846438,0.0269606193749056,0.052982925379286,1.75460634910967e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QL2,Complement C1q-like protein 2,24229,0.0179304895552019,0.00298060320956359,0.0120885072644572,0.0237724718459465,1.81652684277148e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAMPT,Nicotinamide phosphoribosyltransferase,28797,0.0215209180862795,0.00357817179525112,0.0145077013675873,0.0285341348049717,1.82615764910362e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYSMD3,LysM and putative peptidoglycan-binding domain-containing protein 3,24195,0.0432143210440198,0.00718874556213085,0.0291243797422433,0.0573042623457963,1.86579816900706e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNU13,NHP2-like protein 1,24111,0.026094530768604,0.00434355555114284,0.017581161888364,0.034607899648844,1.90939686580531e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLPS,Colipase,29400,0.0294819206862102,0.00491318691696207,0.0198520743289645,0.0391117670434558,1.98925742745796e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLASP1,CLIP-associating protein 1,24016,0.030369267842161,0.00506779852536604,0.0204363827324436,0.0403021529518785,2.09462458526452e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREBZF,CREB/ATF bZIP transcription factor,24016,-0.0108993878118077,0.00182014847199544,-0.0144668788169187,-0.0073318968066966,2.15211057920315e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT2,Thialysine N-epsilon-acetyltransferase,24445,0.0289007841504374,0.00482728449131046,0.0194393065474689,0.0383622617534059,2.16776068109476e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP9,Fatty acid-binding protein 9,29434,0.0231772227755391,0.00387902879311017,0.0155743263410431,0.030780119210035,2.32723693231614e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ASPN,Asporin,24922,0.0114116551957953,0.00191031783544877,0.00766743223831567,0.0151558781532749,2.35086864411892e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBPL1,Insulin-like growth factor-binding protein-like 1,29478,0.0140190335785228,0.00234693735057053,0.00941903637140457,0.0186190307856411,2.3512085431424e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANPEP,Aminopeptidase N,29531,0.0116025895817414,0.00194319384653963,0.00779392964252371,0.0154112495209591,2.38662366259371e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MPO,Myeloperoxidase,29443,0.0189795996801354,0.00317968816740409,0.0127474108720234,0.0252117884882474,2.41423453138421e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEO1,RNA polymerase-associated protein LEO1,24867,0.0124622119488207,0.00208812125656167,0.00836949428595987,0.0165549296116816,2.43216213654434e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHX2,Bifunctional epoxide hydrolase 2,28916,0.0255434093892242,0.00428286186855777,0.017149000126851,0.0339378186515974,2.48844538164022e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIFR,Leukemia inhibitory factor receptor,29434,-0.0100386142910583,0.00168351565690669,-0.0133383049785954,-0.00673892360352117,2.50643293858222e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SATB1,DNA-binding protein SATB1,24867,0.0122247566985314,0.00205970249409799,0.00818773981009932,0.0162617735869634,2.9736934448814e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMBS,Porphobilinogen deaminase,29725,0.0176845692593526,0.002983565696332,0.0118367804945419,0.0235323580241634,3.11299475311438e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1,Programmed cell death protein 1,29661,0.0176020439452086,0.00297106910413866,0.0117787485010969,0.0234253393893204,3.16738415251155e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SFTPA1,Pulmonary surfactant-associated protein A1,28797,0.0235848118920457,0.00400430041602642,0.0157363830766339,0.0314332407074575,3.90788159594205e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF8,Tumor necrosis factor receptor superfamily member 8,29694,-0.0185603331709101,0.00315364789176115,-0.0247414830387619,-0.0123791833030582,4.0146623558242e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXTL1,Exostosin-like 1,24111,0.0194264880925245,0.00330556154981818,0.0129475874548809,0.0259053887301681,4.23494809192531e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBC1D17,TBC1 domain family member 17,28774,0.0181449325141675,0.00309334030042786,0.0120819855253289,0.0242078795030061,4.51844116220286e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA1,Annexin A1,24281,0.0174125904507105,0.00296858382495286,0.0115941661538029,0.0232310147476181,4.53254289432445e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B4GALT1,"Beta-1,4-galactosyltransferase 1",29581,0.0111891971655299,0.00190953294183947,0.00744651259952451,0.0149318817315352,4.68752065670856e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GALNT5,Polypeptide N-acetylgalactosaminyltransferase 5,24922,0.0111871074846932,0.00190942388935025,0.00744463666156672,0.0149295783078197,4.71826261747371e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROCR,Endothelial protein C receptor,24111,-0.0145819537549957,0.00248951373109433,-0.0194614006679406,-0.00970250684205078,4.76418566729202e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549L,UPF0606 protein KIAA1549L,24445,-0.0114667065101385,0.00195996927077614,-0.0153082462808598,-0.00762516673941731,4.9648861940001e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLURP1,Secreted Ly-6/uPAR-related protein 1,24801,0.0151448668831167,0.00259038091056462,0.01006772029841,0.0202220134678234,5.08073791410773e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMPD3,AMP deaminase 3,24845,0.0287278277963868,0.00491553338389297,0.0190933823639566,0.038362273228817,5.15072259687314e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL9,C-X-C motif chemokine 9,29581,0.0268754358468989,0.00460130287530972,0.0178568822112919,0.035893989482506,5.24840080337557e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPA,Apolipoprotein(a),24484,-0.0723367843299318,0.0123852169913536,-0.0966118096329847,-0.0480617590268788,5.26788794775651e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD6,Programmed cell death protein 6,29478,-0.0283133771586279,0.0048492441851284,-0.0378178957614796,-0.0188088585557763,5.3154751290611e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL1A1,Collagen alpha-1(I) chain,29820,-0.0101047987117684,0.00173191542488485,-0.0134993529445427,-0.00671024447899409,5.45210486104332e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AZU1,Azurocidin,28534,0.0309361074179719,0.00530454745512834,0.0205391944059204,0.0413330204300234,5.53580852597586e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH6,Cadherin-6,29478,-0.0154686004966884,0.00265629484559729,-0.0206749383940591,-0.0102622625993177,5.82691771381839e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JCHAIN,Immunoglobulin J chain,28931,-0.0248498752369485,0.00427132986804497,-0.0332216817783166,-0.0164780686955804,6.02438777620429e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP4,Microfibril-associated glycoprotein 4,24381,-0.0129832683201396,0.00223393993544174,-0.0173617905936054,-0.00860474604667378,6.25650813051637e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3,"TNF receptor-associated factor 3, Isoform 2",24229,0.0145465759349383,0.0025071529815587,0.00963255609108326,0.0194605957787934,6.6332794225856e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOSB,Protein fosB,28774,0.0155652762679579,0.00268684360147773,0.0102990628090615,0.0208314897268542,6.97994837355077e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LHB,Lutropin subunit beta,28797,0.0348408312518392,0.00602744540836848,0.023027038251437,0.0466546242522414,7.53078485020649e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF13B,Tumor necrosis factor ligand superfamily member 13B,29786,0.0109909748652906,0.00190635496295465,0.00725451913789948,0.0147274305926817,8.22490799743068e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCAN,Versican core protein,29694,-0.0119879804327083,0.00208185939643655,-0.016068424849724,-0.00790753601569267,8.58001726609391e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTL1,Cytokine-like protein 1,24938,0.00963738662879728,0.00167531969663031,0.00635376002340187,0.0129210132341927,8.89273089998027e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD5,Ectonucleoside triphosphate diphosphohydrolase 5,28916,-0.0085468868035624,0.00148650300450146,-0.0114604326923853,-0.00563334091473953,9.03227959619357e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTCN1,V-set domain-containing T-cell activation inhibitor 1,28797,-0.0128189474182345,0.00222990565425655,-0.0171895625005774,-0.00844833233589166,9.08669554589309e-09
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRK1,NKG2-D type II integral membrane protein,24845,0.0184779093970307,0.00322393027710894,0.0121590060538972,0.0247968127401642,1.00707199922636e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN1,Nectin-1,24229,0.0128351129562248,0.002246489308686,0.00843199391120023,0.0172382320012494,1.12033230112203e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRL,Chymotrypsin-like protease CTRL-1,24845,-0.0269770447285828,0.00472298200120475,-0.0362340894509441,-0.0177200000062214,1.13019606354014e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC2,Mucin-2,24938,0.0362468108832885,0.0063495288980659,0.0238017342430794,0.0486918875234977,1.15214050792068e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL4,Delta-like protein 4,24240,0.0339895132291292,0.00596477441025755,0.0222985553850244,0.045680471073234,1.22358744307274e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACY3,N-acyl-aromatic-L-amino acid amidohydrolase,24111,0.0221634915993312,0.00390085141406031,0.014517822827773,0.0298091603708894,1.34895104033639e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MET,Hepatocyte growth factor receptor,29507,-0.00777044577355761,0.00136913086121504,-0.0104539422615391,-0.00508694928557613,1.39613619956557e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CELA2A,Chymotrypsin-like elastase family member 2A,24938,0.024132841057072,0.00425606314924179,0.0157909572845581,0.0324747248295859,1.4418588404072e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5,Eukaryotic translation initiation factor 5,24111,0.0173076040503513,0.00306022931432915,0.0113095545942661,0.0233056535064364,1.57010281554754e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYVE1,Lymphatic vessel endothelial hyaluronic acid receptor 1,24966,-0.00760793459742325,0.00134859055714488,-0.0102511720894272,-0.00496469710541929,1.70502267906335e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SNX18,Sorting nexin-18,24805,0.0174589359951895,0.00309530847219949,0.0113921313896785,0.0235257406007005,1.71452332642209e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIL1,Nucleotide exchange factor SIL1,24240,0.0126218210565666,0.00224247651684334,0.00822656708355365,0.0170170750295796,1.83772966081923e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUC16,Mucin-16,29349,0.0733559082755946,0.0130872852831224,0.0477048291206747,0.0990069874305145,2.09968782942627e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACP1,Low molecular weight phosphotyrosine protein phosphatase,24229,0.0170867362096538,0.0030524684308047,0.0111038980852766,0.023069574334031,2.19592902314165e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GART,Trifunctional purine biosynthetic protein adenosine-3,24867,0.0104522561203627,0.00186981908518233,0.00678741071340534,0.0141171015273201,2.29474301578101e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDC,Aromatic-L-amino-acid decarboxylase,29433,-0.018664803362486,0.00334428069440182,-0.0252195935235136,-0.0121100132014584,2.41089513998656e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNG,Interferon gamma,28931,0.0438940007748917,0.00788511016821177,0.0284391848451966,0.0593488167045868,2.61917867842582e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANBP2,E3 SUMO-protein ligase RanBP2,24101,-0.0127773785057742,0.00230461331820558,-0.0172944206094571,-0.00826033640209128,2.98292111190626e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELENOP,Selenoprotein P,24966,0.00869273351046642,0.00156966282907101,0.00561619436548724,0.0117692726554456,3.09093603538528e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNPY2,Protein canopy homolog 2,28916,0.0233052784406055,0.00422193628837406,0.0150302833153923,0.0315802735658187,3.41821428324907e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TDGF1,Teratocarcinoma-derived growth factor 1,28774,0.0555321300847601,0.0100610980787637,0.0358123778503832,0.075251882319137,3.42916113987174e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDHR1,Cadherin-related family member 1,28774,0.0163214425332595,0.00296611183514762,0.0105078633363702,0.0221350217301489,3.77335619062226e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MBL2,Mannose-binding protein C,24610,-0.041251626558384,0.00749875406061228,-0.0559491845171841,-0.026554068599584,3.81120625127277e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSAB1,Tryptase alpha/beta-1,29753,0.019924776922558,0.00362647568792824,0.0128168845742186,0.0270326692708973,3.95579584954034e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300C,CMRF35-like molecule 6,29694,0.0131552922838377,0.0023952280575392,0.00846064529106086,0.0178499392766145,4.00001343740444e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPA2,Replication protein A 32 kDa subunit,24229,0.0121296215697949,0.00220863666959748,0.00780069369738387,0.016458549442206,4.01617954727543e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCN,Decorin,28916,-0.00871107145960671,0.00158666727234536,-0.0118209393134036,-0.00560120360580981,4.049234911108e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDHB15,Protocadherin beta-15,24793,-0.0152359227980962,0.00277687855674532,-0.0206786047693171,-0.0097932408268754,4.13498243932819e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF3,Neurotrophin-3,29434,0.0131581807025453,0.00240444448281596,0.00844546951622601,0.0178708918888646,4.47496504787372e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP3,Tubulin polymerization-promoting protein family member 3,28774,0.014823258715475,0.00271838898428943,0.0094952163062677,0.0201513011246823,4.99464024595187e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BAMBI,BMP and activin membrane-bound inhibitor homolog,28797,0.0113340285107541,0.00207987228172087,0.0072574788385812,0.015410578182927,5.09580599281816e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTSL5,ADAMTS-like protein 5,24922,-0.0149036404731944,0.00273525690910872,-0.0202647440150475,-0.00954253693134127,5.12150537217401e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RA,Interleukin-2 receptor subunit alpha,29223,-0.0152453244756132,0.00280336195047415,-0.0207399138985426,-0.00975073505268392,5.42439177457507e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A2,Collagen alpha-2(IX) chain,24445,0.0171533374042621,0.00315800391068129,0.0109636497393268,0.0233430250691974,5.63515108132866e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAV,Integrin alpha-V,29725,0.00624039757445398,0.00114988650516414,0.00398662002433226,0.0084941751245757,5.77671583734442e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH12,Protocadherin-12,24867,0.00961440062632761,0.00177265435329309,0.00613999809387315,0.0130888031587821,5.89119088802453e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX25,ATP-dependent RNA helicase DDX25,24195,-0.0141661962956038,0.00261556591617597,-0.0192927054913087,-0.00903968709989894,6.14897864330445e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROBO4,Roundabout homolog 4,24240,-0.00672410685312208,0.00124979912560308,-0.00917371313930411,-0.00427450056694005,7.51137722458374e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD163,Scavenger receptor cysteine-rich type 1 protein M130,29594,0.0159706745263533,0.00297157287091143,0.0101463916993669,0.0217949573533397,7.73821558227442e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM8,Disintegrin and metalloproteinase domain-containing protein 8,29640,0.010795368852532,0.00200884785895444,0.00685802704898131,0.0147327106560827,7.76281443685701e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC6,Sialic acid-binding Ig-like lectin 6,29725,0.0125024719110231,0.00232902744170695,0.00793757812527747,0.0170673656967687,8.01625626431061e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY96,Lymphocyte antigen 96,29218,-0.0132219807599986,0.00246630040751529,-0.0180559295587286,-0.00838803196126866,8.33628886267505e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PREB,Prolactin regulatory element-binding protein,28931,0.0107710665802324,0.00201161235435828,0.00682830636569012,0.0147138267947746,8.64735675023207e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD109,CD109 antigen,29443,-0.0124898666141675,0.00233843621299233,-0.0170732015916325,-0.00790653163670255,9.30593538299944e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPARCL1,SPARC-like protein 1,29489,-0.0101626207723079,0.00190272877923779,-0.013891969179614,-0.00643327236500187,9.30799817811302e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMS1,PMS1 protein homolog 1,24195,0.0188207409467967,0.00352421567678481,0.0119132782202984,0.0257282036732949,9.35758127071114e-08
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN1,Prorelaxin H1,24867,-0.025453482134232,0.00477951858164257,-0.0348213385542514,-0.0160856257142125,1.01531857603741e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC3,Membrane primary amine oxidase,29594,-0.0111036430426211,0.00209079376687399,-0.0152015988256941,-0.00700568725954805,1.09974184682384e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEPACAM2,HEPACAM family member 2,24845,-0.015432260321779,0.00291508423086953,-0.0211458254142833,-0.00971869522927473,1.20730217961324e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB1,Integrin beta-1,29474,0.00796283334663147,0.00150429409175,0.00501441692680146,0.0109112497664615,1.20920354765961e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LEG1,Protein LEG1 homolog,23603,-0.0256981520441247,0.00486007143889763,-0.035223892064364,-0.0161724120238853,1.25029395391324e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFB2,Transforming growth factor beta-2 proprotein,24793,0.0192033157425109,0.0036366814414015,0.012075420117364,0.0263312113676578,1.29952839239471e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHNAK2,Protein AHNAK2,24240,0.0108653832111055,0.00206485239678653,0.00681827251340394,0.0149124939088071,1.4365953204629e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERC2,ERC protein 2,24195,0.0275396397286115,0.00523369362982739,0.0172816002141498,0.0377976792430732,1.43719293461585e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6ST,Interleukin-6 receptor subunit beta,29478,0.00641543501570564,0.00122033389002084,0.0040235805912648,0.00880728944014648,1.4735214729608e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNA1,Ephrin-A1,29390,0.0102740647059777,0.00195802769772255,0.00643633041844147,0.0141117989935138,1.55541201698095e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP7,Dipeptidyl peptidase 2,29279,0.0218549239648098,0.00416727223711226,0.0136870703800698,0.0300227775495499,1.57863942722298e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPR1,Atrial natriuretic peptide receptor 1,24111,-0.0150424221846801,0.00286894096863763,-0.0206655464832098,-0.00941929788615034,1.59148797699713e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPIHBP1,Glycosylphosphatidylinositol-anchored high density lipoprotein-binding protein 1,24805,-0.0256282141159818,0.00489001633890405,-0.0352126461402338,-0.0160437820917299,1.61079933243075e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP4,Bone morphogenetic protein 4,29169,-0.0167331064543752,0.00320618344430985,-0.0230172260052225,-0.0104489869035279,1.81111789412158e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MNAT1,CDK-activating kinase assembly factor MAT1,24445,0.0158735956527423,0.00304630931284457,0.00990282939956693,0.0218443619059177,1.89592494155116e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHL1,Neural cell adhesion molecule L1-like protein,29542,-0.0111537925334733,0.00214102453606316,-0.0153502006241571,-0.00695738444278951,1.90560194205102e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMMD9,COMM domain-containing protein 9,24793,0.0142352001278027,0.00273765000425469,0.00886940611946347,0.0196009941361419,2.01099751114895e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL9A1,Collagen alpha-1(IX) chain,29434,0.0168523985407052,0.00324358360597131,0.0104949746730014,0.0232098224084089,2.05408060321717e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TK1,"Thymidine kinase, cytosolic",24445,0.0164879677717088,0.0031772074101291,0.0102606412478558,0.0227152942955618,2.12598336515713e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPS10,40S ribosomal protein S10,24111,-0.0151076218570445,0.00291393361231807,-0.0208189317371879,-0.00939631197690106,2.18209769221413e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE6,Ribonuclease K6,24828,0.0110385532588784,0.00213077326123483,0.00686223766685815,0.0152148688508987,2.22975028469487e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD209,CD209 antigen,29527,-0.0139013400649952,0.00269464808135616,-0.0191828503044533,-0.00861982982553715,2.50049551633551e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GP2,Pancreatic secretory granule membrane major glycoprotein GP2,28498,-0.0305539003347979,0.00592860391917282,-0.0421739640163766,-0.0189338366532192,2.57179663190937e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH1,Inter-alpha-trypsin inhibitor heavy chain H1,24966,0.00667477478850896,0.00129577749236515,0.00413505090347326,0.00921449867354465,2.60829293801159e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UXS1,UDP-glucuronic acid decarboxylase 1,28797,0.0187766709321516,0.00364555932421087,0.0116313746566983,0.0259219672076049,2.61420267089028e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM5,Intercellular adhesion molecule 5,29478,0.0160198820573995,0.00311468450328467,0.00991510043096152,0.0221246636838374,2.7162271545211e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GDF15,Growth/differentiation factor 15,29820,-0.0157874875049238,0.00307655427456364,-0.0218175338830685,-0.00975744112677903,2.89169173410332e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX3,Syntaxin-3,24845,0.0136539254919924,0.00266279630536093,0.00843484473348499,0.0188730062504998,2.95560573686551e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFHD1,EF-hand domain-containing protein D1,24867,0.0125305717162942,0.00244637724356567,0.00773567231890551,0.0173254711136829,3.04418951915116e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFAP,Glial fibrillary acidic protein,28753,0.0164121033038481,0.00320519195602254,0.0101299270700439,0.0226942795376523,3.06732697063109e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSPG2,Basement membrane-specific heparan sulfate proteoglycan core protein,29274,0.00923331189251895,0.00180970631276046,0.00568628751950846,0.0127803362655294,3.37993332829326e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN1,Contactin-1,29820,-0.00962964733533167,0.00188820568440451,-0.0133305304767645,-0.00592876419389882,3.419246771483e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YAP1,Transcriptional coactivator YAP1,24845,0.00956644954285656,0.00187577281003419,0.00588993483518956,0.0132429642505236,3.42141744273621e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI4,Protein-arginine deiminase type-4,28722,0.0251130289090722,0.00492540512415165,0.015459234865735,0.0347668229524094,3.44214475511942e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRM1,Muscarinic acetylcholine receptor M1,24195,-0.0130715579501977,0.0025642877169191,-0.0180975618753591,-0.00804555402503621,3.46688769915608e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYT1,Synaptotagmin-1,24845,0.0139191123864656,0.00274277643478007,0.00854327057429664,0.0192949541986345,3.90647604174907e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL21,C-C motif chemokine 21,29581,0.0142640943227763,0.00281142114570886,0.0087537088771869,0.0197744797683656,3.9266953737821e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF10C,Tumor necrosis factor receptor superfamily member 10C,29517,-0.0172346281641548,0.00340729450162385,-0.0239129253873375,-0.010556330940972,4.25864475072171e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B2,Sodium/potassium-transporting ATPase subunit beta-2,24111,-0.0110758193802529,0.00219016026820683,-0.0153685335059383,-0.00678310525456748,4.28841390543455e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP5,Rho GTPase-activating protein 5,24016,0.0267406105637401,0.00532299304025787,0.0163075442048346,0.0371736769226455,5.10743795117875e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDK2,Protein sidekick-2,24381,0.0135049575711243,0.00268879356413364,0.00823492218542233,0.0187749929568262,5.13143341308215e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP3,"Fatty acid-binding protein, heart",24922,0.0176069159266097,0.00351509075459831,0.010717338047597,0.0244964938056224,5.51015685130647e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPH3,Neurexophilin-3,24229,0.0105009210561439,0.00210037520129395,0.00638418566160779,0.0146176564506801,5.78666601340294e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTP1,Glutathione S-transferase P,28604,-0.0240275890397897,0.00483716694531713,-0.0335084362526113,-0.0145467418269682,6.82878124415824e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4D,C-type lectin domain family 4 member D,29434,0.0211473838702527,0.00425766328344369,0.0128023638347031,0.0294924039058023,6.84127546666156e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRRC25,Leucine-rich repeat-containing protein 25,29349,0.0133997759416956,0.00270215515304656,0.00810355184172433,0.0186960000416669,7.12809608850791e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF17,Tumor necrosis factor receptor superfamily member 17,24381,-0.0140680504348155,0.00284247069340828,-0.0196392929938957,-0.00849680787573523,7.50032692118462e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIMP2,Metalloproteinase inhibitor 2,24922,-0.00911629412457923,0.00184480637305128,-0.0127321146157597,-0.00550047363339872,7.79867335995411e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GZMH,Granzyme H,28916,0.0261548577935365,0.00529818814359378,0.0157704090320927,0.0365393065549803,7.99523907736559e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM1,U6 snRNA-associated Sm-like protein LSm1,28797,0.0189058984377611,0.00385315500718634,0.0113537146236759,0.0264580822518463,9.31735180620256e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDIL3,EGF-like repeat and discoidin I-like domain-containing protein 3,28916,0.0120012459151349,0.00244740427121282,0.00720433354355775,0.016798158286712,9.45758756069658e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK14,Kallikrein-14,29725,-0.015660205045587,0.0031943573700437,-0.0219211454908727,-0.00939926460030138,9.51432715461852e-07
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO3,R-spondin-3,29725,0.0096057271993144,0.00196457329337587,0.00575516354429769,0.0134562908543311,1.01633893419822e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17C,Interleukin-17C,28931,-0.0238468269313673,0.00488361740283173,-0.0334187170409175,-0.0142749368218171,1.05027577707857e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LIF,Leukemia inhibitory factor,28774,0.0173985031101109,0.00356447806978384,0.0104121260933346,0.0243848801268873,1.06071158943873e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGT5,Glutathione hydrolase 5 proenzyme,29218,0.00786894656699608,0.0016158007464832,0.00470197710388901,0.0110359160301032,1.121825061354e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS1,A disintegrin and metalloproteinase with thrombospondin motifs 1,24229,0.0105214751956189,0.00216648551624039,0.00627516358378773,0.0147677868074501,1.20241346976972e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN3,Neuronal-specific septin-3,24867,-0.0253829400465224,0.00525542801614908,-0.0356835789581746,-0.0150823011348702,1.37447440241351e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP1,Dipeptidase 1,29163,-0.0162121220586408,0.003367781323654,-0.0228129734530026,-0.00961127066427893,1.48762912125002e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR2,Leukocyte-associated immunoglobulin-like receptor 2,29218,0.0348774423062034,0.00725080066535215,0.0206658730021132,0.0490890116102936,1.51568141904657e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPNMB,Transmembrane glycoprotein NMB,28733,0.00953499578546937,0.00198621430419952,0.0056420157492383,0.0134279758217004,1.58996181012225e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD3,Bromodomain-containing protein 3,24111,0.015969784145942,0.00332703680612332,0.00944879200594032,0.0224907762859437,1.59614548085599e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAC1,Cartilage acidic protein 1,29820,0.00997231876998342,0.002083492616006,0.00588867324261165,0.0140559642973552,1.70657664021155e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPP,"Alkaline phosphatase, placental type",29349,0.0342751232685907,0.00716769139622332,0.020226448131993,0.0483237984051884,1.74495330103702e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLFM4,Olfactomedin-4,23498,0.0408452489145381,0.00855965722324798,0.024068320756972,0.0576221770721041,1.8365478099721e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGL2,Ral guanine nucleotide dissociation stimulator-like 2,24445,0.0214028502359294,0.00450209772792156,0.0125787386892032,0.0302269617826557,2.00593657144102e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD300E,CMRF35-like molecule 2,29642,0.0133832162899905,0.00282131173048484,0.00785344529824018,0.0189129872817408,2.1091495317256e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLP1R,Glucagon-like peptide 1 receptor,24101,-0.0124875262108768,0.00263342520556298,-0.0176490396137803,-0.00732601280797337,2.12899322249366e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR4,Proline-rich protein 4,24203,-0.0229537014039752,0.00484178556319766,-0.0324436011078426,-0.0134638017001078,2.14138713903067e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPCAT2,Lysophosphatidylcholine acyltransferase 2,29349,0.0127613739318142,0.0026934626981627,0.00748218704341532,0.0180405608202131,2.16948030366949e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AHSA1,Activator of 90 kDa heat shock protein ATPase homolog 1,24793,0.0219532260551939,0.00463841703431777,0.0128619286679311,0.0310445234424567,2.22541436761301e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VEGFB,Vascular endothelial growth factor B,24229,0.00947642453711359,0.00200795992722274,0.00554082307975703,0.0134120259944702,2.37828629418904e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPA4,Carboxypeptidase A4,23902,0.0143459548444094,0.00304616730818517,0.00837546692036646,0.0203164427684523,2.49708078404792e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAEA,E3 ubiquitin-protein transferase MAEA,28797,0.0130015160044082,0.0027622112651847,0.00758758192464617,0.0184154500841702,2.52653204551058e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT15,Nucleotide triphosphate diphosphatase NUDT15,24111,0.0167937817522317,0.00357087477667824,0.00979486718994238,0.0237926963145211,2.57801341403273e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FMR1,Synaptic functional regulator FMR1,28797,0.0115818055898198,0.00246355649393403,0.00675323486170909,0.0164103763179305,2.59765108500227e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18BP,Interleukin-18-binding protein,29594,0.0100489910867746,0.00213784601204342,0.00585881290316947,0.0142391692703797,2.60666012976901e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EGFLAM,Pikachurin,24805,0.00999965160751069,0.002137211833042,0.00581071641474837,0.014188586800273,2.90038743898166e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAN,Neurocan core protein,29694,0.0120793231350685,0.00258936385365057,0.0070041699819134,0.0171544762882236,3.09996160345141e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD3,Ly6/PLAUR domain-containing protein 3,29340,0.0110903602722123,0.00238200504251403,0.00642163038888479,0.0157590901555398,3.23991505263051e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRIM26,Tripartite motif-containing protein 26,24016,0.0180434140303197,0.00389110213119121,0.0104168538531849,0.0256699742074545,3.55199415033193e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TINAGL1,Tubulointerstitial nephritis antigen-like,29425,0.00715238884189004,0.00154262558022274,0.00412884270465348,0.0101759349791266,3.55874080888394e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VTA1,Vacuolar protein sorting-associated protein VTA1 homolog,29694,0.0228376761267074,0.0049305550925036,0.0131737881454003,0.0325015641080145,3.63918941165876e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7B,B-cell CLL/lymphoma 7 protein family member B,24793,0.0144089577150708,0.0031167715155398,0.00830008554461281,0.0205178298855288,3.80064558640752e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLC2,Immunoglobulin lambda constant 2,24915,-0.00793371468480088,0.00172480610883228,-0.0113143346581121,-0.0045530947114896,4.2503528147195e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP5,Ectonucleotide pyrophosphatase/phosphodiesterase family member 5,29581,0.013569637175128,0.00295024536550197,0.00778715625874413,0.0193521180915118,4.25271890799412e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG1,Adhesion G-protein coupled receptor G1,29349,-0.0219708292556308,0.00478178264046923,-0.0313431232309505,-0.0125985352803111,4.35186488674526e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBPMS,RNA-binding protein with multiple splicing,24229,0.0203905363295485,0.00447384017761706,0.0116218095814191,0.0291592630776779,5.19631526399263e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP1,Caspase-1,28774,0.0214356985205731,0.00471001593768554,0.0122040672827095,0.0306673297584368,5.35873884201883e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EP300,Histone acetyltransferase p300,24229,0.00954256492180825,0.0020971838722591,0.00543208453218042,0.0136530453114361,5.38601587763885e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRCAM,Neuronal cell adhesion molecule,29478,0.00891539974413716,0.00196193091599114,0.00507001514879452,0.0127607843394798,5.53640201883508e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBLN2,Fibulin-2,24938,-0.00989776349444447,0.00217983604076594,-0.0141702421343457,-0.00562528485454323,5.63568008912514e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF43,E3 ubiquitin-protein ligase RNF43,24445,0.0183158959053114,0.00404124876194439,0.0103950483319004,0.0262367434787224,5.86390020471372e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDGFRB,Platelet-derived growth factor receptor beta,29820,0.0109124888374108,0.00240844537780483,0.00619193589691337,0.0156330417779083,5.89533889767464e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF1AX,"Eukaryotic translation initiation factor 1A, X-chromosomal",24845,0.01722400327545,0.00381006417568328,0.00975627749111074,0.0246917290597892,6.19318880485713e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN4,Contactin-4,29443,-0.00752503336739829,0.00166820319805969,-0.0107947116355953,-0.00425535509920129,6.48142953424457e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBA,Lysosomal acid glucosylceramidase,24195,0.0168490008951214,0.00374393355142113,0.00951089113433601,0.0241871106559068,6.81587383424255e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDRG1,p53 and DNA damage-regulated protein 1,24195,0.016298185979363,0.00362960175906279,0.00918416653159993,0.0234122054271261,7.14344715579001e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS4,Thrombospondin-4,29518,0.014061054855596,0.00313154908992187,0.00792321863934914,0.0201988910718429,7.14499785216042e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4M,C-type lectin domain family 4 member M,24888,-0.0152470704533811,0.00339848974051401,-0.0219081103447886,-0.00858603056197366,7.27523438663229e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC13A1,Solute carrier family 13 member 1,24793,0.0189967687070909,0.00423717493177287,0.010691905840816,0.0273016315733657,7.38071398151793e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB44,Ras-related protein Rab-44,24793,0.0130245116237384,0.00292219861356944,0.00729700234114232,0.0187520209063345,8.3442586858059e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART3,Ecto-ADP-ribosyltransferase 3,29594,-0.0106215419684647,0.002383898082493,-0.015293982210151,-0.00594910172677846,8.39908767811046e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX5,Syntaxin-5,24229,0.0126027787230278,0.00283689142314693,0.0070424715336598,0.0181630859123958,8.93297497453005e-06
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GCNT1,"Beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase",29349,0.0105658423061987,0.00239423160681741,0.00587314835683653,0.0152585362555608,1.02291843129099e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAFB2,Scaffold attachment factor B2,24867,0.00839367838389142,0.00190428704103651,0.00466127578345987,0.012126080984323,1.0487284614099e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRP1,"5,6-dihydroxyindole-2-carboxylic acid oxidase",24229,0.0189483263187421,0.0043019469868459,0.0105165102245241,0.02738014241296,1.06436829664356e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL2L15,Bcl-2-like protein 15,24229,0.0172401245811928,0.0039164799636717,0.00956382385239622,0.0249164253099893,1.07744136656344e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_DRA,,29322,-0.0109451767227907,0.00250392331766163,-0.0158528664254075,-0.00603748702017385,1.23984302613504e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDKL5,Cyclin-dependent kinase-like 5,24101,-0.0161506313654152,0.00370093866495654,-0.02340447114873,-0.00889679158210033,1.28278664765465e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4R,Interleukin-4 receptor subunit alpha,29434,-0.0111067455581589,0.00254923543853639,-0.0161032470176902,-0.0061102440986276,1.32368118401938e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC9A3R2,Na(+)/H(+) exchange regulatory cofactor NHE-RF2,24805,0.0153120196449311,0.00351620617398896,0.00842025554391273,0.0222037837459494,1.33783909074499e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3D,T-cell surface glycoprotein CD3 delta chain,24101,-0.010377819773501,0.00238351800609344,-0.0150495150654441,-0.00570612448155782,1.34231332068183e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NTF4,Neurotrophin-4,28797,0.011874021670018,0.00273642552591992,0.00651062763921495,0.017237415700821,1.43459632690182e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RCC1,Regulator of chromosome condensation,24793,0.0154982560763266,0.00357222732221163,0.00849669052479176,0.0224998216278614,1.43998500425501e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF3,Granulocyte colony-stimulating factor,28931,0.0145541093690065,0.00335737716539012,0.00797365012484183,0.0211345686131711,1.4627612818548e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CENPJ,Centromere protein J,24445,0.0216145023581355,0.00498624447953527,0.0118414631782464,0.0313875415380247,1.46458441094386e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP6V1D,V-type proton ATPase subunit D,29349,0.00780993633219297,0.00180773982426814,0.00426676627662741,0.0113531063877585,1.56345581577525e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NFKB2,Nuclear factor NF-kappa-B p100 subunit,24445,0.0167124006770507,0.00387075267272782,0.00912572543850419,0.0242990759155972,1.58348625416385e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNPEP,Aspartyl aminopeptidase,24845,0.0173426830970338,0.00404415764402325,0.00941613411474821,0.0252692320793194,1.80700699680189e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GM2A,Ganglioside GM2 activator,24421,0.0114178974958069,0.00266484008555912,0.00619481092811102,0.0166409840635028,1.83730423987628e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCG3,Secretogranin-3,29497,-0.00984302876212513,0.00230481182173893,-0.0143604599327334,-0.00532559759151684,1.95519704723959e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B2M,Beta-2-microglobulin,24966,0.00919462578795752,0.0021575119248957,0.00496590241516195,0.0134233491607531,2.03639680748305e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PM20D1,N-fatty-acyl-amino acid synthase/hydrolase PM20D1,29345,0.054612866987894,0.0128370602846498,0.0294522288299803,0.0797735051458076,2.1034190700113e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL1,"Myosin light chain 1/3, skeletal muscle isoform",24111,-0.0120602017250567,0.00283537436445824,-0.0176175354793949,-0.00650286797071856,2.11269245806717e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1RAP,Interleukin-1 receptor accessory protein,29443,-0.0129109060184603,0.00303794915801455,-0.0188652863681688,-0.00695652566875181,2.14547131472952e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1B,Tumor necrosis factor receptor superfamily member 1B,29443,-0.0106979521746133,0.00253228988430486,-0.0156612403478508,-0.00573466400137574,2.4006825938057e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT1,NAD-dependent protein deacetylase sirtuin-1,24229,0.0254319287934784,0.00603863287675043,0.0135962083550476,0.0372676492319093,2.54554581636616e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDK1,Cyclin-dependent kinase 1,24016,0.010643025378328,0.00253505930529145,0.00567430913995676,0.0156117416166993,2.69854184712292e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCA2A,Guanylin,29333,-0.00993184095438708,0.00237334893351726,-0.0145836048640809,-0.00528007704469324,2.86327573857614e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171B,Protein FAM171B,24793,0.00786337090383077,0.00188384877001942,0.00417102731459271,0.0115557144930688,3.00188573269967e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN8,Septin-8,24801,0.00927463218049683,0.00223234488841258,0.00489923619920818,0.0136500281617855,3.26864278468304e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB5,Leukocyte immunoglobulin-like receptor subfamily B member 5,29820,0.0201110097881942,0.00485113732187733,0.0106027806373146,0.0296192389390738,3.39820182541285e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR3B,Low affinity immunoglobulin gamma Fc region receptor III-B,29508,-0.0141354787599849,0.00341106898544831,-0.0208211739714636,-0.0074497835485062,3.42247367614341e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDR1,Epithelial discoidin domain-containing receptor 1,29694,0.00669078048155236,0.00161533425645063,0.00352472533890913,0.00985683562419559,3.45180953058919e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC28A1,Sodium/nucleoside cotransporter 1,24016,0.0170795402577775,0.0041242973193881,0.00899591751177688,0.0251631630037782,3.46674299942105e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL58,"Peptidyl-tRNA hydrolase ICT1, mitochondrial",24867,0.0204270684881882,0.00494852915300886,0.0107279513482908,0.0301261856280856,3.67273610371858e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD7,T-cell antigen CD7,24177,0.0124996106243972,0.00303137043823172,0.00655812456546299,0.0184410966833313,3.74536439357129e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMOD4,Tropomodulin-4,24016,-0.0117439413494738,0.00284831537287632,-0.0173266394803114,-0.00616124321863624,3.75033969625985e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THBS2,Thrombospondin-2,29443,-0.0106549816370516,0.00259290940890131,-0.0157370840784981,-0.00557287919560498,3.97974737343904e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VIM,Vimentin,28916,0.0332209484046104,0.0080845184298997,0.017375292282007,0.0490666045272138,3.98116425308341e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA11,Serpin A11,29820,-0.0116162473773714,0.00283693227654808,-0.0171766346394057,-0.00605586011533719,4.23919399714766e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1A,Lithostathine-1-alpha,29353,-0.0138620438225298,0.00341026075408939,-0.020546154900545,-0.00717793274451457,4.81979149042548e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA1549,UPF0606 protein KIAA1549,24445,0.0195646102992978,0.00483573647441287,0.0100865668094486,0.029042653789147,5.22963330672234e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK5,Serine protease inhibitor Kazal-type 5,29443,-0.00950268550384482,0.00235006063340681,-0.0141088043453222,-0.00489656666236746,5.27725656758089e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTX1,Neuronal pentraxin-1,29443,0.0113879847038631,0.00281823938167659,0.00586423551577701,0.0169117338919492,5.34009451033878e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKCQ,Protein kinase C theta type,28931,0.0122093435516919,0.00302236471488472,0.00628550871051785,0.018133178392866,5.36655667017709e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYRO3,Tyrosine-protein kinase receptor TYRO3,29478,0.00792785397505047,0.00196404457157971,0.00407832661475423,0.0117773813353467,5.43929622214056e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHB6,Ephrin type-B receptor 6,29163,0.00891745525062316,0.0022124523112142,0.00458104872064332,0.013253861780603,5.57818017626498e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGBL1,Integrin beta-like protein 1,24938,0.0103876754304066,0.0025854800344819,0.00532013456282213,0.0154552162979912,5.89421119540523e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB39B,Ras-related protein Rab-39B,24111,0.0251877154050076,0.00627654664005271,0.0128856839905043,0.0374897468195109,6.01357272353691e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TERF1,Telomeric repeat-binding factor 1,24229,-0.00817576412371896,0.00203942181233197,-0.0121730308758896,-0.0041784973715483,6.11943223645601e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAVCR2,Hepatitis A virus cellular receptor 2,29443,-0.00970886674616763,0.00243782504971911,-0.0144870038436171,-0.00493072964871818,6.8331038553152e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLH1,Glutamate carboxypeptidase 2,24229,0.0293032742840856,0.00736664615774448,0.0148646478149064,0.0437419007532647,6.97489683937486e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBE2B,Ubiquitin-conjugating enzyme E2 B,24793,0.00789803139893588,0.00198588778148624,0.00400569134722285,0.0117903714506489,6.99652742171572e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACE,Angiotensin-converting enzyme,24951,-0.00722249832776244,0.00181700310881612,-0.010783824421042,-0.00366117223448284,7.05919626376125e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD200,OX-2 membrane glycoprotein,29434,-0.00730509234406721,0.00183826659198879,-0.0109080948643652,-0.00370208982376919,7.0873052469773e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF9,Tumor necrosis factor receptor superfamily member 9,29218,0.0115058638969564,0.0028973052187751,0.0058271456681572,0.0171845821257556,7.16739492204821e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD79B,B-cell antigen receptor complex-associated protein beta chain,29786,-0.0123007818220423,0.00310109288158169,-0.0183789238699424,-0.0062226397741422,7.30770560001997e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM8,Carcinoembryonic antigen-related cell adhesion molecule 8,28916,0.0133434134629276,0.00337324172976525,0.00673185967258776,0.0199549672532675,7.6504141979876e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BABAM1,BRISC and BRCA1-A complex member 1,24229,0.00805106666774696,0.00204340835716925,0.00404598628769523,0.0120561470477987,8.17038389317974e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMRK2,Nicotinamide riboside kinase 2,24016,-0.0113184643764337,0.00288705483856114,-0.0169770918600136,-0.00565983689285389,8.86406162589698e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALCB,Calcitonin gene-related peptide 2,24845,0.010912154903982,0.0027877136906544,0.00544823607029937,0.0163760737376646,9.08807735102576e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR158,Probable G-protein coupled receptor 158,24867,0.0097442380220277,0.0024895596904825,0.004864701028682,0.0146237750153734,9.1006201587289e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10RA,Interleukin-10 receptor subunit alpha,28931,0.0158047518758999,0.00403973431816826,0.0078868726122901,0.0237226311395097,9.16209352903442e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP1,Prolow-density lipoprotein receptor-related protein 1,29349,-0.00719645770488113,0.00183980330393591,-0.0108024721805955,-0.00359044322916674,9.19173429446531e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QSOX1,Sulfhydryl oxidase 1,24502,0.0115464553350279,0.0029589014402645,0.00574700851210945,0.0173459021579463,9.55465346064347e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF31,E3 ubiquitin-protein ligase RNF31,24229,0.00989424182654442,0.00254026457220443,0.00491532326502374,0.0148731603880651,9.84765971387061e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG1,Arginase-1,29216,0.0139773209711967,0.00359031739495332,0.00694029887708817,0.0210143430653052,9.92076335247724e-05
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3BGRL2,SH3 domain-binding glutamic acid-rich-like protein 2,24101,0.0166863264249641,0.00428919916843697,0.00827949605482767,0.0250931567951006,0.000100384128855436
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRT5,"NAD-dependent protein deacylase sirtuin-5, mitochondrial",28774,0.0145090508462885,0.00374034294253018,0.00717797867892936,0.0218401230136477,0.000105090123544468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,M6PR,Cation-dependent mannose-6-phosphate receptor,24240,0.0109427700901029,0.00282351553252721,0.00540867964634954,0.0164768605338562,0.000106649679235862
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC28A,Coiled-coil domain-containing protein 28A,24195,0.00798462015166804,0.00206484846380634,0.00393751716260762,0.0120317231407285,0.000110503381350701
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP152,Centrosomal protein of 152 kDa,24016,0.0111959904188182,0.00289812998740431,0.00551565564350577,0.0168763251941307,0.000112215606321379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP2,Guanylate-binding protein 2,28931,0.0160430009310956,0.00415712159903435,0.00789504259698825,0.0241909592652029,0.000114024067302202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSAP,Gamma-secretase-activating protein,28797,0.0231765205052734,0.00602787280833479,0.0113618898009372,0.0349911512096096,0.00012086492517851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR3,Transforming growth factor beta receptor type 3,29820,-0.00838913802556017,0.00219382346983044,-0.0126890320264278,-0.0040892440246925,0.000131581547435585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDI2,Protein DDI1 homolog 2,24381,0.0203172077210088,0.0053181211836005,0.00989369020115185,0.0307407252408658,0.000133580431059369
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACSL1,Long-chain-fatty-acid--CoA ligase 1,24111,-0.00996498377392612,0.00261667801274493,-0.0150936726789062,-0.00483629486894605,0.000140296351290619
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM25,Transmembrane protein 25,24867,-0.0119263724293826,0.00313728029667704,-0.0180754418108696,-0.00577730304789558,0.000144165800375851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGB3_CGB5_CGB8,Choriogonadotropin subunit beta 3,24951,0.0113751688896243,0.00299362319998383,0.00550766741765603,0.0172426703615927,0.000145156953441289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLVRB,Flavin reductase,29443,0.0170692381853097,0.00451077431659357,0.00822812052478632,0.0259103558458331,0.000154569058624089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN2,Contactin-2,29725,0.0116888407259829,0.00309237654954448,0.00562778268887568,0.0177498987630901,0.000157204756822286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPP2,Ectonucleotide pyrophosphatase/phosphodiesterase family member 2,29820,-0.00711148086246787,0.00188681927512539,-0.0108096466417136,-0.00341331508322211,0.000164198135046267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,QPCT,Glutaminyl-peptide cyclotransferase,29517,0.00702063330440855,0.0018643510136948,0.00336650531756674,0.0106747612912504,0.000166388679752972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF4,Tumor necrosis factor receptor superfamily member 4,29760,0.00991478137996841,0.00263696723492366,0.00474632559951804,0.0150832371604188,0.000170294046584837
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUK1,Guanylate kinase,24111,-0.0104682814692944,0.00278754030906278,-0.0159318604750574,-0.00500470246353134,0.000173483583656642
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COMP,Cartilage oligomeric matrix protein,29214,0.00874090742738333,0.00233119623027811,0.00417176281603823,0.0133100520387284,0.000177502806394449
NMR metabolomics,X23508.Triglycerides in Medium VLDL,F3,Tissue factor,29541,-0.00707999126408974,0.00189346839269594,-0.0107911893137738,-0.00336879321440571,0.000184980850698213
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUP50,Nuclear pore complex protein Nup50,24111,-0.00877970402091403,0.00234865496087309,-0.0133830677442253,-0.00417634029760276,0.000185782779074263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MELTF,Melanotransferrin,24922,0.00761955329167563,0.00205612018365306,0.00358955773171563,0.0116495488516356,0.00021118736694038
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUDT10,Diphosphoinositol polyphosphate phosphohydrolase 3-alpha,24240,-0.00669983167085648,0.001815617294631,-0.0102584415683332,-0.00314122177337971,0.000224645926886055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST7,Cystatin-F,29498,0.0237649267194992,0.00644302133108946,0.0111366049105639,0.0363932485284346,0.000226006864609686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSMR,Oncostatin-M-specific receptor subunit beta,29628,-0.00517044472196061,0.0014022336695727,-0.00791882271432311,-0.00242206672959811,0.000227058181674483
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAMDC2,MAM domain-containing protein 2,24922,-0.00886115916805722,0.00240558217358205,-0.013576100228278,-0.00414621810783641,0.000230465805101682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCC,Netrin receptor DCC,24195,0.00584625502473224,0.00158869623029058,0.0027324104133627,0.00896009963610178,0.000233825210122621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSC1,Hamartin,24229,0.019163847309039,0.00521407191511949,0.00894426635540479,0.0293834282626732,0.000237981072321671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRKAG3,5'-AMP-activated protein kinase subunit gamma-3,24195,-0.00809628783873301,0.00220398965720125,-0.0124161075668475,-0.00377646811061856,0.00023979574284232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH3,Cadherin-3,29694,0.00919636699033041,0.00250896470090869,0.00427879617654938,0.0141139378041114,0.000247379631559383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSM,Oncostatin-M,29293,0.0179882976480582,0.00492086339971895,0.00834340538460906,0.0276331899115073,0.000257113453591472
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WASL,Neural Wiskott-Aldrich syndrome protein,24229,-0.0154116786136773,0.00421931150013618,-0.0236815291539442,-0.0071418280734104,0.000260092602760732
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD3,Extracellular superoxide dismutase,24951,-0.0151340932169892,0.00415548053114832,-0.0232788350580399,-0.00698935137593851,0.000271118168399382
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLA2G1B,Phospholipase A2,29787,-0.0107786114372315,0.00298597310044997,-0.0166311187141134,-0.00492610416034954,0.000306996960216432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEDD9,Enhancer of filamentation 1,24229,0.00834299733140683,0.00231537637796438,0.00380485963059665,0.012881135032217,0.000314831204350324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGMA,Repulsive guidance molecule A,29694,-0.00784678218281928,0.00218101004727003,-0.0121215618754685,-0.00357200249017002,0.000321473353378169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME1,Nucleoside diphosphate kinase A,24229,-0.0054701262665759,0.00152134420214995,-0.00845196090278979,-0.00248829163036201,0.000324303551717255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FUT1,"Galactoside alpha-(1,2)-fucosyltransferase 1",24381,-0.0159683322664665,0.00444797349379468,-0.0246863603143041,-0.00725030421862895,0.000331296628815317
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDRG1,Protein NDRG1,28774,0.0167935059213299,0.00467897441430067,0.00762271606930054,0.0259642957733592,0.000332318891044043
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAUR,Urokinase plasminogen activator surface receptor,29278,-0.00684080659540682,0.00190615740775172,-0.0105768751146002,-0.00310473807621345,0.000332753443567589
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP164,Centrosomal protein of 164 kDa,28931,0.0156739955764256,0.00437545311253633,0.0070981074758544,0.0242498836769968,0.000341198078898585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17RA,Interleukin-17 receptor A,29443,0.0109005540434749,0.00305423334696854,0.00491425668341653,0.0168868514035332,0.000358918494210175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OPTC,Opticin,29349,-0.0111468884485603,0.00312804934868316,-0.0172778651719793,-0.0050159117251413,0.00036648545346792
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NECTIN4,Nectin-4,29566,-0.00788873124089453,0.00221537596858252,-0.0122308681393163,-0.00354659434247279,0.000370166898467863
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTXR,Neuronal pentraxin receptor,29478,0.00838191586783743,0.00235813884850645,0.00375996372476479,0.0130038680109101,0.000379345221162951
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOD2,"Superoxide dismutase [Mn], mitochondrial",29443,0.00925676574445822,0.00260763353107037,0.00414580402356029,0.0143677274653562,0.000386019018917269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDN1,Endothelin-1,24240,0.00719351072143433,0.00202660171121912,0.00322137136744485,0.0111656500754238,0.000386630415587339
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMNB1,Lamin-B1,24756,0.014477930158938,0.00408067943143161,0.00647979847333209,0.022476061844544,0.000389002481267526
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TTN,Titin,24111,-0.0165461644797483,0.00466754484297142,-0.0256945523719723,-0.00739777658752435,0.000393446890610884
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP6,Dipeptidyl aminopeptidase-like protein 6,29349,-0.00820016362863149,0.00232270447074604,-0.0127526643912937,-0.00364766286596926,0.000415508179693432
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD86,T-lymphocyte activation antigen CD86,24805,0.00733551702467677,0.00207780000579861,0.0032630290133115,0.0114080050360421,0.000415644873181305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARTN,Artemin,28931,0.0109375432234725,0.00310542408632315,0.00485091201427909,0.0170241744326658,0.000428839124752148
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE1,Ribonuclease pancreatic,24951,0.00594535507270343,0.00169129313771011,0.00263042052279161,0.00926028962261524,0.000440083303272466
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PEAR1,Platelet endothelial aggregation receptor 1,29820,0.00550850762691028,0.00157547324348474,0.00242058006968019,0.00859643518414037,0.000472241215477856
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN2,Neuroligin-2,24101,-0.0115331526309395,0.00330229838746359,-0.0180056574703681,-0.00506064779151084,0.000479446877340668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM19,Probable RNA-binding protein 19,24111,-0.0116093253546092,0.00332580118103952,-0.0181278956694466,-0.00509075503977174,0.000482644814976376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP290,Centrosomal protein of 290 kDa,24445,0.0128563102562349,0.00368609492006268,0.00563156421291207,0.0200810562995578,0.000487894013522855
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPS16,"28S ribosomal protein S16, mitochondrial",24229,0.00705004219018959,0.00202484056800688,0.00308135467689612,0.0110187297034831,0.000498977235229862
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLRC1,NKG2-A/NKG2-B type II integral membrane protein,24101,-0.0148424485276638,0.00426524869953805,-0.0232023359787584,-0.00648256107656923,0.000502571639721689
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD8,Ly6/PLAUR domain-containing protein 8,28797,0.012427277105366,0.0035856665453675,0.00539937067644567,0.0194551835342863,0.000529386239339008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1R,Macrophage colony-stimulating factor 1 receptor,24951,0.00963284535335043,0.0027794685190671,0.00418508705597892,0.0150806036507219,0.000529713365983573
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENO1,Alpha-enolase,29392,0.0189399697251298,0.00546561931788524,0.00822735586207473,0.0296525835881849,0.000530410921081131
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GKN1,Gastrokine-1,28114,0.006748349636891,0.0019502507567976,0.0029258581535677,0.0105708411202143,0.000540480663968999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLN,Mesothelin,29293,0.013356123131006,0.00387903475847369,0.00575321500439753,0.0209590312576144,0.000575770721605288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHI3L1,Chitinase-3-like protein 1,28935,0.0187533668327628,0.00545366460714296,0.00806418420276258,0.029442549462763,0.000585397290178092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBFOX3,RNA binding protein fox-1 homolog 3,24867,0.00918381257267706,0.00267123846053117,0.00394818519003597,0.0144194399553181,0.000586910841224531
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAPRT,Nicotinate phosphoribosyltransferase,24845,0.00791404249681141,0.00230727533690214,0.00339178283648321,0.0124363021571396,0.000604477302211276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SH3GL3,Endophilin-A3,24307,0.0199466823084429,0.00581876117457626,0.00854191040627347,0.0313514542106124,0.000609065444679092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOM1,Myomesin-1,24101,0.0113380095998168,0.00331497090340408,0.00484066662914481,0.0178353525704888,0.000626687052225483
NMR metabolomics,X23508.Triglycerides in Medium VLDL,METAP1,Methionine aminopeptidase 1,28774,0.00704073376005446,0.00207512568520745,0.00297348741704786,0.0111079801030611,0.000692452298427607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNLIPRP2,Pancreatic lipase-related protein 2,29454,0.0693647287562875,0.0204567039565236,0.0292695890015012,0.109459868511074,0.000697787677533084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSTN1,Calsyntenin-1,28774,0.0121469825276179,0.00358412512356493,0.00512209728543067,0.0191718677698052,0.000702148214826367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLIN3,Perilipin-3,29478,0.00998683830465728,0.00294724451445271,0.00421023905632996,0.0157634375529846,0.000703593023968314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLT8D2,Glycosyltransferase 8 domain-containing protein 2,28774,0.0111601240518925,0.00329574682186956,0.00470046028102813,0.0176197878227568,0.000709573311591859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACADM,"Medium-chain specific acyl-CoA dehydrogenase, mitochondrial",24445,0.0165353998453598,0.00489218153949913,0.0069467240279415,0.0261240756627781,0.00072608594535351
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA2,GDNF family receptor alpha-2,29349,0.00492680154220165,0.00145795724331392,0.00206920534530638,0.00778439773909693,0.00072778569655779
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CUZD1,CUB and zona pellucida-like domain-containing protein 1,24195,0.00888142610409961,0.0026426522443701,0.00370182770513421,0.014061024503065,0.000778372886402936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RECK,Reversion-inducing cysteine-rich protein with Kazal motifs,24240,-0.00488957698715843,0.00145826060901023,-0.00774776778081849,-0.00203138619349837,0.000800573312551645
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B3,Sodium/potassium-transporting ATPase subunit beta-3,24111,-0.00934717367320917,0.00278997454771082,-0.0148155237867224,-0.00387882355969596,0.00080856141225875
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2B,Sodium channel subunit beta-2,24195,-0.00673862063651664,0.00201185438552461,-0.0106818552321449,-0.00279538604088841,0.000810937223988377
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPTP,Ceramide-1-phosphate transfer protein,24111,-0.00926830719971859,0.00276771116154508,-0.0146930210763469,-0.00384359332309024,0.000813083334109044
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100G,Protein S100-G,24867,-0.0107876273258953,0.00322441833525055,-0.0171074872629864,-0.00446776738880422,0.000822250673978992
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCTPP1,dCTP pyrophosphatase 1,29478,0.00736039161260757,0.00220059631255674,0.00304722283999636,0.0116735603852188,0.000824666497018156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLL1,Delta-like protein 1,29566,-0.00692951436434705,0.00207211798024721,-0.0109908656056316,-0.00286816312306253,0.000826317879615691
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB104A_DEFB104B,Beta-defensin 104,24101,0.013052905550819,0.003910807751575,0.00538772235773201,0.020718088743906,0.000846181787305742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRAL,GDNF family receptor alpha-like,24025,-0.0143381337692864,0.00435325629260201,-0.0228705161027863,-0.00580575143578644,0.000990360382668714
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGF2BP3,Insulin-like growth factor 2 mRNA-binding protein 3,24111,0.0104116614872044,0.00318388103595587,0.00417125465673091,0.0166520683176779,0.00107654089072117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCL28,C-C motif chemokine 28,29327,0.0133987018065382,0.00410674692182437,0.00534947783976246,0.021447925773314,0.00110518681637974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC1,"Myosin-binding protein C, slow-type",24922,-0.0157645670275961,0.00484852523234833,-0.0252676764829988,-0.00626145757219337,0.00114984763598336
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLMP,CXADR-like membrane protein,29725,0.00477147851844659,0.00146758882527436,0.00189500442090885,0.00764795261598432,0.00115032167621567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYO6,Unconventional myosin-VI,24867,0.00841579917672548,0.00259404057730313,0.00333147964521135,0.0135001187082396,0.00117902662806155
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GGA1,ADP-ribosylation factor-binding protein GGA1,28774,0.0153174417670328,0.00472447295391722,0.00605747477735508,0.0245774087567106,0.0011876738844977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD1,26S proteasome non-ATPase regulatory subunit 1,24867,0.0109771380229396,0.00338744853937047,0.00433773888577348,0.0176165371601057,0.00119463500419468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTHFD2,"Bifunctional methylenetetrahydrofolate dehydrogenase/cyclohydrolase, mitochondrial",24845,-0.00577894133325293,0.00178413899756779,-0.0092758537684858,-0.00228202889802006,0.00120080071585782
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL2,Protein kinase C-binding protein NELL2,29581,0.00640577326267376,0.00197936920148765,0.00252620962775797,0.0102853368975896,0.00121236006987725
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAG,S-arrestin,24101,-0.0118656139854735,0.00366913798010078,-0.0190571244264711,-0.004674103544476,0.00122278022498011
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCND2,G1/S-specific cyclin-D2,24445,0.00827363658218097,0.00255917635188897,0.00325765093247858,0.0132896222318834,0.00122690372069121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM5,Carcinoembryonic antigen-related cell adhesion molecule 5,28393,0.014305411410983,0.00443344559547309,0.00561585804385578,0.0229949647781103,0.0012536744352941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1H,Voltage-dependent T-type calcium channel subunit alpha-1H,24111,-0.013112229088926,0.00407550820866962,-0.0211002251779184,-0.00512423299993353,0.00129563487496169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH7B,Myosin-7B,24016,-0.00987953457194968,0.00308371792435124,-0.0159236217036781,-0.00383544744022125,0.00135816159530908
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPK13,Mitogen-activated protein kinase 13,24016,0.00939672246791567,0.00293751539834872,0.00363919228715219,0.0151542526486791,0.00138147744020736
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCP2,Non-specific lipid-transfer protein,28797,0.0168986364374918,0.00528347127532668,0.00654303273785151,0.0272542401371321,0.00138343654969682
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPS,Calcyphosin,24845,0.0210031778550092,0.00657812522868619,0.00811005240678425,0.0338963033032341,0.00141036078048047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AOC1,Amiloride-sensitive amine oxidase [copper-containing],28931,0.0122796452600406,0.00386263240440171,0.00470888574741321,0.0198504047726679,0.00147895275569905
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPESP1,Sperm equatorial segment protein 1,24922,0.00669357147598554,0.00210817499321111,0.00256154848929175,0.0108255944626793,0.00149990497637891
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK11,Kallikrein-11,29296,0.00678175558636387,0.0021383765720131,0.0025905375052182,0.0109729736675095,0.00151836089604994
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAT1,Diamine acetyltransferase 1,24111,-0.0110852803401121,0.00350472565798616,-0.0179545426297649,-0.00421601805045921,0.00156371666654813
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPR101,Probable G-protein coupled receptor 101,24101,-0.0135394955842175,0.00428326049086955,-0.0219346861463218,-0.00514430502211318,0.00157409458530376
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC12A2,Solute carrier family 12 member 2,24111,-0.00605690007585654,0.00191628957571604,-0.00981282764425998,-0.00230097250745311,0.00157561699228459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HCG22,Protein PBMUCL2,24111,-0.0121440696653638,0.00385407476758071,-0.019698056209822,-0.00459008312090557,0.00162928942789055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAP,Gamma-aminobutyric acid receptor-associated protein,24793,0.0107750444897162,0.00342587626867049,0.00406032700312207,0.0174897619763104,0.00166173061583513
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHPK,Sedoheptulokinase,24445,-0.00902853717120342,0.00288270028239262,-0.014678629724693,-0.00337844461771389,0.00173841259090019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX9,Transcription factor SOX-9,24195,0.00592752332791544,0.00189772562099444,0.00220798111076634,0.00964706554506454,0.00178932131801274
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFA1_DEFA1B,Neutrophil defensin 1,28862,0.0113178627076754,0.00363772406128555,0.00418792354755576,0.0184478018677951,0.00186479964312668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD55,Complement decay-accelerating factor,28490,0.00566418838243572,0.00182134717088106,0.00209434792750884,0.0092340288373626,0.00187342023790936
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBQ1,Hemoglobin subunit theta-1,29725,-0.0129530375993899,0.00416844121693815,-0.0211231823845887,-0.00478289281419113,0.0018891520091761
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF1A,Tumor necrosis factor receptor superfamily member 1A,29443,0.00638970740307536,0.00206892774289015,0.00233460902701066,0.0104448057791401,0.0020141455862864
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAYN,Layilin,29163,-0.00748657622584286,0.00242515052883158,-0.0122398712623528,-0.00273328118933296,0.00202338950005084
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPO,Erythropoietin,29434,0.0162098049335052,0.00525785920929691,0.00590440088328324,0.0265152089837271,0.00205137653331868
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNPT1,"Polyribonucleotide nucleotidyltransferase 1, mitochondrial",28931,0.0252315969460761,0.0081856446022127,0.0091877335257392,0.041275460366413,0.00205517820812974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM1,V-set and transmembrane domain-containing protein 1,28774,0.0105441532293788,0.00342123291522265,0.00383853671554245,0.0172497697432152,0.00205826671779893
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM9,Disintegrin and metalloproteinase domain-containing protein 9,24805,-0.00645330133352979,0.00209525068305196,-0.0105599926723116,-0.00234660999474795,0.00207250525520852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NBL1,Neuroblastoma suppressor of tumorigenicity 1,29566,0.00574638214834494,0.00186786965496019,0.00208535762462297,0.00940740667206692,0.00209682426542153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHISA5,Protein shisa-5,24938,0.00540556810640287,0.00175746026031554,0.00196094599618442,0.00885019021662132,0.00210177189760553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PON1,Serum paraoxonase/arylesterase 1,24951,-0.00561784854305243,0.00183442875415457,-0.00921332890119538,-0.00202236818490948,0.00219766059490393
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ELAVL4,ELAV-like protein 4,24101,0.0179773827966506,0.00588294322695294,0.00644681407182288,0.0295079515214784,0.00224670170644072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSPG5,Chondroitin sulfate proteoglycan 5,24101,-0.0105659278784525,0.00347422093149477,-0.0173754009041823,-0.00375645485272277,0.00235861848483619
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANEAL,"Glycoprotein endo-alpha-1,2-mannosidase-like protein",24016,0.0107498418756411,0.00355110826783275,0.00378966967068895,0.0177100140805933,0.00247109181620157
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ICAM2,Intercellular adhesion molecule 2,29820,-0.00666923127493294,0.00220625951879795,-0.0109934999317769,-0.00234496261808895,0.00250604162329071
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL2,Kin of IRRE-like protein 2,28774,0.00837920335930373,0.00277340567294946,0.0029433282403228,0.0138150784782847,0.00251939187087613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PNMA2,Paraneoplastic antigen Ma2,24101,0.00920332234741044,0.00304674569697448,0.00323170078134046,0.0151749439134804,0.00252450708401952
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRXN3,Neurexin-3,24195,0.00738617553920951,0.0024517429087354,0.00258075943808812,0.0121915916403309,0.00259268873540582
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRTN,Neurturin,28931,0.0103109096999369,0.00343002693591374,0.00358805690554594,0.0170337624943278,0.00264872947801649
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRTN3,Myeloblastin,28671,-0.00989067728613345,0.00329279969021348,-0.0163445646789519,-0.00343678989331502,0.00266923176966198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCAR2,Cell cycle and apoptosis regulator protein 2,24845,0.0116732681105529,0.00388724252900129,0.00405427275371037,0.0192922634673954,0.00267625974077446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ID4,DNA-binding protein inhibitor ID-4,24445,-0.00910600736185269,0.00304761651952326,-0.0150793357401183,-0.00313267898358711,0.00281170240580466
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAN,Brevican core protein,29218,0.00703874585880407,0.00235822380837808,0.00241662719438302,0.0116608645232251,0.00284030413455098
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMBN,Ameloblastin,28931,-0.0059046429346278,0.00198351590132433,-0.0097923341012235,-0.00201695176803211,0.00291461058035545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK15,Kallikrein-15,24754,0.0106718280817371,0.00359209627528054,0.00363131938218729,0.017712336781287,0.00297195076226812
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRLB,Fc receptor-like B,28797,0.01253481898594,0.00424626866886908,0.00421213239495665,0.0208575055769234,0.00316017682567448
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA4,Leukocyte immunoglobulin-like receptor subfamily A member 4,24111,-0.0104030166809232,0.00353122987008284,-0.0173242272262856,-0.00348180613556087,0.00322216374854054
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYBPC2,"Myosin-binding protein C, fast-type",24240,-0.0173624813860267,0.00590261606896309,-0.0289316088811943,-0.00579335389085902,0.00326947317390463
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN2,Transcobalamin-2,29757,-0.00611145563481201,0.00207910976867551,-0.010186510781416,-0.00203640048820801,0.00329039690743626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TYMP,Thymidine phosphorylase,29301,0.0135187774205677,0.00460611142111973,0.00449079903517304,0.0225467558059624,0.00333843929916502
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK2B,Divergent protein kinase domain 2B,24381,0.005717606725801,0.00195574636456135,0.00188434385126075,0.00955086960034125,0.00346448766425422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF1,Signaling lymphocytic activation molecule,28931,-0.0120155912549415,0.00412840752909824,-0.020107270011974,-0.00392391249790891,0.00361165070625521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA6C,Semaphorin-6C,24229,0.00529259691683569,0.00181977501998307,0.00172583787766887,0.00885935595600252,0.00363636870440519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSRP3,Cysteine and glycine-rich protein 3,24111,-0.0199135135727934,0.00684859440638901,-0.0333367586093158,-0.0064902685362709,0.00364454119398218
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FRMD7,FERM domain-containing protein 7,24195,0.00676393657959994,0.00233053052037694,0.00219609675966115,0.0113317763995387,0.00370748854159019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRC1,Macrophage mannose receptor 1,24951,0.00568699854497577,0.00196475516179009,0.00183607842786721,0.00953791866208434,0.00380083092101233
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPON1,Spondin-1,29497,0.00658170389553564,0.00227541890018357,0.00212188285117584,0.0110415249398954,0.00382439463140247
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRG3,Proteoglycan 3,24938,-0.0100109517865544,0.00346559363971126,-0.0168035153203884,-0.00321838825272032,0.00387209625777888
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REXO2,"Oligoribonuclease, mitochondrial",24111,-0.00959475002821944,0.00332422687547114,-0.0161102347041429,-0.00307926535229601,0.0039013388915668
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTRC,Chymotrypsin-C,29456,0.0127645799826911,0.00442528590705108,0.00409101960487101,0.0214381403605112,0.00392364300187768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKMT1A_CKMT1B,"Creatine kinase U-type, mitochondrial",29365,-0.0133135894261473,0.00462825732163376,-0.0223849737765494,-0.00424220507574511,0.00402289617511834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA7A,Semaphorin-7A,29736,0.00549178597021556,0.00191580883048701,0.00173680066246103,0.0092467712779701,0.00415247470810674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH23,Cadherin-23,24845,-0.00527511174289097,0.00184194860535987,-0.00888533100939632,-0.00166489247638562,0.00418842873186745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSBPL2,Oxysterol-binding protein-related protein 2,24845,0.00777576112178055,0.00271795743636432,0.00244856454650649,0.0131029576970546,0.00422814091773314
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FABP1,"Fatty acid-binding protein, liver",29454,0.0185794090431441,0.00651104307422143,0.00581776461767004,0.0313410534686181,0.00432675950123156
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNGR1,Interferon gamma receptor 1,29581,0.00415775292874774,0.00145755633973555,0.00130094250286607,0.00701456335462941,0.00434000115944488
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HYAL1,Hyaluronidase-1,29265,0.00454395029137267,0.00159445164731558,0.00141882506263414,0.0076690755201112,0.00437702138442803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RYR1,Ryanodine receptor 1,24111,-0.00674814063737,0.00237166928300408,-0.011396612432058,-0.002099668842682,0.00444052601033611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIF1L,Allograft inflammatory factor 1-like,24240,0.0113237019067381,0.00397999647287162,0.00352290881990975,0.0191244949935665,0.00444272129183029
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYH4,Myosin-4,24111,-0.00922977571441796,0.00324585758685002,-0.015591656584644,-0.00286789484419193,0.00446507931090171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNXB,Tenascin-X,29443,-0.00506613379701321,0.0017897181858589,-0.00857398144129664,-0.00155828615272977,0.00464794802574767
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MANSC4,MANSC domain-containing protein 4,24111,0.0130850756520271,0.00462816312177268,0.0040138759333526,0.0221562753707015,0.00469851289902452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDA1,DET1- and DDB1-associated protein 1,24111,0.00784932900651865,0.00277698327938009,0.00240644177893368,0.0132922162341036,0.00470886506948851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENTPD6,Ectonucleoside triphosphate diphosphohydrolase 6,28916,0.00531757419474233,0.00189157263337263,0.00161009183333197,0.00902505655615269,0.0049391512206719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNL1,Thioredoxin-like protein 1,24069,0.0191314125771342,0.00681966914879384,0.00576486104549828,0.0324979641087701,0.00503056547092382
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGF,Beta-nerve growth factor,29218,0.00236489772921984,0.000843785013371095,0.00071107910301249,0.00401871635542718,0.00507061703086389
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B4,Protein ATP1B4,24016,-0.00817736979794067,0.00292258015932862,-0.0139056269102248,-0.00244911268565657,0.00514615993083876
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MN1,Transcriptional activator MN1,24195,-0.0114706715363744,0.00411473817555327,-0.0195355583604588,-0.00340578471228995,0.00531244691353613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VCPKMT,Protein-lysine methyltransferase METTL21D,24016,0.0166740179985089,0.00601179933047854,0.00489089131077098,0.0284571446862469,0.00554913496632292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPN1,Epsin-1,24445,0.00838533932284762,0.00303570111320741,0.00243536514096109,0.0143353135047341,0.00574489153884652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEFL,Neurofilament light polypeptide,28674,0.0085773624806187,0.00310916366780811,0.0024834016917148,0.0146713232695226,0.00580621429220164
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYLPF,"Myosin regulatory light chain 2, skeletal muscle isoform",24195,-0.00939132322165909,0.00340457749159225,-0.0160642951051799,-0.00271835133813828,0.00581215745947524
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DRAXIN,Draxin,29218,0.0081945728934837,0.00297602808468758,0.00236155784749604,0.0140275879394714,0.00589933951265883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL52,"39S ribosomal protein L52, mitochondrial",23975,0.00493283596398798,0.00179535592695863,0.00141393834714906,0.00845173358082689,0.00600866437270439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GBP6,Guanylate-binding protein 6,24111,-0.00878379664378193,0.00320754255127994,-0.0150705800442906,-0.00249701324327325,0.00617689267165161
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAIP2B,Polyadenylate-binding protein-interacting protein 2B,23970,-0.00994704023467829,0.00364107066889813,-0.0170835387457186,-0.00281054172363796,0.00630164110428872
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD5,Sushi domain-containing protein 5,24273,-0.0064795519207959,0.00238231542277767,-0.0111488901494401,-0.00181021369215167,0.00653570927254237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IVD,"Isovaleryl-CoA dehydrogenase, mitochondrial",28774,0.0094075030475435,0.00347520294021178,0.00259610528472841,0.0162189008103586,0.00679267639595908
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRTAM,Cytotoxic and regulatory T-cell molecule,29218,-0.00952647910383417,0.00352138704878703,-0.0164283977194567,-0.0026245604882116,0.00682781863617303
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1B,5-hydroxytryptamine receptor 1B,24101,-0.00806853465314361,0.00298760623858282,-0.0139242428807659,-0.00221282642552127,0.00692486043297958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADRA2A,Alpha-2A adrenergic receptor,24111,-0.0132687065798337,0.00491438111034213,-0.0229008935561042,-0.00363651960356309,0.00693930760945437
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRNN,Cornulin,28580,0.0125053560359418,0.0046369030818358,0.00341702599554362,0.0215936860763399,0.00700251529799232
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR4,Toll-like receptor 4,24229,0.00530052294186337,0.00197000525364159,0.00143931264472586,0.00916173323900088,0.00713696787668633
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB5,Integrin beta-5,29566,0.00699710661692892,0.00261211561349135,0.00187736001448588,0.012116853219372,0.00739467239516491
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL14,C-X-C motif chemokine 14,28931,0.0110185689923167,0.00412967221634513,0.00292441144828025,0.0191127265363532,0.00763135967845074
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRHR1,Corticotropin-releasing factor receptor 1,28916,0.0112917694874629,0.00423609046751692,0.00298903217112971,0.0195945068037961,0.00768912713111313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSIG10L,V-set and immunoglobulin domain-containing protein 10-like,24111,-0.00623602756654202,0.00234040802395915,-0.010823227293502,-0.00164882783958208,0.00771531829478585
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTA2,"Actin, aortic smooth muscle",28916,-0.00803563267488033,0.00302174066443852,-0.0139582443771798,-0.00211302097258083,0.00783526980099245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUSP29,Dual specificity phosphatase 29,24195,-0.0123385501613954,0.00464503952567523,-0.0214428276317189,-0.00323427269107199,0.00790585879266484
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DYNC1H1,Cytoplasmic dynein 1 heavy chain 1,24793,0.00868958694363076,0.00329218087498185,0.00223691242866633,0.0151422614585952,0.0083089665620379
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TJP3,Tight junction protein ZO-3,24101,-0.00783768870794091,0.00297670985867931,-0.0136720400309523,-0.00200333738492947,0.00846873991097995
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD99,CD99 antigen,29443,-0.00358918396810223,0.00136358852833392,-0.00626181748363672,-0.000916550452567745,0.00848880301580151
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPM1B,Protein phosphatase 1B,24229,0.0114289073968326,0.00434244059528451,0.002917723830075,0.0199400909635903,0.00849604989622311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNN,Tenascin-N,24938,0.00794447319972703,0.00301942175487526,0.00202640656017152,0.0138625398392825,0.00851553344690814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NINJ1,Ninjurin-1,28797,0.0100916842138019,0.00383829961079507,0.00256861697664353,0.0176147514509602,0.00856297316254525
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KEL,Kell blood group glycoprotein,28774,0.00654062135361389,0.00249016577929745,0.00165989642619089,0.0114213462810369,0.00862932513248411
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17A,Interleukin-17A,28879,-0.00775334690154126,0.00296345626503979,-0.0135617211810193,-0.00194497262206327,0.00889297629865322
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SULT1A1,Sulfotransferase 1A1,29694,-0.0231126101188149,0.00889578892913745,-0.0405483564199243,-0.00567686381770547,0.009377335039479
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL4,Myosin light chain 4,24240,-0.00937523860825591,0.00361438803766973,-0.0164594391620886,-0.00229103805442323,0.00949605448511706
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CKAP4,Cytoskeleton-associated protein 4,29678,0.00487448805235029,0.00188288662960899,0.00118403025831667,0.00856494584638392,0.00963474437127622
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL22,Interleukin-22,24793,-0.0121125638436643,0.00469490655340541,-0.0213145806883389,-0.00291054699898968,0.00988753289411329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL1,Killer cell immunoglobulin-like receptor 3DL1,28797,0.021990593400017,0.00855613208747216,0.00522057450857156,0.0387606122914624,0.010170258450428
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH17,Cadherin-17,29478,-0.0120900408526221,0.00470643331810259,-0.0213146501561031,-0.00286543154914098,0.0102090415950017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THAP12,52 kDa repressor of the inhibitor of the protein kinase,23970,0.0156624426802268,0.00609801819781383,0.00371032701251174,0.0276145583479419,0.0102215059354195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF5,Fibroblast growth factor 5,28931,-0.00589857936372646,0.00229669200656232,-0.0104000956965886,-0.0013970630308643,0.0102250292824902
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15,Interleukin-15,29434,0.00583471486537372,0.00227272750436232,0.00138016895682358,0.0102892607739239,0.0102550460334551
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QBP,"Complement component 1 Q subcomponent-binding protein, mitochondrial",24867,0.012130299096524,0.00473368462661614,0.00285227722835637,0.0214083209646916,0.0103965276723239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TG,Thyroglobulin,24793,-0.0198595141906665,0.00775154300391205,-0.0350525384783341,-0.0046664899029989,0.0104127552298662
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP112,Centrosomal protein of 112 kDa,24111,0.00816433032642367,0.00318760446577908,0.00191662557349667,0.0144120350793507,0.0104349208744075
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX39A,ATP-dependent RNA helicase DDX39A,24229,0.00414262478684094,0.00162141953066535,0.000964642506736851,0.00732060706694503,0.0106267604169677
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAD51,DNA repair protein RAD51 homolog 1,24445,0.00946716393010455,0.00370965700758408,0.00219623619523975,0.0167380916649693,0.0107156952759595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INHBB,Inhibin beta B chain,24381,0.00916345258977643,0.00359977388712423,0.00210789577101293,0.0162190094085399,0.0109162609571514
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6,Seizure protein 6 homolog,24195,-0.00552404418833285,0.00217012657829456,-0.00977749228179019,-0.00127059609487551,0.0109184768633547
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFIT1,Interferon-induced protein with tetratricopeptide repeats 1,24445,0.00923554360558399,0.00363070237777581,0.0021193669451434,0.0163517202660246,0.0109735408959443
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTO1,Protein LTO1 homolog,28931,0.00721353201491507,0.00285565328629635,0.00161645157377423,0.0128106124560559,0.0115404955912174
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNASE10,Inactive ribonuclease-like protein 10,24240,-0.00835397471951441,0.0033396399602838,-0.0148996690416707,-0.00180828039735816,0.0123747965481207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTK7,Inactive tyrosine-protein kinase 7,28774,0.00664393071356504,0.00266502042139191,0.0014204906876369,0.0118673707394932,0.012671997030855
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTSV,Cathepsin L2,29618,0.00715639446644572,0.00287225197949974,0.00152678058662624,0.0127860083462652,0.0127236997902267
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK3,Prostate-specific antigen,24938,-0.0153818455944052,0.00617478688396387,-0.0274844278869744,-0.00327926330183599,0.0127422452565616
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTNNA1,Catenin alpha-1,24101,-0.00607379881812223,0.00244132554365941,-0.0108587968836947,-0.00128880075254979,0.0128563242175928
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL11,Interleukin-11,28931,0.0107613999223888,0.00433101936099834,0.00227260197483204,0.0192501978699455,0.0129707012757975
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL15RA,Interleukin-15 receptor subunit alpha,28931,0.00604770581520885,0.00244014072811339,0.00126502998810661,0.0108303816423111,0.0132020463873332
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DTX2,Probable E3 ubiquitin-protein ligase DTX2,24195,-0.0108439090031203,0.00437899908189855,-0.0194267472036414,-0.00226107080259911,0.0132803442662489
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB3GAP1,Rab3 GTPase-activating protein catalytic subunit,24101,0.00992170596987832,0.00401783122245172,0.00204675677387295,0.0177966551658837,0.0135401733530396
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS1,"Nitric oxide synthase, brain",28774,-0.00926730844852251,0.00375676247192276,-0.0166305628934911,-0.00190405400355391,0.0136371469825323
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TUBB3,Tubulin beta-3 chain,24101,-0.00480815147381538,0.00195485620765587,-0.00863966964082089,-0.000976633306809878,0.0139164235032268
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLSPN,Claspin,28719,0.00592790552845203,0.0024106242082604,0.00120308208026165,0.0106527289766424,0.0139354110762661
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEF,Thyrotroph embryonic factor,24111,0.00730089712329143,0.00297886533345664,0.00146232106971641,0.0131394731768664,0.0142570595334505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC1A,C-type lectin domain family 1 member A,28916,-0.00568913913874341,0.00232263082760623,-0.0102414955608516,-0.00113678271663519,0.0143138448992019
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT1,Vascular endothelial growth factor receptor 1,29288,0.00381509101292238,0.00155774016128422,0.000761920296805316,0.00686826172903944,0.0143264331465671
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA5,Leukocyte immunoglobulin-like receptor subfamily A member 5,29433,0.00543981990416824,0.00222122597478941,0.00108621699358101,0.00979342281475547,0.014330465800254
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF9,Fibroblast growth factor 9,23970,0.00693790675008128,0.00283684131711448,0.0013776977685369,0.0124981157316257,0.0144664752663299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALDH2,"Aldehyde dehydrogenase, mitochondrial",24793,0.00879004126145854,0.00360280829707608,0.00172853699918942,0.0158515455237276,0.0147033784848787
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTBR,Tumor necrosis factor receptor superfamily member 3,29326,-0.00480331611026556,0.00197367759817187,-0.00867172420268243,-0.000934908017848688,0.014951791830015
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTTG1,Securin,24445,0.00698028469707157,0.00287428306117335,0.00134668989717181,0.0126138794969713,0.015167308063022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRND,Prion-like protein doppel,24845,-0.00868564378764959,0.00357839087670677,-0.0156992899059949,-0.00167199766930432,0.0152208957723777
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNG,Uracil-DNA glycosylase,24793,0.00578426952303306,0.00239002607134472,0.00109981842319742,0.0104687206228687,0.0155203945738576
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRDX2,Peroxiredoxin-2,24556,0.0103349258563643,0.00427777938405026,0.0019504782636258,0.0187193734491028,0.0157012195148302
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CST6,Cystatin-M,28830,0.00817660530670532,0.00338526656914279,0.00154148283118545,0.0148117277822252,0.0157262559370597
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OTOA,Otoancorin,24101,-0.00899345076016152,0.00373269524215844,-0.0163095334347921,-0.00167736808553098,0.015987460660517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC10,Sialic acid-binding Ig-like lectin 10,29434,0.00566803405504548,0.00235452243705539,0.00105317007841691,0.0102828980316741,0.0160772259669374
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RALB,Ras-related protein Ral-B,24229,0.00492958025056462,0.00205392012139239,0.000903896812635534,0.0089552636884937,0.0163988243114365
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WIF1,Wnt inhibitory factor 1,29725,-0.00565447305102379,0.00236056556287817,-0.010281181554265,-0.00102776454778257,0.0166088859710503
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL2,Killer cell immunoglobulin-like receptor 2DL2,24793,-0.0144066432955482,0.00603187072224275,-0.026229109911144,-0.00258417667995237,0.0169284119377407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMC3,26S proteasome regulatory subunit 6A,24016,-0.00500850768112626,0.00210293079509359,-0.00913025203950969,-0.000886763322742825,0.0172416240038237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA3,Leukocyte immunoglobulin-like receptor subfamily A member 3,24938,-0.0227792696917707,0.00957572239098644,-0.0415476855781041,-0.00401085380543727,0.0173739197647567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC12A,C-type lectin domain family 12 member A,24229,0.00336826009524192,0.00141644423935009,0.000592029386115749,0.00614449080436809,0.0174160161199911
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANP32C,Acidic leucine-rich nuclear phosphoprotein 32 family member C,24240,-0.00664012346762654,0.00279606129674588,-0.0121204036092485,-0.00115984332600462,0.0175655703651891
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY6D,Lymphocyte antigen 6D,29283,0.00629241898321055,0.00266219853612795,0.00107450985239978,0.0115103281140213,0.0181039833917171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM3D,Protein FAM3D,24805,0.0137911368871902,0.00586815467144039,0.00228955373116701,0.0252927200432133,0.0187728412821773
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYB5A,Cytochrome b5,24016,0.0117914751505486,0.00502367510172898,0.00194507195115981,0.0216378783499374,0.0189241393018478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK1,Kallikrein-1,29199,-0.0206757776411441,0.00883829756581381,-0.0379988408701391,-0.003352714412149,0.0193245832593005
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GATA3,Trans-acting T-cell-specific transcription factor GATA-3,24016,0.00430268555746808,0.00184387108776142,0.000688698225455694,0.00791667288948046,0.0196297792704025
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRAF3IP2,E3 ubiquitin ligase TRAF3IP2,24111,-0.00775893064782026,0.00332850540583224,-0.0142828012432514,-0.00123506005238907,0.0197586403415039
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNW1,Interferon omega-1,24111,-0.00582027083504449,0.00250597312650902,-0.0107319781630022,-0.000908563507086802,0.0202111330262227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MKI67,Proliferation marker protein Ki-67,24229,0.00629402258946842,0.00271066795472448,0.000981113398208442,0.0116069317807284,0.0202441353340477
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRA6,Leukocyte immunoglobulin-like receptor subfamily A member 6,24922,0.0118824428142139,0.00512934008428425,0.00182893624901675,0.021935949379411,0.02053558542997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACHE,Acetylcholinesterase,24381,0.00531047722064168,0.00229344201599963,0.000815330869282411,0.00980562357200095,0.0205935546306882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIF20B,Kinesin-like protein KIF20B,24101,0.0122652840119334,0.005316225865598,0.00184548131536132,0.0226850867085055,0.0210553851846134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF2,Cyclic AMP-dependent transcription factor ATF-2,28774,0.0107971448340445,0.00472110456381985,0.00154377988895764,0.0200505097791315,0.0222033164088189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FSTL3,Follistatin-related protein 3,29351,0.00505154047823436,0.00220993484996606,0.000720068172300884,0.00938301278416783,0.0222711677381418
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI3,Elafin,29014,0.00869969551848026,0.00381795526561812,0.00121650319786875,0.0161828878390918,0.022696491286239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SDC1,Syndecan-1,29478,0.00632822249924616,0.00278464407676435,0.000870320108788034,0.0117861248897043,0.0230609243330507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN2,Neutrophil gelatinase-associated lipocalin,28586,-0.00604270283404264,0.00266122386873647,-0.0112587016167661,-0.000826704051319168,0.0231757012058896
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D1,DCN1-like protein 1,24101,-0.0118062227938866,0.0052072666554688,-0.0220124654386055,-0.00159998014916779,0.0233832238092007
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RB,Cytokine receptor common subunit beta,24229,-0.00683880447528899,0.00301703955737023,-0.0127522020077346,-0.00092540694284333,0.0234156999269704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EIF5A,Eukaryotic translation initiation factor 5A-1,28931,0.0047036808716643,0.00207904895077287,0.000628744928149485,0.00877861681517912,0.0236788851180369
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOCK9,Dedicator of cytokinesis protein 9,24101,0.018591518395941,0.00822736999732061,0.00246587320119264,0.0347171635906894,0.0238477865772142
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LPO,Lactoperoxidase,28452,-0.00938350021259445,0.00418247350793501,-0.0175811482881471,-0.00118585213704182,0.0248703928195266
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUMF1,Formylglycine-generating enzyme,24229,0.0103585669530658,0.00461917101247297,0.00130499176861878,0.0194121421375128,0.0249370249340929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL24,"39S ribosomal protein L24, mitochondrial",24111,0.00613837299614042,0.00273816523864086,0.000771569128404336,0.0115051768638765,0.0249844459458485
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CADPS,Calcium-dependent secretion activator 1,24195,-0.00670549221676971,0.00299513123017256,-0.0125759494279079,-0.000835035005631484,0.0251781562255498
NMR metabolomics,X23508.Triglycerides in Medium VLDL,B3GAT3,Galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase 3,24111,-0.00317133743055463,0.0014202703132472,-0.00595506724451914,-0.000387607616590132,0.0255639503258116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA4,Ephrin type-A receptor 4,24381,0.00440000301828149,0.00198691336971323,0.00050565281364356,0.00829435322291942,0.0268041960463734
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB116,Beta-defensin 116,24101,-0.0118645958966069,0.00536423004960514,-0.022378486793833,-0.00135070499938083,0.0269899423298945
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CFD,Complement factor D,24966,0.00299678929046825,0.00135742721871189,0.00033623194179294,0.00565734663914355,0.0272743993358826
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF1,Macrophage colony-stimulating factor 1,29581,0.00412509386791368,0.00187110388043041,0.000457730262270066,0.00779245747355729,0.0274876616198688
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AIDA,"Axin interactor, dorsalization-associated protein",24195,0.0129164104362924,0.00586361324543719,0.00142372847523546,0.0244090923973492,0.0276177273715985
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RSPO1,R-spondin-1,29218,-0.0053547116767194,0.00243175305914409,-0.0101209476726418,-0.000588475680796981,0.0276733452714852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPB1,Signal-regulatory protein beta-1,29409,0.00703435976436972,0.00319815626256644,0.000765973489739497,0.0133027460389999,0.0278498112920849
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRK,Receptor-type tyrosine-protein phosphatase kappa,24805,0.00327249935837115,0.00148859763399368,0.000354847995743526,0.00619015072099877,0.0279314322431201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEZ6L,Seizure 6-like protein,29566,0.00417678202167373,0.00190581902456149,0.0004413767335332,0.00791218730981425,0.0284165931840817
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STOML2,"Stomatin-like protein 2, mitochondrial",24016,0.0140813948633922,0.00643217751054671,0.0014743269427206,0.0266884627840637,0.02859109139666
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD70,CD70 antigen,29434,-0.00642342716619913,0.00296190976058963,-0.0122287702969548,-0.000618084035443465,0.0301151590532282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,INSL4,Early placenta insulin-like peptide,24793,-0.0076889069352032,0.00356939113924988,-0.014684913568133,-0.000692900302273427,0.0312401516618035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCAT2,"Branched-chain-amino-acid aminotransferase, mitochondrial",24101,-0.00810121657866016,0.00377667112936603,-0.0155034919922176,-0.000698941165102736,0.0319573761168546
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD177,CD177 antigen,29413,-0.0190209850773594,0.00887783456135499,-0.0364215408176152,-0.00162042933710357,0.032159422924384
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM20,Carcinoembryonic antigen-related cell adhesion molecule 20,24445,0.00656287544360247,0.00307339885523424,0.000539013687343368,0.0125867371998616,0.0327398724764813
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK1,Serine protease inhibitor Kazal-type 1,29443,0.00631445992057061,0.00296499948025237,0.000503060939275952,0.0121258589018653,0.0332074346614724
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFRC,Transferrin receptor protein 1,29565,-0.00568716241243397,0.00267140618308541,-0.0109231185312814,-0.00045120629358656,0.0332706009256846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA0319,Dyslexia-associated protein KIAA0319,24845,0.00455267052022945,0.00213875356304004,0.000360713536670961,0.00874462750378793,0.0332925499606282
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCR1,Natural cytotoxicity triggering receptor 1,29375,0.00546317770241131,0.00256673055058763,0.000432385823259549,0.0104939695815631,0.03330744602022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5PO,"ATP synthase subunit O, mitochondrial",28774,0.00622078682685997,0.00294196825796094,0.000454529041256529,0.0119870446124634,0.0344813115576352
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAMA1,Laminin subunit alpha-1,24111,-0.00791701887466837,0.00375791960497781,-0.0152825413004249,-0.000551496448911858,0.0351490630004844
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA3G,Semaphorin-3G,24381,0.00646012878424333,0.00307169342070841,0.000439609679654843,0.0124806478888318,0.035465823177182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPTBN2,"Spectrin beta chain, non-erythrocytic 2",24101,0.00469486104234943,0.00223249751768482,0.000319165907687178,0.00907055617701169,0.035479297495778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLIRP,"SRA stem-loop-interacting RNA-binding protein, mitochondrial",24016,0.00836911562084602,0.00398436590856729,0.000559758440054137,0.0161784728016379,0.0356962779475874
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLITRK1,SLIT and NTRK-like protein 1,24229,0.00471968526960617,0.00225002027742589,0.000309645525851429,0.00912972501336091,0.0359491549449338
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DENND2B,DENN domain-containing protein 2B,24111,-0.00737426631072601,0.00353353022868982,-0.0142999855589581,-0.000448547062493955,0.0369040225767567
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RTKN2,Rhotekin-2,24111,-0.00749061556471161,0.0035998223923877,-0.0145462674537915,-0.000434963675631714,0.0374600777775925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRFN2,Leucine-rich repeat and fibronectin type-III domain-containing protein 2,24195,-0.00684180364728573,0.00328990619901401,-0.0132900197973532,-0.000393587497218265,0.0375695456164016
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX33,Testis-expressed protein 33,24445,-0.00558858435468047,0.00270932690689084,-0.0108988650921865,-0.000278303617174423,0.0391497284598991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX2,"Ferredoxin-2, mitochondrial",24111,0.0080607713170722,0.00391900149969475,0.0003795283776705,0.0157420142564739,0.0397120580160201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXNDC15,Thioredoxin domain-containing protein 15,29566,-0.00389691723783569,0.00189513791253891,-0.00761138754641195,-0.000182446929259425,0.0397651581587001
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPOX,"Oxygen-dependent coproporphyrinogen-III oxidase, mitochondrial",24229,0.00401260628277417,0.00195148432931738,0.000187696997312104,0.00783751556823624,0.0397757031475578
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VASN,Vasorin,29065,0.00391673575475697,0.00190561721699945,0.000181726009438048,0.0076517455000759,0.0398528433906846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DEFB118,Beta-defensin 118,24101,0.00821181258354139,0.00400282103903779,0.000366283347027329,0.0160573418200554,0.0402284562554677
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MICB_MICA,MHC class I polypeptide-related sequence A_MHC class I polypeptide-related sequence B,29434,0.0212507393004277,0.0103944116010551,0.0008776925623597,0.0416237860384957,0.0409190908086308
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AGBL2,Cytosolic carboxypeptidase 2,24101,0.0129553766266462,0.00634390042152584,0.000521331800455558,0.0253894214528369,0.041144702239701
NMR metabolomics,X23508.Triglycerides in Medium VLDL,H2AP,Huntingtin-interacting protein M,24016,-0.00726351323016961,0.00356225080691606,-0.0142455248117251,-0.000281501648614142,0.0414586107994705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE4D,"cAMP-specific 3',5'-cyclic phosphodiesterase 4D",24111,-0.00863161858135622,0.00424040681018179,-0.0169428159293125,-0.000320421233399908,0.0418050937618243
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPA33,Cell surface A33 antigen,29349,0.0189676353720419,0.00935063925634532,0.000640382429605093,0.0372948883144788,0.0425197456986625
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SYNGAP1,Ras/Rap GTPase-activating protein SynGAP,24101,-0.00803812298822131,0.00398315459564872,-0.0158451059956928,-0.000231139980749813,0.0435992663633736
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13RA2,Interleukin-13 receptor subunit alpha-2,24101,-0.00401669721334304,0.00200730091144578,-0.00795100699977676,-8.23874269093158e-05,0.0453988603456758
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMIGO1,Amphoterin-induced protein 1,24195,0.0069770521398739,0.00348871321494778,0.000139174238576245,0.0138149300411716,0.0455230150679506
NMR metabolomics,X23508.Triglycerides in Medium VLDL,YY1,Transcriptional repressor protein YY1,24229,0.00388088060440645,0.00194129608372878,7.59402802980474e-05,0.00768582092851485,0.0456067065604656
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MUCL3,Mucin-like protein 3,24016,-0.00607233939035057,0.00305215533167378,-0.0120545638404312,-9.0114940269957e-05,0.0466546124784407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR1,Folate receptor alpha,29383,0.00395007365645498,0.00200169957403372,2.67424913488858e-05,0.00787340482156108,0.0484639337240973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,L1CAM,Neural cell adhesion molecule L1,29566,0.00393629126891749,0.0020069213265963,2.72546878873643e-06,0.00786985706904624,0.0498466467812653
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOP56,Nucleolar protein 56,24111,0.0150908570953304,0.00771741105517975,-3.52685728218765e-05,0.0302169827634827,0.050543879024901
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKR1B10,Aldo-keto reductase family 1 member B10,24195,0.00846135284523629,0.00433723961844515,-3.96368069162066e-05,0.0169623424973888,0.0510850833844462
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP13,Collagenase 3,28774,-0.00442135528438055,0.00227234511226998,-0.00887515170442972,3.24411356686068e-05,0.0516976908688344
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC44A4,Choline transporter-like protein 4,24195,-0.00933138508849219,0.00482093207275594,-0.0187804119510938,0.000117641774109452,0.0529286335471003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA1,DnaJ homolog subfamily A member 1,24016,-0.00627249134398352,0.00325537905733083,-0.0126530342963519,0.000108051608384899,0.0540153175798644
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMD5,26S proteasome non-ATPase regulatory subunit 5,24195,-0.00743903615819751,0.00386623201084081,-0.0150168508994455,0.000138778583050479,0.0543531520166697
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STX1B,Syntaxin-1B,24195,0.00555032293267802,0.00289334774576899,-0.00012063864902921,0.0112212845143852,0.0550841334885286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BEX3,Protein BEX3,24016,-0.00629730749317544,0.00328387128759643,-0.0127336952168645,0.00013908023051357,0.0551675799707194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPP10,Inactive dipeptidyl peptidase 10,29434,0.00468487991783783,0.00244412644504346,-0.000105607914447361,0.00947536775012302,0.055274146833311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RELB,Transcription factor RelB,24229,0.00656408105978223,0.00343205104469564,-0.000162738987821237,0.0132909011073857,0.0558132950254426
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC15,Sialic acid-binding Ig-like lectin 15,28774,0.0103921576329996,0.00544727048689314,-0.000284492521310931,0.0210688077873102,0.0564304615216443
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINA3,Alpha-1-antichymotrypsin,24883,0.001960818992567,0.00102847525859985,-5.4992514288716e-05,0.00397663049942271,0.056592983467823
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS5,Transmembrane protease serine 5,29079,-0.00501263849621064,0.00264256294545375,-0.0101920618693,0.000166784876878707,0.0578529973421768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L2,Mortality factor 4-like protein 2,24016,-0.00486364151466442,0.0025691572088519,-0.00989918964401414,0.000171906614685305,0.0583581423985172
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GLI2,Zinc finger protein GLI2,24229,-0.00438549902991242,0.00231882630458942,-0.00893039858690768,0.000159400527082836,0.0586018228067357
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC1,Plexin domain-containing protein 1,28797,0.00434132623325254,0.00230128643944676,-0.000169195188063114,0.00885184765456819,0.059240627635832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR3DL2,Killer cell immunoglobulin-like receptor 3DL2,24016,-0.0109946987542132,0.00583509098159133,-0.0224314770781322,0.000442079569705824,0.0595448966869969
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP2,Contactin-associated protein-like 2,29434,-0.00539023604424237,0.00286852691298608,-0.0110125487936951,0.000232076705210344,0.0602413303023371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FDX1,"Adrenodoxin, mitochondrial",24111,0.00817711187939085,0.00436411745007832,-0.000376558322762652,0.0167307820815443,0.0609818240352165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPN9,Tyrosine-protein phosphatase non-receptor type 9,24173,0.00500804428537175,0.00267499371742769,-0.000234943400786524,0.01025103197153,0.0611950919675095
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSBP1,"Single-stranded DNA-binding protein, mitochondrial",24229,0.00459500171807659,0.00245637319932689,-0.000219489752604118,0.0094094931887573,0.0614063848781118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYOC,Myocilin,29443,-0.00591936191660714,0.00316636382837431,-0.0121254350202208,0.000286711187006509,0.061570022487507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSLNL,Mesothelin-like protein,24195,-0.00489134678694986,0.00261837712932242,-0.0100233659604218,0.000240672386522069,0.0617625351686476
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX53,Probable ATP-dependent RNA helicase DDX53,24195,0.00461847775632738,0.00247924575403242,-0.00024084392157617,0.00947779943423093,0.0624946490363085
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRA,Paired immunoglobulin-like type 2 receptor alpha,29443,0.00545910776469649,0.00293094833187717,-0.000285550965782759,0.0112037664951757,0.0625322010333249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REST,RE1-silencing transcription factor,24016,-0.00453318004922564,0.00243807616719613,-0.00931180933693005,0.000245449238478765,0.0629930761255866
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FHIP2A,FHF complex subunit HOOK interacting protein 2A,24111,0.00605407931937874,0.00325769942276931,-0.000331011549249113,0.0124391701880066,0.0631256930995205
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSF2RA,Granulocyte-macrophage colony-stimulating factor receptor subunit alpha,29218,0.00783514623087836,0.00422797447176891,-0.000451683733788698,0.0161219761955454,0.0638683881689446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SSB,Lupus La protein,28774,0.00763618715658907,0.0041371979139025,-0.000472720754659831,0.015745095067838,0.064940396076171
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CALY,Neuron-specific vesicular protein calcyon,24111,-0.00490997230435753,0.00267259925209091,-0.0101482668384557,0.000328322229740647,0.0661996978807929
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RG,Cytokine receptor common subunit gamma,24793,0.00472934254146715,0.00258418683347729,-0.000335663652148334,0.00979434873508264,0.0672457077520563
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ART5,Ecto-ADP-ribosyltransferase 5,24101,-0.00797368931955722,0.0043655567896,-0.0165301806271732,0.000582801988058778,0.0677873573385141
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS8,A disintegrin and metalloproteinase with thrombospondin motifs 8,29566,0.00569325853312264,0.00313688721586049,-0.000455040409963921,0.0118415574762092,0.069543437491138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPACA5_SPACA5B,Sperm acrosome-associated protein 5,24867,-0.00372371318060708,0.00205905282316611,-0.00775945671401266,0.000312030352798506,0.0705471304388024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3BL1,Uroplakin-3b-like protein 1,24404,-0.00680159020569505,0.0037762544677216,-0.0142030489624294,0.000599868551039289,0.0716920268389485
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMGCS1,"Hydroxymethylglutaryl-CoA synthase, cytoplasmic",24111,-0.00542305570226941,0.00301398532393636,-0.0113304669371847,0.000484355532645849,0.0719841685833698
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VNN2,Vascular non-inflammatory molecule 2,29349,-0.0057241688527307,0.00318427684029347,-0.0119653514597059,0.000517013754244496,0.0722450803420977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CORO6,Coronin-6,24101,-0.0046817835675553,0.00261172202671058,-0.00980075873990804,0.000437191604797433,0.0730487970364651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF9,Complement C1q and tumor necrosis factor-related protein 9A,24322,-0.00602993485757497,0.0033865627024496,-0.0126675977543762,0.000607728039226252,0.0749989322432772
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOWAHA,Ankyrin repeat domain-containing protein SOWAHA,24195,-0.00609143900043542,0.00342475901029946,-0.0128039666606224,0.00062108865975152,0.0753101341811919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NUBP1,Cytosolic Fe-S cluster assembly factor NUBP1,24793,0.0119912543422649,0.00674444350011622,-0.00122785491796285,0.0252103636024927,0.0754250332390808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD58,Lymphocyte function-associated antigen 3,29409,-0.00217190650403795,0.00122237654655269,-0.00456776453528123,0.000223951527205322,0.0756131263593619
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPC2,PDZ domain-containing protein GIPC2,24845,0.00366851970753902,0.00206663813603366,-0.000382091039086952,0.00771913045416499,0.0758911994798819
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADCYAP1R1,Pituitary adenylate cyclase-activating polypeptide type I receptor,28797,0.00435805742260304,0.00245791840514497,-0.000459462651481097,0.00917557749668717,0.0762279487181757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF11B,Tumor necrosis factor receptor superfamily member 11B,29454,0.00362979750211604,0.00204762168941158,-0.00038354100913065,0.00764313601336273,0.07629050782683
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABRA4,Gamma-aminobutyric acid receptor subunit alpha-4,24101,-0.00798592927152037,0.004517498254189,-0.0168402258497308,0.000868367306690071,0.077110858179118
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIK2,"Glutamate receptor ionotropic, kainate 2",24867,0.0051290484049348,0.00291087908015872,-0.000576274592176293,0.0108343714020459,0.0780769769233053
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGN,Mimecan,29443,-0.00511806027005146,0.00291929311634609,-0.0108398747780898,0.00060375423798687,0.0795807048008512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SOX2,Transcription factor SOX-2,24826,0.0028983150704887,0.00165564678675958,-0.000346752631560085,0.00614338277253748,0.080033460784175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNA1C,Voltage-dependent L-type calcium channel subunit alpha-1C,24101,-0.00397024101705188,0.00227805313789242,-0.00843522516732103,0.000494743133217265,0.0813774815686512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1GALT1C1,C1GALT1-specific chaperone 1,24111,0.00395468481533472,0.00226986968216586,-0.000494259761710368,0.0084036293923798,0.0814771302243464
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPLX2,Complexin-2,24016,-0.00371770523740794,0.00214006557477708,-0.00791223376397102,0.000476823289155144,0.0823660781115251
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRB3,Adhesion G protein-coupled receptor B3,29169,-0.00403605357510612,0.00233236003487123,-0.00860747924345372,0.000535372093241481,0.0835588695047803
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRV1,Adhesion G-protein coupled receptor V1,24101,-0.00841343623414354,0.00487484907841979,-0.0179681404278463,0.00114126795955925,0.0843806575169832
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL1A,Interleukin-1 alpha,28931,0.00664574351595048,0.0038615309885836,-0.000922857221673388,0.0142143442535743,0.0852592327657865
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX1,ATP-dependent RNA helicase DDX1,24805,0.00597886907637692,0.00347616161112049,-0.000834407681419245,0.0127921458341731,0.085451662345095
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIF1A,Hypoxia-inducible factor 1-alpha,24229,0.00783116881170341,0.00455942674306013,-0.00110530760469443,0.0167676452281013,0.0858864917062856
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPTN,Neuroplastin,28797,0.00969944308423263,0.0056628424439714,-0.00139972810595132,0.0207986142744166,0.0867559974090276
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DBH,Dopamine beta-hydroxylase,24919,0.0128886800306417,0.00758394283301767,-0.00197584792207298,0.0277532079833563,0.0892432322074355
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAM12,Disintegrin and metalloproteinase domain-containing protein 12,24229,0.00413880539337283,0.00244058586840696,-0.000644742908704811,0.00892235369545047,0.0899319694672789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MB,Myoglobin,29820,-0.00611603218706522,0.00363615913428017,-0.0132429040902544,0.00101083971612392,0.0925786473150311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PADI2,Protein-arginine deiminase type-2,28931,0.00657722723235807,0.00391465633962267,-0.00109549919330236,0.0142499536580185,0.0929380723936202
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY1A_AMY1B_AMY1C,Alpha-amylase 1A_Alpha-amylase 1B_Alpha-amylase 1C,23494,0.00583155469710283,0.00347230606825387,-0.000974165196674758,0.0126372745908804,0.093078225857219
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LAIR1,Leukocyte-associated immunoglobulin-like receptor 1,29454,0.00449877953852012,0.00269735628829352,-0.000788038786535166,0.00978559786357542,0.0953565950489588
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH22,Cadherin-22,24445,-0.00330475139455877,0.00198542459064008,-0.00719618359221332,0.000586680803095789,0.0960241513138972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IMPG1,Interphotoreceptor matrix proteoglycan 1,24101,-0.00347040563738369,0.00209067905216092,-0.0075681365796191,0.00062732530485172,0.0969391700296259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DPEP2,Dipeptidase 2,29349,-0.0033686801504496,0.00203009644965303,-0.00734766919176954,0.000610308890870337,0.0970520458500051
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC39A14,Zinc transporter ZIP14,28774,0.00384688099727376,0.00232598028941082,-0.000712040369971443,0.00840580236451897,0.0981637962079252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC4A1,Band 3 anion transport protein,24938,-0.00536947138730377,0.00324796947920274,-0.0117354915665411,0.000996548791933596,0.0983072556663799
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RA,Interleukin-20 receptor subunit alpha,28931,0.0051947934589692,0.00314334258544103,-0.000966158008495224,0.0113557449264336,0.0984163191194375
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCARB1,Scavenger receptor class B member 1,28774,0.0065798119951973,0.00399098151231206,-0.00124251176893434,0.014402135759329,0.0992261557648749
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TRPV3,Transient receptor potential cation channel subfamily V member 3,24111,-0.00577079172436894,0.0035011577802886,-0.0126330609737346,0.00109147752499672,0.0993139242314808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HIP1,Huntingtin-interacting protein 1,24111,0.00383055693362515,0.00232688915608269,-0.00073014581229692,0.00839125967954722,0.0997327992693033
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLB1,"Phospholipase B1, membrane-associated",24845,0.00684975737654351,0.00416437552467787,-0.0013124186518251,0.0150119334049121,0.100014183988136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD160,CD160 antigen,29786,0.00534198296876009,0.00324912831542679,-0.00102630852947642,0.0117102744669966,0.10016031543037
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDNRB,Endothelin receptor type B,24229,0.00521670940817115,0.0031759728861939,-0.0010081974487689,0.0114416162651112,0.100488070060835
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC2,WAP four-disulfide core domain protein 2,27939,0.00455130040081094,0.00277400648908535,-0.000885752317796356,0.00998835311941823,0.100871869068075
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LY9,T-lymphocyte surface antigen Ly-9,29116,0.00334558633841882,0.0020410089793756,-0.000654791261157351,0.00734596393799498,0.101186052432136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORF4L1,Mortality factor 4-like protein 1,24445,-0.00456680566342912,0.00278866480188575,-0.0100325886751252,0.00089897734826695,0.101511440835169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFOD2,Glucose-fructose oxidoreductase domain-containing protein 2,28797,0.0139208534572163,0.00867593838782037,-0.00308398578291165,0.0309256926973442,0.10860697833367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JUN,Transcription factor AP-1,28931,0.00555573328336203,0.00347902698909123,-0.00126315961525678,0.0123746261819808,0.110294115197458
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LGALS4,Galectin-4,29454,0.00601077597201271,0.00377872820941936,-0.00139553131844924,0.0134170832624747,0.111690644113889
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAP1,Antigen peptide transporter 1,24445,-0.00662667545020488,0.00417248344539988,-0.0148047430031886,0.00155139210277888,0.112257461692002
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN2A,Sodium channel protein type 2 subunit alpha,24101,0.00542243104195951,0.00341564208304103,-0.00127222744080092,0.0121170895247199,0.112405998002746
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN15,Tetraspanin-15,24111,-0.00556598299762999,0.00351736367514264,-0.0124600158009096,0.00132804980564959,0.113564486745301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRME1,Break repair meiotic recombinase recruitment factor 1,24101,-0.00453246855791092,0.0028663026379165,-0.0101504217282273,0.00108548461240542,0.113823849588523
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A3,Protein S100-A3,24793,0.00486620350479,0.00308340564871005,-0.0011772715666817,0.0109096785762617,0.114534467846748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MTR,Methionine synthase,24111,0.00715333197615376,0.00453621359249035,-0.00173764666512732,0.0160443106174348,0.114822696112664
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNPDA1,Glucosamine-6-phosphate isomerase 1,24240,0.00362545956988786,0.00230284354635313,-0.00088811378096428,0.00813903292074,0.115421838736277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LELP1,Late cornified envelope-like proline-rich protein 1,24101,-0.00801342172316211,0.00509501751933408,-0.0179996560610569,0.00197281261473268,0.115779262325489
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SUSD4,Sushi domain-containing protein 4,24793,-0.00457114282018049,0.00290868056854913,-0.0102721567345368,0.0011298710941758,0.116067249296727
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCD1LG2,Programmed cell death 1 ligand 2,29349,0.00340546710876513,0.00216763926334028,-0.000843105847381817,0.00765404006491208,0.1161820941886
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NXPE4,NXPE family member 4,24111,-0.00373270955446063,0.00239082361681673,-0.00841872384342142,0.000953304734500154,0.11847433853471
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF3,Trefoil factor 3,29426,-0.00501208156768827,0.00321118889672461,-0.0113060118052685,0.00128184866989196,0.118577448195953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMEM132A,Transmembrane protein 132A,24240,0.00674987790745326,0.00435370833529378,-0.00178339042972255,0.0152831462446291,0.121064744183505
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIRREL1,Kin of IRRE-like protein 1,24101,-0.00631623926157052,0.00410275311929899,-0.0143576353753965,0.00172515685225549,0.12369239128445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRRT3,Proline-rich transmembrane protein 3,24240,0.00405367913938623,0.00264210063351865,-0.00112483810231033,0.00923219638108278,0.12497784652794
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSTM4,Glutathione S-transferase Mu 4,24111,-0.00768460271326037,0.00506639462436611,-0.017614736177018,0.00224553075049721,0.129335521677343
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCLRE1C,Protein artemis,24016,-0.00327690939625008,0.00216310472895953,-0.00751659466501074,0.000962775872510595,0.129808317508983
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF7,Fibroblast growth factor 7,24016,-0.00836412584444304,0.0055216204137865,-0.0191865018554646,0.00245825016657851,0.129837364338768
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGEF5,Rho guanine nucleotide exchange factor 5,24101,-0.00782714726484116,0.00518235492207153,-0.0179845629121014,0.00233026838241905,0.130968364071968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALM3,Paralemmin-3,24111,0.00773969206720263,0.00513356447851102,-0.00232209431067898,0.0178014784450842,0.131653567770903
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAP1A,Ras-related protein Rap-1A,24229,-0.0072402562935162,0.00481662274742051,-0.0166808368784604,0.00220032429142799,0.132805390018814
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MERTK,Tyrosine-protein kinase Mer,29786,0.00263329166498394,0.00176363677216228,-0.000823436408454126,0.00609001973842202,0.135420778286299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HTR1A,5-hydroxytryptamine receptor 1A,24101,-0.0079601761589324,0.00535464468757852,-0.0184552797465863,0.0025349274287215,0.137135483304678
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT3,Kunitz-type protease inhibitor 3,24805,0.015181287854085,0.0102264066371519,-0.00486246915473269,0.0352250448629027,0.137684184527287
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASP4,Caspase-4,24445,-0.017323962750813,0.0116958818887594,-0.0402478912527814,0.00559996575115538,0.138565670148642
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GID8,Glucose-induced degradation protein 8 homolog,24867,0.0034661722333279,0.00234925208377743,-0.00113836185087585,0.00807070631753166,0.140107900998836
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BATF,Basic leucine zipper transcriptional factor ATF-like,24195,0.00859776777142002,0.00583475897876402,-0.00283835982695745,0.0200338953697975,0.140617717098686
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDAN1,Codanin-1,24845,0.00230418257009706,0.00156732491498747,-0.000767774263278387,0.00537613940347251,0.14153728514116
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36A,Interleukin-36 alpha,24229,-0.00594796610068777,0.00404738083093277,-0.013880832529316,0.00198490032794046,0.141687448506633
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENOPH1,Enolase-phosphatase E1,24793,0.00564968435876426,0.00384850993614417,-0.0018933951160783,0.0131927638336068,0.142111850194447
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PILRB,Paired immunoglobulin-like type 2 receptor beta,29478,0.00584542465211239,0.00398217388594028,-0.00195963616433055,0.0136504854685553,0.142142635493512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCER1A,High affinity immunoglobulin epsilon receptor subunit alpha,24867,-0.00242734304082616,0.00165419058192019,-0.00566955658138972,0.000814870499737409,0.142282594263024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FBN2,Fibrillin-2,24195,0.0061341021344037,0.00419963912569475,-0.00209719055195802,0.0143653948207654,0.144131097124123
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINT1,Kunitz-type protease inhibitor 1,29333,-0.00264133419799444,0.00180878478858195,-0.00618655238361506,0.00090388398762618,0.144223555764977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALPI,Intestinal-type alkaline phosphatase,24229,0.0124602903864588,0.00854179910392274,-0.00428163585722974,0.0292022166301474,0.144648802882829
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD82,CD82 antigen,24445,-0.00421539075855037,0.00288978879809747,-0.0098793768028214,0.00144859528572066,0.144655231234636
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NPHS2,Podocin,24229,-0.010452635132531,0.00718012954181488,-0.0245256890344882,0.00362041876942617,0.145468484449244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NEB,Nebulin,24111,-0.00382606919611836,0.00263571978823622,-0.00899207998106135,0.00133994158882463,0.146619718094182
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COPE,Coatomer subunit epsilon,28774,0.00475920582506309,0.00328778957308714,-0.0016848617381877,0.0112032733883139,0.147756734942289
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP4,Peptidoglycan recognition protein 4,24111,0.00612861563211145,0.0042397942637077,-0.00218138112475564,0.0144386123889785,0.148330959303065
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL36G,Interleukin-36 gamma,24149,0.00683466929293514,0.00472931862407731,-0.00243479521025639,0.0161041337961267,0.148423130086147
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MCEE,"Methylmalonyl-CoA epimerase, mitochondrial",24867,-0.00423452431213313,0.00293299651146696,-0.00998319747460837,0.00151414885034212,0.148820899219878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF12,Fibroblast growth factor 12,24229,0.00468197816171146,0.00325348444630802,-0.00169485135305225,0.0110588076764752,0.150144809288424
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRR5,Proline-rich protein 5,24229,0.00475933066671386,0.00331184004883456,-0.00173187582900188,0.0112505371624296,0.150712338558311
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HAGH,"Hydroxyacylglutathione hydrolase, mitochondrial",29632,-0.00706975784818389,0.0049321005994142,-0.0167366750230357,0.00259715932666795,0.151749200700666
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCL1B,T-cell leukemia/lymphoma protein 1B,28916,0.00776296521358024,0.00541775778899586,-0.00285584005285165,0.0183817704800121,0.151904615288069
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERVV_1,,24111,-0.0045890232587603,0.00320895440835522,-0.0108785738991365,0.00170052738161592,0.152710446747381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PYDC1,Pyrin domain-containing protein 1,24240,-0.00413160105153602,0.00291595306825135,-0.00984686906530866,0.00158366696223662,0.156526314227851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACTN4,Alpha-actinin-4,28931,0.00314518874845338,0.0022207673776669,-0.00120751531177374,0.0074978928086805,0.156709541028793
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD33,Myeloid cell surface antigen CD33,29566,0.00776933645208299,0.005495335546234,-0.00300152121853566,0.0185401941227016,0.157429507676392
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF6,Complement C1q tumor necrosis factor-related protein 6,24867,0.00315062177188398,0.00223276323490992,-0.00122559416853946,0.00752683771230742,0.15823166538773
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHLHE40,Class E basic helix-loop-helix protein 40,24101,-0.00693642574741683,0.00492208008702072,-0.0165837027179774,0.00271085122314378,0.158775105264618
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DOC2B,Double C2-like domain-containing protein beta,24195,0.00353620799404471,0.00252028913222326,-0.00140355870511288,0.00847597469320231,0.160601007051003
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT14,"Keratin, type I cytoskeletal 14",27986,0.00282425277504732,0.00202067482625282,-0.00113626988440821,0.00678477543450285,0.162220863937403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAMT,Guanidinoacetate N-methyltransferase,24111,-0.00360633709108654,0.00259235765581875,-0.00868735809649129,0.00147468391431821,0.164195275924249
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRING1,SREBP regulating gene protein,24016,0.00575060346819853,0.00414006497026153,-0.00236392387351408,0.0138651308099111,0.164841727806641
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBM25,RNA-binding protein 25,24016,-0.00445532016187192,0.00323049990612434,-0.0107870999778756,0.00187645965413178,0.167863630366114
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSTN,Osteocrin,24195,-0.00400017140723274,0.0029061703917067,-0.00969626537497788,0.00169592256051239,0.168697958476681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GH2,Growth hormone variant,28797,0.015796286627918,0.0114800036241995,-0.00670452047551301,0.0382970937313491,0.168837688593912
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRG2,Adhesion G-protein coupled receptor G2,29478,0.00258418529199913,0.00187828736115288,-0.00109725793586052,0.00626562851985877,0.168887829902008
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RIPK4,Receptor-interacting serine/threonine-protein kinase 4,24111,-0.00661761187217285,0.0048228122153768,-0.0160703238143114,0.00283510006996568,0.170030159148737
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LCN15,Lipocalin-15,24867,-0.00593346141166293,0.00432470988634437,-0.0144098927888979,0.00254296996557202,0.170078740511709
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WNT9A,Protein Wnt-9a,28931,-0.00273849001698114,0.00200218372534082,-0.00666277011864916,0.00118579008468688,0.171400467820748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEPTIN7,Septin-7,24445,0.00500699414574774,0.00366185466554981,-0.00217024099872989,0.0121842292902254,0.171531870168431
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLAU,Urokinase-type plasminogen activator,29443,-0.00275379303386904,0.00201666708676428,-0.00670646052392703,0.00119887445618895,0.172101074835723
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNLZ,DNL-type zinc finger protein,24101,-0.00854224614978343,0.00627715208923842,-0.0208454642446907,0.00376097194512386,0.173574648643684
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBX2,Chromobox protein homolog 2,24111,-0.00380197691594271,0.00280153395559576,-0.00929298346891041,0.00168902963702498,0.174760427572424
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DL3,Killer cell immunoglobulin-like receptor 2DL3,28797,-0.00727665895803683,0.00536587654971015,-0.0177937769954687,0.00324045907939507,0.175078360381408
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL25,Interleukin-25,23913,0.00325284872324018,0.00240568114473187,-0.00146228632043429,0.00796798376691464,0.176339204059981
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GABARAPL1,Gamma-aminobutyric acid receptor-associated protein-like 1,24445,-0.00605972791439317,0.00448379997716294,-0.0148479758696325,0.00272852004084618,0.176556954348237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMG,Oligodendrocyte-myelin glycoprotein,29349,0.00614271111243478,0.00455145677791666,-0.00277814417228187,0.0150635663971514,0.177150152418227
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCGN,Secretagogin,28931,-0.00410996790982273,0.00305973564842061,-0.0101070497807271,0.00188711396108166,0.179203905296275
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3E,T-cell surface glycoprotein CD3 epsilon chain,24445,0.00330616498741882,0.00246143964082392,-0.00151825670859607,0.00813058668343371,0.179225056286614
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISLR2,Immunoglobulin superfamily containing leucine-rich repeat protein 2,28301,0.00350592460234115,0.00261924433297299,-0.00162779429028591,0.0086396434949682,0.18073604189257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RANGAP1,Ran GTPase-activating protein 1,28797,-0.00448938411861647,0.00339760315580991,-0.0111486863040039,0.00216991806677096,0.186398999747296
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCBLD2,"Discoidin, CUB and LCCL domain-containing protein 2",29566,-0.0031895537363755,0.0024164382883838,-0.00792577278160775,0.00154666530885674,0.186865250205226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIAA2013,Uncharacterized protein KIAA2013,24793,0.00509768116468044,0.00386874344849232,-0.00248505599436451,0.0126804183237254,0.187630307110545
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CPVL,Probable serine carboxypeptidase CPVL,29662,0.0037183528073584,0.00282322017572774,-0.00181515873706797,0.00925186435178476,0.187828402729005
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDEM2,ER degradation-enhancing alpha-mannosidase-like protein 2,24111,-0.00339364103874054,0.00258134368172566,-0.00845307465492284,0.00166579257744176,0.188629966293358
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPPP2,Tubulin polymerization-promoting protein family member 2,24445,-0.00726557665440676,0.00552719095891692,-0.0180988709338839,0.0035677176250704,0.188685218758024
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCNE1,G1/S-specific cyclin-E1,24229,0.00840887112544091,0.00642916064433731,-0.00419228373746022,0.021010025988342,0.190910574724898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC8,Histone deacetylase 8,24229,0.00556391237386271,0.00426373836043996,-0.00279301481259961,0.013920839560325,0.191926507261446
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL12RB2,Interleukin-12 receptor subunit beta-2,24229,-0.00376396834988284,0.00289458057818667,-0.00943734628312871,0.00190940958336303,0.193493355674246
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWC2L,von Willebrand factor C domain-containing protein 2-like,24867,0.00417179963942602,0.00323613157389168,-0.00217101824540167,0.0105146175242537,0.197364319638099
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3A,Acid sphingomyelinase-like phosphodiesterase 3a,29536,-0.00577711323481299,0.00448405725858144,-0.0145658654616326,0.00301163899200662,0.197628194902361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL19,Interleukin-19,28654,-0.00625968279524551,0.00487851938474264,-0.0158215807893411,0.00330221519885005,0.199463508006866
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CREB3,Cyclic AMP-responsive element-binding protein 3,24016,-0.00505014173605965,0.00395026543910808,-0.0127926619967115,0.00269237852459219,0.201109866516548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHRDL2,Chordin-like protein 2,29478,0.00472738439859313,0.00369867957861685,-0.00252202757549589,0.0119767963726821,0.201214512681262
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DHODH,Dihydroorotate dehydrogenase,24111,0.00420914917219442,0.00329490606428173,-0.00224886671379778,0.0106671650581866,0.201448081371941
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPRKB,EKC/KEOPS complex subunit TPRKB,24016,-0.00584758592503608,0.00458245645797768,-0.0148292005826723,0.00313402873260019,0.201939211691602
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMC3,Structural maintenance of chromosomes protein 3,24016,0.0047693880507005,0.00375987591394986,-0.00259996874064123,0.0121387448420422,0.204633134042683
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KDM3A,Lysine-specific demethylase 3A,24229,-0.00789931048729163,0.00629905821972141,-0.0202454645979456,0.00444684362336233,0.209837292405451
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C9orf40,Uncharacterized protein C9orf40,24805,0.00697540289911305,0.00556806348111618,-0.00393800152387466,0.0178888073221008,0.210307776146713
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESPL1,Separin,24016,-0.00481739421855748,0.00385619857304212,-0.01237554342172,0.00274075498460507,0.211582214567789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP2B4,Plasma membrane calcium-transporting ATPase 4,24111,-0.00538923880626914,0.00435140108765615,-0.0139179849380752,0.00313950732553691,0.215540354743166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFBP7,Insulin-like growth factor-binding protein 7,29820,-0.0025721119570741,0.00210364475081114,-0.00669525566866394,0.00155103175451574,0.221455295497017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IZUMO1,Izumo sperm-egg fusion protein 1,24016,-0.00416324013600772,0.00340918463711425,-0.0108452420247517,0.00251876175273621,0.222028533104088
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLXDC2,Plexin domain-containing protein 2,24845,0.0022914540453778,0.00187859955628862,-0.0013906010849479,0.0059735091757035,0.222564739045572
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP4,Zona pellucida sperm-binding protein 4,24016,-0.00268721446441232,0.00221746563712232,-0.00703344711317207,0.00165901818434742,0.225585406276812
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD2,Glutamate decarboxylase 2,24229,-0.00387632449921199,0.00322051927487775,-0.0101885422779724,0.0024358932795484,0.228743078225152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK4,Serine protease inhibitor Kazal-type 4,29434,0.00545767325205887,0.00454119152379672,-0.0034430621345827,0.0143584086387004,0.229444787268359
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENDOU,Poly(U)-specific endoribonuclease,23037,0.00443953664018049,0.00369767340482143,-0.00280790323326952,0.0116869765136305,0.229907213997176
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RRP15,RRP15-like protein,24101,-0.00757665469981625,0.0063270719039284,-0.0199777156315159,0.00482440623188341,0.231124367813764
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RPGR,X-linked retinitis pigmentosa GTPase regulator,24195,0.00346980171512552,0.00290012268422177,-0.00221443874594915,0.00915404217620019,0.231539463818719
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BSND,Barttin,24016,-0.00281474963552706,0.00235644632202718,-0.00743338442670033,0.0018038851556462,0.232298474285435
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCUN1D2,DCN1-like protein 2,24016,-0.00665629195024238,0.00557915192805107,-0.0175914297292225,0.00427884582873771,0.232855636603407
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC1,Sialoadhesin,29581,-0.00349658256825245,0.00294225876588663,-0.00926340974939023,0.00227024461288534,0.234685100404489
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NMI,N-myc-interactor,24706,0.00594170563246455,0.00500145924418294,-0.00386115448613401,0.0157445657510631,0.234847038137087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDE1C,"Calcium/calmodulin-dependent 3',5'-cyclic nucleotide phosphodiesterase 1C",24016,-0.00453333911761524,0.00382766698832108,-0.0120355664147246,0.00296888817949407,0.236281959009595
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PITHD1,PITH domain-containing protein 1,23970,-0.00653561427031772,0.00554708262161441,-0.017407896208682,0.00433666766804653,0.238725602247496
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GHRHR,Growth hormone-releasing hormone receptor,28774,0.00448021402573964,0.00381750392803245,-0.00300209367320396,0.0119625217246832,0.240565901116652
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAB6B,Ras-related protein Rab-6B,28774,0.00391085071024658,0.0033351434972191,-0.00262603054430286,0.010447731964796,0.240958570334403
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DUOX2,Dual oxidase 2,28916,0.00579781838872078,0.00495106463471678,-0.00390626829532411,0.0155019050727657,0.241598551289601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BST1,ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 2,29694,0.00381546892914472,0.00325896777870034,-0.00257210791710796,0.0102030457753974,0.241704683044106
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLAMF8,SLAM family member 8,28797,0.00433490327072874,0.00371668012190415,-0.00294978976820339,0.0116195963096609,0.243487695117199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIE1,Tyrosine-protein kinase receptor Tie-1,29820,0.00331465669668179,0.00284998802929734,-0.00227131984074101,0.00890063323410458,0.244821642574121
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PLCB1,"1-phosphatidylinositol 4,5-bisphosphate phosphodiesterase beta-1",24229,-0.00356898519540471,0.00308299908722864,-0.00961166340637284,0.00247369301556342,0.247024762887334
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSLP,Thymic stromal lymphopoietin,28916,0.00482373827743283,0.00419621997521109,-0.0034008528739809,0.0130483294288466,0.250341366247623
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGM2,Phosphoglucomutase-2,24195,0.0048037398415483,0.00418277965576865,-0.00339450828375825,0.0130019879668549,0.250791584757882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NDST1,Bifunctional heparan sulfate N-deacetylase/N-sulfotransferase 1,24793,0.0049643145804556,0.00432889479581592,-0.00352031921934361,0.0134489483802548,0.251481280433906
NMR metabolomics,X23508.Triglycerides in Medium VLDL,JMJD1C,Probable JmjC domain-containing histone demethylation protein 2C,24016,0.00455548395292194,0.00399152090434288,-0.00326789701959009,0.012378864925434,0.25376053812434
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP5F1D,"ATP synthase subunit delta, mitochondrial",24111,-0.00406893922243152,0.00356621697737767,-0.0110587244980917,0.0029208460532287,0.253894605455701
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMUT,"Methylmalonyl-CoA mutase, mitochondrial",24111,0.00391464147169006,0.00346800613230786,-0.00288265054763335,0.0107119334910135,0.258998785246268
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DLGAP5,Disks large-associated protein 5,24867,-0.00405535594832609,0.00359291570237627,-0.0110974707249836,0.00298675882833139,0.259031546398239
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC123,Cell division cycle protein 123 homolog,24016,0.00496390328087558,0.00440758680691861,-0.00367496686068489,0.0136027734224361,0.260084546914299
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHH,Sonic hedgehog protein,24229,-0.00331925354925342,0.00298790867084077,-0.00917555454410132,0.00253704744559449,0.26662447065459
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FLT3,Receptor-type tyrosine-protein kinase FLT3,28797,-0.00234853124879762,0.00212241158770083,-0.00650845796069124,0.00181139546309601,0.268502530457611
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PMCH,Pro-MCH,24111,-0.00637662625389668,0.00581817738470824,-0.0177802539279248,0.00502700142013147,0.273096960475337
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED10,Transmembrane emp24 domain-containing protein 10,24111,-0.00377698247773125,0.00345225956265499,-0.010543411220535,0.00298944626507253,0.273939170746072
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HADH,"Hydroxyacyl-coenzyme A dehydrogenase, mitochondrial",24111,-0.0050782796429533,0.00465877263496148,-0.0142094740074778,0.00405291472157119,0.275703482128175
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL4,Interleukin-4,28931,0.00690102377701251,0.00637083986445621,-0.00558582235732167,0.0193878699113467,0.278719633952607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPT1,Palmitoyl-protein thioesterase 1,24195,0.00582281651499919,0.00539537899590749,-0.00475212631697949,0.0163977593469779,0.280499142332167
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSAPL1,Proactivator polypeptide-like 1,24805,-0.00377107100792408,0.00349642270263041,-0.0106240595050797,0.00308191748923153,0.280798325958757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANK2,Ankyrin-2,24111,-0.00538970816105017,0.00501682388123636,-0.0152226829682734,0.00444326664617309,0.282687011365644
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EDDM3B,Epididymal secretory protein E3-beta,24793,0.00388238187601957,0.00361502067058095,-0.0032030586383191,0.0109678223903582,0.282851777257784
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53INP1,Tumor protein p53-inducible nuclear protein 1,28916,0.00232853254632565,0.00217232636349169,-0.00192922712611806,0.00658629221876936,0.283770609121883
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHEK2,Serine/threonine-protein kinase Chk2,28916,0.00247103797045585,0.0023158579315284,-0.00206804357533981,0.00701011951625151,0.28597732501355
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL31,Interleukin-31,24229,-0.0042045276745921,0.00395582071778859,-0.0119579362814577,0.00354888093227353,0.2878509919195
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCP11,T-complex protein 11 homolog,24445,-0.00437401622070153,0.00412464388790137,-0.0124583182409882,0.00371028579958514,0.288946262599436
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STC2,Stanniocalcin-2,29396,-0.00190386994339422,0.00179885261427575,-0.00542962106737469,0.00162188118058624,0.289890855270726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GUCY2C,Heat-stable enterotoxin receptor,24445,-0.00611857569821962,0.00579273701991875,-0.0174723402572604,0.00523518886082113,0.29086467631707
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHP1,Calcineurin B homologous protein 1,24101,0.0053489227775076,0.00509006996595419,-0.00462761435576261,0.0153254599107778,0.293335976678468
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPT,Microtubule-associated protein tau,28774,0.00384604313891987,0.00367206253599644,-0.00335119943163315,0.0110432857094729,0.294933370119704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PIK3IP1,Phosphoinositide-3-kinase-interacting protein 1,29443,0.00199815573926823,0.00191891238064513,-0.00176291252679621,0.00575922400533268,0.297746758224419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OSCAR,Osteoclast-associated immunoglobulin-like receptor,29497,-0.00244995969049016,0.00235432539014294,-0.00706443745517032,0.00216451807419001,0.298060162411519
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THY1,Thy-1 membrane glycoprotein,29694,-0.00204211709791898,0.00197947860700605,-0.00592189516765084,0.00183766097181287,0.302247357215948
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CINP,Cyclin-dependent kinase 2-interacting protein,24445,0.00312662314163697,0.00303202200437775,-0.00281613998694343,0.00906938627021736,0.302456931697419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLHL41,Kelch-like protein 41,24867,0.00355320488805899,0.00345328390256989,-0.003215231560978,0.010321641337096,0.303520204197501
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HEBP1,Heme-binding protein 1,28916,-0.00379917736819521,0.00369565118509236,-0.0110426536909762,0.00344429895458583,0.303952327662927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA8,Carbonic anhydrase-related protein,24229,0.00193873287091048,0.00189282121987694,-0.00177119672004832,0.00564866246186928,0.30572476113813
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFRSF21,Tumor necrosis factor receptor superfamily member 21,29694,-0.00195647058509653,0.00191330463478069,-0.00570654766926668,0.00179360649907361,0.306523820162729
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MSMB,Beta-microseminoprotein,29313,0.00492417936276511,0.0048217724022216,-0.00452649454558922,0.0143748532711194,0.307149912798934
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC7A,C-type lectin domain family 7 member A,29786,0.0041168818485651,0.004081506467114,-0.00388287082697835,0.0121166345241085,0.313142447293043
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1,DNA topoisomerase 1,24805,0.00792415845909495,0.00786413316378658,-0.00748954254192674,0.0233378594601166,0.313640614781544
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOLR3,Folate receptor gamma,29461,-0.0130605579733992,0.0129988384557212,-0.0385382813466128,0.0124171653998144,0.315026426458994
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVI2B,Protein EVI2B,24016,-0.00286309723326442,0.0028572082820406,-0.008463225466064,0.00273703099953516,0.316324192880977
NMR metabolomics,X23508.Triglycerides in Medium VLDL,USP28,Ubiquitin carboxyl-terminal hydrolase 28,24845,0.00254937277888897,0.00256788883562822,-0.00248368933894234,0.00758243489672029,0.32082227789856
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UBQLN3,Ubiquilin-3,24111,-0.00347141128098714,0.00350028516613352,-0.0103319702066088,0.00338914764463455,0.321328968658659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF2,Trefoil factor 2,29536,0.00395044791372108,0.00399618528736648,-0.00388207524951723,0.0117829710769594,0.322889140733326
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITPRIP,"Inositol 1,4,5-trisphosphate receptor-interacting protein",24101,-0.00312341903625451,0.00316686751283553,-0.00933047936141215,0.00308364128890312,0.324005491638786
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ROR1,Inactive tyrosine-protein kinase transmembrane receptor ROR1,29478,-0.00214436544601425,0.00220628649878962,-0.00646868698364189,0.0021799560916134,0.331091230873621
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPINK8,Serine protease inhibitor Kazal-type 8,24111,0.00252715785150956,0.00260842223790724,-0.00258534973478863,0.00763966543780775,0.332632061498329
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN7,Tetraspanin-7,24101,-0.00631328454692413,0.00654656731716119,-0.0191445564885601,0.00651798739471181,0.334872326597165
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCAM1,Neural cell adhesion molecule 1,29594,0.00201684558385866,0.00209280907732822,-0.00208506020770465,0.00611875137542198,0.335202920223532
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ERCC1,DNA excision repair protein ERCC-1,24016,0.00224086803778305,0.00232593991486735,-0.00231797419535695,0.00679971027092305,0.335344126088023
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP7,Retinoid-binding protein 7,24805,0.00402417183418014,0.00417843719469601,-0.00416556506742403,0.0122139087357843,0.335516466232259
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GRIN2B,"Glutamate receptor ionotropic, NMDA 2B",24101,-0.00374161291168852,0.00392564449740689,-0.011435876126606,0.00395265030322899,0.340538498939788
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL4A4,Collagen alpha-4(IV) chain,24405,-0.00349640442225722,0.0036730370171534,-0.0106955569758779,0.00370274813136345,0.341151541620778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT17,"Keratin, type I cytoskeletal 17",24111,0.00259126589555741,0.00272371208615884,-0.00274720979331392,0.00792974158442874,0.341424648772288
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMG4,Proteasome assembly chaperone 4,24229,0.00370810734316217,0.00389812513594007,-0.00393221792328035,0.0113484326096047,0.341484918358109
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KLK12,Kallikrein-12,28797,-0.00913736987961543,0.00961415565607036,-0.0279811149655133,0.00970637520628247,0.341912990772946
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NLGN1,Neuroligin-1,24195,-0.00447067134063644,0.0047562873832485,-0.0137929946118035,0.00485165193053063,0.347252703732346
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RAC3,Ras-related C3 botulinum toxin substrate 3,24195,0.0045090053231603,0.00483179595778938,-0.00496131475410688,0.0139793254004275,0.350728881275766
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSG1,Tryptase gamma,24229,0.00173068147401884,0.00185846452280765,-0.00191190899068415,0.00537327193872184,0.351737331423117
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSCA,Prostate stem cell antigen,24805,0.0166634616137712,0.0180103904876997,-0.0186369037421203,0.0519638269696627,0.354863718441741
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT8,"Keratin, type II cytoskeletal 8",24101,0.00465911016745898,0.00505348212478714,-0.00524571479712381,0.0145639351320418,0.356558490216439
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL13,Interleukin-13,28931,-0.0030820044166826,0.00334309203537713,-0.00963446480602177,0.00347045597265657,0.356587202592391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM1,Leucine-rich repeat and transmembrane domain-containing protein 1,24195,-0.00265205425213693,0.00288098956160613,-0.00829879379288494,0.00299468528861109,0.357301976893471
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CBLN1,Cerebellin-1,24101,-0.00607558816186574,0.00664033947055169,-0.0190906535241471,0.00693947720041558,0.36022628246078
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPLA2,Acyl-protein thioesterase 2,24101,0.00687268655326289,0.00752079374253573,-0.00786806918210714,0.0216134422886329,0.360818149596792
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGFBR1,TGF-beta receptor type-1,24229,0.00137668789515741,0.00150728424855507,-0.00157758923201054,0.00433096502232535,0.361064159211748
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC11A,C-type lectin domain family 11 member A,29388,-0.00304829801194844,0.00333850122853409,-0.00959176041987526,0.00349516439597839,0.361211221345135
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZP3,Zona pellucida sperm-binding protein 3,24240,-0.0163768981340419,0.0183363485469859,-0.0523161412861343,0.0195623450180505,0.3717918999659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PHLDB2,Pleckstrin homology-like domain family B member 2,24016,-0.00578379905519193,0.00650365116996589,-0.0185309553483251,0.00696335723794122,0.37384235202331
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UHRF2,E3 ubiquitin-protein ligase UHRF2,24111,-0.00217231080706185,0.00245467318941773,-0.00698347025832059,0.00263884864419689,0.376181933287867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIGLEC5,Sialic acid-binding Ig-like lectin 5,29443,-0.00728653252169969,0.00823501163665629,-0.023427155329546,0.00885409028614665,0.376259015809388
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA2,Ephrin type-A receptor 2,28347,0.00192424506447129,0.0021811791951669,-0.00235086615805584,0.00619935628699841,0.377673970227972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGLON5,IgLON family member 5,24016,-0.00570678563047998,0.00648951353540328,-0.0184262321598704,0.00701266089891044,0.379200967784087
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GTF2IRD1,General transcription factor II-I repeat domain-containing protein 1,24445,-0.00434523885211546,0.00496720306748828,-0.0140809568643925,0.00539047916016156,0.381699048778658
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3A,Microtubule-associated proteins 1A/1B light chain 3A,24101,-0.00192379166971288,0.00222058917993969,-0.00627614646239468,0.00242856312296892,0.386310776305848
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2RB,Interleukin-2 receptor subunit beta,28931,-0.00226002236728752,0.00261333888850195,-0.00738216658875133,0.00286212185417629,0.387154296327313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RETN,Resistin,29362,-0.00251385014263793,0.00292624818595583,-0.00824929658711136,0.0032215963018355,0.390309269601265
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDH4,Cadherin-4,24101,0.0028717742518939,0.00334378549622883,-0.00368204532071462,0.00942559382450241,0.390437752085953
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASA1,Ras GTPase-activating protein 1,28774,0.0019378731675468,0.00225793934053446,-0.00248768793990074,0.00636343427499433,0.390762384389367
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNNI3,"Troponin I, cardiac muscle",28916,0.00498554357307549,0.00584213027210698,-0.0064650317602542,0.0164361189064052,0.393456967717404
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TCN1,Transcobalamin-1,24546,0.00202460456152933,0.00237278709974256,-0.00262605815396609,0.00667526727702474,0.393523411377853
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNT,Aryl hydrocarbon receptor nuclear translocator,28931,0.00220203557712089,0.00258366195008143,-0.00286194184503871,0.00726601299928049,0.394058853207256
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARHGAP30,Rho GTPase-activating protein 30,24445,0.00228494445454621,0.00269398241751507,-0.00299526108378332,0.00756514999287573,0.396353805167445
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOTCH2,Neurogenic locus notch homolog protein 2,24938,-0.00126659062468537,0.00149633548840346,-0.00419940818195615,0.00166622693258542,0.397303379123556
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NME3,Nucleoside diphosphate kinase 3,29497,0.00138576977546665,0.00165641193423607,-0.00186079761563604,0.00463233716656935,0.402818947194456
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DIPK1C,Divergent protein kinase domain 1C,24195,0.00246477314808178,0.00294911516282958,-0.00331549257106419,0.00824503886722776,0.403294249679438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM21,Carcinoembryonic antigen-related cell adhesion molecule 21,29434,0.00492190047386707,0.00589102061823302,-0.00662449993786964,0.0164683008856038,0.403447546251882
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAFAH1B3,Platelet-activating factor acetylhydrolase IB subunit alpha1,24867,0.00669981380514399,0.00801959227883246,-0.00901858706136764,0.0224182146716556,0.403483266559136
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRAME,Melanoma antigen preferentially expressed in tumors,24016,-0.00145146914411297,0.00176819072722271,-0.00491712296946949,0.00201418468124355,0.411723827151843
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SIRPA,Tyrosine-protein phosphatase non-receptor type substrate 1,29527,-0.00326114000266858,0.00397505319947781,-0.0110522442736451,0.00452996426830793,0.411993829945867
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AKAP12,A-kinase anchor protein 12,24381,-0.00121971053021595,0.00149576526467692,-0.00415141044898272,0.00171198938855082,0.414827049714633
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RICTOR,Rapamycin-insensitive companion of mTOR,24229,-0.002734598866765,0.00335968565086834,-0.00931958274246694,0.00385038500893695,0.415684543605997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RLN2,Prorelaxin H2,24326,0.00638887988023776,0.00788142104361438,-0.00905870536524643,0.021836465125722,0.417588775607802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTAG1A_CTAG1B,Cancer/testis antigen 1,24396,-0.0028336717746387,0.00350311645975489,-0.00969978003575828,0.00403243648648088,0.418580418922269
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PAPPA,Pappalysin-1,28931,0.00264647031859854,0.00327210707370275,-0.00376685954585884,0.00905980018305592,0.418638587902613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDAC9,Histone deacetylase 9,24101,-0.00354006184091839,0.00450632207584986,-0.0123724531095841,0.00529232942774734,0.432123218355448
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DKKL1,Dickkopf-like protein 1,29349,-0.00463997607124414,0.00595192984366589,-0.0163057585648293,0.007025806422341,0.435647329161857
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMDHD2,N-acetylglucosamine-6-phosphate deacetylase,24938,-0.00137554826711753,0.00176481389591236,-0.00483458350310575,0.00208348696887069,0.435734067609651
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF20,Fibroblast growth factor 20,24229,-0.00236868439295088,0.00305205176090135,-0.00835070584431752,0.00361333705841576,0.437700034253152
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HNF1A,Hepatocyte nuclear factor 1-alpha,24195,0.00383609979034593,0.00495543600076101,-0.00587655477114564,0.0135487543518375,0.438867677258337
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POLR2A,DNA-directed RNA polymerase II subunit RPB1,24229,-0.0015892771087379,0.0020534914632265,-0.00561412037666184,0.00243556615918603,0.43897442680257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SERPINB5,Serpin B5,28916,0.00260966521723357,0.00337588030367726,-0.00400706017797386,0.009226390612441,0.439509464051507
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF75D,Zinc finger protein 75D,24445,0.00320809112649436,0.00417837213998739,-0.00498151826788092,0.0113977005208696,0.442622394377045
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SELL,L-selectin,24966,0.00123495180014116,0.00161054833614064,-0.00192172293869449,0.00439162653897681,0.443213843727535
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TAGLN3,Transgelin-3,24016,-0.00322155248311084,0.00420280135814062,-0.0114590431450664,0.00501593817884477,0.443371496728183
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3A,Sodium channel protein type 3 subunit alpha,24195,-0.00200337084384562,0.00262684232850892,-0.0071519818077231,0.00314524012003186,0.445677429449383
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAPRE3,Microtubule-associated protein RP/EB family member 3,24016,-0.00757323485595413,0.0099851536524421,-0.0271441360147407,0.0119976663028324,0.448189377629994
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARMCX2,Armadillo repeat-containing X-linked protein 2,24101,-0.00328409914259304,0.00434824733757963,-0.0118066639242491,0.00523846563906304,0.450094604207187
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PI16,Peptidase inhibitor 16,24951,0.00128576527177957,0.00170306496662999,-0.00205224206281521,0.00462377260637435,0.450273297537263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3RA,Interleukin-3 receptor subunit alpha,28931,0.00164229970863199,0.00219409330520651,-0.00265812316957276,0.00594272258683675,0.454158977746181
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MED21,Mediator of RNA polymerase II transcription subunit 21,24111,0.00252592347579388,0.00337951625754766,-0.00409792838899953,0.00914977534058729,0.454816399323708
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PTPRF,Receptor-type tyrosine-protein phosphatase F,29820,0.00149434458825249,0.00200047568630545,-0.00242658775690619,0.00541527693341117,0.455072696772898
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL9,Interleukin-9,24445,-0.00293422811113532,0.003945053585648,-0.0106665331390054,0.00479807691673476,0.457020391739863
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PPIE,Peptidyl-prolyl cis-trans isomerase E,24445,-0.00325433042549267,0.00437559626864343,-0.0118304991120338,0.00532183826104845,0.457037555630534
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTLA,B- and T-lymphocyte attenuator,24016,0.00448740600689632,0.00606905121495088,-0.0074079343744074,0.0163827463882,0.459676420579163
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TIGIT,T-cell immunoreceptor with Ig and ITIM domains,24445,0.00184561814752819,0.00253097716752781,-0.00311509710082632,0.00680633339588269,0.465879169642524
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LSM8,U6 snRNA-associated Sm-like protein LSm8,24445,0.00437735617853299,0.00600358161628033,-0.00738966378937646,0.0161443761464424,0.465932729534478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FOS,Proto-oncogene c-Fos,23970,-0.00178553799185887,0.00246774410949782,-0.0066223164464746,0.00305124046275686,0.469348678601255
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GIPR,Gastric inhibitory polypeptide receptor,24229,0.00234136671723126,0.0032768435567366,-0.00408124665397247,0.00876398008843499,0.474913249188933
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OGT,UDP-N-acetylglucosamine--peptide N-acetylglucosaminyltransferase 110 kDa subunit,24445,0.00311773686283812,0.0043823139974093,-0.00547159857208411,0.0117070722977604,0.47682075935017
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP8,Neutrophil collagenase,29640,0.00356507143102906,0.00501880286505153,-0.00627178218447193,0.0134019250465301,0.477497058609032
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HRAS,GTPase Hras,24421,0.00485231678190616,0.00684633645996327,-0.00856650267962185,0.0182711362434342,0.478488592448715
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDXDC1,Pyridoxal-dependent decarboxylase domain-containing protein 1,24016,0.00280976841387535,0.0040116808060757,-0.00505312596603302,0.0106726627937837,0.48368632074839
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NCLN,Nicalin,28931,-0.00252160570730383,0.00363064677472869,-0.00963767338577205,0.0045944619711644,0.48735329762568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL33,Interleukin-33,28931,0.00187494718454887,0.0027041575730479,-0.00342520165862502,0.00717509602772276,0.48809096944942
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR1,Toll-like receptor 1,24229,0.00127027723370533,0.00183345291209061,-0.00232329047399227,0.00486384494140293,0.488420815416482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA11,Carbonic anhydrase-related protein 11,28797,0.0015289794253127,0.00221230227923107,-0.0028071330419802,0.0058650918926056,0.489491992921092
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EXOSC10,Exosome component 10,24111,-0.00286265591385508,0.00421871687470981,-0.0111313409882863,0.00540602916057614,0.497422701552244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD10,Frizzled-10,24195,0.00283330373796583,0.00418586032802069,-0.00537098250495473,0.0110375899808864,0.498491813525551
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP53BP1,TP53-binding protein 1,24229,-0.00409190369200845,0.00607443103047794,-0.0159977885117452,0.0078139811277283,0.500554604734614
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP15,Matrix metalloproteinase-15,24922,0.00228936884648657,0.0034181314143834,-0.00441016872570489,0.00898890641867803,0.50300932935536
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD2,T-cell surface antigen CD2,24111,0.00178542535086658,0.00267183237487881,-0.00345136610389588,0.00702221680562904,0.503986786350617
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNFSF8,Tumor necrosis factor ligand superfamily member 8,24938,0.00167311179605622,0.00251654712242987,-0.00325932056390633,0.00660554415601877,0.506156290477739
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNIP4,Kv channel-interacting protein 4,28774,0.00235473034727394,0.0035440395028022,-0.00459158707821838,0.00930104777276626,0.506426931056558
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNPO1,Transportin-1,24445,0.00160041046672374,0.00245992267567249,-0.00322103797759434,0.00642185891104183,0.515314845155757
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DAND5,DAN domain family member 5,24229,-0.00245642596129181,0.00378300285435243,-0.00987111155582258,0.00495825963323895,0.516129768295277
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TEX101,Testis-expressed protein 101,24195,0.00228003539372646,0.00351985740176333,-0.00461888511372968,0.0091789559011826,0.517144031492046
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAG,Myelin-associated glycoprotein,24195,0.00212596549783032,0.00329795108155566,-0.00433801862201878,0.00858994961767942,0.519171670763452
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDCL2,Phosducin-like protein 2,24016,0.00236253125171668,0.00368922883062621,-0.00486835725631069,0.00959341975974405,0.521927662014169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHC1,SHC-transforming protein 1,24016,-0.00515306473673248,0.00811310548235589,-0.02105475148215,0.0107486220086851,0.525334571372706
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CGN,Cingulin,24195,0.00175488068160836,0.00277395874980216,-0.00368207846800389,0.0071918398312206,0.526983355484145
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC6A,C-type lectin domain family 6 member A,28797,0.00206035158812508,0.00326283019208567,-0.00433479558836284,0.00845549876461299,0.527743841465854
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCRL6,Fc receptor-like protein 6,29434,0.00292313800104528,0.00470771939859251,-0.00630399202019604,0.0121502680222866,0.53465415431257
NMR metabolomics,X23508.Triglycerides in Medium VLDL,APOH,Beta-2-glycoprotein 1,29443,-0.00154233883975226,0.00249151572128608,-0.00642570965347298,0.00334103197396846,0.535897193367194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RASGRF1,Ras-specific guanine nucleotide-releasing factor 1,24016,-0.00189445765402355,0.00307731436650265,-0.00792599381236873,0.00413707850432164,0.538150888557166
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CSH1,Chorionic somatomammotropin hormone 1,24951,0.00136409755898373,0.00223065433607536,-0.00300798493972397,0.00573618005769144,0.540858636666061
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CXCL12,Stromal cell-derived factor 1,28931,0.00168368252883247,0.00277813818124419,-0.00376146830640614,0.00712883336407108,0.544488248468934
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NOS2,"Nitric oxide synthase, inducible",24111,-0.00167113199465664,0.00275815126490441,-0.00707710847386929,0.00373484448455601,0.544594536462143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAP1LC3B2,Microtubule-associated proteins 1A/1B light chain 3 beta 2,24111,-0.002772654191084,0.00457627718565929,-0.0117421574749762,0.00619684909280822,0.544603141615371
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPHA10,Ephrin type-A receptor 10,28774,0.00275147901333751,0.00454166347375896,-0.00615018139523006,0.0116531394219051,0.544631984008834
NMR metabolomics,X23508.Triglycerides in Medium VLDL,REG1B,Lithostathine-1-beta,29820,-0.00236337058438127,0.00390562279262055,-0.0100183912579176,0.00529165008915502,0.545103852699968
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GJA8,Gap junction alpha-8 protein,24016,0.00260580559235337,0.00432583294507853,-0.00587282698000055,0.0110844381647073,0.546925319301851
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRYBB2,Beta-crystallin B2,24845,0.00286560889057941,0.00480389111172415,-0.00655001768839993,0.0122812354695587,0.550834479980035
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UNC5D,Netrin receptor UNC5D,24229,0.00109339994155572,0.00183480140852946,-0.00250281081916201,0.00468961070227345,0.551232389562859
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEACAM18,Carcinoembryonic antigen-related cell adhesion molecule 18,24445,-0.00283143535705272,0.00477784248985582,-0.0121960066371701,0.00653313592306468,0.553442329442263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB1,Leukocyte immunoglobulin-like receptor subfamily B member 1,29820,0.00112644947103818,0.0019014924984233,-0.00260047582587149,0.00485337476794785,0.55358538893478
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TXK,Tyrosine-protein kinase TXK,24445,-0.0030666743356151,0.00517866152467759,-0.0132168509239832,0.00708350225275298,0.553738830713771
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD48,CD48 antigen,29536,0.00121144652528467,0.00207618032027689,-0.00285786690245804,0.00528075995302738,0.559562735361639
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGAX,Integrin alpha-X,24445,0.00215173766585642,0.00371998548751885,-0.00513943388968053,0.00944290922139336,0.562981633107674
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TBR1,T-box brain protein 1,24195,0.00193916480635792,0.00335862616893506,-0.00464374248475479,0.00852207209747063,0.563695953700857
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRISP2,Cysteine-rich secretory protein 2,29725,0.00228712988191629,0.00399154399696031,-0.00553629635212592,0.0101105561159585,0.566653241925465
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MYL6B,Myosin light chain 6B,24195,-0.00363851929207483,0.00637826568066696,-0.0161399200261821,0.00886288144203241,0.568373824903029
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL17F,Interleukin-17F,28931,-0.00302851766224366,0.00531885931642185,-0.0134534819224305,0.00739644659794316,0.569094348239512
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYTH3,Cytohesin-3,24016,0.002893193320314,0.00510002457881911,-0.00710285485417146,0.0128892414947995,0.570522425235318
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TOP1MT,"DNA topoisomerase I, mitochondrial",24016,-0.00185592094675147,0.00339590350575255,-0.00851189181802647,0.00480004992452352,0.584715290758201
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CRX,Cone-rod homeobox protein,28916,-0.00406844229506279,0.00744442667304612,-0.0186595185742332,0.0105226339841076,0.584720680017022
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FZD8,Frizzled-8,24101,0.00166963094071347,0.00305865513137251,-0.00432533311677665,0.00766459499820359,0.585159713013973
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OMP,Olfactory marker protein,24101,-0.00186593284959396,0.00343104584056314,-0.00859078269709771,0.0048589169979098,0.586558042083816
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAD1,Glutamate decarboxylase 1,24016,-0.000983070810901542,0.00180957278038293,-0.00452983346045208,0.002563691838649,0.586954969964028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PALLD,Palladin,24229,-0.00149296901500397,0.00277498631103073,-0.00693194218462421,0.00394600415461627,0.590575430333487
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TSPAN1,Tetraspanin-1,28916,0.00208739540009582,0.00393580436560976,-0.00562678115649931,0.00980157195669095,0.595866041549134
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2,Low-density lipoprotein receptor-related protein 2,24195,0.0013307392491627,0.00252056006241961,-0.00360955847317973,0.00627103697150512,0.597536250718967
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF4,E3 ubiquitin-protein ligase RNF4,24445,-0.00241111299962269,0.00460128716935034,-0.0114296358515494,0.00660740985230398,0.600277470296709
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORC3,MORC family CW-type zinc finger protein 3,24845,0.00102276448911289,0.00195259366074175,-0.00280431908594094,0.00484984806416671,0.600423778258751
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AXL,Tyrosine-protein kinase receptor UFO,29594,0.000999895999387305,0.00191302470718117,-0.00274963242668779,0.0047494244254624,0.601202239014199
NMR metabolomics,X23508.Triglycerides in Medium VLDL,WFDC12,WAP four-disulfide core domain protein 12,29662,-0.00230775502871134,0.00441707965410329,-0.0109652311507538,0.00634972109333112,0.601352797040236
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTF,Ciliary neurotrophic factor,24101,-0.00123819838429515,0.00237159606774719,-0.00588652667707965,0.00341012990848934,0.601609007684785
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MLLT1,Protein ENL,24016,-0.00250889454548889,0.00481026866965203,-0.0119370211380069,0.00691923204702908,0.60197417497173
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VSTM2B,V-set and transmembrane domain-containing protein 2B,24445,0.00148567066010146,0.00285190486326904,-0.00410406287190585,0.00707540419210877,0.602413451812769
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAGE2A,G antigen 2A,24016,0.00229847581973567,0.00441958001188151,-0.00636390100355209,0.0109608526430234,0.603021973734666
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TET2,Methylcytosine dioxygenase TET2,24421,-0.00361701744949536,0.00697435097904897,-0.0172867453684313,0.0100527104694406,0.604032506678778
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZPR1,Zinc finger protein ZPR1,24101,0.00347359024652056,0.00671837142874931,-0.00969441775382808,0.0166415982468692,0.605140933950401
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THSD1,Thrombospondin type-1 domain-containing protein 1,24059,-0.00123095344822455,0.00239340342269434,-0.00592202415670545,0.00346011726025636,0.607039374817927
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCAR,Immunoglobulin alpha Fc receptor,29434,-0.00169938525568469,0.0033085002695429,-0.00818404578398878,0.00478527527261939,0.607506048531096
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IDI2,Isopentenyl-diphosphate delta-isomerase 2,28774,-0.00169298465169957,0.00330065105285875,-0.00816226071530271,0.00477629141190358,0.608008103757947
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGM2,Protein-glutamine gamma-glutamyltransferase 2,29427,0.00261604860846971,0.00510162001693749,-0.00738312662472777,0.0126152238416672,0.608103601406925
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CAPN3,Calpain-3,24793,0.00134874181035837,0.00263440653692622,-0.00381469500201703,0.00651217862273377,0.608675320976399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL3A1,Collagen alpha-1(III) chain,24938,-0.000827867829703866,0.00161818369180571,-0.00399950786564305,0.00234377220623532,0.608933331988292
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PROK1,Prokineticin-1,29434,0.0021677275238472,0.0042548543459365,-0.00617178699418833,0.0105072420418827,0.610425509488252
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3,Microfibril-associated glycoprotein 3,28916,0.00172265207158385,0.00338601283597457,-0.0049139330869263,0.00835923723009401,0.610927618741098
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LYPD1,Ly6/PLAUR domain-containing protein 1,28774,-0.00222895168396885,0.00438315312402924,-0.0108199318070662,0.00636202843912846,0.611087713612557
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLK,STE20-like serine/threonine-protein kinase,24445,0.00275479503719886,0.00542753443179806,-0.00788317244912534,0.0133927625235231,0.611767091020626
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GNGT1,Guanine nucleotide-binding protein G(T) subunit gamma-T1,24195,-0.00180074009408332,0.0035654811704492,-0.00878908318816375,0.00518760299999711,0.613529536580113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,THRAP3,Thyroid hormone receptor-associated protein 3,24111,-0.00397852892992632,0.00787971298981358,-0.0194227663899609,0.0114657085301083,0.613628178892113
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF830,Zinc finger protein 830,24793,-0.00277555605526459,0.00550240262906498,-0.0135602652082319,0.00800915309770277,0.613966395169744
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FAM171A2,Protein FAM171A2,24867,0.00549160013166378,0.0110033569884676,-0.0160749795657328,0.0270581798290603,0.61772458064864
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ST8SIA1,"Alpha-N-acetylneuraminide alpha-2,8-sialyltransferase",24229,0.00169053395927504,0.00340068632713621,-0.00497481124191194,0.00835587916046202,0.619112102554472
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPDL3B,Acid sphingomyelinase-like phosphodiesterase 3b,24793,-0.00262045519942494,0.00532219981197558,-0.0130519668308971,0.0078110564320472,0.622466989055791
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTN5,Contactin-5,29511,0.00125963673529533,0.0025690609252768,-0.00377572267824719,0.00629499614883785,0.62391806851816
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED4,Transmembrane emp24 domain-containing protein 4,24111,-0.00192794814924063,0.00394330764879131,-0.0096568311408716,0.00580093484239034,0.624905267780613
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DDX4,Probable ATP-dependent RNA helicase DDX4,24229,-0.00184036574483285,0.0037844055624404,-0.00925780064721603,0.00557706915755033,0.626757134280762
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IKZF2,Zinc finger protein Helios,28797,-0.00305987813958549,0.00633826073196345,-0.0154828691742338,0.00936311289506287,0.629267654699805
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT19,"Keratin, type I cytoskeletal 19",29378,-0.00225567753848482,0.00469906373186156,-0.0114658424529335,0.00695448737596383,0.631211759021657
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNGB3,Cyclic nucleotide-gated cation channel beta-3,24101,0.00178576789478738,0.00377403749316185,-0.00561134559180984,0.0091828813813846,0.6360949442964
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PKLR,Pyruvate kinase PKLR,29491,-0.0020901853663708,0.00447251036447024,-0.0108563056807325,0.00667593494799086,0.64025971759678
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPGN,Epigen,24793,-0.00155466653862296,0.00333228057264849,-0.008085936461014,0.00497660338376808,0.640827893167075
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC34A3,Sodium-dependent phosphate transport protein 2C,24016,-0.0015992820083789,0.0034365270903542,-0.00833487510547313,0.00513631108871532,0.641665444973789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRTM2,Leucine-rich repeat and transmembrane domain-containing protein 2,24867,-0.000827110935341668,0.00181949217645783,-0.00439331560119902,0.00273909373051568,0.649412951480307
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB7,Integrin beta-7,29725,0.00143496117725016,0.00317702936687391,-0.00479201638182271,0.00766193873632303,0.651511771375681
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MMP9,Matrix metalloproteinase-9,29411,-0.00188422630051692,0.00419470821144798,-0.010105854394955,0.00633740179392113,0.653296997415976
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ISM2,Isthmin-2,24938,-0.00135359089611376,0.00305406960836557,-0.00733956732851028,0.00463238553628275,0.657618473562726
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRIG1,Leucine-rich repeats and immunoglobulin-like domains protein 1,29632,-0.0010440043424443,0.0023869233083599,-0.00572237402682971,0.00363436534194111,0.661835382755212
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PODXL2,Podocalyxin-like protein 2,29566,0.000842439864671456,0.00193435563960298,-0.00294889718895038,0.0046337769182933,0.663192221407419
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC4C,C-type lectin domain family 4 member C,29434,0.00140550604008851,0.00324959885570333,-0.00496370771709002,0.00777471979726703,0.665369027921786
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ABO,Histo-blood group ABO system transferase,24951,0.00425825586942871,0.010013552321487,-0.0153683066806859,0.0238848184195433,0.670658636045391
NMR metabolomics,X23508.Triglycerides in Medium VLDL,VWA5A,von Willebrand factor A domain-containing protein 5A,24016,0.00235574280672708,0.00554649338491139,-0.00851538422769925,0.0132268698411534,0.671039859424931
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GADD45B,Growth arrest and DNA damage-inducible protein GADD45 beta,24445,-0.00145476023170981,0.00342622075248796,-0.00817015290658621,0.00526063244316659,0.671134819640138
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTLA4,Cytotoxic T-lymphocyte protein 4,24938,-0.00087668573019989,0.00206980936616229,-0.00493351208787798,0.0031801406274782,0.671891347476704
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCN3B,Sodium channel subunit beta-3,24101,0.00135209921713512,0.00320636621102595,-0.00493237855647574,0.00763657699074599,0.673253553754568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLNS1A,Methylosome subunit pICln,24195,-0.000967858355262534,0.00232992275376045,-0.00553450695263301,0.00359879024210795,0.677850140097974
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCDH17,Protocadherin-17,29478,-0.0010361538690266,0.00249676684978637,-0.00592981689460788,0.00385750915655467,0.678146207129997
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGLYRP1,Peptidoglycan recognition protein 1,29673,-0.001218129417426,0.00293712082631429,-0.00697488623700202,0.00453862740215002,0.678338256235361
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEND1,Cell cycle exit and neuronal differentiation protein 1,24101,0.00169389250899941,0.00409687954754455,-0.0063359914041879,0.00972377642218672,0.679273895358601
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCNA,Proliferating cell nuclear antigen,24016,0.00179566470150959,0.00440109757088189,-0.00683048653741891,0.0104218159404381,0.683274496296825
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RBP1,Retinol-binding protein 1,24195,-0.00196694526753989,0.00482266872767553,-0.0114193759737839,0.00748548543870415,0.683384395225208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LTA4H,Leukotriene A-4 hydrolase,29725,-0.00163929624689251,0.00406334103823261,-0.00960344468182843,0.00632485218804341,0.686630738233047
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL5,Interleukin-5,28931,0.00394709391639483,0.00986421258606478,-0.0153867627522921,0.0232809505850818,0.689054277272381
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHGB,Secretogranin-1,29590,0.00112463410581106,0.00285374609865937,-0.00446870824756129,0.00671797645918342,0.693517097126041
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTN1A1,Butyrophilin subfamily 1 member A1,24751,-0.00110354018232848,0.0028008793808845,-0.0065932637688621,0.00438618340420514,0.693586094372438
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA5,Annexin A5,28650,0.000830145686430614,0.00211271339426683,-0.00331077256633238,0.00497106393919361,0.694375082628918
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ALMS1,Alstrom syndrome protein 1,24445,-0.00121822859789232,0.00310406607450354,-0.00730219810391926,0.00486574090813462,0.694720160036422
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GPHA2,Glycoprotein hormone alpha-2,24805,-0.00126353586927197,0.00323363630342461,-0.0076014630239842,0.00507439128544025,0.695987112497561
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE2,Adhesion G protein-coupled receptor E2,29581,-0.000760419534859805,0.00195557027923092,-0.0045933372821524,0.00307249821243279,0.697391412376789
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BCL7A,B-cell CLL/lymphoma 7 protein family member A,24016,0.00167760295263673,0.00443724082571421,-0.00701938906576312,0.0103745949710366,0.705379373435162
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SAP18,Histone deacetylase complex subunit SAP18,24445,-0.00190411611643848,0.00510390426240181,-0.011907768470746,0.00809953623786908,0.709099210318576
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PRC1,Protein regulator of cytokinesis 1,24793,0.00116877492723357,0.00315393069713292,-0.00501292923914695,0.00735047909361408,0.710955605757752
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ECSCR,Endothelial cell-specific chemotaxis regulator,24101,0.00128605304891893,0.00349037044653623,-0.00555507302629207,0.00812717912412994,0.712535393238522
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SKIV2L,Helicase SKI2W,24111,-0.00102089708184454,0.00278395717543927,-0.00647745314570551,0.00443565898201643,0.713840670916696
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OFD1,Oral-facial-digital syndrome 1 protein,24445,-0.00169888556463944,0.0046557540057043,-0.0108241634158199,0.00742639228654099,0.715189064052979
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NELL1,Protein kinase C-binding protein NELL1,29566,0.00105079607809165,0.00293117816341357,-0.00469431312219894,0.00679590527838224,0.719979716753772
NMR metabolomics,X23508.Triglycerides in Medium VLDL,COL5A1,Collagen alpha-1(V) chain,24381,-0.00100530198236978,0.00280431211559498,-0.00650175372893594,0.00449114976419637,0.719983989519215
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE1,Adhesion G protein-coupled receptor E1,24805,-0.00134731247285805,0.0038052854664056,-0.00880567198701303,0.00611104704129693,0.723294349373057
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MORN4,MORN repeat-containing protein 4,24016,0.00190412506772182,0.00545623333367258,-0.00879009226627643,0.0125983424017201,0.727106180539231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NENF,Neudesin,24793,0.00263918032680881,0.00763132102253398,-0.0123182088773578,0.0175965695309754,0.729469417649149
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMPRSS11B,Transmembrane protease serine 11B,24101,-0.00185154820997208,0.00536986373808706,-0.0123764811366227,0.00867338471667856,0.730245056334158
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC51B,Organic solute transporter subunit beta,24111,0.00179111828221578,0.00531096464802245,-0.00861837242790822,0.0122006089923398,0.735932030604263
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL21R,Interleukin-21 receptor,24229,-0.00128083431333783,0.00382533855063281,-0.00877849787257814,0.00621682924590248,0.737756976993338
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EVPL,Envoplakin,24445,-0.000788372365638813,0.00235803601085665,-0.00541012294691785,0.00383337821564022,0.738130165425547
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATF4,Cyclic AMP-dependent transcription factor ATF-4,24016,-0.000784581243212094,0.00236587208065687,-0.00542169052129955,0.00385252803487537,0.740175681530722
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BHMT2,S-methylmethionine--homocysteine S-methyltransferase BHMT2,24111,0.000593433894019984,0.00179952128774573,-0.00293362782996165,0.00412049561800162,0.741574205190802
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EFNB2,Ephrin-B2,24195,-0.00130743053119808,0.00401475361481498,-0.00917634761623544,0.00656148655383929,0.744687092247909
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPSD1,Tryptase delta,24867,-0.000837823085662644,0.00259747376512992,-0.00592887166531728,0.004253225493992,0.747036468389742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CNTNAP4,Contactin-associated protein-like 4,24195,0.00230229082256847,0.00716858353177934,-0.011748132899719,0.016352714544856,0.74808890233237
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENPEP,Glutamyl aminopeptidase,24111,-0.000990382013265003,0.00309709558565377,-0.00706068936114639,0.00507992533461638,0.749139647802933
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BTNL10,Butyrophilin-like protein 10,24016,-0.000908078317105924,0.00284393201891182,-0.00648218507417308,0.00466602843996123,0.749498925812399
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL18RAP,Interleukin-18 receptor accessory protein,29038,0.0037119293108365,0.0119241493973423,-0.0196594035079543,0.0270832621296273,0.755578525706854
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARNTL,Aryl hydrocarbon receptor nuclear translocator-like protein 1,24111,-0.00113389351685052,0.00365030114983232,-0.00828848377052186,0.00602069673682083,0.756084506571738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UPK3A,Uroplakin-3a,24101,-0.00104524540051026,0.00342350777974339,-0.0077553206488073,0.00566482984778677,0.760129530895338
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANKRA2,Ankyrin repeat family A protein 2,24016,-0.00117022610078059,0.00387343647211651,-0.00876216158612895,0.00642170938456777,0.762566456643575
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PCARE,Photoreceptor cilium actin regulator,24101,-0.00174257959902104,0.0058871263989722,-0.0132813473410065,0.00979618814296447,0.767233906346335
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HBZ,Hemoglobin subunit zeta,24922,-0.00217412319620971,0.0073538933611705,-0.0165877541841039,0.0122395077916845,0.767505600839204
NMR metabolomics,X23508.Triglycerides in Medium VLDL,S100A16,Protein S100-A16,28722,0.00125656457500018,0.00426871863815366,-0.007110123955781,0.00962325310578136,0.768480561874098
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NGFR,Tumor necrosis factor receptor superfamily member 16,24922,-0.000604250987651006,0.00206388422887797,-0.00464946407625182,0.00344096210094981,0.769697583721007
NMR metabolomics,X23508.Triglycerides in Medium VLDL,STEAP4,Metalloreductase STEAP4,24101,0.00148770625973434,0.00514919573787977,-0.00860471738651001,0.0115801299059787,0.772644991476809
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPBGL,Trophoblast glycoprotein-like,24195,-0.000823979272637081,0.00286213276086283,-0.00643375948392822,0.00478580093865406,0.773433443315607
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TLR2,Toll-like receptor 2,24445,-0.000454297927356532,0.00159879108902554,-0.00358792846184658,0.00267933260713352,0.776297149121324
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF6,Fibroblast growth factor 6,24229,-0.000774994508705758,0.00286214334538674,-0.00638479546566376,0.00483480644825224,0.786567029816143
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MRPL28,"39S ribosomal protein L28, mitochondrial",24867,-0.000671768756275897,0.00253691333945515,-0.00564411890160799,0.00430058138905619,0.791167523293987
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GAL,Galanin peptides,29581,0.00118230351809625,0.00446892620920443,-0.00757679185194442,0.00994139888813693,0.791349523239972
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FH,"Fumarate hydratase, mitochondrial",24101,0.00152240439537987,0.00583595504352896,-0.00991606748993689,0.0129608762806966,0.794197791686905
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CEP350,Centrosome-associated protein 350,24016,0.000648847180576612,0.00257239587997354,-0.00439304874417153,0.00569074310532476,0.800861914907089
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RNF168,E3 ubiquitin-protein ligase RNF168,24229,-0.000710820111046842,0.00283741465598272,-0.00627215283677298,0.0048505126146793,0.802189820293741
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGFL4,Insulin growth factor-like family member 4,24229,0.0013058989487818,0.00523637102040451,-0.00895738825121105,0.0115691861487747,0.8030611788461
NMR metabolomics,X23508.Triglycerides in Medium VLDL,OLR1,Oxidized low-density lipoprotein receptor 1,29216,0.000999991312573136,0.00404403655654121,-0.00692632033824763,0.0089263029633939,0.804696727782355
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNC4,Potassium voltage-gated channel subfamily C member 4,24101,0.000933470453720097,0.00389983159743846,-0.00671019947725928,0.00857714038469947,0.810827136027305
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADAMTS16,A disintegrin and metalloproteinase with thrombospondin motifs 16,28916,-0.000527002006406598,0.00220538158912227,-0.00484954992108624,0.00379554590827304,0.811136879854067
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITGB2,Integrin beta-2,29274,-0.000476135284135441,0.0019934140910656,-0.00438322690262402,0.00343095633435314,0.811220330649264
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATRAID,All-trans retinoic acid-induced differentiation factor,24805,0.000464645316185218,0.00196691344187268,-0.00339050502988523,0.00431979566225567,0.813255619062363
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDC25A,M-phase inducer phosphatase 1,24016,-0.000648651854730993,0.00281458137517572,-0.0061652313500754,0.00486792764061341,0.817735359324296
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARG2,"Arginase-2, mitochondrial",24793,-0.000670198422773123,0.00300969372355776,-0.00656919812094634,0.00522880127540009,0.823786449029018
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ESR1,Estrogen receptor,24229,0.000885349742655754,0.00400287035432491,-0.00696027615182108,0.00873097563713258,0.824955142573189
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ATP1B1,Sodium/potassium-transporting ATPase subunit beta-1,24111,-0.000747408366955137,0.00338675307521211,-0.00738544439437087,0.00589062766046059,0.825338945833286
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TP73,Tumor protein p73,24195,0.000528905857174442,0.00240363787278446,-0.0041822243734831,0.00524003608783198,0.825838820970756
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SCIN,Adseverin,24101,-0.00109962790081453,0.0051064056308572,-0.0111081829372946,0.00890892713566558,0.829501853214043
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN4,Prefoldin subunit 4,24016,0.000786938043189546,0.00372255877258319,-0.0065092771510735,0.00808315323745259,0.832579232270205
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LILRB2,Leukocyte immunoglobulin-like receptor subfamily B member 2,29673,0.000503846226688749,0.00239635099475506,-0.00419300172303116,0.00520069417640866,0.833469627628553
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CHIT1,Chitotriosidase-1,29579,0.0022131516196177,0.0105667085903955,-0.0184975972175575,0.0229239004567929,0.834101767691244
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD164L2,CD164 sialomucin-like 2 protein,24195,-0.000525197180487798,0.00254660951730892,-0.00551655183441328,0.00446615747343769,0.836609954707775
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TNR,Tenascin-R,29218,-0.000599829615442843,0.00292744066419301,-0.00633761331726114,0.00513795408637545,0.837652477634811
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SEMA4C,Semaphorin-4C,29349,-0.000395975401308198,0.00195042056586996,-0.00421879971041332,0.00342684890779693,0.839120400092465
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KCNH2,Potassium voltage-gated channel subfamily H member 2,24195,-0.00109830511261466,0.00543489564381804,-0.011750700574498,0.0095540903492687,0.839852804690534
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PSMA1,Proteasome subunit alpha type-1,28797,-0.000644423748542281,0.00321612878368617,-0.00694803616456718,0.00565918866748262,0.841190684759565
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KIR2DS4,Killer cell immunoglobulin-like receptor 2DS4,24805,-0.00237505650629924,0.0119765165545797,-0.0258490289532755,0.0210989159406771,0.842804578323
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BLOC1S2,Biogenesis of lysosome-related organelles complex 1 subunit 2,24101,0.00100166497625033,0.0051220032809609,-0.00903746145443304,0.0110407914069337,0.844955301445041
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KHDC3L,KH domain-containing protein 3,24016,-0.000917173237291991,0.00469994801183548,-0.0101290713404895,0.00829472486590556,0.84528077302194
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PGR,Progesterone receptor,24229,-0.00134847878853249,0.00707636287803418,-0.0152181500294795,0.0125211924524145,0.848871144917208
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CYP24A1,"1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial",24111,-0.00112683845989548,0.00600137308577787,-0.0128895297080201,0.0106358527882291,0.851063676975993
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ENG,Endoglin,29820,-0.000221478971575292,0.00119294095457101,-0.00255964324253447,0.00211668529938388,0.852714269642856
NMR metabolomics,X23508.Triglycerides in Medium VLDL,EPB41L5,Band 4.1-like protein 5,24195,-0.000808802544201101,0.00437149551490679,-0.00937693375341841,0.00775932866501621,0.853216973737021
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LRP2BP,LRP2-binding protein,24195,-0.00106257287688933,0.00574726840581185,-0.0123272189522806,0.0102020731985019,0.85332226665629
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MEGF11,Multiple epidermal growth factor-like domains protein 11,24111,0.00040870361273151,0.00226301304304035,-0.00402680195162757,0.00484420917709059,0.856681875459862
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL10,Interleukin-10,28931,0.0010223412946045,0.00567781350508856,-0.0101061731753691,0.0121508557645781,0.857107529032688
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2A,Pancreatic alpha-amylase,28334,0.000593738998517064,0.0033239062591128,-0.00592111726934403,0.00710859526637815,0.858231965901014
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PXDNL,Peroxidasin-like protein,24793,0.000704723182746966,0.00401795959225928,-0.00717047761808122,0.00857992398357516,0.860772039781958
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IGDCC3,Immunoglobulin superfamily DCC subclass member 3,24101,0.000596754564878096,0.00341362132056586,-0.00609394322343099,0.00728745235318718,0.861225929042133
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL24,Interleukin-24,28931,-0.000581734548243944,0.00338239173568534,-0.00721122235018721,0.00604775325369933,0.863447293015735
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HLA_A,,24867,0.00039029719320805,0.00227036384099395,-0.00405961593514008,0.00484021032155618,0.863510049671568
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CTHRC1,Collagen triple helix repeat-containing protein 1,24938,-0.000329559072029666,0.00194972763220786,-0.00415102523115708,0.00349190708709775,0.865775783452301
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SLC1A4,Neutral amino acid transporter A,24195,0.000606044859380567,0.00359053299121168,-0.00643139980339433,0.00764348952215546,0.86596349988999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HSP90B1,Endoplasmin,28626,-0.000775235415650867,0.00465638517037492,-0.00990175034958572,0.00835127951828398,0.867773568176271
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD5L,CD5 antigen-like,24833,-0.000545236242490769,0.00328139652737912,-0.00697677343615384,0.0058863009511723,0.868032535626363
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CD3G,T-cell surface glycoprotein CD3 gamma chain,24229,-0.00103912304137385,0.00630518408281397,-0.0133972838436892,0.0113190377609415,0.869099196278659
NMR metabolomics,X23508.Triglycerides in Medium VLDL,KRT6C,"Keratin, type II cytoskeletal 6C",24111,-0.000452033490827901,0.00276637541007897,-0.00587412929458268,0.00497006231292688,0.870202667902245
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FCGR2A,Low affinity immunoglobulin gamma Fc region receptor II-a,29372,0.000638679101596459,0.00412092234253393,-0.00743832868977004,0.00871568689296295,0.876834599858608
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SPRR1B,Cornifin-B,24445,0.000869659347021873,0.00594633729606977,-0.0107851617532749,0.0125244804473186,0.883724244248991
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PDIA2,Protein disulfide-isomerase A2,24016,-0.000398279767545566,0.00283608139198086,-0.00595699929582806,0.00516043976073693,0.888318967037115
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CA3,Carbonic anhydrase 3,29761,-0.000568452261543202,0.00415844416169692,-0.00871900281846916,0.00758209829538276,0.891270195745313
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CDSN,Corneodesmosin,29676,-0.000407200814581187,0.00300648282700486,-0.00629990715551072,0.00548550552634835,0.892264187931521
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GSN,Gelsolin,24845,-0.000176703154146933,0.00132261406787976,-0.00276902672719126,0.00241562041889739,0.893718822082197
NMR metabolomics,X23508.Triglycerides in Medium VLDL,C1QTNF5,Complement C1q tumor necrosis factor-related protein 5,24381,-0.000347809417905495,0.00261331745006025,-0.00546991162002359,0.0047742927842126,0.894122395243769
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CCDC50,Coiled-coil domain-containing protein 50,24867,-0.00067471826201196,0.00531218082451337,-0.0110865926780582,0.00973715615403424,0.898930803318482
NMR metabolomics,X23508.Triglycerides in Medium VLDL,FGF3,Fibroblast growth factor 3,24229,0.000263142405490827,0.00208669789456529,-0.00382678546785715,0.0043530702788388,0.899650096519808
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL1,Interferon lambda-1,28774,-0.000382424350994,0.00314503688092242,-0.00654669663760194,0.00578184793561393,0.903219718616906
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RUVBL1,RuvB-like 1,28797,-0.000872528406406076,0.00717767619505744,-0.0149407737487187,0.0131957169359065,0.903247229291747
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFF1,Trefoil factor 1,29319,-0.000641291593952867,0.00547313573438295,-0.0113686376333434,0.0100860544454377,0.906725522960231
NMR metabolomics,X23508.Triglycerides in Medium VLDL,POF1B,Protein POF1B,24229,-0.000370250421455381,0.0031880364465171,-0.00661880185662889,0.00587830101371813,0.90754457235924
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMMR,Hyaluronan mediated motility receptor,23975,0.000372153185408391,0.0033693984607593,-0.00623186779767984,0.00697617416849662,0.912052690819509
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SMPD3,Sphingomyelin phosphodiesterase 3,24229,0.000434800527947515,0.00401537975901984,-0.00743534379973137,0.0083049448556264,0.913771479980584
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL6,Interleukin-6,29349,0.000538317491838602,0.00510877286470208,-0.00947487732297747,0.0105515123066547,0.916081993835742
NMR metabolomics,X23508.Triglycerides in Medium VLDL,LMOD2,Leiomodin-2,24101,-0.000459354984632347,0.00440243128752296,-0.00908812030817735,0.00816941033891265,0.916899448381386
NMR metabolomics,X23508.Triglycerides in Medium VLDL,UGDH,UDP-glucose 6-dehydrogenase,24111,0.00069871805738786,0.00682420569285706,-0.012676725100612,0.0140741612153877,0.918449410737423
NMR metabolomics,X23508.Triglycerides in Medium VLDL,AMY2B,Alpha-amylase 2B,27585,-0.000338238143793665,0.00340457692416415,-0.0070112089151554,0.00633473262756807,0.92086263576223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NAAA,N-acylethanolamine-hydrolyzing acid amidase,29087,0.000380218503679019,0.00412392195956126,-0.00770266853706104,0.00846310554441908,0.926541141343992
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DCDC2C,Doublecortin domain-containing protein 2C,24016,-0.000398274706101639,0.00440626163879751,-0.00903454751814476,0.00823799810594148,0.927979370740052
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ANXA10,Annexin A10,28774,-0.000512335825315605,0.00569636193959316,-0.0116772052269182,0.010652533576287,0.92833481879919
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL3,Interleukin-3,24016,-0.000372315204667663,0.00421127885283798,-0.00862642175623011,0.00788179134689478,0.92955229826028
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ITIH5,Inter-alpha-trypsin inhibitor heavy chain H5,24793,0.000269913150401223,0.00309817915358131,-0.00580251799061815,0.00634234429142059,0.930576887875548
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL2,Interleukin-2,28931,0.000186870087863512,0.00219121924688982,-0.00410791963604053,0.00448165981176755,0.932038325746372
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20,Interleukin-20,28931,0.000289757660268498,0.00339901796639834,-0.00637231755387225,0.00695183287440924,0.932065247575226
NMR metabolomics,X23508.Triglycerides in Medium VLDL,GFRA3,GDNF family receptor alpha-3,29157,0.000165416894383142,0.00195438143060993,-0.00366517070961232,0.0039960044983786,0.932548972337223
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLEC2L,C-type lectin domain family 2 member L,24195,0.000287900949715831,0.00349240108953766,-0.00655720518577798,0.00713300708520965,0.934300379189198
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IFNL2,Interferon lambda-2,24101,0.000350111761282927,0.00430349546610055,-0.00808473935227415,0.00878496287484001,0.935160147140207
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZNF174,Zinc finger protein 174,24229,0.000213747168506182,0.00262844570807406,-0.00493800641931898,0.00536550075633134,0.93518754696904
NMR metabolomics,X23508.Triglycerides in Medium VLDL,PFDN6,Prefoldin subunit 6,24195,0.000337990730531287,0.0045477229206814,-0.00857554619400426,0.00925152765506684,0.94075568471179
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HMCN2,Hemicentin-2,24343,-0.000279319718408478,0.00400331552478391,-0.00812581814698494,0.00756717871016799,0.944375629985942
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ACRV1,Acrosomal protein SP-10,24229,-0.000364201009705008,0.00533583657233617,-0.0108224406914839,0.0100940386720739,0.945582689070846
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MFAP3L,Microfibrillar-associated protein 3-like,24195,-0.000274070652352243,0.00457400716023479,-0.00923912468641242,0.00869098338170794,0.952220517527852
NMR metabolomics,X23508.Triglycerides in Medium VLDL,SHD,SH2 domain-containing adapter protein D,24059,0.000341433415243377,0.00592711689379817,-0.011275715696601,0.0119585825270878,0.954063497365623
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HDDC2,5'-deoxynucleotidase HDDC2,24805,-0.000158920992177162,0.0030251179718244,-0.00608815221695298,0.00577031023259866,0.958103774193034
NMR metabolomics,X23508.Triglycerides in Medium VLDL,DNAJA4,DnaJ homolog subfamily A member 4,24845,-0.000255869940293696,0.00487151810499839,-0.00980404542609054,0.00929230554550315,0.958111869232988
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BRD2,Bromodomain-containing protein 2,24101,-0.000125395073851976,0.00241192818523349,-0.00485277431690962,0.00460198416920567,0.958537446912999
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CLINT1,Clathrin interactor 1,24016,-0.000154595635344079,0.0033168510700445,-0.0066556237326313,0.00634643246194314,0.962825120762705
NMR metabolomics,X23508.Triglycerides in Medium VLDL,NRN1,Neuritin,24867,-8.77710387155166e-05,0.00248148340966841,-0.00495147852166559,0.00477593644423456,0.971784678469517
NMR metabolomics,X23508.Triglycerides in Medium VLDL,RGS8,Regulator of G-protein signaling 8,28931,0.000149579157043846,0.00452422134426478,-0.00871789467771513,0.00901705299180282,0.973625488366169
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TFAP2A,Transcription factor AP-2-alpha,24101,-0.000122039902103353,0.00417260144540128,-0.00830033873508986,0.00805625893088315,0.976667107376356
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ARID3A,AT-rich interactive domain-containing protein 3A,24101,8.14003136119078e-05,0.00279121187679893,-0.00538937496491399,0.00555217559213781,0.97673477438738
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TMED1,Transmembrane emp24 domain-containing protein 1,24445,9.24344211561245e-05,0.00375200711140278,-0.00726149951719332,0.00744636835950557,0.980345510899878
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TARM1,"T-cell-interacting, activating receptor on myeloid cells protein 1",24195,-0.000119411658542055,0.00540286894258308,-0.0107090347860049,0.0104702114689208,0.982367150067344
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CACNB1,Voltage-dependent L-type calcium channel subunit beta-1,24101,-8.96912746852844e-05,0.00413979765363836,-0.00820369467581647,0.00802431212644591,0.982714869628881
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TGOLN2,Trans-Golgi network integral membrane protein 2,24951,-3.65770860750362e-05,0.00180014353747484,-0.00356485841952572,0.00349170424737565,0.983789075171075
NMR metabolomics,X23508.Triglycerides in Medium VLDL,MAGEA3,Melanoma-associated antigen 3,24445,7.84735172629854e-05,0.00591296958369692,-0.011510946866783,0.0116678939013089,0.989411356130153
NMR metabolomics,X23508.Triglycerides in Medium VLDL,CASQ2,Calsequestrin-2,24111,4.4327836046518e-05,0.00339926731633259,-0.00661823610396535,0.00670689177605839,0.989595661845306
NMR metabolomics,X23508.Triglycerides in Medium VLDL,IL20RB,Interleukin-20 receptor subunit beta,24229,-3.30946116082841e-05,0.00293551009921914,-0.0057866944060778,0.00572050518286124,0.991005022374102
NMR metabolomics,X23508.Triglycerides in Medium VLDL,TPT1,Translationally-controlled tumor protein,28931,4.74432516407262e-05,0.0045311531877525,-0.00883361699635416,0.00892850349963562,0.991646007650745
NMR metabolomics,X23508.Triglycerides in Medium VLDL,HK2,Hexokinase-2,28916,1.39867855362433e-05,0.00190409876891859,-0.00371804680154419,0.00374602037261668,0.994139146811602
NMR metabolomics,X23508.Triglycerides in Medium VLDL,BMP10,Bone morphogenetic protein 10,24381,1.38864983662545e-05,0.00198086362798691,-0.00386860621248809,0.0038963792092206,0.994406672896055
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ZCCHC8,Zinc finger CCHC domain-containing protein 8,24111,2.18106107330701e-05,0.00413624354957773,-0.00808522674643928,0.00812884796790542,0.995792779567858
NMR metabolomics,X23508.Triglycerides in Medium VLDL,ADGRE5,Adhesion G protein-coupled receptor E5,29673,3.76270457677762e-06,0.00210992064162979,-0.00413168175301761,0.00413920716217117,0.998577113787041
